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3Abstract
Background: Maternal and neonatal mortality are high in Malawi, and cost-effective
and sustainable interventions are needed in order to reduce mortality rates and make
progress to achieve Millennium Development Goals 4 and 5 for mother and child
health. Where health systems are weak and many women deliver at home, community-
based interventions have the potential to make an important contribution to health
improvements.
Methods: A cluster-randomised study with a factorial design was used to evaluate the
impact of two community-based interventions on maternal and child health outcomes. A
prospective pregnancy and birth monitoring system was developed to collect
information on pre-specified pregnancy, birth and infant outcomes. The research
presented here focuses on the women’s group intervention, which uses participatory
methods to mobilise communities to take actions for maternal and child health problems
they identify.
Results: 18,562 pregnancies were followed up, resulting in 18,340 live births, 362
stillbirths, 434 neonatal deaths and 73 maternal deaths. 11,450 live births were
identified retrospectively, resulting in 484 infant deaths. Statistically significant
reductions in maternal and neonatal mortality as a result of the women’s group
intervention were not seen (adjusted odds ratio 0.94 (95% CI 0.56-1.61) and 0.95 (95%
CI 0.71-1.28) respectively). There were significant improvements in antenatal care and
immunisation, and reductions in births attended by traditional birth attendants, and there
were non-significant reductions in mortality and increases in health-care seeking.
Discussion:
Although women’s groups showed promising signs of community-level action for
mother and child health, methodological factors, such as low power and baseline
imbalance after randomisation, may have limited the ability of this study to detect an
impact of the intervention on mother and child health outcomes. Design and
implementation factors may also have caused delays and limited the measurable impact
of the intervention at this time. Follow-up over a longer period may show greater
impact.
4Table of contents
Abstract ......................................................................................................................................3
List of figures.............................................................................................................................8
List of tables............................................................................................................................ 10
Additional material ............................................................................................................... 11
List of abbreviations ............................................................................................................. 12
Chapter 1 : Introduction ..................................................................................................... 14
1.1 Aim and chapter outline ......................................................................................................14
1.2 Overview ...................................................................................................................................15
Chapter 2 : Review of the epidemiology of maternal and neonatal mortality ........ 17
2.1 Methodological considerations in measuring maternal and neonatal mortality
..............................................................................................................................................................17
2.1.1 Case definition and classification systems ................................................................ 20
2.1.2 Incomplete identification and underreporting ........................................................... 22
2.1.3 Misclassification of cause of death ........................................................................... 24
2.1.4 Large margins of uncertainty .................................................................................... 26
2.1.5 Varying sources of data............................................................................................. 27
2.1.6 Use of ‘selected’ populations .................................................................................... 28
2.1.7 Summary of methodological considerations ............................................................. 28
2.2 Epidemiology of maternal and neonatal mortality....................................................29
2.2.1 Frequency.................................................................................................................. 29
2.2.2 Temporal trends......................................................................................................... 37
2.2.3 Distribution................................................................................................................ 40
2.2.4 Aetiology of maternal death ...................................................................................... 45
2.2.5 Aetiology of neonatal death ...................................................................................... 58
Chapter 3 : Review of evidence for community-based approaches to reduce
maternal and neonatal mortality ....................................................................................... 66
3.1 Review of interventions to reduce maternal and neonatal mortality ................66
3.1.1 Antenatal interventions ............................................................................................. 70
3.1.2 Intrapartum interventions .......................................................................................... 74
3.1.3 Postnatal interventions .............................................................................................. 76
3.1.4 Summary of evidence and gaps in knowledge .......................................................... 78
3.2 Complex interventions for complex populations .......................................................81
3.2.1 Complex interventions .............................................................................................. 81
3.2.2 Complex populations................................................................................................. 86
3.3 Community-based interventions to reduce maternal and neonatal mortality89
3.3.1 The importance of community participation in health interventions ........................ 90
53.3.2 Model strategies for participatory, community-based interventions ......................... 93
3.4 Complex evaluations of complex interventions in complex populations – the
importance of effectiveness trials...........................................................................................99
3.5 Rationale for the MaiMwana trial ................................................................................. 101
Chapter 4 : Methods ...........................................................................................................105
4.1 Background to MaiMwana Project................................................................................ 105
4.2 Objectives............................................................................................................................... 106
4.2.1 Objectives of MaiMwana Project............................................................................ 106
4.2.2 Specific objectives of this PhD ............................................................................... 107
4.3 Study design .......................................................................................................................... 108
4.3.1 Primary research question ....................................................................................... 110
4.3.2 Hypothesis............................................................................................................... 110
4.3.3 Study endpoints and outcomes ................................................................................ 110
4.4 Methods .................................................................................................................................. 110
4.4.1 Setting ..................................................................................................................... 110
4.4.2 Target group and eligibility criteria......................................................................... 113
4.4.3 Intervention activities .............................................................................................. 114
4.4.4 Sample size.............................................................................................................. 117
4.4.5 Background and orientation .................................................................................... 120
4.4.6 Phase I – Formative research, mapping and enumeration of study clusters and
random allocation to interventions ................................................................................... 124
4.4.7 Phase II – Prospective surveillance ......................................................................... 129
4.4.8 – Phase III – Re-census ........................................................................................... 133
4.4.9 Data management, quality control and trial monitoring.......................................... 133
4.4.10 Statistical analysis ................................................................................................. 137
4.4.11 Ethical issues ......................................................................................................... 142
4.4.12 Role of the investigator ......................................................................................... 144
Chapter 5 : Results..............................................................................................................145
5.1 Participation in baseline census and prospective data collection .................... 145
5.1.1 Baseline census and prospective enumeration ........................................................ 145
5.1.2 Prospective trial enrolment...................................................................................... 145
5.2 Characteristics of the study population and participants.................................... 148
5.2.1 Socioeconomic and demographic characteristics of the whole study population ... 148
5.2.2 Principal Components Analysis for socioeconomic status...................................... 150
5.2.3 Socioeconomic and demographic characteristics of pregnant women during
prospective baseline ......................................................................................................... 154
5.2.4 Primary (mortality) outcomes for mothers and infants during prospective baseline156
5.2.5 Secondary (behavioural and process) outcomes for mothers and infants during
prospective baseline ......................................................................................................... 157
65.2.6 Main cause and time of death.................................................................................. 158
5.2.7 Socioeconomic and demographic characteristics related to primary and secondary
outcomes .......................................................................................................................... 162
5.2.8 Exposure to the intervention.................................................................................... 170
5.2.9 Socioeconomic and demographic characteristics related to exposure to the
intervention ...................................................................................................................... 171
5.3 Intervention impact ........................................................................................................... 174
5.3.1 Impact on primary (mortality) outcomes................................................................. 174
5.3.2 Impact on secondary (behavioural and process) outcomes ..................................... 179
5.3.3 Variation in exposures and outcomes between clusters by study arm .................... 182
5.4 Sub-group analysis and effect modification .............................................................. 184
5.4.1 Impact according to intervention group .................................................................. 184
5.4.2 Impact according to level of exposure .................................................................... 189
5.4.3 Impact according to socioeconomic status .............................................................. 193
Chapter 6 : Discussion – impact of the women’s group intervention .....................197
6.1 Key findings........................................................................................................................... 197
6.1.1 Summary of findings............................................................................................... 197
6.1.2 Mortality.................................................................................................................. 198
6.1.3 Behaviour ................................................................................................................ 199
6.1.4 Sub-group analysis .................................................................................................. 200
6.2 Did the study address the research hypothesis? ..................................................... 204
6.3 Strengths and limitations of the study design and methods ............................... 205
6.3.1 Strengths.................................................................................................................. 205
6.3.2 Limitations .............................................................................................................. 206
6.4 Limitations of the intervention...................................................................................... 224
6.4.1 Intervention design.................................................................................................. 224
6.4.2 Intervention implementation ................................................................................... 229
6.5 Alternative explanations for the results..................................................................... 237
6.5.1 Chance..................................................................................................................... 237
6.5.2 Bias.......................................................................................................................... 238
6.5.3 Confounding............................................................................................................ 239
6.6 Evidence for a causal association between intervention and outcome........... 241
6.6.1 Consistency ............................................................................................................. 241
6.6.2 Temporality ............................................................................................................. 242
6.6.3 Biological gradient .................................................................................................. 244
6.6.4 Plausible mechanism............................................................................................... 244
6.6.5 Experimental evidence ............................................................................................ 245
6.6.6 Analogy ................................................................................................................... 245
Chapter 7 : Conclusion ......................................................................................................246
77.1 Summary and interpretation of the main findings ................................................. 246
7.2 Recommendations for further research ..................................................................... 253
7.2.1 Further analysis of existing data.............................................................................. 253
7.2.2 Further data collection and processing from this study population......................... 258
7.2.3 Further studies ......................................................................................................... 260
7.3 Implications for policy-makers...................................................................................... 260
7.4 Concluding remarks ........................................................................................................... 262
References .............................................................................................................................263
Appendices ............................................................................................................................289
Appendix 1 – Glossary of terms and definitions of outcomes .................................... 289
1.1 Primary outcomes....................................................................................................... 289
1.2 Secondary outcomes................................................................................................... 291
1.3 Mortality rates and ratios............................................................................................ 292
Appendix 2 – Time-line of activities and achievements to date ................................ 294
Appendix 3 – Details of the infant feeding and care counselling intervention .... 300
Appendix 4 – Example data collection forms ................................................................... 302
Appendix 5 – Letter of ethical approval from Malawi National Health Sciences
Research Committee ................................................................................................................. 333
Appendix 6 – Intra-cluster correlation coefficients and intercluster coefficients of
variation ........................................................................................................................................ 334
Appendix 7 – Interaction plots for primary mortality outcomes.............................. 335
8List of figures
FIGURE 2.1: TREND IN THE NUMBER OF MATERNAL DEATHS GLOBALLY, FROM 1980 TO 2008....................37
FIGURE 2.2: TRENDS IN UNDER-FIVE AND NEONATAL MORTALITY RATES GLOBALLY, FROM 1965 TO 201539
FIGURE 2.3: THE THREE DELAYS MODEL (ADAPTED FROM THADDEUS AND MAINE, 1994 (17)) .................57
FIGURE 3.1: SCHEMATIC REPRESENTATION OF A STRATEGY AIMED AT MATERNAL AND NEONATAL HEALTH
OUTCOMES (ADAPTED FROM CAMPBELL, 2006 (106)) .......................................................................83
FIGURE 4.1: STUDY DESIGN – SHOWING TWO-BY-TWO FACTORIAL DESIGN AND ZONE ALLOCATION ........108
FIGURE 4.2: MAP OF MALAWI SHOWING MCHINJI DISTRICT .....................................................................112
FIGURE 4.3: GEO-POLITICAL ORGANISATION OF MCHINJI DISTRICT .........................................................112
FIGURE 4.4: WOMEN’S GROUP COMMUNITY MOBILISATION ACTION CYCLE..............................................116
FIGURE 4.5: MAP OF MCHINJI DISTRICT SHOWING ENUMERATION AREAS AND DEMARCATION OF 48 STUDY
CLUSTERS ........................................................................................................................................123
FIGURE 4.6: STUDY VILLAGES AND BUFFER AREAS IN THREE CLUSTERS NEAR MCHINJI BOMA.................124
FIGURE 4.7: A DETAIL FROM A VILLAGE MAP DRAWN DURING THE BASELINE CENSUS..............................126
FIGURE 4.8: RANDOM ALLOCATION OF ZONES TO FOUR DIFFERENT COMBINATIONS OF INTERVENTION ....128
FIGURE 5.1: TRIAL PROFILE (CONSORT DIAGRAM).................................................................................147
FIGURE 5.2: FREQUENCY DISTRIBUTION OF HOUSEHOLD SOCIOECONOMIC SCORES ..................................152
FIGURE 5.3: BOX-PLOTS SHOWING DISTRIBUTION OF CLUSTER-LEVEL MEAN AND MEDIAN SOCIOECONOMIC
SCORES ............................................................................................................................................153
FIGURE 5.4: CAUSES OF NEONATAL DEATH FROM 98 NEONATAL DEATHS IN MCHINJI, MALAWI ..............160
FIGURE 5.5: CAUSES OF NEONATAL DEATH FOR AFRICA FROM WHO ESTIMATES FOR 2000-2003 (53) ....160
FIGURE 5.6: DAY OF DEATH FOR 640 NEONATAL DEATHS .........................................................................161
FIGURE 5.7: DAY OF DEATH FOR 82 MATERNAL DEATHS...........................................................................161
FIGURE 5.8: PROPORTION OF BIRTHS RESULTING IN INFANT, MATERNAL, NEONATAL AND PERINATAL DEATH
BY MATERNAL AGE ..........................................................................................................................163
FIGURE 5.9: PROPORTION OF MOTHERS RECEIVING ANTENATAL CARE, SKILLED BIRTH ATTENDANCE AND
POSTNATAL CARE BY MATERNAL AGE .............................................................................................164
FIGURE 5.10: INFANT, MATERNAL, NEONATAL AND PERINATAL MORTALITY RATES BY CLUSTER-LEVEL
SOCIOECONOMIC SCORE...................................................................................................................165
FIGURE 5.11: PERCENTAGE OF MOTHERS RECEIVING ANTENATAL CARE, SKILLED BIRTH ATTENDANCE AND
POSTNATAL CARE BY CLUSTER-LEVEL SOCIOECONOMIC SCORE ......................................................167
FIGURE 5.12: DISTRIBUTION OF THE NUMBER OF WOMEN’S GROUP MEETINGS ATTENDED BY THOSE WHO
HAD EVER ATTENDED AT LEAST ONCE .............................................................................................170
FIGURE 5.13: DISTRIBUTION OF PERCENTAGE COVERAGE OF WOMEN’S GROUPS IN INTERVENTION ZONES171
FIGURE 5.14: PROPORTION OF WOMEN WHO EVER ATTENDED A WOMEN’S GROUP BY AGE, INTERVENTION,
SOCIOECONOMIC AND TRIBAL GROUPS ............................................................................................173
FIGURE 5.15: TRENDS IN INFANT, MATERNAL, NEONATAL AND PERINATAL MORTALITY FROM BASELINE TO
STUDY YEAR 3 .................................................................................................................................175
9FIGURE 5.16: DISTRIBUTION OF MORTALITY AND PROCESS OUTCOMES BY INTERVENTION ALLOCATION..182
FIGURE 5.17: TRENDS IN UNADJUSTED INFANT, MATERNAL, NEONATAL AND PERINATAL MORTALITY FROM
BASELINE TO STUDY YEAR 3 BY INTERVENTION GROUP ...................................................................189
FIGURE 6.1: IMPLEMENTATION OF MEETINGS 2 TO 12 (M2 TO M12) AND THE START OF THE
IMPLEMENTATION PHASE (IMP) – SHOWING AVERAGE AND RANGE OF TIMES, AND TIMING OF
STRATEGIES .....................................................................................................................................232
10
List of tables
TABLE 2.1: ADVANTAGES AND DISADVANTAGES OF DIFFERENT TYPES OF STUDY FOR ESTIMATING
MORTALITY RATES ............................................................................................................................19
TABLE 2.2: POPULATION-BASED STUDIES ESTIMATING MATERNAL MORTALITY IN MALAWI (1981-2006) .33
TABLE 2.3: POPULATION-BASED STUDIES ESTIMATING PERINATAL MORTALITY IN MALAWI (1996-2004) .34
TABLE 2.4: POPULATION-BASED STUDIES ESTIMATING NEONATAL MORTALITY IN MALAWI (1992-2006)..35
TABLE 2.5: POPULATION-BASED STUDIES ESTIMATING INFANT MORTALITY IN MALAWI (1977-2010) .......36
TABLE 2.6: GLOBAL GEOGRAPHIC DISTRIBUTION OF MATERNAL AND NEONATAL MORTALITY ...................41
TABLE 2.7: GEOGRAPHIC AND SOCIOECONOMIC DISTRIBUTION OF SELECTED DHS HEALTH INDICATORS IN
MALAWI ............................................................................................................................................43
TABLE 2.8: GEOGRAPHIC AND SOCIOECONOMIC DISTRIBUTION OF SELECTED MICS HEALTH INDICATORS IN
MALAWI ............................................................................................................................................43
TABLE 2.9: DISTRIBUTION OF CAUSES OF MATERNAL DEATHS FROM MALAWIAN AND REGIONAL STUDIES 47
TABLE 3.1: SUMMARY OF EVIDENCE FROM META-ANALYSES AND REVIEWS OF THE IMPACT OF KEY
INTERVENTIONS ON MATERNAL AND NEONATAL OUTCOMES .............................................................68
TABLE 3.2: SUMMARY OF ANTEPARTUM, INTRAPARTUM AND POSTNATAL INTERVENTIONS RECOMMENDED
FOR INCLUSION IN PROGRAMMES.......................................................................................................79
TABLE 3.3: DESIGN OF STUDIES USING COMMUNITY-BASED WOMEN’S GROUPS TO CHANGE BEHAVIOUR AND
MOBILISE COMMUNITIES TO REDUCE NEONATAL MORTALITY............................................................98
TABLE 3.4: RESULTS FROM STUDIES USING COMMUNITY-BASED WOMEN’S GROUPS TO CHANGE BEHAVIOUR
AND MOBILISE COMMUNITIES TO REDUCE NEONATAL MORTALITY ....................................................98
TABLE 4.1: STUDY OUTCOMES ..................................................................................................................107
TABLE 4.2: SOCIOECONOMIC AND HEALTH INDICATORS IN MCHINJI AND MALAWI ..................................113
TABLE 4.3: SUMMARY OF ACTIVITIES IN WOMEN’S GROUP AND INFANT FEEDING AND CARE COUNSELLING
INTERVENTIONS ...............................................................................................................................114
TABLE 4.4: PARAMETERS USED TO ESTIMATE SAMPLE SIZE, AND THE ESTIMATED EFFECT SIZES THAT
WOULD BE DETECTABLE ..................................................................................................................119
TABLE 4.5: STUDY PROCEDURES AND TIME-LINE ......................................................................................131
TABLE 4.6: SURVEILLANCE TOOLS AND CONTENT ....................................................................................132
TABLE 4.7: HEALTH CARE SEEKING AND HEALTH BEHAVIOUR DATA COLLECTION TOOLS AND CONTENT .132
TABLE 4.8: DATASETS USED FOR ANALYSES PRESENTED IN THIS THESIS...................................................139
TABLE 5.1: COMPOSITION OF BASELINE AND PROSPECTIVELY ENUMERATED POPULATION SAMPLE..........145
TABLE 5.2: BASIC INFORMATION ABOUT HOUSEHOLDS IN THE STUDY AREAS ...........................................149
TABLE 5.3: BASIC INFORMATION ABOUT WOMEN LIVING IN THE STUDY AREAS ........................................150
TABLE 5.4: COMPARISON OF SOCIOECONOMIC AND DEMOGRAPHIC CHARACTERISTICS BY INTERVENTION
ALLOCATION FOR WOMEN WHO BECAME PREGNANT DURING THE PROSPECTIVE BASELINE PHASE ..155
TABLE 5.5: PROSPECTIVE BASELINE MORTALITY RATES BY INTERVENTION ALLOCATION.........................156
TABLE 5.6: PROSPECTIVE BASELINE SECONDARY OUTCOMES BY INTERVENTION ALLOCATION ................157
11
TABLE 5.7: CAUSES OF NEONATAL DEATH AND STILLBIRTH .....................................................................159
TABLE 5.8: PRIMARY MORTALITY OUTCOMES AND SELECTED SECONDARY OUTCOMES BY AGE GROUP AND
EDUCATIONAL LEVEL ......................................................................................................................168
TABLE 5.9: PRIMARY MORTALITY OUTCOMES AND SELECTED SECONDARY OUTCOMES BY MARITAL STATUS
AND SOCIOECONOMIC QUINTILE ......................................................................................................169
TABLE 5.10: EXPOSURE TO WOMEN’S GROUP INTERVENTION BY SUB-GROUP ...........................................172
TABLE 5.11: BIRTHS, DEATHS AND MORTALITY RATES IN INTERVENTION AND CONTROL CLUSTERS AT
BASELINE AND DURING TRIAL..........................................................................................................176
TABLE 5.12: WOMEN’S GROUP IMPACT ON MORTALITY RATES .................................................................177
TABLE 5.13: WOMEN’S GROUP IMPACT ON PROCESS INDICATORS AND SECONDARY OUTCOMES...............181
TABLE 5.14: INTRACLUSTER CORRELATION COEFFICIENTS AND INTERCLUSTER COEFFICIENTS OF VARIATION
FOR PRIMARY AND KEY SECONDARY OUTCOMES .............................................................................183
TABLE 5.15: COMPARISON OF PRIMARY AND SECONDARY OUTCOMES BY FOUR INTERVENTION GROUPS..187
TABLE 5.16: COMPARISON OF PRIMARY AND SECONDARY OUTCOMES BY EXPOSURE LEVEL ....................191
TABLE 5.17: EFFECTS OF INTERACTION BETWEEN WOMEN’S GROUP INTERVENTION AND SOCIOECONOMIC
QUINTILE ON PRIMARY AND SECONDARY OUTCOMES ......................................................................195
TABLE 7.1: FACTORS THAT LIMITED THE EFFECTIVENESS AND IMPACT OF THE INTERVENTION IN THIS STUDY
........................................................................................................................................................248
TABLE 7.2: FACTORS AFFECTING ABILITY TO SEE SIGNIFICANT EFFECTS ..................................................249
Additional material
A CD-ROM containing ‘Umodzi’ (Together) – a film about MaiMwana women’s
groups – has been attached in the back cover.
12
List of abbreviations
AIDS Acquired Immune Deficiency Syndrome
ANC Antenatal Care
ARV Antiretroviral therapy
DC District Commissioner
CHW Community health worker
DHS Demographic and Health Survey
EA Enumeration Area
EBF Exclusive Breastfeeding
ENC Essential Newborn Care
FI Field Interviewer
GVH Group Village Headman
HIV Human Immunodeficiency Virus
HMIS Health Management Information System (Malawi)
HSA Health Surveillance Assistant
IMCI Integrated Management of Childhood Illness
IMPAC Integrated Management of Pregnancy and Childbirth
IMR Infant Mortality Rate
IPT Intermittent Presumptive Treatment (of malaria)
ITN Insecticide Treated Net
LBW Low birth weight
LTR Lifetime risk (of maternal death)
MCH Mother and Child Health
MDG Millennium Development Goal
MEO Monitoring and Evaluation Officer
MTCT Mother-to-Child Transmission of HIV
MMR Maternal Mortality Ratio
NGO Non-Governmental Organisation
NSO National Statistics Office
NMR Neonatal Mortality Rate
NVP Nevirapine
PMR Perinatal Mortality Rate
13
PMTCT Prevention of Mother-to-Child Transmission (of HIV)
PNC Postnatal care
RCT Randomised Controlled Trial
SBA Skilled birth attendance
SES Socioeconomic status
SMP Safer Motherhood Programme
SNL Saving Newborn Lives
SP Sulphadine-Pyrimethamine (used for malaria prophylaxis in pregnancy)
TA Traditional Authority
TB Tuberculosis
TBA Traditional Birth Attendant
TTV Tetanus toxoid vaccination
UN United Nations
UNICEF United Nations Children’s Fund
VCT Voluntary Counselling and Testing
VDC Village Development Committee
VH Village Headman
VMC Volunteer MaiMwana Counsellor
WCBA Woman of childbearing age
WE Woman Enumerator
WG Women’s group
WHO World Health Organisation
ZF Zonal Facilitator
14
Chapter 1 : Introduction
1.1 Aim and chapter outline
The aim of this thesis is to evaluate the impact of a participatory, community-based
women’s group intervention in rural Malawi on neonatal and maternal mortality rates
and other health outcomes. This intervention was implemented as part of a cluster
randomised controlled trial, and available data will be used to evaluate the effectiveness
of women’s groups as a low-cost strategy for improving mother and child survival.
Chapter one will provide an outline of the thesis and an overview of the rationale for the
research, setting the study in the context of international literature on safe motherhood
and child survival. Chapter two will explore the background and setting for the study in
more depth in order to provide context, and will review the quality and availability of
existing literature on the epidemiology of maternal and neonatal mortality, with a focus
on sub-Saharan Africa and Malawi. Chapter three will critically examine the literature
on interventions to reduce maternal and neonatal mortality and discuss their potential as
public health interventions in developing countries. Consideration will also be given to
approaches for evaluating complex public health interventions. Chapter four will outline
the methodology used to conduct this study and describe the processes undertaken in
study design, implementation and analysis. Chapter five will present the results in terms
of the characteristics of the study population, descriptive baseline data, main impact of
the intervention on pre-specified outcomes, and sub-group analysis exploring variations
in impact among different groups. Chapter six will discuss the findings in the context of
current knowledge and make interpretations as to the broader meaning of these results.
There will be discussion of the influence of methodological factors on the observed
outcomes. Strengths and weaknesses of the study design, data collection, statistical
analysis and intervention implementation will be highlighted, and alternative
explanations for the findings will be explored. Chapter seven will summarise the main
conclusions from the research and suggest ways that the findings could be carried
forward with further research and policy recommendations.
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1.2 Overview
Maternal and child mortality in Malawi are high. The most recent Demographic and
Health Survey (DHS) estimates a national maternal mortality ratio of 984 per 100,000
live births (1), which represents a lifetime risk of maternal death during a woman’s
reproductive years of approximately one in 15. This is slightly lower than the previous
survey (1,120 per 100,000) (2), but considerably higher than the figure reported in the
first survey in 1992 (620 per 100,000) (3). Neonatal mortality is also high, though
consecutive DHS survey estimates have shown a decrease, from 41 and 42 per 1,000
live births in the 1992 and 2000 surveys to 27 in 2004. Larger reductions in both will
need to be made in order to achieve the Millennium Development Goals for maternal
and child mortality (4). Neonatal mortality accounts for over one third of infant deaths
(infant mortality rate 76 per 1000 live births), and although this is a smaller proportion
than in Southeast Asian settings (5), it is still substantial. Efforts to reduce child
mortality will have limited success if they do not target this high-risk neonatal period.
Studies differ in the exact proportions reported, but the most significant causes of
maternal death in Malawi are postpartum haemorrhage, infections (including HIV) and
complications of obstructed labour and abortion (6-8). The major causes of neonatal
death in Malawi have not been reported, but the main causes of neonatal death
estimated for sub-Saharan Africa (accounting for 88% of newborn deaths), are
infections, preterm birth and intrapartum-related causes such as asphyxia (9).
Maternal and neonatal mortality and morbidity in Malawi are exacerbated by the high
burden of human immunodeficiency virus (HIV) and malaria, and both have major
direct and indirect effects on women and infants’ health during and after pregnancy. An
estimated 13.3% of women of childbearing age are infected with HIV (1), and routine
health facility data reported 2,096,425 new cases of malaria infection among children
under five years old in the year ending June 2007, (which represents an average of one
case per child under five-years, or 94% of the under-five population), and 3,948 malaria
deaths (10). The exact contribution of HIV and malaria is difficult to measure due to
lack of widespread diagnostic testing (11), but some studies have suggested that both
contribute significantly to the burden of maternal and neonatal illness and death in sub-
Saharan Africa (9, 12-16).
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Determinants of maternal and neonatal death may be socio-environmental, behavioural
or related to quality of health care (17, 18). Safe motherhood and neonatal health
programmes have typically focused on improving quality of obstetric services and
increasing access to skilled care at delivery. However, almost half (45.6%) of women in
rural areas of Malawi give birth at home in the community, with a traditional birth
attendant or relative (1). In this context, focusing only on improvements in clinical
quality of care may have limited immediate benefit. Community-level interventions are
also needed to create awareness and demand for better services, and to tackle
emergency situations when labour starts and becomes complicated a long distance away
from a health facility. Vital signs of sick infants may deteriorate very rapidly, and
delays in health-care seeking can be fatal. In addition, community-level interventions
can be an effective way to promote preventative health behaviours, such as those related
to hygiene, nutrition and malaria prevention (19-22).
In the context of limited access to good quality maternity, postnatal and child health
services, interventions involving community mobilisation and participation have shown
large reductions in both maternal and neonatal mortality in Asian and South American
settings (23-25). The potential of such interventions in an African setting, where HIV
and malaria are much more prevalent, has not been evaluated.
This PhD dissertation will evaluate the impact on mortality rates of a participatory
community intervention using women’s groups to mobilise communities to change
mother and child care and health-seeking behaviours, and to take actions to improve
their health. Furthermore, this thesis will explore the factors that predict coverage and
uptake of the trial intervention, and will explore contextual influences on health and on
the ability of the intervention to achieve a measurable effect.
17
Chapter 2 : Review of the epidemiology of maternal and
neonatal mortality
Maternal and infant mortality are high in Malawi, and though there have been
reductions in recent years, insufficient progress has been made so far to achieve the
Millennium Development Goals (MDG) set out for maternal and child health (4).
Neonatal mortality makes up a large part of child mortality (one out of every five deaths
in children under five in Malawi (1)), and the MDG for child health will be difficult to
achieve without focusing on this component.
The women’s group intervention described in this study focused on improving maternal
and newborn health, as well as looking at the wider effects on perinatal and infant
outcomes. Implicit in our ability to evaluate the impact of this and other population-
level interventions for mother and child health is the need to understand the
epidemiology of maternal and neonatal mortality and to be able to make accurate
measurements of mortality outcomes. Therefore detailed discussion is given to current
levels and trends of mortality rates, focusing on sub-Saharan Africa and Malawi, as well
as methods available for their estimation and the accuracy of such methods. This
background will highlight the importance and policy-relevance of this study, and will
also allow assessment of the validity and generalisability of the findings.
2.1 Methodological considerations in measuring maternal and neonatal
mortality
Accurate data on mortality rates are important for monitoring progress towards
Millennium Development Goals for health, and for evaluating the effectiveness of
national and international strategies, programmes and policy-changes (26). In this study,
reliable estimates of mortality were important for the design and sample size
calculations, as well as to provide a reference against which to compare the findings.
Maternal mortality is notoriously difficult to measure. Underreporting of deaths or
misclassification of reported deaths as non-maternal are common problems, especially
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in countries with weak or non-existent vital registration systems. Neonatal mortality is
also difficult to measure and often goes unreported. Misclassification may happen
particularly in relation to the time of death, with early neonatal deaths being mis-
reported as stillbirths or later neonatal deaths as post-neonatal.
There are substantial limitations in the availability and quality of information about
maternal and neonatal health outcomes, especially in developing countries. In trying to
understand the epidemiology of maternal and neonatal mortality in Malawi and to be
able to estimate the impact of maternal and neonatal health interventions, it is important
to understand the methodological difficulties involved in making mortality estimates.
Baseline measures of mortality are also important for designing studies to evaluate the
effectiveness of new interventions, and for the research presented in this thesis,
consideration of the advantages and disadvantages of different methods of data
collection was a necessary prerequisite.
Some of the difficulties in measuring mortality encountered include varying definitions
and classification systems, incomplete identification and underreporting,
misclassification of cause of death, large margins of uncertainty, varying sources of
data, and use of ‘selected’ populations. This section will provide a basis for reviewing
the literature on the epidemiology of maternal and neonatal mortality in Malawi
discussed in section 2.2, and also for considering the quality of evidence for the
effectiveness of interventions described in Chapter 3. Table 2.1 summarises the
advantages and disadvantages of different types of study and forms of data collection
for estimating maternal and neonatal mortality rates.
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Table 2.1: Advantages and disadvantages of different types of study for estimating mortality rates
Type of study Advantages Disadvantages
Hospital-based studies - Cheap, quick and easy - Biased sample who use health facilities
Vital registration - Provides ongoing data over long time period
- Can monitor changes over time
- Biased sample who use health facilities
- Still prone to misclassification of cause of death and underreporting
Population census - Eliminates sampling error
- Allows detailed breakdown of results by geographic
and socioeconomic strata and over time
- Retrospective estimates for 1-2 years before the survey
- Expensive
- Infrequent, so can’t be used for monitoring
- Retrospective data prone to recall biases
Cross-sectional survey
(e.g. using sisterhood methods)
- Relatively cheap, quick and easy - Identifies pregnancy-related deaths not maternal deaths
- Retrospective data prone to recall biases
- Retrospective estimates for period some years before the survey
- Require large sample sizes to achieve precise estimates
- Difficult to monitor changes over time
Longitudinal (prospective) survey
(e.g. demographic surveillance
system)
- Prospective data less prone to recall biases
- Prospective data provides current estimates
- Expensive and time-consuming
- Losses to follow-up can introduce selection bias
- May fail to identify maternal deaths due to indirect causes (e.g. malaria, HIV)
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2.1.1 Case definition and classification systems
Although clear case definitions exist for both maternal and neonatal mortality (see
Appendix 1 for a list of definitions), there are several slightly different, overlapping
definitions that are used, and many studies do not report the definition used at all (27).
This can lead to confusion in interpreting findings and in making comparisons between
studies using different definitions. Comparisons between regions with different disease
profiles and political situations may also be difficult to interpret.
Maternal mortality
According to the International Statistical Classification of Diseases (ICD-10)
established by the World Health Organisation (WHO) as a general international
standard diagnostic classification, a maternal death is defined as “the death of a woman
while pregnant or within 42 days of termination of pregnancy, irrespective of the
duration and site of the pregnancy, from any causes related to or aggravated by the
pregnancy or its management but not from accidental or incidental causes.” (28).
However, the choice of 42 days as the cut-off point for maternal deaths was not based
on a study of the timing of deaths in relation to pregnancy and delivery. In recognition
of the fact that the 42-day limit is somewhat arbitrary and that both improvements in
health care and malaria, anaemia and AIDS-related illnesses may result in later deaths
that are still related to or aggravated by pregnancy, a ‘late maternal death’ category was
also introduced (28). This includes deaths due to obstetric causes up to one year after
termination of pregnancy. In addition, where it is difficult to ascertain cause of death, a
category of ‘pregnancy-related death’ was introduced based more on the timing of death
in relation to pregnancy than on the medical cause, and may include some non-obstetric
deaths. Appendix 1 provides a list of definitions.
Although clear definitions exist, they are not always uniformly applied. In a WHO
systematic review of maternal mortality, 2204 articles were reviewed and it was found
that half of them did not report the definition used for maternal death and two-thirds did
not use any method to confirm the death as maternal (27).
Whichever definition is used, the number of maternal deaths is then used to calculate
indicators that are used internationally to monitor maternal mortality. The most
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commonly used is the maternal mortality ratio (MMR), also referred to as ‘obstetric
risk’ because it describes the risk of dying once pregnant. It is usually calculated as the
number of maternal deaths per 100,000 live births.
The 42-day (6-week) maternal mortality definition is the most widely used to estimate
MMR, and was used in the early rounds of Demographic and Health Surveys (DHS)
(29). Recent DHS surveys (starting from the late 1980s) have used slightly different
methods to estimate maternal mortality, and use a two-month rather than a 42-day cut-
off for maternal death. This discrepancy is assumed to have little effect, with most
maternal deaths happening during or soon after delivery (30). However, this may not be
the case where the background adult female mortality rate is high, and the proportion of
deaths due to non-maternal causes included is large (31). DHS surveys collect no data
on cause of death, so include all pregnancy-related deaths rather than only true maternal
deaths (32). Again, this is assumed to have little effect, but would have the largest effect
where background adult female mortality rates are high, for example with high HIV
prevalence or conflict (31).
Neonatal mortality
A neonatal death is defined as the death of a live-born baby within 28 completed days of
birth (Appendix 1). A neonatal death is therefore defined solely by its timing in relation
to birth rather than a specific clinical cause. It is sometimes difficult to determine
whether a baby died during birth or immediately after, especially where the baby is very
premature, asphyxiated or neurologically depressed. Misclassification of very early
neonatal deaths as stillbirths could lead to underestimates of neonatal mortality (33). To
avoid the problem of differentiating between stillbirths and live births, in the late 1940s
stillbirths and early neonatal deaths (deaths within the first 7 days) were combined to
form the category of perinatal deaths (34). Where most stillbirths and early neonatal
deaths are due to asphyxia, this makes aetiological sense, though is less important where
other causes are more prominent.
Aside from the difficulties of differentiating between live births and stillbirths, the case
definition is relatively universally applied, though some studies have used a 42-day (six-
week) cut-off rather than a 28-day (four-week) cut-off and others have preferred to
confine outcomes to the perinatal period, which can make comparisons between studies
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difficult. DHS surveys report both neonatal and perinatal mortality rates, but define
neonatal mortality as “the probability of dying within the first month of life”, so include
deaths on the 29th, 30th and 31st days of life, thus slightly lengthening the period
compared to the standard definition (29).
2.1.2 Incomplete identification and underreporting
In many countries, births and deaths are routinely registered providing reasonably
accurate population and mortality estimates. However, most of the countries with the
highest reported maternal and neonatal mortalities (5, 35-37) do not have vital
registration systems to record events such as births and deaths. Attempts have been
made in Malawi to launch national village health register and birth registration systems,
but so far, coverage is patchy and data is unreliable (38). In the absence of vital
registration systems most developing countries rely mainly on routinely collected health
facility data or on surveys, like the retrospective DHS household surveys conducted by
the international company ICF Macro, for making national mortality estimates. Health
facility data is often poorly kept and provides a biased view as it only represents the
proportion of the population with access to health services. Demographic and Health
Surveys use cluster sampling to produce nationally representative estimates, and are
widely used in international reports making comparisons between countries (5, 37).
However, there are several methodological weaknesses of Demographic and Health
Surveys discussed below.
Maternal mortality estimates from DHS surveys
DHS surveys collect retrospective information about events some time after they have
happened. Maternal mortality is usually estimated using the sisterhood method, which
involves asking all women of childbearing age about their live born sisters, and
collecting details of any sisters who died during or soon after pregnancy (30, 39). There
is possibility for bias in the fact that only surviving siblings are interviewed, so where a
deceased woman has no surviving sisters of childbearing age deaths of her other
siblings (including maternal deaths) will not be counted. This can be particularly
problematic where fertility rates are low. According to Stanton and colleagues, who
compared DHS survey data on maternal mortality from 13 countries, sisterhood data is
more likely to underestimate than overestimate maternal mortality (40). Adult female
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mortality rates estimated using the same methods were consistently lower than mortality
rates estimated using model life tables or census. However, DHS methods include all
pregnancy-related deaths, and may overestimate maternal mortality where a high
proportion of non-maternal deaths occur amongst women of reproductive age (31).
Discussion in the 2000 Malawi DHS suggests that over- or underestimation of maternal
mortality may result from over- or underestimating all-cause adult female mortality due
to misclassification of maternal deaths as non-maternal or vice versa; inclusion of all
pregnancy-related rather than specifically maternal deaths; or omission of female deaths
leading to underestimation of adult female mortality (2).
Childhood mortality estimates from DHS surveys
In retrospective surveys, underreporting of the births of deceased children and their
subsequent deaths is also a concern, especially for deaths of children in the neonatal
period and early infancy. Data from the 2004 Malawi DHS survey suggest that there
may have been more underreporting of neonatal deaths compared to previous years (1).
For example, the number of neonatal deaths as a proportion of infant deaths was lower
in the immediate years preceding the survey compared to previous years – 39% in years
0-4 compared to 43% and 42% for the 5-9 and 10-14 years preceding the survey
respectively. This is particularly strange given that where infant mortality is falling
neonatal deaths tend to make up a larger proportion of the total rather than a smaller one
(41). Because of these particular methodological concerns in the 2004 Malawi DHS,
mortality rates and trends must be interpreted with caution.
Underreporting of infant deaths is usually greater for deaths that occur in very early
infancy (42). In some cultures a pregnancy loss or very early death within the first few
hours or days may not be reported at all. Completeness and accuracy of recall,
especially of ages and dates, may deteriorate with time. In DHS surveys that ask about
outcomes of pregnancies in the previous five years it may be difficult to adhere to
WHO/ICD-10 definitions because gestational age is usually not known, menstrual
periods can be irregular and women don’t always have records to rely on (42).
Other possible biases in neonatal and child mortality estimates arise because only
surviving mothers are interviewed about the birth history. If mothers that died have
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systematically different birth histories, this will not be captured. Where adult female
mortality is high this bias would be at its highest. It has been shown that children of
women who die have a greater risk of dying themselves (14, 43), in which case
mortality rates from retrospective surveys would underestimate the size of the problem.
In the same way, women older than 49 are not interviewed in this survey, so their birth
histories are not included. This presents more of a problem for estimating mortality rates
10 years prior to the survey (42).
Prospective data collection and surveys
Studies and surveys using prospective data collection tend to avoid many of the recall
biases and problems of underreporting encountered in retrospective surveys, as they
collect information about events as they arise. But they are usually costly and time-
consuming to conduct as they require following up large populations over long periods
of time. Following up participants who move out of the study area is also costly, and
becomes a problem where there are high levels of in- out- and internal-migration, which
is especially the case in urban areas (44, 45). Systematic differences between those lost
to follow-up and not lost to follow-up can result in selection biases.
2.1.3 Misclassification of cause of death
Classification of maternal and neonatal deaths requires accurate medical histories for
events leading to the death, including stage of pregnancy and dates of birth and death.
Recall of such details can be difficult, especially in populations with little
documentation on times and dates of events coupled with low literacy levels.
Maternal deaths
For maternal events, physician diagnosis is required for true classification of a death due
to maternal causes, as well as an accurate history about the timing of events. Where
deliveries commonly occur in the absence of a skilled health worker a reliable diagnosis
may be difficult to get. Even in countries that have well-established vital registration
systems it is still possible to find MMR underestimated, with misreporting of up to 70%
of maternal deaths (46). This is especially the case where deaths in early pregnancy or
several weeks after birth account for a large proportion of maternal deaths and where
pregnancy status at the time of death is not known. Some vital registration systems
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don’t include classification of cause of death, and as such maternal mortality estimates
in these countries are usually made using statistical models (37, 46).
Neonatal deaths
Classification of neonatal death does not require clinical diagnosis, but depends on clear
reporting of time of death in relation to birth, and thus requires detailed histories from
parents or relatives including dates of birth and death. Misclassification of neonatal
deaths happens as a result of imprecision regarding the timing of events. Cultural beliefs
around stillbirths and early neonatal deaths sometimes make families reluctant to admit
that a child was born alive and then died soon after birth, thus resulting in
misclassification of a live born baby as a stillbirth. Infants that die during delivery also
present a special problem, as it is often not clear at what stage the baby died, especially
if the baby shows few signs of life immediately after it is born. ICD-10 states that “a
stillbirth or foetal death is a death prior to the complete expulsion or extraction from its
mother of a product of conception, irrespective of the duration of pregnancy” (28), but
other studies have used the definition of a stillbirth as “fetal death after 28 weeks of
gestation but before delivery of the baby’s head” (22). Furthermore, neonatal deaths
might be misclassified as post-neonatal if the family reports that the baby died around
one month of age and cannot provide accurate dates, in which case the death is often
recorded as “30 days”, which is beyond the neonatal period.
Other methodological problems may arise through misreporting dates of birth and age at
death. This may happen deliberately or just in the process of rounding dates to the
nearest month or year. In the 2004 Malawi DHS, the dates of births for children that
survived or had died were 32% and 82% higher respectively after the cut-off for
requirement for interview compared with before it, suggesting that dates were
deliberately misreported by interviewers to avoid having to do extra interviews (1).
Similarly, neonatal deaths may be misclassified as stillbirths to avoid filling in death
registration and survey forms. Digit preference and rounding of ages may also affect
neonatal and infant mortality estimates, where deaths are reported as exactly 1-month
rather than in days. This would have the effect of underestimating neonatal mortality,
but over-estimating post-neonatal mortality (42).
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Cause-specific maternal and neonatal deaths
Misclassification may particularly be a problem in large surveys like DHS where
accurate clinical diagnosis is not possible. When trying to classify maternal and
neonatal deaths by cause further problems arise. Where coexisting causes of death are
found, rules for diagnosticians or coders are not always clear or consistently applied
(47). Researchers have tried to develop algorithms to enable automated classification of
large sets of data without the need for a physician (48). A study in Nepal comparing
physician review with algorithm-based cause-of-death assignment for neonatal deaths
showed high correlation for some conditions (prematurity and diarrhoea) but not for
others (asphyxia and sepsis) (49). A study in Mozambique comparing clinical autopsy
for maternal deaths to complete necropsy (gold standard), found very low sensitivity of
clinical data and verbal autopsy, especially for infectious causes – HIV 33% and
puerperal sepsis 50%. Eclampsia was the main source of false positives (57%) (50). In
practice, classifications of cause of death often vary depending on the interests of the
investigators. For example, whether HIV and malaria are classified as specific
conditions or as general infectious conditions, or whether abortion-related mortality is
classified as abortion or as post-abortal sepsis.
2.1.4 Large margins of uncertainty
Large margins of uncertainty around mortality estimates may arise due to non-sampling
or sampling errors (37, 51). Non-sampling errors include systematic errors and random
errors that are not due to sampling, such as recall error and misclassification as
discussed above and other errors in the implementation of data collection, data entry and
imputation of missing data. Efforts must be made at the implementation stage to avoid
non-sampling errors, though they are difficult to avoid completely and difficult to
evaluate statistically. Sampling errors arise as a result of chance when using a sample to
estimate population mortality rates, and they reflect the degree of variability between all
the possible samples that could have been selected. Sampling error can be reduced by
increasing the sample size, and can be estimated from the standard error (45). The
standard error can then be used to calculate confidence intervals within which the true
value for the population can be assumed to fall.
Data from WHO reports are derived using inflation factors that try to account for the
large margins of uncertainty inherent in estimating mortality rates. Margins of
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uncertainty associated with MMR are very large (much larger than for other commonly
used DHS/health indicators) (36). Even for countries with highly developed statistical
systems an inflation factor of 50% was used in the WHO 2000 report (35), and the
calculated MMR was multiplied by two in the WHO 2005 report (36). This was done to
adjust for possible misclassification and underreporting, though inflation factors are
based on fairly crude guesswork, and true figures could be higher or lower than these
adjusted estimates. For countries that rely on surveys for mortality estimates, even with
rigorous definition, identification and classification of deaths, maternal and neonatal
mortality estimates are usually imprecise, due to the relatively small numbers of events
used in calculating them, and the large associated random error. In the 2004 Malawi
DHS survey only 240 and 289 maternal and neonatal deaths respectively were used to
estimate the mortality rates, leaving large margins of uncertainty around the estimates
(1). As such, apparent differences between regions or over time can be due to chance
rather than real epidemiological differences. Sampling error is also of particular concern
in epidemiological studies trying to make comparisons in mortality rates between
populations exposed to different interventions or risk factors (52).
2.1.5 Varying sources of data
Data used to produce international reports tends to come from many different sources
using different sampling and data collection techniques (5, 37, 53). Most data is
collected retrospectively through surveys, and is thus prone to recall error as well as
underreporting and misclassification. Prospectively collected data can minimise some of
these sources of error, but is often costly and time-consuming so is seldom done on a
large scale for long periods of time. Reports that make within-country national
comparisons between regions and over time may also draw data from several different
sources using different data collection techniques (54). Most research studies tend to use
hospital-based populations, as it is usually easier to recruit a study sample and to collect
follow-up data. Therefore, when seeking to describe patterns of maternal and neonatal
health outcomes by country or region, or when looking at trends over time, it is
important to take into account the problems inherent in measuring the magnitude and
nature of the problem. It is worth considering whether apparent differences in mortality
estimates between studies reflect chance, methodological, diagnostic or real differences,
or in the case of facility-based data, differences in the use of health services.
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2.1.6 Use of ‘selected’ populations
Hospital-based surveys or routine statistics only collect data from women who give
birth in health facilities. In Malawi, this excludes the 43% of the population who give
birth elsewhere (1). Women who give birth in health facilities are likely to be different
from the general population in terms of various socioeconomic and demographic
characteristics, which may also be associated with mortality risk. In addition, hospital
deliveries usually include high-risk cases or emergency admissions, so are likely to
provide a biased picture of the epidemiology of maternal and neonatal health at
population-level. However, such studies are still useful in investigating the
epidemiology of hospital-based deaths (55).
2.1.7 Summary of methodological considerations
In conclusion, different methodological factors result in over and underestimation of
maternal and neonatal mortality, but few data exist in order to determine to what extent
these errors compensate for one another (30, 42). The degree of over or underestimation
may vary depending of the relative proportion of deaths happening at different stages of
maternal and neonatal periods, which in turn depends on the maternal and neonatal
epidemiology in that setting (31, 50). Comparisons between countries and over time
should be made with caution due to potentially large errors and different data collection
and estimation methods. As a result of these uncertainties, as well as contextual
differences that affect implementation, several publications have described the
limitations of mortality statistics (particularly maternal mortality) for measuring
programme impact (56, 57).
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2.2 Epidemiology of maternal and neonatal mortality
This section will explore available data for estimates of maternal and neonatal mortality
from various sources such as routine data collection systems, surveys and research
studies. Estimates in different geographic, demographic and socioeconomic settings and
over time will be discussed, and some details of the aetiology will be explored. This will
provide context for the research in this thesis, and give a reference against which the
findings can be compared to assess their validity.
2.2.1 Frequency
The maternal mortality ratio (MMR) is the health indicator with the largest discrepancy
between developing and developed countries and varies by a factor of over 100 between
the poorest and least poor countries (51, 58). It is an important indicator for comparison
of the performance of health-care systems between countries because it is generally
assumed that maternal mortality reflects the quality of essential and comprehensive
obstetric care. Maternal mortality has received increased attention since its inclusion in
the Millennium Development Goals (MDGs) (4). Universal access to maternal
healthcare is seen as the starting point to achieve the target of MDG 5, which is the
reduction of maternal mortality by three-quarters between 1990 and 2015. This requires
that births are attended by skilled birth attendants (doctors, nurses, or midwives) who
are able to prevent, detect, and manage or refer women with obstetric complications.
However, community-based action is also fundamental and has shown great promise as
a means of improving home care with small but significant increases in uptake of
services (22). Neonatal mortality rates (NMR) are less variable between developing and
developed countries than maternal mortality rates, but are still high and vary by a factor
of about 30 (59).
Global estimates of maternal and neonatal mortality
An estimated 358,000 maternal deaths occurred globally in the year 2008, representing
an MMR of 260 deaths per 100,000 live births and a lifetime risk of maternal death of 1
in 140 (37). However, this burden is not distributed uniformly, and 99% of women who
die during pregnancy, childbirth, or in the immediate postpartum period are from
developing countries, and more than half of them are from sub-Saharan Africa. The
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estimated MMR for sub-Saharan Africa is more than twice as high (640 per 100,000) as
that for south Asia (280 per 100,000), and almost 50 times as high as that for developed
regions (14 per 100,000). The same report estimates that the adult lifetime risk of
maternal death is 1 in 31 in the sub-Saharan Africa region. The bounds of uncertainty
for these estimates are large so they cannot be used as precise estimates, but they give
an idea of the magnitude of the problem.
Worldwide, almost 11 million children under the age of five, and 4 million newborns,
die every year. In a report using DHS, WHO and UN data sources, neonatal mortality is
estimated to be 30 per 1,000 live births globally, with a rate of 44 per 1,000 in sub-
Saharan Africa compared to 4 per 1,000 in developed countries (5). The authors
highlight that newborn deaths are double the number of deaths due to HIV, but have
received much less attention. As with maternal mortality, 99% of neonates that die are
born in developing countries, and 28% of the global burden of neonatal deaths is in sub-
Saharan Africa (5). Most newborns die immediately after birth as a result of premature
birth or asphyxia, or subsequently from infectious diseases that can be prevented or
treated by existing inexpensive means (60). The target of MDG 4 is to reduce the
under-five morality rate by two-thirds, between 1990 and 2015 (4). Achieving the target
requires a substantial reduction in newborn deaths, as they count for 38% of under-five
deaths globally, and 24% in sub-Saharan Africa (5). The proportion neonatal varies
depending on overall child mortality rates, with countries that have lower under-five
mortality rates having a higher proportion of them being neonatal deaths (41).
Estimates of maternal and neonatal mortality in Malawi
Routine sources of data often only include births and deaths that occur at facilities, and
where most women give birth at home these figures are likely to vastly underestimate
mortality rates. In Malawi for example, the Health Management Information System
(HMIS) is facility-based and does not include births and deaths that occur outside
facilities, but only 57% of births happen in facilities so this is clearly not representative
of the whole population (1). Attempts are being made to improve reporting of vital
events at community level through community birth and death registration systems and
facility-led maternal death audits (38). HMIS does not provide national MMR and NMR
estimates, but gives a national case fatality rate of 2.5% for the reporting period July
2006 to June 2007 – that is the percentage of women with direct obstetric complications
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in emergency obstetric care (EmOC) facilities that die from them (10). This gives an
indication of the quality of care provided. The UN recommends that a CFR of less than
1% should be aimed for. A national population and housing census was conducted in
1987, 1998 and 2008, but this does not provide estimates of maternal or neonatal
mortality. Infant mortality was estimated to be 121 per 1000 live births in 1998 and 87
per 1000 live births in 2008 (61, 62).
The most commonly cited national estimates of maternal and neonatal mortality in
Malawi come from the Demographic and Health Survey (1, 63). In the most recent
Malawi DHS report for 2004, maternal mortality was estimated to be 984 per 100,000
live births, neonatal mortality was 27 per 1,000 live births, perinatal mortality was 34
per 1,000 births and infant mortality was 76 per 1,000. Another more recent survey
providing national mortality estimates is the Multiple Indicator Cluster Survey (MICS),
which was conducted by the Malawi National Statistics Office and UNICEF in 2006
(63). This reports an estimated maternal mortality ratio of 807 per 100,000 live births,
and neonatal and infant mortality rates of 33 and 72 per 1,000 live births respectively.
Perinatal mortality rates were not determined in this study.
WHO model estimates are derived from adjusted national datasets available in 2008,
including vital registration systems, national surveys and censuses. Using these data
sources, the estimate for Malawi is 510 maternal deaths per 100,000 live births (with a
range of uncertainty of 300 to 760), and a lifetime risk of maternal death of 1 in 36
(estimates are adjusted for age distribution and AIDS-deaths) (37). This is considerably
lower than the WHO report for 2005, in which Malawi was estimated to have an MMR
of 1,100 per 100,000 live births, and the highest proportion of maternal deaths as a
fraction of all reproductive age deaths of any country in the world, with over two-thirds
of deaths in women of childbearing age being due to maternal causes (36). This is also
considerably lower than another model-based estimate of maternal mortality that gives
an estimate of 1,140 for Malawi in 2008 (64). WHO sources estimate that Malawi’s
NMR was 40 per 1,000 live births and perinatal mortality rate (PMR) was 43 per 1,000
in the year 2000 (53, 59).
A summary of all population-based studies and surveys conducted in Malawi that
reported maternal mortality estimates is given in Table 2.2, and summaries of all studies
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and surveys reporting perinatal, neonatal and infant mortality figures are given in Table
2.3, Table 2.4 and Table 2.5. Most of these studies did not report margins of error for
their mortality estimates, but these have been calculated from available data. Mortality
rates from hospital-based studies were not included as they cover highly selected
populations.
Estimated maternal mortality ratios range between 398 and 1,120. The range of
estimates using prospective methods was somewhat narrower and lower (398 and 513)
than those derived from retrospective surveys using sisterhood methods conducted
around the same time (409 and 1,120). Perinatal mortality rates were estimated to be
between 30 and 68 per 1000 births, neonatal mortality rates between 27 and 47 per
1,000 live births, and infant mortality rates between 55 and 165 per 1,000 live births.
It is evident that, whether using population-based or model-based estimates of mortality,
considerable variability exists. This may be as a result of changes over time due to the
different time periods represented, different study population characteristics, or different
methods.
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Table 2.2: Population-based studies estimating maternal mortality in Malawi (1981-2006)
Study/
primary author
(Publication
date)
Date data
collected
(Period refers to)
Study design Case definition Population Number of
maternal
deaths
MMR estimate
(per 100,000
live births)
(95% CI)
Maternal
age
(Years)
Chiphangwi1
(1992) (65)
1989
(reference period
not given, approx
1976)
Retrospective
sisterhood survey
(indirect sisterhood)
Unknown 7 TAs in Thyolo District,
Southern region
150 409
(349-480)
>=15
DHS
(1992) (3)
1992
(refers to period
1986-1992)
Retrospective direct
sisterhood survey
Deaths during pregnancy, childbirth
and up to 6 weeks afterwards
Cluster samples across
Malawi
71 620
(492-781)
15-49
McDermott
(1996) (14)
Sept 1987 – July
1989
Prospective cohort
(part of antimalarial
trial)
All deaths during pregnancy, childbirth
and up to 6 weeks afterwards (not
excluding incidental/accidental deaths)
Antenatal attenders,
Mangochi District,
Southern region
15 398
(241-656)
Unknown
Kulmala1
(2000) (66)
June 1995 – Aug
1996
Prospective cohort Not given – not originally aiming to
estimate MMR
Pregnant women
identified at rural ANC,
Mangochi District,
Southern region
4 513
(200-1,311)
All
pregnant
DHS
(2000) (2)
2000
(refers to period
1994-2000)
Retrospective direct
sisterhood survey
Deaths during pregnancy, childbirth
and up to 2 months afterwards
Cluster samples across
Malawi, with over-
sampling for 11 districts
344 1,120
(1,008-1,244)
15-49
Van den Broek2
(2003) (67)
2002
(refers to period
1998-2002)
Retrospective
household survey
asking about all
births in the last year
“The death of a woman associated with
child-birth”. Timing not stated.
All households in
catchment of rural health
centre, Chiradzulu
District, Southern region
9 413
(144-682)
>=10
DHS
(2004) (1)
2004
(refers to period
1998-2004)
Retrospective direct
sisterhood survey
Deaths during pregnancy, childbirth
and up to 2 months afterwards
Cluster samples across
Malawi, with over-
sampling for 10 districts
240 984
(868-1,116)
15-49
MICS
(2006) (63)
2006
(refers to period
2000-2006)
Retrospective direct
sisterhood survey
Deaths during pregnancy, childbirth
and up to 2 months afterwards
Cluster samples in all
districts of Malawi
469 807
(737-883)
15-49
1 Complete paper not seen, abstract only. Other details from Geubbels 2006 (54).
2 Probably underestimated maternal deaths as most husbands left households after maternal death, and households headed by single women that died would be missed.
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Table 2.3: Population-based studies estimating perinatal mortality in Malawi (1996-2004)
Study/
primary author
(Publication
date)
Date data
collected
(Period refers to)
Study design Case definition Population Number of
perinatal
deaths
PMR estimate
(per 1,000
births)
(95% CI)
Maternal
age
(Years)
McDermott
(1996) (68)
1987-1990 Prospective cohort Stillbirths plus deaths within 7 days
of delivery
Antenatal attenders,
Mangochi District,
Southern region
264 68
(61-76)
All
pregnant
Kulmala
(2000) (69)
June 1995 – Aug
1996
Prospective cohort Stillbirths plus deaths within 7 days
of delivery
Pregnant women identified
at rural ANC, Mangochi
District, Southern region
52 65
(50-84)
All
pregnant
DHS
(2000)1 (2)
2000
(refers to 1995-
2000)
Retrospective
household survey of
birth histories
Deaths after 7m gestation or within
first 7 days of life
Cluster samples across
Malawi, with over-sampling
for 11 districts
568 48
(44-52)
15-49
Van den Broek
(2003) (67)
2002
(refers to period
1998-2002)
Retrospective
household survey
Not clear – seems only to include
stillbirths
All households in catchment
of rural health centre,
Chiradzulu District,
Southern region
66 30
(24-38)
>=10
DHS
(2004) (1)
2004
(refers to 1999-
2004)
Retrospective
household survey of
birth histories
Deaths after 7m gestation or within
first 7 days of life
Cluster samples across
Malawi, with over-sampling
for 10 districts
372 34
(31-38)
15-49
1 PMR estimate not available in 1992 DHS
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Table 2.4: Population-based studies estimating neonatal mortality in Malawi (1992-2006)
Study/
primary author
(Publication
date)
Date data
collected
(Period refers to)
Study design Case definition Population Number of
neonatal
deaths
NMR estimate
(per 1,000 live
births)
(95% CI)
Maternal
age
(Years)
DHS
(1992) (3)
1992
(refers to period
1987-1992)
Retrospective
household survey of
birth histories
Deaths during first month of life Cluster samples across
Malawi
188 41
(36-47)
15-49
McDermott
(1993) (70)
1987-1990 Prospective cohort Deaths during first 28 days Antenatal attenders,
Mangochi District,
Southern region
135 47
(40-55)
All
pregnant
Kulmala
(2000) (69)
June 1995 – Aug
1996
Prospective cohort Deaths within 28 days of delivery Pregnant women identified
at rural ANC, Mangochi
District, Southern region
28 37
(26-53)
All
pregnant
DHS
(2000) (2)
2000
(refers to period
1995-2000)
Retrospective
household survey of
birth histories
Deaths during first month of life Cluster samples across
Malawi, with over-sampling
for 11 districts
515 42
(37-48)
15-49
DHS
(2004) (1)
2004
(refers to period
1999-2004)
Retrospective
household survey of
birth histories
Deaths during first month of life Cluster samples across
Malawi, with over-sampling
for 10 districts
289 27
(23-31)
15-49
MICS
(2006) (63)
2006
(refers to period
2002-2006)
Retrospective
household survey of
birth histories
Deaths during first month of life Cluster samples in all
districts of Malawi
Unknown 33
(29-38)
15-59
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Table 2.5: Population-based studies estimating infant mortality in Malawi (1977-2010)
Study/
primary author
(Publication date)
Date data
collected
(Period refers to)
Study design Case definition Population Number of
infant
deaths
IMR estimate
(per 1,000 live
births) (95% CI)
Maternal
age
(Years)
Population and
Housing census
1977 (71)
1977
(refers to period
1976-1977)
Retrospective
household survey of
birth histories
Deaths of infants under
one year of age
All households in Malawi Unknown 165 Unknown
Population and
Housing census
1987 (72)
1987
(refers to period
1986-1987)
Retrospective
household survey of
birth histories
Deaths of infants under
one year of age
All households in Malawi Unknown 159 Unknown
DHS
(1992) (3)
1992
(refers to period
1987-1992)
Retrospective
household survey of
birth histories
Deaths during first year
of life
Cluster samples across Malawi 569 134
(124-145)
15-49
McDermott
(1993) (70)
1987-1990 Prospective cohort Deaths within first 365
days
Antenatal attenders, Mangochi District,
Southern region
407 149
(136-163)
All
pregnant
Population and
Housing census
1998 (61)
1998
(refers to period
1997-1998)
Retrospective
household survey of
birth histories
Deaths of infants under
one year of age
All households in Malawi Unknown 125 Unknown
Vaahtera
(2000) (73)
June 1995 – Aug
1996
Prospective cohort Not specified
(assumed deaths during
first year of life)
Pregnant women identified at rural
ANC, Mangochi District, Southern
Region
100 136
(113-163)
All
pregnant
DHS
(2000) (2)
2000
(refers to period
1995-2000)
Retrospective
household survey of
birth histories
Deaths during first year
of life
Cluster samples across Malawi, with
over-sampling for 11 districts
1,159 104
(96-111)
15-49
DHS
(2004) (1)
2004
(refers to period
1999-2004)
Retrospective
household survey of
birth histories
Deaths during first year
of life
Cluster samples across Malawi, with
over-sampling for 10 districts
742 76
(69-83)
15-49
MICS
(2006) (63)
2006
(refers to period
2002-06)
Retrospective
household survey of
birth histories
Deaths during first year
of life
Cluster samples in all districts of
Malawi
Unknown 72
(68-77)
15-59
Population and
Housing census
2008 (62)
2008
(refers to period
2007-2008)
Retrospective
household survey of
birth histories
Deaths of infants under
one year of age
All households in Malawi Unknown 87 >=12
Jahn
(2010) (74)
2002-06 Demographic
surveillance system
(prospective data)
Deaths during first year
of life
General population (32,000) in
Karonga District, Northern Region
195 55
(48-63)
All
pregnant
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2.2.2 Temporal trends
Maternal mortality
For the reasons discussed in section 2.1, as well as changes in data collection methods
over time, it is difficult to draw firm conclusions about temporal trends in maternal
mortality globally, but there has been little sign of progress in reducing maternal
mortality in sub-Saharan Africa over the past few decades (58). The smallest reduction
in maternal mortality between 1990 and 2005 comparing WHO datasets was in sub-
Saharan Africa (75). However, more recent reports suggest that greater progress has
been made, and MMR has decreased by 41% globally since 1980 (Figure 2.1) (37, 64).
Figure 2.1: Trend in the number of maternal deaths globally, from 1980 to 2008
(From Hogan 2010 (64))
In Malawi, data in Table 2.2 do not show an obvious trend over time. There may have
been an increase in maternal mortality in the late 1990s and early 2000s, followed by a
slight reduction in recent years, but due to varying methodologies and wide margins of
uncertainty it is difficult to tell. Consecutive DHS surveys have shown an increase from
620 per 100,000 live births in 1992 to 1,120 in 2000 and then a slight drop to 984 in
2004. As shown in Figure 2.1, the increase between 1992 and 2000 may reflect the
emergence of HIV as an important contributor to maternal ill health in the 1990s, when
global maternal mortality trends in the presence and absence of HIV started to diverge
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(64). Although there was a rise in maternal mortality between the 1992 and 2000 DHS
surveys in Malawi, there was a concomitant rise in all-cause adult female mortality, and
the proportion of all female deaths that are maternity-related has remained constant at
around 20%. This might reflect a true increase in maternal deaths that may be both
direct (due to health service deterioration related to the HIV epidemic) and indirect (due
to AIDS-related infections and sepsis) (54, 76, 77). It may also reflect errors in data
collection. There may have been systematic underreporting or misclassification of
maternal deaths in 1992 such that there were fewer reported maternal deaths, or
systematic over-reporting or misclassification in 2000 such that there were more
reported maternal deaths. Possible explanations suggested in the 2000 survey are that
there may have been reporting of AIDS-related sibling deaths as maternal to avoid the
associated stigma of AIDS, or general underreporting of AIDS deaths leading to
underestimating all-cause female mortality (2). It has been suggested that it is inevitable
that maternal mortality will be overestimated in household surveys using sisterhood
methods where there is a combination of high non-maternal mortality (i.e. due to HIV)
and high fertility, as all pregnancy-related deaths are included in estimations (31). In
this context, failure to differentiate between direct and indirect maternal deaths, or
maternal and non-maternal deaths, may lead to unrealistic conclusions about progress
towards achieving reductions in maternal mortality (78). Increases in reported mortality
rates due to HIV or methodological changes may have obscured any improvements in
maternity care services over the same period.
Neonatal and infant mortality
Public health interventions have enabled faster reductions in child and infant mortality
than in neonatal mortality, and neonatal deaths will make an increasingly larger
contribution to the total burden of childhood deaths (Figure 2.2). However in countries
affected by malaria and with high HIV prevalence rates, post-neonatal and child
mortality have been declining more slowly (59). Temporal trends in neonatal mortality
show an overall global reduction of 16% between 1996 and 2005. This reduction was
not seen in sub-Saharan Africa though, with neonatal mortality rates staying at about the
same levels during the same period (5). As for maternal mortality, temporal trends in
infant and neonatal mortality should be interpreted with caution.
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Figure 2.2: Trends in under-five and neonatal mortality rates globally, from 1965 to 2015
(Trend for deaths in children younger than age 5 years fitted assuming constant proportional reduction
every year.)
(From Lawn 2005 (5))
A similar pattern is seen in Malawi, with large reductions in infant mortality over the
last few decades, and a relatively smaller reduction in neonatal mortality (Table 2.4 and
Table 2.5). The most recent DHS neonatal mortality estimate is much lower than all of
the other estimates, and suggests that there might be a possible downwards trend in
recent years. Although there were concerns about data quality in the 2004 DHS survey,
and authors of the report suggest that there may have been some methodological
problems that resulted in an underestimation of NMR for that year, such as: sampling
constraints; transference of birth dates; and underreporting of deceased children (1).
There is evidence that mortality rates for the period 0-4 years before the survey were
underestimated in the 2004 DHS, but overestimated for the period 5-9 years before the
survey, suggesting that the apparent reduction in 2004 may be an artefact of the data (1).
However, the most recent estimate of neonatal mortality from the MICS 2006 survey
(33 per 1,000 live births) is close to the 2004 DHS figure using similar nationally-
representative sampling and survey methodology, which supports the hypothesis that
the neonatal mortality rate has declined in recent years (63).
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Mother and child health behaviours
In tandem with changes in mortality we would expect to see changes in related health
behaviours, such as accessing skilled medical care. Little change has been observed in
antenatal attendance or skilled delivery care between subsequent DHS surveys (1-3).
Antenatal attendance has remained fairly static at around 90% in 1992 and 93% in both
2000 and 2004, while 55% of deliveries were attended by skilled personnel in both 1992
and 2000 surveys and 57% in 2004. There is some evidence that postnatal care coverage
may have increased between surveys. Postnatal care attendance was not measured in
1992, but in 2000 7% of mothers reported that they received a postnatal check-up after
birth. In 2004 31% of women received postnatal care within 42 days of birth (21% in
the first 2 days). MICS data from 2006 reports similar figures to 2004 DHS figures,
with 92% ANC attendance and 54% skilled delivery care, again suggesting little change
in health care access over time (63).
Thus, unless the quality of skilled medical care got very much worse over time, the
large apparent increase in maternal mortality between the 1992 and 2000 DHS surveys
is unlikely to be due to an increase in the number of obstetric deaths. There may have
been an increase in non-obstetric (indirect) maternal deaths, largely as a result of
increasing HIV prevalence, but it is also likely that more of non-maternal deaths were
included in the estimates. On the other hand, it is plausible that the increase in postnatal
care attendance could potentially be related to the reduction in neonatal mortality seen
between 2000 and 2004 DHS surveys.
2.2.3 Distribution
Geographical distribution
Comparisons of maternal and neonatal mortality rates between countries should be
made with caution, and interpretation of data looking at geographical distributions must
take into account differences in definitions, reporting systems, sources of data and
accuracy and completeness of data.
For both maternal and neonatal mortality, rates appear to be highest where data is
weakest, mainly in Africa and Asia. WHO reports have consistently shown higher
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maternal and neonatal mortality in sub-Saharan Africa than any other region of the
world (Table 2.6). Major contributing factors to poor health in Africa are weak health
care infrastructure, drought and famine, endemic malaria, pandemic HIV and conflict.
Khan describes the region-specific contributions to maternal mortality of sepsis and
HIV in Africa, anaemia in Asia, abortion in Latin America and the Caribbean and other
direct causes (related to caesarean section and anaesthesia) and embolism in developed
countries (79).
Table 2.6: Global geographic distribution of maternal and neonatal mortality
UN region Maternal
mortality
ratio*
Range of
uncertainty of
MMR estimates*
Neonatal
mortality
rate**
Perinatal
mortality
rate**
Lower
estimate
Upper
estimate
Developed regions 14 13 16 5 10
Countries of the
commonwealth of independent
states
40 34 48 33 50
Developing regions 290 220 410 42 61
Africa 590 430 850 41 62
Northern Africa 92 60 140 22 34
Sub-Saharan Africa 640 470 930 44 66
Asia 190 130 270 32 50
Eastern Asia 41 27 66 21 34
South Asia 280 190 420 43 65
South-Eastern Asia 160 110 240 19 33
Western Asia 68 45 110 28 39
Latin America and the
Caribbean
85 72 100 15 21
Oceania 230 100 500 26 42
WORLD TOTAL 260 200 370 30 47
* from WHO 2008 (37)
** from WHO 2006 (59)
Comparisons of maternal and neonatal mortality rates between geographical regions
within countries is usually limited by small numbers of deaths from each region. Due to
these sampling constraints, maternal mortality data from the Malawi DHS reports and
other population-based surveys is not broken down by geographic, socio-economic or
demographic characteristics in order to identify high-risk groups, though data on infant
and neonatal deaths is presented in this way. Thus, for sub-national data for Malawi, the
focus will be on the distribution of infant, neonatal and perinatal mortality, as well as
coverage of maternity care as a proxy for maternal mortality.
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In Malawi, health statistics are not uniformly distributed. Most health indicators tend to
be worse in the Southern Region, better in the Central Region and best in the Northern
Region. This pattern is thought to be due to higher education and literacy levels and
lower population density in the north of the country. Key maternal and child health
indicators from DHS and MICS surveys give slightly different geographic patterns, as
shown in Table 2.7 and Table 2.8, and do not follow consistent north-to-south trends.
Interestingly, the pattern of mortality distribution does not correspond with the pattern
of coverage of health care services in and around pregnancy, with highest coverage of
antenatal, delivery and postnatal care services being in the north where mortality is
highest and the lowest coverage being in the central region where mortality is lowest
(1). MICS 2006 indicators show a more consistent increasing north-to-south trend,
particularly for post-neonatal, infant and maternal mortality (63). The picture for
neonatal mortality is the opposite to DHS, with the highest mortality being found in the
Central Region. However, most of the regional differences are small and regional
estimates are likely to have large confidence intervals that overlap (though no data on
denominators is available to calculate them), so differences due to sampling and non-
sampling errors associated with the survey cannot be ruled out (42).
A DHS review of child mortality statistics found that neonates born to mothers in rural
areas were 27% more likely to die than those from urban areas (80). A clear
geographical pattern also exists between urban and rural areas in Malawi, with all
mortality rates being higher in rural than in urban areas, and coverage of all health care
services being lower in rural areas. The differences in mortality rates between urban and
rural areas are much smaller in the MICS survey compared to DHS figures (1, 63).
Maternal mortality is actually slightly higher in urban areas, although there were only
77 maternal deaths in urban areas, so this estimate is likely to lack precision. It is not
clear whether the smaller urban-rural differential in the MICS survey is because
estimates are centred on a later time point, or because of a different sample mix. There
is some evidence that the ‘urban advantage’ in maternal health globally is diminishing,
as high levels of urbanisation are associated with increasing exclusion of the poorest
mothers (81). Higher HIV prevalence in urban areas may also account for some of the
loss of ‘urban advantage’ in Malawi (77, 82).
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Table 2.7: Geographic and socioeconomic distribution of selected DHS health indicators in Malawi
Region/district Perinatal
mortality
rate
Neonatal
mortality
rate
Infant
mortality
rate
ANC
attendance
(%)
Skilled
birth
attendant
(%)
Postnatal
check-up
within 42
days (%)
Northern 40 39 82 96 67 34
Central 32 34 90 91 52 27
Southern 34 39 98 94 59 34
Urban 15 22 60 98 84 42
Rural 37 39 98 92 53 29
Lowest 24 36 109 90 47 24
Second 45 41 100 91 47 27
Middle 35 40 95 92 52 29
Fourth 34 36 89 96 63 33
Highest 30 29 66 97 85 44
Total 34 27* 76* 93 57 31
* Refers to the five year period preceding the survey, whereas the other figures refer to a ten year period
Table 2.8: Geographic and socioeconomic distribution of selected MICS health indicators in Malawi
Region/district Maternal
mortality
ratio
Neonatal
mortality
rate
Infant
mortality
rate
ANC
attendance
(%)
Skilled
birth
attendant
(%)
Postnatal
check-up
within 42
days (%)
Mchinji - 24* 65* 97 59 41
Northern 543** 33 57 82 58 27
Central 678** 35 73 92 51 34
Southern 1029** 31 75 94 56 33
Urban 861** 30 70 97 78 53
Rural 802** 34 73 91 50 29
Lowest - 32 72 90 43 27
Second - 34 79 89 48 29
Middle - 30 76 94 52 29
Fourth - 39 71 92 54 32
Highest - 32 62 95 77 50
Total 807** 33 72 92 54 33
* Refers to the period 10 years preceding the survey
** Refers to the period 0-6 years preceding the survey
Other mortality estimates refer to the five-year period preceding the survey, and ANC, skilled attendance
and postnatal care refer to the two years preceding the survey.
Distribution by socioeconomic and demographic characteristics
Few studies present maternal mortality figures broken down by age, though young age
and first pregnancy are well known risk factors for poor maternal and infant outcome (5,
73, 80, 82, 83). In one prospective cohort study of 4,053 pregnant women in Malawi, no
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association between age, pregnancy number and maternal mortality was found, though
the number of deaths was small (14). Another later study looking only at infant
outcomes found a strong relationship between maternal age, primiparity and infant
mortality (73). Malawi DHS data suggest that complications in pregnancy are slightly
higher among older women and women with more previous pregnancies. Coverage of
maternity services is also lowest in this age group. Malawi DHS data also shows that
much higher rates of neonatal death are found amongst mothers younger than 20 years
or older than 40 (56 and 48 per 1,000 respectively) compared with women aged
between 20 and 40 (29-34 per 1,000) (1). It is not clear whether or not this effect is
independent of parity (as first born infants, or infants born 7th or more, are at higher risk
than those between 2nd and 6th). The same patterns are seen in the MICS data (63).
Coverage of antenatal, delivery and postnatal services is higher among the wealthiest
groups of the population and the women with the highest level of education in both
surveys (Table 2.7 and Table 2.8) (1, 63). The DHS review of child mortality estimates
found that infants born to mothers with no schooling at all or only primary schooling
(less than 8 years of school) were 58% and 45% (respectively) more likely to die in the
first month than children whose mothers attended secondary school (more than 8 years
of school) (80). Malawi DHS data similarly show that neonatal mortality is more likely
for women with little or no education (36-39 per 1,000), compared to those with
secondary education (25 per 1,000) (1). A markedly higher NMR in the poorest socio-
economic groups is seen compared to the wealthiest (36 compared to 29 per 1,000). For
post-neonatal mortality and infant mortality this socioeconomic differential is even
more pronounced, with mortality rates in the poorest groups being almost twice as high
as in the wealthiest. As with the urban-rural gradient, the socioeconomic gradient is less
pronounced in the MICS survey (63), and it has been suggested that the HIV epidemic
may be partly responsible for reducing the gap between the poor and the least poor, as
HIV disproportionately affects wealthier households (74). Other studies have suggested
that addressing inequity is a priority for any strategy that hopes to reduce neonatal
mortality (5).
Analysis of the relationship between maternal mortality and poverty is difficult using
survey data, as most surveys use the sisterhood method to identify maternal deaths
(asking women about any sisters they had who died during or soon after pregnancy),
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and this does not allow individual-linked data on cause of death and socio-economic
factors. Prospective data would provide the best opportunity to explore the relationship
between socioeconomic status and maternal mortality, but an alternative is the ‘familial
technique’, which assigns socio-economic status for maternal deaths according to the
socio-economic status of the sibling interviewed (84). Consistent trends of increasing
maternal mortality with increasing poverty were shown, though these were not
significant in countries with HIV prevalence over 2%. A study of trends in maternal
mortality in Malawi showed a flattened socioeconomic gradient, which the authors
suggest is due to higher prevalence of HIV amongst wealthier women balancing out the
effects of lower access to skilled medical care amongst poorer women (85).
2.2.4 Aetiology of maternal death
Understanding the distribution and relative contributions of causes of maternal and
neonatal death is essential to inform policy-makers and to inform the development of
interventions to tackle these problems. Where health care systems are weak and over-
stretched, reporting on causes of death is poor. In areas with low coverage and uptake of
health services and poor diagnostic facilities, physician diagnosis at the time of death is
uncommon. Therefore, population data on cause of death is largely dependent on verbal
autopsy reports of variable quality (86). Studies that do report cause of death may use
different systems for classifying them. For example, obstructed labour may require
caesarean section that then results in post-operative sepsis and maternal death. The
accepted classification system would identify the cause of death as obstructed labour,
being the first complication, while other approaches would give sepsis as the immediate
cause of death, with obstructed labour as an underlying cause. Definitions and
diagnostic methods are often not reported, which makes comparisons across studies
difficult (27). Global estimates of cause-specific maternal and neonatal mortality are
generally generated through statistical modelling.
Distribution of causes of maternal death in Malawi
Maternal deaths can be categorised into two main groups; direct maternal deaths as a
result of obstetric complications of the pregnant state (pregnancy, labour and
puerperium) and indirect maternal deaths as a result of previously existing disease that
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was aggravated by the physiological effects of pregnancy. A summary of studies with
cause-specific maternal mortality data from Malawi, neighbouring countries and the
region is given in Table 2.9 below.
Direct causes of maternal death
Direct maternal deaths arise from risks of pregnancy and childbirth as well as from poor
quality health care and incorrect treatment. Globally, 80% of maternal deaths are
attributed to direct causes, with 25% of all deaths due to haemorrhage and 15% to
infections (53). The epidemiology of cause-specific deaths is different in high and low
mortality countries, and population estimates are often based on very limited and
relatively unreliable data. Verbal autopsy data is prone to misclassification (55, 58), but
is often the only form of cause of death data in countries where the majority of women
give birth and die at home. A recent WHO systematic review of population datasets
reporting maternal deaths by cause found haemorrhage, hypertensive disorders, sepsis
and abortion to be the leading causes of death worldwide (79), with haemorrhage
accounting for a third of deaths in Africa and Asia, and hypertensive disorders for a
quarter of deaths in Latin America and the Caribbean. However, reviews that have
presented combined results for the African region as a whole often obscure sub-regional
differences, for example the epidemiology of HIV and malaria related maternal deaths
varies across Africa, with the highest prevalence of HIV being in the south and the
highest prevalence of malaria being in sub-Saharan equatorial regions (87, 88). Such
reviews may also be heavily biased towards countries that have better reporting systems
– only 8 datasets were chosen to represent the whole of Africa in Khan et al’s study and
these did not include the countries with the highest maternal mortality (as reported in
other sources (36, 37)). In general there is a paucity of data from sub-Saharan African
countries. The precise proportion of maternal deaths attributable to unsafe abortion is
not known, as restrictive abortion laws tend to compound the problem as well as
increasing the likelihood of underreporting. In a multicentre hospital-based study in
west Africa, it was found that a third of deaths during early pregnancy were caused by
induced abortion (89).
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Table 2.9: Distribution of causes of maternal deaths from Malawian and regional studies
Primary author
Study location
(date published)
Direct deaths
(% of all deaths)
Indirect deaths
(% of all deaths)
(%)
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Hospital-based studies
Wiebenga
QECH, Blantyre
1992* (90)
78 4 13 7 17 5 5 9 4 24 15
Driessen
12 hospitals
1990* (54)
UK 10 12 14 18 6 8 3 2 17 10
Sangala
KCH, Lilongwe
1992* (54)
UK 14 24 15 18 11 8 3 - 8 -
Lema
QECH, Blantyre
2005 (8)
204 11 29 3 24 9 2 NC NC 20 3
Safe Motherhood Project
Hospitals, Southern Region
2003 (91)
304 11 20 15 6 13 9 7 9 9 3
Kongnyuy
9 hospitals, Central Region
2009 (6)
43 30 16 7 7 5 7 - 16 12 0
Community studies
Hofman
Mangochi, Southern Region
2004 (92)
UK 30 5 30 14 7 7 5 - - 2
McDermott
Mangochi, Southern Region
1996 (14)
15 27 0 0 0 7 7 0 0 0 60
Farish, community
2003* (54)
UK 33 7 7 - 7 7 7 7 13 7
Estimates from neighbouring countries
Ahmed
Tertiary hospital, Zambia
1999 (15)
251 5 8 2 14 13 NC NC NC 571 -
Menendez
Tertiary hospital, Mozambique
2008 (16)
139 17 9 - - 13 1 7 13 362 6
Department of Health, South Africa
2004 (93)
3296 13 8 - 4 283 NC 2 20 234 3
Regional estimates
Khan
Africa
2006 (79)
4508 34 10 4 4 17 4 NC 6 17 5
Khan
Developed countries
2006 (79)
2823 13 2 0 8 57 0 NC 0 14 5
Percentages do not add up to 100% due to rounding
* Full article not seen. Abstract, and details from Geubbels 2006 (54).
QECH = Queen Elizabeth Central Hospital, KCH = Kamuzu Cebtral Hospital, UK = unknown, NC = not classified
with this cause for this study
- = no deaths reported for this cause
1 Classification in this study differed from other studies – of the 57% ‘other’ indirect causes of death, 14% of deaths
were due to TB (92% AIDS-related), 17% due to malaria (37% AIDS-related) and 26% due to other indirect causes.
2 This category included pneumonia (12%) and malaria (10%)
3 This category included pregnancy-related hypertension, which accounts for 19% of maternal deaths in this study
4 The largest other cause in this category was pneumonia, responsible for 10% of maternal deaths
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The Confidential Enquiries study, which investigated the cause of death in 304
institutional maternal deaths in southern Malawi in 2001, found that roughly two-thirds
of the deaths audited were as a result of direct obstetric causes. Of those direct obstetric
deaths, 32% were due to sepsis, 24% due to obstructed labour and ruptured uterus, 17%
to haemorrhage, 10% to complications of abortion, and 8% to eclampsia (91, 94). A
more recently published retrospective survey (referring to a similar period) of 204
maternal deaths at Queen Elizabeth Central Hospital, a tertiary hospital in Blantyre,
found that three-quarters of maternal deaths were as a result of direct causes, with the
main direct causes being sepsis and complications of abortion. Though AIDS wasn’t
included as an indirect cause of maternal death in itself in this study, 19% of all the
women who died were confirmed (with serological tests) or suspected (on clinical
grounds) of having HIV, and over 70% of them died as a result of infections. The most
recent study of the aetiology of maternal death in Malawi was conducted in nine
hospitals in three districts of the Central Region (6). Again, two-thirds of the deaths
were as a result of direct obstetric causes, but the most common single cause was
haemorrhage, accounting for 30% of all maternal deaths. AIDS and sepsis both
accounted for 16% of maternal deaths each.
Little data is available on causes of death at community level in Malawi. However,
small localised studies have found that a high proportion of deaths were due to
haemorrhage, ruptured uterus, obstructed labour and complications of abortion (92). In
such cases early care-seeking is essential, and strategies that address community-level
transport problems would be beneficial. Strategies that improve education for girls and
increase the chances that a pregnancy results in a living child thus reducing fertility, are
also likely to reduce mortality risks (67).
Indirect causes of maternal death
Indirect causes of maternal death are even less well documented in developing
countries, due to poor diagnostic capabilities as well as failure to report pregnancy
where the primary cause of death is a condition not unique to pregnancy. Inclusion or
exclusion of conditions not unique to pregnancy can have a substantial impact on
maternal mortality figures. The main indirect causes of maternal death globally are
anaemia and HIV/AIDS (53, 79).
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In studies where blood is not tested for infection (either during the course of the illness
or at post-mortem), the contribution of infection to maternal death aetiology is
underestimated. Two studies in African tertiary hospitals found the proportion of
indirect maternal deaths to be much larger than in any of the Malawian studies. A
prospective autopsy study in a tertiary hospital in Mozambique found that only 38% of
maternal deaths were as a result of obstetric complications (16). Similarly, at a Zambian
tertiary hospital only 42% of maternal deaths were as a result of direct causes (15).
Infectious diseases, including malaria, pneumonia, HIV/AIDS, TB and meningitis
accounted for over half of all maternal deaths in both studies. Thus infection can be a
direct or an indirect cause. The marked difference in the contribution of infectious
causes to maternal death in these studies may be due to the prospective nature, the
availability of better diagnostic facilities, or simply the personal interests of the
researchers.
HIV and AIDS
HIV is an important condition in most fields of health in sub-Saharan Africa. It was
estimated in 2007 that 22 million people in Sub-Saharan Africa were HIV positive,
which represents about two-thirds of all people living with HIV in the world (88).
About 77% of all HIV-infected women and 77% of all HIV/AIDS orphans live in Sub-
Saharan Africa (88). Malawi has one of the highest HIV prevalences in the world, with
DHS estimating 11.8% of people aged 15-49 years are infected (1), and UNAIDS
similarly estimating 11.9% of people aged 15-49 years are infected (88). Data from the
national sentinel surveillance system (of women attending antenatal clinics) were
modelled to estimate a national prevalence of 12.0% in 2007, with the lowest rates
being in the Central Region and rural areas (95). In Malawi HIV is largely responsible
for the decline in life expectancy from 42 years at birth in 1994 to 36.3 years at birth in
2004. More indirectly, HIV has depressed Malawi’s GDP by at least 10% through larger
societal effects on people of working age, impaired economic viability of most homes
due to the loss of main income generators, and an increased burden on families caring
for sick people and orphans. Health facilities are hugely over-burdened and under-
staffed. 12.3% of pregnant women aged between 15 and 49 years are HIV positive in
Malawi (95).
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The relationship between HIV and maternal morbidity and mortality is complicated (32,
96), though HIV is becoming a leading cause of maternal death where HIV-related
mortality rates are high (58). AIDS can itself be a cause of maternal death, increase the
risk of obstetric complications (such as puerperal sepsis) and non-obstetric
complications (such as malaria), or aggravate illnesses such as TB and anaemia.
Conversely, biological changes in pregnancy may increase the incidence of HIV (97).
Furthermore, the quality of care may deteriorate in the context of high HIV prevalence
due to acute shortages of health professionals (96). In settings where HIV status is
known, it has been suggested that women who are HIV-positive might receive a lower
quality of care due to the stigma associated with infection (94).
The exact contribution of HIV to maternal deaths in Africa is not known. The most
recent WHO estimates for 2008 suggest that 9% of maternal deaths in Africa are caused
by HIV (37). However estimates vary widely between countries, with the same report
estimating 32% of maternal deaths to be due to HIV in Malawi. A confidential enquiry
in South Africa reported the cause of maternal deaths in 20% of cases as being HIV –
the biggest single cause of maternal death in this population. 36% of all the women who
died were known to be HIV-positive, which is similar to the proportion positive for all
pregnant women in South Africa, but HIV status was unknown for 54% of women and
the authors suggest that it could have been a primary or underlying cause for an even
larger proportion of the deaths (93). A hospital autopsy study in Mozambique found that
53% of women that died a maternal death were HIV positive and HIV was reported as
the main cause of death in 13% of maternal deaths (16). Another facility-based study in
Zambia, using a different classification system, found that more than three quarters of
all indirect deaths were due to three infectious causes – 30% were related to malaria,
25% to TB and 22% to respiratory tract infections of which 37%, 92% and 97%
respectively were AIDS-related (15). In Malawi, the confidential enquiry found the
main indirect causes of institutional maternal death were anaemia and HIV, each
accounting for about a quarter of indirect maternal deaths (91). Another retrospective
study at Queen Elizabeth Central Hospital in Malawi found over half of all deaths to be
due to infectious causes, including puerperal sepsis, post-abortal sepsis and other
infections, and 18.6% of women were thought to HIV-positive based on clinical
symptoms or serology (8). The most recent maternal death review from Malawi
attributes 16% of all maternal deaths to HIV (6). Although the methods and
51
classification systems are different, all five studies suggest a significant contribution to
maternal mortality from both malaria and AIDS. Ahmed and colleagues describe an
eight-fold increase in maternal mortality in Zambia over a 15-year period (from 118 to
921 per 100,000 live births), which they suggest is mainly due to non-obstetric causes
such as malaria and AIDS-related illnesses.
Similar increases in maternal mortality were reported in several sub-Saharan African
countries concurrent with the rise in prevalence of HIV in the region over the last two
decades (98). The increases in both HIV prevalence and maternal mortality were higher
in urban than in rural areas.
These hospital-based studies may still underestimate the contribution of HIV to
maternal mortality. Many maternal deaths related to HIV might happen in the days or
weeks after being discharged, so would not be counted among maternal deaths reported
in hospital-based studies. A population-based study in Rakai, Uganda, where HIV status
was known, found that the maternal ratio was five-times higher in HIV-positive women
compared to HIV-negative women (1,687 compared to 310 per 100,000 live births)
(99). In Nairobi, Kenya, Nduati and colleagues presented data from women enrolled at
antenatal clinics that showed a three-times higher mortality rate among HIV-positive
women who breastfed compared to those who used formula feed (100). However, this
was a post-hoc analysis and had only small numbers of women who died. A prospective
study in Malawi found no association between breastfeeding by HIV-positive women
and mortality, but 1,800 per 100,000 of the women had died by 12 months post-partum
(101). A population-based study in Malawi reported high mortality in the year following
delivery (15 deaths classified as maternal and 12 non-maternal deaths). HIV and malaria
were identified as important contributors to these deaths (14). Neither HIV nor anaemia
were associated with increased mortality during the maternal period, but during the non-
maternal period (up to one-year post-partum) the mortality rates were 1,852 and 145 per
100,000 women in HIV-positive and HIV-negative women respectively.
Malaria and anaemia
A key component of Safe Motherhood is the eradication of anaemia during pregnancy.
As with HIV, where serological tests during the illness or post-mortem are absent, the
exact contribution of malaria and anaemia to maternal mortality is unknown. Anaemia
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is a leading indirect cause of maternal death globally, and poor nutrition and malaria
both play significant roles in this. Pregnant women are more susceptible than the
general population to malaria and its consequences, and malaria-related maternal
mortality can be very high (53). Brabin estimated that 6% of maternal deaths in Africa
were attributable to anaemia in 2001, and that there would be 9 severe-malaria anaemia-
related maternal deaths and 41 non-malarial anaemia-related deaths per 100,000 live
births in holoendemic malarious areas (12). Placental malaria is associated with
maternal anaemia, premature delivery, intra-uterine growth retardation, low birth weight
and infant mortality (53, 102, 103). HIV infection can contribute to maternal anaemia
directly and also through increasing the risk of higher frequency and higher parasite
density of malaria infections during pregnancy (104). A systematic review of global
data calculated the population attributable risk of anaemia associated with malaria in
pregnancy to be 3-15% (105). WHO recommends that all women living in areas of
stable malaria transmission receive intermittent presumptive treatment (IPT) for malaria
during pregnancy. HIV infection reduces a woman’s capacity to control Plasmodium
falciparum infection and reduces the efficacy of IPT (104).
The WHO systematic review of causes of maternal death reports that 3.7% of maternal
deaths in Africa are caused by anaemia (79), and a hospital-based autopsy study in
Mozambique reported 10% maternal deaths as being due to malaria and 1% due to
severe anaemia (16).
The range of estimates of the contribution of anaemia to maternal mortality in Malawi is
fairly consistent, ranging from 2-9% (Table 2.9). The confidential enquiry in Malawi
found that 9% of maternal deaths were due to anaemia (91), and the recent review in the
Central Region found that 7% of deaths were due to anaemia (6). Though the
retrospective review at Queen Elizabeth Central Hospital found only 2% of deaths as
being due to anaemia and 1.5% due to malaria (8).
Little data is available on the distribution of indirect causes of maternal death at
community-level, though three community-based studies in Malawi all estimated the
contribution of anaemia to maternal mortality to be 7% (14, 54, 92). Most of the major
indirect causes of maternal death can be addressed through improved quality and earlier
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initiation of antenatal care, which includes provision of iron and antimalarial tablets, as
well as HIV counselling and testing.
Timing of death
The majority of maternal deaths occur during labour, delivery or within 24 hours of
giving birth, and thus the place of delivery, person attending and how quickly they can
be referred in case of a problem are crucial factors that determine pregnancy and birth
outcomes (106).
In Matlab, Bangladesh population-based data show that most maternal deaths happen
during pregnancy or within the first day of birth (52%), 25% on days two to seven, and
only 23% were between one and six weeks post-partum, suggesting that focusing on
improving intrapartum care would substantially reduce the number of deaths in this
population (83). Similarly, in Nepal 75% of deaths happened during pregnancy or the
perinatal period, and the other 25% between one and six weeks post-partum (107). In
both studies many deaths were also reported for several months following delivery, and
increased understanding of the causes of death in the late post-partum period is needed,
as well as a renewed focus on improvements in post-partum care (83). In Guinea Bissau,
women who had recently delivered (0 to 42 days post-partum) had 16 times higher risk
of death compared to women who delivered more than 6-months previously, and the
risk was still 3 times higher up to 3 months post-partum (108). Hoj and Pradhan both
suggest increasing the post-partum period for definition of maternal death to 12 weeks
rather than 6 weeks. None of these studies were done in a population with a high
prevalence of HIV, and in countries with high burdens of malaria and HIV, later deaths
may be more common. A prospective cohort study in Malawi showed that mortality
rates in the first year after birth were almost as high for the period six weeks to one year
(341 per 100,000 live births) as they were using the ICD definition up to 42 days. (398
per 100,000 live births) (14). Most of these late maternal deaths were attributed to
anaemia and HIV.
The confidential enquiry in Malawi found that nearly two thirds of institutional maternal
deaths happened after delivery, and three quarters of these happened after the first 24
hours (91). Similarly, in a recent institutional review in the Central Region of Malawi,
70% of deaths happened after delivery, with 60% of these happening after the first 24
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hours (6). This suggests that many institutional maternal deaths could potentially be
prevented through better post-partum care. However, these studies did not follow
women up after discharge, and they may not have included later maternal deaths.
Determinants and risk factors for maternal death
There are socio-environmental determinants that make a mother at higher or lower risk
of maternal or neonatal death. These are interlinked cultural, demographic and
socioeconomic factors that have an impact on access to services as described above, but
also to medical causes of death through illiteracy, poverty, low status of women,
inadequate access to information and essential reproductive health services (109).
Because of the relatively small numbers of maternal deaths in most studies, it is difficult
to do sub-group analyses on the different risk factors for maternal death. No studies
were found presenting the descriptive epidemiology of maternal death and its risk
factors in general populations. Maternal deaths are also influenced by many different
categories of events or conditions, making it difficult to disentangle them. These include
biology, economics, culture, demography and the distribution and quality of health
services (110). McCarthy and Maine developed a framework to help understand the
mechanisms through which these factors lead to maternal death. Individual risk factors
for maternal death include young or old age, low education, nulliparity, short stature,
obesity, genetic factors, previous history of complication, HIV, malaria and nutrition.
Household factors include poverty, gender imbalances and lack of decision-making
power. Community factors include cultural beliefs and practices, long distance from
health facility, lack of transport, and lack of community resources (e.g. clean drinking
water). Health facility factors include availability, accessibility and acceptability, lack
of trained personnel and poor organisation and management of health systems.
Previous experience and perceptions about quality of care might influence a woman’s
choice about whether to deliver at a health facility or not. Reports of unfriendly staff
may deter women from using facilities (94). Cultural beliefs also play a part in decisions
about where to give birth, who can be in contact with the mother and baby and things
that should be done around delivery. Lack of knowledge about complications and
danger signs can affect decision-making about seeking care, and gender imbalances can
make it difficult for women to access household resources needed for care-seeking and
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home care. Although lack of availability of transport and financial barriers affect the
ability of women from poor households to seek care, regardless of who makes the
decision. Health system factors may also contribute to poor outcomes. Facilities may be
long distances away, especially those offering comprehensive emergency obstetric care
(CEOC). Low staffing levels, poor motivation amongst staff and poor supervision
contribute to poor quality of care. It has been suggested that HIV may have worsened
this situation by increasing overcrowding in facilities, taking funding and attention away
from other services and affecting the number of health workers directly through
infections (94).
All of these factors tend to contribute towards delays in reaching a health facility and
receiving appropriate medical care when it is needed. Thaddeus and Maine describe
three important delays that contribute to maternal death (17). These delays and their
contributing factors are outlined in Figure 2.3. The first delay is in recognising the
problem and the need to seek medical help. The second delay is in reaching an
appropriate facility, and can be due to weak referral systems, cultural, social or financial
factors. The third delay is in receiving appropriate care on arriving at the facility. Delays
can be considerable where facilities are understaffed and patient numbers are
unmanageable. Inadequate equipment, training and supervision may also contribute to
poor quality care. Factors that can cause delay include: failure to recognise danger
signs; delay in decision-making (gender imbalances); use of traditional birth attendants;
cultural beliefs; distance from health facility; lack of transport; poverty; poor perception
of facility care; lack of resources for delivery at health facility; poor referral systems;
shortage of skilled attendants; poor monitoring and treatment of patients; availability of
emergency obstetric care; poor infrastructure; lack of drugs and equipment; lack of
quality post-partum care (91, 111).
Individual risk factors for maternal death include caesarean section, abortion and
multiple gestation. Maternal mortality is higher in women following a caesarean section
compared to women having a normal vaginal delivery. 24% of women who died in a
hospital-based study in Mozambique had delivered by caesarean section (16), and a
large part of this was due to untreated infections, especially in HIV-positive women. In
a multi-country study in Latin America increased rates of caesarean delivery in facilities
were associated with greater maternal, perinatal and neonatal mortality even after
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adjusting for demographic factors and limiting the analysis only to elective caesarean
sections (112). In Malawi, a study of 8070 caesarean sections in 25 secondary and
tertiary hospitals found that 1% of women died during or after the procedure (113).
Mortality was two times higher in women having caesarean section who also had
ruptured uterus compared to those who did not, and up to 38 times higher in women
requiring transfusion for blood loss. Maternal deaths after abortion or stillbirth can be
particularly common, accounting for about half of all maternal deaths in a study in
Bangladesh (108). Maternal deaths are also increased during multiple pregnancies, with
a study in Malawi reporting a 6.93 (1.59-30.24) risk ratio for multiple gestations
compared to singletons, and contributing to an estimated 11.5% of maternal deaths
(114).
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Figure 2.3: The three delays model (Adapted from Thaddeus and Maine, 1994 (17))
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Summary of aetiology of maternal death
All the studies discussed above suggest that the epidemiology and aetiology of maternal
mortality in sub-Saharan Africa is likely to be very different from Asia and will require
different strategies for reducing it. In particular, focusing attention on the contributions
of HIV and malaria in sub-Saharan Africa will be important.
As mentioned in section 2.1.3, it is difficult to compare studies that use different
classification systems for cause of death and different rules for classifying coexisting
causes. Perhaps the most striking finding from comparing the studies shown in Table
2.9 is the absence of any very consistent patterns at all, highlighting the challenges
faced in measuring and understanding the epidemiology of maternal mortality. As well
as the different classification systems used, the true aetiological profile is also likely to
differ considerably in different settings, for example between community, health centre
and referral hospitals and between rural and urban populations.
Misclassification of cause of death is a major problem in trying to understand the
aetiology of maternal mortality, especially in Africa where HIV might account for a
substantial proportion of maternal deaths but go undiagnosed due to lack of testing and
stigma (50). Such incorrect diagnostic categorisation means that the course of clinical
management chosen may be inappropriate to address the true cause. Focusing attention
on HIV treatment and prevention for pregnant women in Africa will be an essential
component in reducing maternal mortality and vertical transmission. Understanding the
relative contributions of direct and indirect maternal deaths will also be important in
guiding policy-makers (78).
2.2.5 Aetiology of neonatal death
Reliable data on causes of neonatal death are even more scarce than for maternal
mortality. The limited presenting signs of neonatal illness makes diagnosis even in ideal
clinical settings difficult, and almost impossible at community-level. Many estimates
are generated from models and limited population data, and the data presented in this
section summarises the best available evidence on the aetiology of neonatal death, but
relies heavily on two main sources (5, 59).
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Babies die after birth because they are severely malformed, born prematurely, suffer as
a consequence of obstetric complications or because of practices that lead to infections.
The risk factors for neonatal death and stillbirth relate to maternal health, care during
pregnancy, management of pregnancy and delivery complications, hygiene and
newborn care. Early neonatal deaths (during the first week of life) are mainly due to
complications of pregnancy and childbirth, whereas later neonatal deaths (in the next
three weeks of the neonatal period) are mainly related to infection (5).
In a review of the global epidemiology of neonatal death, the most common cause of
death was reported to be severe infection (36% - including sepsis/pneumonia, tetanus
and diarrhoea), followed by preterm birth (28%), and asphyxia (23%) (5).
No cause-specific neonatal mortality data were found for Malawi, though estimates for
2000 of the direct causes of neonatal deaths based on data from the World Health
Report (53) suggest that 87% of neonatal deaths in Malawi may be due to three causes –
infection, asphyxia and preterm birth (115). Indirect causes of neonatal death include
low birth-weight, maternal infection (especially syphilis, malaria and HIV) and maternal
complications in pregnancy (68, 69, 105).
Infections
Neonatal infections can be acquired in hospital as a complication of treatment, or at
home. Some sources of infection include unhygienic cord care, feeding practices
causing diarrhoea, and generally poor environmental hygiene. Prolonged labour or
prolonged rupture of membranes is also the cause of many neonatal infections. Preterm
infants are more vulnerable to infection, and neonatal tetanus is more common where
maternal immunisation rates are low (5). Poor feeding practices lead to diarrhoea as
well as poor growth (59). Most infections occur during or after birth, but infections such
as syphilis and HIV can also be acquired during pregnancy, and result in many cases of
stillbirth and neonatal death (68, 70, 73, 82).
The distribution of causes of neonatal death varies between countries, with countries
with higher neonatal mortality rates having a higher proportion of deaths due to severe
infection, tetanus and diarrhoea (5). Distributions of causes of death also differ within
countries. For example, neonatal tetanus tends to occur within only a few districts in
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countries that still have a higher rate. Tetanus deaths have been reduced by 50%
globally since 1990, and two thirds of low and middle-income countries had eliminated
neonatal tetanus. Most of the countries that remain with a high incidence of neonatal
tetanus are in Africa.
HIV is a major cause of maternal morbidity and also has adverse consequences for the
newborn. Prematurity coupled with low birth weight is the most common adverse
perinatal outcome associated with maternal HIV infection (116, 117). There is no
evidence that maternal HIV infection is associated with congenital abnormalities (117).
Infants that are infected perinatally tend to progress to AIDS earlier than those infected
later on, through breastfeeding. However, median age at onset of HIV-related symptoms
is beyond the neonatal period between 5 and 11 months. In Uganda, infant mortality
rates were over two times higher in infants born to HIV-positive mothers (209 per 1,000
live births) compared to HIV-negative mothers (98 per 1,000), irrespective of the
infant’s HIV status (99). HIV-infected infants have a seven-fold higher risk of infant
death than non-infected infants (118).
Prematurity and low birth weight
Prematurity is responsible for around a quarter of all neonatal deaths globally (5).
Prematurity is the main cause of early neonatal death, and resulted in 62% of deaths in a
WHO multicentre trial of calcium supplementation (119). Prematurity causes death
primarily as a result of immaturity of the organs, but is also an indirect risk factor for
neonatal deaths caused by infection. Preterm birth results in infants being born with low
birth weight. Low birth weight is not considered a direct cause, but is associated with
many neonatal deaths. Globally, around 15% of infants weigh less that 2500g at birth,
mainly as a result of being born prematurely (59). Maternal health and nutrition, as well
as infections such as malaria, are important determinants of birth weight.
One study looking at preterm births in southern Malawi found that 20% of women who
had attended ANC at either a health centre or district hospital delivered before 37
completed weeks (120). Preterm babies were twice as likely to die within 24 hours of
birth compared to babies born at term. Another study reported a similar incidence of
preterm births, and estimated that preterm was an underlying factor in 68% of neonatal
deaths (69). Preterm delivery was associated with maternal malaria, and was more
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common amongst primigravid women. Another study in Malawi found that preterm
delivery was two to three times more likely when cord, placental or maternal peripheral
paracitaemia were present (121).
A major underlying cause of newborn death is low birth weight (due to preterm birth
and in-utero growth restriction), with an estimated 60-80% of all neonatal deaths
occurring among low birth weight babies (5). In Malawi it was estimated that low birth
weight contributed to 80% of neonatal deaths, 46% of perinatal deaths and 38% of
infant deaths (122). However, few babies are weighed at birth in developing countries,
and even fewer are of known gestational age, so it is difficult to estimate the precise
contribution of low birth-weight to neonatal mortality. Efforts to reduce low birth-
weight births at population level have met with limited success, but extra attention to
warmth, feeding and prevention and early treatment of infections can reduce deaths in
preterm babies without the need for high-tech equipment.
Malaria is one of the few contributors to low birth weight that is amenable to
intervention through strategies such as intermittent presumptive treatment of malaria in
pregnancy (IPT), chemoprophylaxis and use of insecticide-treated nets (ITN) (105).
Concomitant HIV infection increases the risk of malaria and its adverse effects (123).
As mentioned above, maternal HIV infection independently contributes significantly to
prematurity and low birth weight in infants, and could also be tackled through PMTCT
programmes that focus not only on the HIV status of the infant, but also on the health of
the mother during and after her pregnancy (124). Steketee et al reviewed studies
between 1985 and 2000 and found that the population attributable risks of low birth-
weight associated with malaria and HIV were substantial (8-14% and 11-38%
respectively) (105). They suggest that between 25% and 90% of these adverse events
could be eliminated with full implementation of existing antimalarial and PMTCT
interventions.
Asphyxia
Asphyxia is responsible for about a quarter of neonatal deaths and is the main cause of
neonatal death in the first 24 hours (5). Asphyxia is mainly due to complications of birth
such as obstructed labour and malpresentation. It is more common in the absence of
good quality obstetric care. Complications of birth are also responsible for most
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stillbirths where the baby was alive at the start of labour but was born dead (fresh
stillbirth). Less severe asphyxia and trauma causes disability (40, 125).
Congenital anomalies
Congenital abnormalities are more common in developing countries and up to 1% of
infants are born with a major congenital anomaly (59). Maternal syphilis and nutrient
deficiency are both strongly related to birth defects. Lawn and colleagues estimate that
7% of neonatal deaths globally are due to congenital abnormalities (5).
Stillbirth
Foetuses may die in-utero, as a result of maternal illnesses or complications, but
complications during birth are the cause of death for most infants that were alive at the
onset of labour but die before birth (59). It is important to know at what point before
birth the deaths occur so that appropriate interventions can be developed. Where women
receive good care during childbirth, less than 10% of stillbirths are caused by labour
complications.
Timing of death
38% of deaths in children under five years old happen in the first 28 days of life. In
Africa this proportion is much smaller than in south-east Asia (24% compared to 50%),
due to the larger contribution of post-neonatal causes of child mortality such as malaria
and HIV in Africa (5). Even within the neonatal period there is considerable variation in
daily risk of death, with most deaths happening in the first 24 hours after birth (25-45%
of all neonatal deaths) and three quarters of deaths within the first week (5).
Determinants and risk factors for neonatal death
A framework for understanding the determinants and risk factors for child mortality,
similar to that for maternal mortality (Figure 2.3), has been developed (18). This model
combines social, environmental, and biological factors, by dividing them into five
groups of ‘proximate determinants’ and exploring how they are determined themselves
by ‘socioeconomic determinants’, and in turn how they relate to outcomes such as
morbidity and mortality. The authors argue for the need for a multidisciplinary approach
to the study of child survival, as childhood diseases have multifactorial origins. Many of
the same pathways apply for maternal and child survival, and many of the individual
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maternal, household, community and health facility risk factors are the same for
neonates and mothers, as pregnancy and birth outcomes are often inter-related.
Intrapartum complications carry a high risk for neonates, with obstructed labour and
malpresentation accounting for the highest risk (5), and perinatal mortality following
caesarean section is particularly high (126). Intrapartum risks outweigh risks during the
antenatal period or individual characteristics about the mother like age or parity. Skilled
attendance and facility delivery rates are lowest in the countries with the highest NMRs
(53). Skilled attendance at delivery is less than 40% in Africa and within countries it
tends to be lower in rural areas than in urban areas (Table 2.7 and Table 2.8). As for
maternal mortality, delays in receiving appropriate care for neonates can make a critical
difference to the outcome. Thaddeus and Maine’s three delays model outlined in Figure
2.3 (17) can be applied to neonatal death as well as maternal death, but additional
cultural and social factors may create barriers to care-seeking for neonates. In many
cultures babies are not named for several weeks or until the umbilical stump falls off,
reflecting the hesitance to emotionally invest in a child in the face of high mortality
rates, until it is definitely here to stay. A study in Guinea showed lower rates of health-
care seeking for sick neonates compared to post-neonatal infants (60% compared to
more than 90%) (127). In Malawi, dead newborns are buried in a separate, un-marked
graveyard because they are “not yet considered a significant member of the
community”, and taboos and seclusion restrict postnatal contact with people other than
the mother and close female relatives (128).
For infants, another important underlying cause of death may be that the mother has
died or is too sick to provide adequate care. A study in Egypt found that infants whose
mother died were at higher risk of dying themselves (43), and studies in sub-Saharan
Africa in HIV prevalent populations showed that infants whose mothers are infected
with HIV are at higher risk of dying, even when they are not infected themselves (82,
129), though this risk mainly affects children after the neonatal period (130).
Multiple pregnancies often result in higher rates of stillbirth, neonatal and maternal
death due to complications in pregnancy and childbirth and higher rates of prematurity
(114, 131). In a comparison of DHS datasets for 1990-2000 the risk of neonatal death
was about six times higher for multiple births compared to single births (80). The
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incidence of multiple births varies according to the region. In Malawi, infant deaths
were twice as common and perinatal deaths were 3.6 times as common for multiple
births compared to singletons (131).
Other biodemographic risk factors for neonatal death are mother’s age at birth, length of
preceding birth interval, birth order and sex of the child (80). When mothers give birth
at a young age they are more at risk of complications and infants are more at risk of
being born prematurely or with low birth weight. Older mothers are also at more risk of
pregnancy complications and their children are more likely to have congenital
anomalies. In the review of DHS datasets, mothers under the age of 20 and mothers
aged between 40 and 49 are 45% and 30% respectively were found to have their child
die in the first month of life (80). High birth order or high parity and first birth also
contribute to this effect, and it is difficult to disentangle the effects of each. Birth
intervals of less than 24 months also contribute a significant risk, with these infants
being almost twice as likely to die in the first month as children born after an interval of
24 months.
More boys than girls are born globally, but girls have a biological survival advantage
compared to boys in the neonatal period, (mainly due to lower vulnerability to
infectious diseases) (59, 80). This may be offset by the effects of decreased care-seeking
for girls, sex-selective abortion and female infanticide, especially in south Asia (5, 132-
134). On average, boys are 28% more likely to die in the first month of life (80).
Malawi DHS data show a higher neonatal mortality rate among males compared to
females – 42 per 1,000 compared to 32 per 1,000 – and this female advantage persists to
5 years. This is the opposite to patterns seen in Asia, in countries with a strong
preference for sons (135).
As described in section 2.2.3, poverty is a strong socioeconomic determinant of
neonatal death. Poor children are more likely to die as they are more likely to be
exposed to disease, less likely to receive preventive interventions, more likely to acquire
disease, have lower resistance to disease, lower access to health facilities, are less likely
to be managed appropriately in health facilities, less likely to get life-saving drugs and
have lower access to secondary and tertiary care (136-138). Socio-economic
differentials in neonatal mortality exist even within developed countries (139). Looking
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at data from 23 countries in sub-Saharan African and Asia, one estimate suggests that if
neonatal mortality rates for the whole population were equivalent to those seen in the
richest socioeconomic quintile, mortality would be reduced by 19% in sub-Saharan
Africa and 40% in Malawi (115). In the DHS review of childhood mortality estimates,
urban/rural residence and mother’s education were used as proxy measures of
socioeconomic status. Place of residence also affects access to health facilities,
transport, cash and opportunities for education. Malawi DHS and MICS data show an
urban-rural gradient (Table 2.7 and Table 2.8). Data on the relationship between poverty
and adverse infant outcomes in Malawi are more complicated, and some studies suggest
that HIV may be closing the equity gap in infant mortality, through increasing mortality
in less poor families rather than reducing mortality amongst the poorest (74, 82).
Cultural factors that may contribute towards neonatal health include women’s status and
decision-making power, early childbearing, birth spacing, cord care, wrapping and
bathing practices, use of colostrums and when and what other foods are introduced (59,
140).
Reductions in late neonatal mortality will be possible through immunisation,
breastfeeding and improved hygiene, but to prevent early neonatal deaths improvements
in access and quality of skilled delivery care will be required. In Africa, prevention and
treatment of malaria and HIV in pregnant women will also contribute to reductions in
neonatal mortality rates as well as stillbirth and maternal mortality rates (5).
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Chapter 3 : Review of evidence for community-based
approaches to reduce maternal and neonatal mortality
Effective maternal and newborn health interventions exist, but they are too often not
available to the poorest mothers and children amongst whom the highest mortality rates
are found (5, 58, 136). Low uptake of interventions amongst the poorest and most at risk
mothers may be related to difficulty accessing health services due to cultural, logistical
or financial barriers. As described in Chapter 2, a large proportion of women in Malawi
give birth at home, and this is higher in rural areas and amongst the poorest women
(Table 2.7 and Table 2.8). This chapter will summarise the available evidence for the
efficacy of key maternal and neonatal health interventions that can be delivered at
community-level, and go on to explore factors related to maintaining their effectiveness
at population level in poor communities. Several models for population-level,
community-based approaches to health promotion will be reviewed. This will provide
some further background to the rationale and development of the intervention in this
study.
3.1 Review of interventions to reduce maternal and neonatal mortality
Several recent reviews have summarised the evidence for effective interventions that
tackle maternal and neonatal health issues worldwide (60, 106, 138, 141-143). These
reviews have suggested that maternal and neonatal mortality could be reduced by 74%
and 41-72% respectively if universal coverage of these known interventions was
achieved (60, 138). The review by Bhutta et al identifies antenatal, intrapartum and
postnatal interventions for which the weight of evidence is sufficient to include them in
maternal and neonatal health programmes. They focus only on community-based
interventions for perinatal and neonatal outcomes, while other reviews consider the
broader spectrum of health care settings, especially for many maternal care
interventions that require skills and resources only normally available at health facilities
(143).
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The authors explored the global literature for evidence of the effectiveness of
interventions, principally from randomised controlled trials, but also from studies using
less rigorous designs, as well as from several Cochrane systematic reviews. A summary
of the main findings is presented in Table 3.1 and will be discussed in the following
section. Where Cochrane systematic reviews were available, references to these are
included.
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Table 3.1: Summary of evidence from meta-analyses and reviews of the impact of key interventions on maternal and neonatal outcomes
Interventions Maternal outcomes Risk reduction on maternal
outcome(s)
% reduction in maternal mortality
Neonatal
outcomes
Risk reduction on neonatal/perinatal
outcome(s)
% reduction in neonatal mortality
Preventive Cause-specific
mortality/morbidity
All-cause
mortality
Cause-specific
mortality/morbidity
All-cause
mortality
Intermittent malaria prophylaxis in pregnancy
(first/second pregnancies)
Placental malaria
Severe antenatal anaemia
65% (53-73%)
40% (24-52%)
- Perinatal deaths
Low birth weight
27% (1-47%)
43% (28-54%)
38% (-5 to 63%)1
Use of ITN in pregnancy
(first/second pregnancies)
- - - Low birth weight
Stillbirth/abortion
23% (2-39%)
33% (3-53%)
-
Iron and folate in pregnancy Iron-deficiency anaemia
(term)
67% (31-84%) Neural tube
defects
72% (42-87%) -
Screening for pre-eclampsia Deaths from hypertensive
disorders of pregnancy
48%2 - Preterm deaths 15%2
Calcium supplementation Pre-eclampsia 52% (31-67%) 20% (3-35%) Preterm
Low birth weight
19% (-3 -36%)1
16% (-3 -32%)1
-
Tetanus toxoid vaccination (2 or 3 doses) - - - Neonatal tetanus 98% (70-100%) 69% (45-83%)
Syphilis screening and treatment
(Prevalence dependent)
- - - Congenital
syphilis
Low prev – <1%
Moderate prev – 1-2%
High prev – 4-5%
-
Detection and treatment of asymptomatic
bacteruria
Deaths from sepsis (and
cases of infertility)
10% - Low birth weight 34% (11-51%) -
Antibiotics for premature (preterm) rupture of
membranes
- - - Neonatal sepsis 32% (13-47%) -
Corticosteroids for preterm labour - - - Preterm - 40% (25-52%)
Normal delivery by skilled birth attendant Deaths from sepsis 40%2 - Severe infection
Neonatal tetanus
15%
60%
-
Detection and management of obstructed
labour and breech (planned c-section)
Obstructed labour deaths
(and fistula)
95%2 - Asphyxia 40% Perinatal/neonatal
– 71% (14-90%)
Active management of third stage labour
(including partograph)
Postpartum haemorrhage
deaths and cases of anaemia
62%2 - Asphyxia - Early neonatal –
40%3
Hygienic delivery practices Puerperal sepsis - - Neonatal tetanus 55-99% 58-78%
Breastfeeding - - - Diarrhoea,
pneumonia
- 55-87%
Newborn temperature management - - - Hypothermia 18-42%
Kangaroo mother care
(Low birth weight infants)
- - - Infections 51% (7-75%) -
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Interventions Maternal outcomes Risk reduction on maternal
outcome(s)
% reduction in maternal mortality
Neonatal
outcomes
Risk reduction on neonatal/perinatal
outcome(s)
% reduction in neonatal mortality
Curative Cause-specific
mortality/morbidity
All-cause
mortality
Cause-specific
mortality/morbidity
All-cause
mortality
Magnesium sulphate for treatment of pre-
eclampsia/eclampsia
Eclampsia 59% (42-71%) - Asphyxia - -
Newborn resuscitation - - - Birth asphyxia - 6-42%
Initial management of postpartum
haemorrhage
Postpartum haemorrhage
deaths and cases of anaemia
75%2 - - - -
Referral care for severe postpartum
haemorrhage
Postpartum haemorrhage
deaths and cases of anaemia
75%2 - - - -
Management of maternal sepsis Sepsis deaths and cases of
infertility)
90%2 - - - -
Management of severe neonatal infections - - - Deaths from
severe infection
50% -
Management of low and very low birth weight
babies (LBW and vLBW)
- - - Preterm deaths
- LBW
- vLBW
40%
25%
-
Community-based case management for
neonatal pneumonia
- - - Deaths from
severe infection
40% 27% (18-35%)
Universal coverage of key interventions - - 74% - - 41-72%
(Source: Wagstaff, 2004; Bhutta, 2005; Darmstadt 2005 and Adam 2005, Gamble 2009, Barros 2010 (60, 138, 142-145))
1 Borderline statistical significance – 95% confidence intervals overlap zero
2 Based on expert panel assessment of available evidence (143)
3 This evidence comes from a before and after trial (146). A Cochrane review found no significant effect of partograph on maternal or neonatal/perinatal outcomes (147).
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3.1.1 Antenatal interventions
Prevention and management of health problems in pregnancy can be tackled through a
wide range of antenatal interventions. In developing countries, problems during
pregnancy are mainly related to nutritional deficits, infectious diseases and hypertension
(142, 148). Antenatal care is one of the main pillars of the World Health Organisation’s
(WHO) Safe Motherhood package (149), but there is a lack of strong evidence as to the
optimal content, frequency and timing of visits (150). Antenatal care varies in different
settings, so systematic studies of ‘standardised’ antenatal care programmes on maternal
and newborn health outcomes are difficult. The exact margin of reduction in maternal
mortality after antenatal care is not known, and a WHO systematic review of antenatal
care trials found no evidence of reductions in perinatal mortality (150). Some of the
most important components of antenatal care are tetanus toxoid vaccination, iron-folate
supplementation, detection and management of pre-eclampsia and screening and
treatment for infectious diseases like syphilis and malaria. The evidence is mixed, but a
review of the components of antenatal care suggests that quality antenatal care within a
functional health system can reduce the risk of maternal mortality and adverse
pregnancy outcomes (148). There is less consensus on the critical number of visits and
the most cost-effective components. A WHO randomised trial found little difference in
maternal or neonatal health outcomes for women having four antenatal visits compared
to those having more frequent visits (151).
Nutrition-related interventions
Poor maternal nutrition in pregnancy is common in developing countries and
contributes to anaemia, low birth-weight and other adverse pregnancy outcomes (152).
Several nutrition-related, antenatal interventions have been tested that supplement the
mother’s normal diet, including supplementation with nutrients such as protein, iron,
folate (periconceptual and antenatal), iodine, vitamin A (antenatal), zinc, calcium and
multiple micronutrients.
A Cochrane systematic review found that high-protein supplementation alone (without
energy supplementation) did not show any effect on pregnancy outcomes, but there was
strong evidence in favour of balanced protein-energy supplementation in reducing
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perinatal and neonatal deaths (153). Most of this evidence comes from efficacy trials,
and there was no evidence from trials of community-level supplementation or home-
available diets.
Oral iron supplementation is commonly included in antenatal care packages as it clearly
reduces maternal iron-deficiency anaemia. However, there is a lack of evidence for a
clear effect on maternal or perinatal/neonatal outcomes (154, 155). Pending the results
of better-designed trials, reviewers recommended that continued iron supplementation
to reduce the risk of adverse maternal outcomes is prudent, especially in malaria-
endemic areas (142). There is strong evidence to support the use of folic acid
supplements, given along with iron, for improving birth outcomes. Periconceptual folic
acid also reduces the risk of neural tube defects.
Iodine plays an important role in cognitive development and evidence for its benefits is
strong. Though much of this evidence comes from developed countries, its use is still
advocated in maternal and child health programmes in developing countries (60, 106).
There is some evidence for the benefit of vitamin A supplements taken before and
during pregnancy in reducing pregnancy-related mortality (up to 12 weeks postpartum)
through improvements of the immune and haematological status of the mother (156),
though a recent cluster-randomised controlled trial in Ghana found no evidence of
impact on pregnancy-related or all-cause adult female mortality (157). The effects of
vitamin A supplementation for child survival have been clearly shown, but the effects of
antenatal supplementation on perinatal/neonatal mortality are not clear (142, 158).
Evidence for the benefit of isolated zinc supplementation in pregnancy is weak, and
isolated zinc deficiency is unlikely to exist (159). Finally, there is emerging evidence of
multiple micronutrient deficiencies in pregnancy in developing countries, and given the
increased nutritional requirements during pregnancy, multiple micronutrient
supplementation would seem to be a plausible means of improving pregnancy outcomes
(142). The evidence of the benefits of multiple vitamin supplements for women in
developing countries is unclear (160), and there is some evidence that increased birth
weight increases the risk of obstructed labour and perinatal death (142). The widespread
use of multiple micronutrients is not recommended until further trials have been
conducted in developing country settings (142, 160).
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The benefits of antenatal calcium supplementation to prevent pregnancy-induced
hypertension and pre-eclampsia and consequent death or morbidity are strongly
supported, especially for mothers living in communities with low dietary intake of
calcium (141, 161). Screening women at antenatal visits to identify those at particular
risk of pre-eclampsia may further enhance the effects of calcium supplementation and
enable better management of pregnancy-related hypertension (143, 148).
Infection control and prevention
Malaria is a major problem in endemic countries and can cause severe complications in
pregnancy, especially in primigravidae (first pregnancies) (123). HIV infection may
impair the ability to acquire pregnancy-specific immunity to malaria, thus increasing the
risk of complications (104). A Cochrane review reported that in malaria-endemic areas,
malaria prophylaxis during pregnancy reduces maternal anaemia and improves birth
weight. Benefits for the outcome of the infant were not clearly demonstrated, though
perinatal mortality was reduced amongst low parity women (162). Continuing research
into different prophylaxis strategies is necessary as resistance continues to emerge to
new anti-malarial drugs (163). There is strong evidence for the benefits of using
insecticide treated bed-nets on placental malaria, low birth weight, childhood mortality
and on maternal anaemia, and some for improved pregnancy outcomes (144). Further
operations research is needed into how to make this intervention feasible at scale, and
longitudinal follow-up after social marketing and mass free distribution in Kenya
showed increased coverage and sustained child survival effects (164). Hookworm
infestation is associated with anaemia in endemic areas, and de-worming with
mebendazole can reduce the prevalence of anaemia in pregnancy (165), but clear impact
on maternal anaemia during the third trimester of pregnancy and other pregnancy
outcomes has not been shown (145, 165). Further community-based effectiveness trials
are needed to evaluate the benefits and possible complications.
Genitourinary tract infections may cause intrauterine infections or inflammatory
reactions leading to preterm birth, and can be a significant underlying factor in late
foetal deaths (145). Case identification and treatment of maternal syphilis can have
significant benefits for perinatal/neonatal outcomes, though uncertainty remains about
what the optimal treatment regimens are (142, 166). Implementing accessible, quality
diagnostic and treatment services has been challenging, and further operational research
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is needed to investigate ways to achieve this (166). Screening and treatment of
asymptomatic bacteriuria (urinary tract infection without symptoms) has been
associated with improved birth outcomes in developed countries, through reductions in
low birthweight and preterm births, though the evidence is inconsistent (145, 167).
Logistical and technical requirements are major barriers to widespread implementation
in developing countries, and operational research would be needed to find ways to make
such services more widely available (142, 167). Mixed evidence exists for the benefits
of antibiotic treatment of bacterial vaginosis (145, 168). It may reduce low birth weight
and other adverse birth outcomes, but may also increase the risk of preterm births (142).
Once again, there is difficulty in operationalising this intervention through developing
country health systems. Premature rupture of membranes is strongly associated with
infection, and this infection is related to preterm birth (145). Routine antibiotic therapy
for preterm labour where membranes are intact has no clear benefit, however, where
membranes rupture prematurely, antibiotic therapy has shown to be clearly beneficial in
improving neonatal outcomes (142, 169).
There is overwhelming evidence for the benefits of tetanus toxoid immunisation on
neonatal outcomes (170). In addition, clean delivery practices and clean umbilical cord
care contribute to infection prevention (19, 171, 172). Clean delivery kits may help
promote hygienic practices in the community, but general behaviour-change
interventions are necessary alongside the kits. Research into maternal immunisation for
pneumococcal infection is in its preliminary stages, but could provide a promising
means of protecting young infants from infection (142).
Maternal education
Finally, general maternal educational level is associated with better perinatal and
neonatal outcomes, even after correction for socioeconomic status (80, 142), though
there is little available evidence for effective strategies to improve educational capacity
of mothers. A Cochrane review of studies in developed countries found little evidence
for benefits on maternal and neonatal health outcomes of health promotion interventions
targeted at women before pregnancy (173), and another review of group or individual
antenatal education was inconclusive (174). In one study in Nepal an individual health
education intervention to promote behaviour change in relation to newborn and infant
care and breastfeeding failed to achieve any significant improvement in knowledge or
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behaviour outcomes (23), and it has been suggested that community participatory
learning can be a more effective way to change behaviour (22).
3.1.2 Intrapartum interventions
Community-based interventions
Interventions targeting prevention and management of complications during delivery
are usually developed and tested for use in health facility settings. Although
community-based interventions have been used as a means of promoting the use of
these services (175), few interventions have been developed for the management of
complications of delivery in communities, despite the fact that many births happen at
home. Some interventions such as caesarean section obviously cannot be adapted to
community settings, however, model-based predictions suggest that it may be possible
to augment health-facility care by providing drugs for emergency treatment of
postpartum haemorrhage and sepsis in the community, as a back-up for women who are
not able to reach a health facility in time (176). Other intrapartum interventions that
have the potential for use at community-level relate to infection prevention. One such
intervention is maternal vaginal and newborn skin antisepsis, though meta-analyses
have not shown significant reductions in postnatal infections or neonatal deaths in a
hospital-based setting using chlrohexidine (177, 178). Other community-level methods
of infection prevention during delivery might include use of clean razor blades and
cutting surfaces, plastic sheets to lie on, soap for hand-washing (or latex gloves), and
clean threads to tie the umbilical cord. In some settings these have all been combined to
form ‘clean home delivery kits’ or ‘birth kits’ (19, 171). Kits such as these have been
tested in community settings, and there is strong evidence for the benefits of hygienic
delivery practices in reducing deaths from sepsis and tetanus in mothers and neonates
(60, 142, 143).
The assistance of a skilled birth attendant during delivery is highly desirable (175), but
the majority of women in developing countries give birth at home, without access to
medical care. Training traditional birth attendants (TBAs) for improved maternity care
is controversial, and evidence in support of continued TBA training programmes is
inconclusive for maternal outcomes (179). Training TBAs or community health workers
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(CHWs) to provide advice and support for newborn care after delivery may be more
acceptable to policy-makers as the skills and equipment for managing the most common
problems are less technical. Studies have shown that training TBAs has been beneficial
for perinatal and neonatal outcomes, and little evidence was found to suggest no benefit
(179). Further research is needed in this area, and also to investigate other interventions
that TBAs and CHWs could deliver in the community.
Facility-based interventions
Some obstetric complications cannot be managed or treated at community-level, and
effective interventions in health facilities are included as components of basic and
comprehensive emergency obstetric care (BEmOC and CEmOC), such as active
management of labour by a trained health worker, caesarean section, blood transfusion,
magnesium sulphate, antibiotics for premature rupture of membranes and
corticosteroids for preterm labour. When deliveries are attended by trained health
workers, interventions such as management guidelines can help to improve the quality
of care provided. However, a Cochrane review found no evidence that using a
partogram to monitor the progress of labour makes any difference to the likelihood of
caesarean section and delivery complications (147). On the other hand, active
management of third stage of labour (especially use of drugs like oxytocin or
misoprostol) is associated with a reduction in deaths from anaemia and post-partum
haemorrhage (180-182).
In a comprehensive emergency obstetric care setting (CEmOC), caesarean section is
possible. According to a panel of experts, management of obstructed labour (including
external cephalic version for breech presentation, and vacuum extraction, forceps or
caesarean section for persistent breech) is expected to have a large impact on maternal
deaths (95% of deaths due to obstructed labour prevented) (143). Breech birth can result
in poor outcomes, and there is clear benefit for perinatal and neonatal mortality with
planned caesarean section for breech, though slight increase in maternal morbidity
(183). If appropriately managed in accordance with clinical protocols in a modern
labour setting, vaginal delivery of breech can achieve a similar level of safety as
caesarean section (184). In developed countries, caesarean delivery is the main risk
factor for postpartum maternal infection (185). Antibiotic prophylaxis following
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caesarean section significantly reduces the incidence of fever and infection in mothers,
but there is uncertainty about the consequences for the baby (186).
For the treatment of pre-eclampsia/eclampsia, there is clear evidence for the benefit of
magnesium sulphate, as compared to placebo or other drugs such as phenytoin or
diazepam. Three Cochrane reviews of magnesium sulphate found evidence for
significantly reduced maternal deaths and reduced risk of further fits (187-189).
3.1.3 Postnatal interventions
There are many interventions to improve postnatal care that could be applied at
community-level. Even apparently quite sophisticated interventions such as newborn
resuscitation, hypothermia prevention and care for preterm or low birthweight infants
have been adapted and tested in community settings.
There is preliminary evidence for the capacity of trained TBAs or CHWs to learn
resuscitation skills and save newborn lives (179). However, in a six-country
effectiveness study using the WHO Neonatal Resuscitation Programme to train TBAs,
no impact on perinatal or neonatal mortality rates was seen, though the incidence of
stillbirths was reduced (190). Simple drying, stimulation and warming as a part of
routine neonatal care might be more straightforward as a way of promoting the basic
elements of newborn resuscitation at community level (142).
Few studies have evaluated the prevention, recognition and management of
hypothermia in the newborn in developing country settings. A Cochrane review
including mainly studies from North America, found that inexpensive interventions
such as plastic wraps and skin-to-skin contact showed reductions in heat losses, though
no evidence was available for mortality outcomes (191). Simple, routine care practices
could be carried out at community-level, such as immediate drying, wrapping and
breastfeeding, delayed bathing and close contact with the mother. Thus, development
and evaluation of culturally appropriate behaviour-change interventions is required to
promote these practices at home.
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Skin-to-skin contact for preterm low birthweight infants after birth also promotes
increased weight gain and reduces the risk of nosocomial infection. All newborns in the
community may benefit from this intervention, but especially high-risk infants. A
Cochrane review of Kangaroo Mother Care (skin-to-skin contact between mother and
newborn) found evidence that it reduced infant morbidity in low birthweight infants, but
not infant mortality, though the quality of the evidence was poor and further research
was recommended (192). Another intervention that has only been tested in hospital-
based settings so far, but has the potential to be adapted to community settings, is the
application of topical emollients (193). Serious bacterial infections can enter through
the skin of newborns, especially preterm infants whose skin is not fully developed, so
emollients can be applied to enhance skin-barrier function. As mentioned above,
evidence for the benefits of neonatal skin antisepsis for infection prevention is limited.
Benefits of antisepsis of the umbilical cord has similarly limited evidence, though might
be useful just as a way of replacing harmful practices such as cow dung application
(142, 172).
Other important neonatal infections with prevention and treatment interventions include
ophthalmia neonatorum and pneumonia. Gonorrhoea and Chlamydia are the main
causes of ophthalmia neonatorum and can be treated or prevented with prophylactic
application of with silver nitrate, tetracycline or erythromycin ointments. The benefits
of routine prophylaxis in areas endemic for gonorrhoea have been shown, though the
evidence for Chlamydia is less clear (142). The impact of training CHWs to recognise
and manage neonatal pneumonia in communities in developing countries is significant
(194). Case management is superior to no case management, though the impact is
limited given that distinguishing pneumonia from sepsis can be difficult and use of oral
antibiotics alone may lead to under-treatment of infections. However, research in India
showed that training of CHWs to identify and treat sick newborns with parenteral
antibiotics was feasible and effective in reducing neonatal mortality due to pneumonia
(195).
Nutritional interventions can be easily applied at community-level, and the benefits of
breastfeeding have been extensively reviewed, showing reduced neonatal and infant
morbidity and mortality with early and exclusive breastfeeding in community settings in
developing countries (196). Lack of exclusive breastfeeding is also linked with
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increased risk of neonatal sepsis (197), and based on a systematic review of the optimal
duration of exclusive breastfeeding, WHO and UNICEF recommend exclusive
breastfeeding for the first six-months of life (198, 199). The benefits of vitamin A
supplementation on child mortality in developing countries are also well known, and
there is interest in the potential benefits for neonatal and infant outcomes. There is some
evidence for the benefits of neonatal vitamin A administration, but further research is
needed (200).
3.1.4 Summary of evidence and gaps in knowledge
On the basis of their review, Bhutta et al recommend several interventions for
immediate inclusion in programmes. These are shown in Table 3.2. These closely
resemble interventions advocated by WHO (201, 202) and identified by the Saving
Newborn Live Initiative of Save the Children/USA (203), suggesting that there is a
convergence of expert opinion. Effective interventions span maternal and newborn care,
illustrating the importance of a coordinated approach to both. To prioritise the highest
impact and most appropriate interventions for sub-Saharan Africa and Malawi, an
evidence-based approach based on local epidemiological, coverage data and contextual
considerations is needed (9).
The pillars of essential newborn care are: resuscitation where necessary, immediate
breastfeeding, warmth, hygiene (especially for delivery and cord care), and prevention,
early detection and management of major diseases (204). These in addition to effective
pregnancy, childbirth and postnatal care will be the most important strategies to reduce
neonatal and perinatal mortality. “Basic” and “Comprehensive” emergency obstetric
care (BEmOC and CEmOC) care at facilities will also be essential. BEmOC facilities
should offer skilled attendance at birth, administration of intravenous fluids, antibiotics,
anticonvulsants and oxytocics, manual removal of the placenta, provide help for
retained products of conception and carry out an assisted delivery when necessary.
CEmOC facilities should include all the basic functions, in addition to the ability to
perform blood transfusions and caesarean sections (205). Good maternal nutrition, the
prevention and management of anaemia (and malaria) and high-quality antenatal care
will reduce the incidence of complications and thus perinatal, neonatal and maternal
deaths.
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Table 3.2: Summary of antepartum, intrapartum and postnatal interventions recommended for inclusion
in programmes
Antepartum care Intrapartum care Immediate newborn
care
Postpartum care
 Tetanus toxiod
immunisation
 Nutrition: iodine,
iron/folate
(periconceptual)
 Maternal infections:
syphilis, malaria
(endemic areas)
 Breastfeeding
counselling
 Birth preparedness
 Danger signs
 Clean delivery
 Skilled care at
delivery
 Danger signs
 Newborn
resuscitation
 Prevention of
hypothermia:
drying, warming
 Prevention of
hypoglycaemia:
immediate
breastfeeding
 Prophylactic eye
care (areas
endemic for
gonorrhoea)
 Exclusive
breastfeeding
 Clean umbilical
cord care
 Maintenance of
temperature
 Pneumonia and
sepsis
management
 Early postpartum
visit
 Birth spacing
Adapted from Fig 1. Bhutta 2005 (142)
As well as specific maternal and neonatal interventions, general public health
interventions like immunisation, improved nutrition and water and sanitation also make
important contributions to maternal and child survival. Treatment and management of
diarrhoea, respiratory infections, malaria, malnutrition, HIV/AIDS and pregnancy
complications contribute to general improvements in the health of mothers and children.
Knowledge gaps
Community-based strategies have the potential to achieve higher coverage than facility-
based interventions where health service use is low, and they may be a means of both
changing behaviours related to prevention and care as well as increasing awareness and
uptake of health services (206). There is a paucity of evidence from community-based
trials of maternal and newborn health interventions in developing countries, particularly
RCTs (142). Gaps identified in the knowledge base of mother and child health include
the need for better understanding of family and community practices and to develop
tools to build individual, household and community capacity for appropriate self-care
and care-seeking. Critical questions remain on how to operationalise effective
interventions, such as which cadre of health worker to deliver the interventions, how
they can be linked efficiently to referral systems and how they will be trained and
supervised (142). The main question is how to effectively deliver services in an
integrated way within existing mother and child health programmes, and maintain high
levels of coverage in various epidemiological contexts and populations (206).
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Strategies, packages and combinations of interventions need to be tested through
effectiveness trials in health systems settings.
Poverty, illiteracy, gender imbalances and dysfunctional health systems are underlying
factors in all maternal and child health issues (142). However these cannot be addressed
by public health interventions alone, but require national and international level
strategic changes to bring about social development, economic growth and reduce
inequity over a longer period of time (207). Implementation of evidence-based, cost-
effective health programmes is critical in the shorter term to bring about reductions in
mortality.
None of these reviews evaluated the evidence for the impact of HIV prevention and
prevention of mother-to-child transmission of HIV interventions on maternal and
neonatal mortality. There is accumulating evidence for the impact of such interventions,
with five Cochrane reviews looking at reduction of MTCT (208-212). They describe
considerable benefits for the mother and newborn of interventions such as ARVs,
caesarean delivery, complete avoidance of breastfeeding (if affordable and feasible) and
exclusive breastfeeding (where access to clean water is limited) as well as longer-term
benefits, especially in countries with high HIV prevalence. Vaginal disinfection and
vitamin A supplementation were not found to be effective ways of reducing MTCT
(208, 211, 212).
Similarly, none of the reviews evaluated the benefits of family planning interventions
for maternal and neonatal health. Availability of family planning is likely to reduce
attempts at unsafe abortion and thus the incidence of complications of abortion (106).
Other obstetric and neonatal conditions would also be avoided, due to the reduced
number of pregnancies and physiological burden on the mother. A recent review
provides strong evidence for the benefits of contraception in reducing not only the
number of deaths through a reduced number of total pregnancies, but reducing the
proportion of high-risk births and associated maternal deaths (213).
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3.2 Complex interventions for complex populations
Most of the interventions described above are single clinical interventions, but single
interventions on their own cannot tackle the complexity of prevention and treatment for
maternal and neonatal health problems at population level. Combined packages of
interventions are required to address the spectrum of disease conditions and their
determinants. Population dynamics and behaviours are also complex, and interventions
and evaluations that take into account complex population factors such as coverage,
adherence and quality are also needed.
3.2.1 Complex interventions
Maternal and neonatal health strategies
As described in Chapter 2, the epidemiology and aetiology of maternal and neonatal
health is complex. An added level of complexity is that individuals are not only at risk
of one disease condition, though they may be more at risk of one or another, and
sometimes several related pathologies may arise – e.g. obstructed labour, ruptured
uterus, neonatal death from asphyxia, maternal death from haemorrhage or sepsis.
Because of this complexity of aetiology and causal pathways, people are simultaneously
exposed to multiple risk factors for multiple diseases, so approaches that combine
several interventions in one package, programme or public health strategy are likely to
be more successful at reducing mortality rates on a population level (141). The health of
the newborn is inextricably linked to the health of the mother, so many strategies to
improve the health of women improve both pregnancy and neonatal outcomes.
In practice, interventions are rarely applied in isolation. Safe motherhood and integrated
management of childhood illness (IMCI) strategies are examples of such public health
approaches (214). Interventions for both mother and child health span antenatal,
intrapartum and postnatal periods, and the integration of maternal and neonatal care is
important. Maternal care packages not only improve the health of mothers, but also
improve the outcomes for infants. Using integrated approaches and interventions that
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benefit mothers and newborns simultaneously, and avoiding vertical programmes that
focus on one or the other is likely to be more cost-effective.
A review of packaged interventions for neonatal health found that evidence for the
effectiveness of mother and newborn health strategies, as opposed to single
interventions, is limited (215). Interventions were largely combined together out of
convenience rather than anticipated synergistic effects. There is some evidence for the
benefit of antenatal care packages that combine some of the interventions into one
package (150), but a large-scale effectiveness trial to determine the magnitude of effect
would now be unethical (142). Community-based case management of neonatal
pneumonia was identified as the most cost-effective intervention for sub-Saharan
African countries with high mortality to achieve mother and neonatal health millennium
development goals (216). Several studies have shown that packages of newborn care in
settings where health services are limited can be beneficial, but few of the studies
reviewed were done with existing staff and infrastructure, so concerns about
replicability and sustainability arise, and the cost-effectiveness at larger scale is not
clear (142, 217, 218). A recent multi-country study looking at the impact of TBA
training on perinatal and neonatal outcomes found no effect of training TBAs with
either general essential newborn care or specific newborn resuscitation skills on
neonatal mortality, but a significant reduction in stillbirth rate (relative risk 0.69 (95%
CI, 0.54 to 0.88; P=0.003)) (190).
Skilled care during delivery is a major long-term goal for improving mother and child
health outcomes, and health system capacities need to be developed. Since health
systems are currently struggling in many developing countries, the question arises as to
whether large reductions in mortality can be achieved in the shorter term by focusing
mainly on preventive behaviour-change interventions, without investing in active
management of illness and curative interventions (142). Understanding what the added
benefit and cost-effectiveness would be of interventions for active identification and
management of illness is an important next step.
Campbell et al have summarised the key decision points for policy-makers: a suitable
package of interventions needs to be defined, a means of distributing this package needs
to be developed and the most appropriate target population needs to be identified (106).
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This combination of package, delivery mechanism and target population makes up a
health ‘strategy’ (Figure 3.1). Similar emphasis on the importance of distinguishing
between biological and behavioural interventions and the mechanisms through which
they can be delivered has been made in child survival literature, and the need for better
understanding and evidence for successful delivery mechanisms (206).
Figure 3.1: Schematic representation of a strategy aimed at maternal and neonatal health outcomes
(adapted from Campbell, 2006 (106))
Maternal, perinatal, neonatal and infant care in developing countries requires an
integrated and holistic package of interventions at various levels, including direct
health-related measures as well as poverty alleviation, improved educational
opportunities, gender balancing and empowerment. These need to be intentionally
combined in evidence-based packages, and delivered through context-specific and cost-
effective mechanisms (206, 215, 219). One approach for selecting components for
community-based neonatal mortality reduction packages has been to use models such as
the Lives Saved Tool (LiST), that predict mortality effects with inclusion of different
components (220).
Maternal and neonatal
health outcomes
Packageage
Means of distribution Target
Strategy
Single intervention
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Focusing on supply or demand
There is a tendency to dichotomise the choices about how to focus interventions, such
as the debate about the relative merits of health-facility strengthening and community-
based interventions, but most often interventions, strategies and programmes fall along
a continuum (141). For example, the questions relating to whether it is better to focus
on improving supply or creating demand for health services are often posed. Traditional
health interventions focus mainly on improving availability and quality of formal health
services – the ‘supply’ of health care. Meanwhile, community-based health
interventions have often focused on creating ‘demand’ for health services through
greater recognition of danger signs and improved health care-seeking patterns, using
methods such as community mobilisation. However, issues relating to supply and
demand are closely linked and changes in one can influence the other. Focusing on
either supply or demand alone is unlikely to achieve great impact on health outcomes –
creating demand without good quality services (and vice versa) cannot meet people’s
health needs.
Current international opinion suggests that both facility and community approaches are
important to ensure the continuum of care throughout pregnancy, childbirth and the
postpartum periods (221, 222). The Making Pregnancy Safer initiative recognises that
availability of quality health services will not produce desired health outcomes unless
the capacities and awareness of individuals, families and communities are improved,
and linkages between them and the health care delivery system are built and
strengthened (223).
Focusing on prevention or treatment
Another question commonly posed by policy-makers is whether it is better to focus on
prevention efforts or to develop good facilities to treat illnesses and complications
(141). Promotion of family planning is an example of a primary prevention strategy for
maternal mortality, by preventing unwanted pregnancies, moving births into lower risk
categories and reducing the total number of births. Family planning alone may have an
impact on the maternal mortality rate, by reducing the total number pregnancies and
deaths, but it might have little effect on the maternal mortality ratio unless the risk of
dying once a woman becomes pregnant is also addressed. However, a recent review
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suggests that by reducing high-risk births increased use of contraception can avert
additional maternal deaths and reduce the maternal mortality ratio (213).
Another preventive approach that is increasingly popular among public health decision-
makers is micronutrient supplementation. It is perceived to be cheap, safe and relatively
easy to implement. However, the evidence base for its effectiveness is weak. There are
many trials and Cochrane reviews related to micronutrient supplements, and there is
some evidence for the benefits of antenatal vitamin A and calcium supplements (for
maternal outcomes) and iron-folate and protein-energy supplements (for neonatal
outcomes) (153-155, 158, 161).
It is believed that antenatal care offers an opportunity to detect early signs of, or risk
factors for, morbidity and mortality. However, this risk assessment approach may not in
fact be a cost-effective use of resources, and emphasis has shifted from universal access
to antenatal care to universal access to professional delivery care (141). However,
antenatal discussions have other benefits and are still an important part of pregnancy
and birth planning. Skilled attendance at delivery is a preventive strategy at normal
deliveries, but when complications arise emergency obstetric care (EmOC) provides a
package of interventions focused on direct obstetric complications that cause the
majority of maternal deaths.
Improving quality of services
Effective facility-based interventions need to be delivered through high quality health
systems, and the improvement of obstetric services is one of the key elements of the
Safe Motherhood programme (141). Making improvements to existing health services
within the constraints of tightly limited health budgets is a challenge in many
developing countries, and will require long-term government investment and support
from the international community (221). Long-term planning for the training and
deployment of additional health workers, especially midwives, will be a crucial part of
this.
One way of improving the quality of existing services is through auditing. Confidential
enquiries into maternal deaths were developed as a way of identifying the causes of
maternal deaths and the avoidable factors contributing to them (224). A confidential
86
enquiry in Malawi found that the quality of care had been “sub-standard” in 62% of
deaths. Deficient hospital care was the principal avoidable factor in 38% of deaths, and
hospital and health-centre care is reported to have deteriorated since a previous audit in
1989 (94, 225). Recommended improvements included strengthening supervision,
regular reviews of maternal and perinatal deaths, maternity waiting homes to reduce
delays in reaching health facilities, and better telecommunication and transport systems
to reduce barriers to timely care and referral.
Another approach to auditing is facility-based maternal death review, which reviews
each case of maternal death that occurs so that lessons can be learned from the
management of the case to improve future practice (141). In a maternal death review in
nine hospitals in Malawi, the main factors that contributed to maternal deaths were
grouped into health worker factors, administrative factors, patient/family factors and
TBA factors (6). Of those, health worker factors were the most prevalent, and they
included inadequate resuscitation, lack of obstetric life-saving skills, inadequate
monitoring, incomplete assessments and delays in starting treatment. Major institutional
problems were encountered with shortages of staff and equipment. A study of the
process of maternal death review in Senegal concluded that it was a beneficial strategy
for improving maternal health, and had a marked effect on resources, management and
maternal outcomes (226).
3.2.2 Complex populations
As described in Chapter 2, the epidemiology of maternal and neonatal mortality is
complex and many inter-related factors determine health outcomes for mothers and
neonates. As such, approaches to tackling maternal and neonatal mortality are also
complex, and must take into account the important contextual factors that determine
health outcomes in different settings (57). ‘Vertical programmes’ take single disease
conditions and identify straightforward clinical actions to prevent or treat the disease
(e.g. screening test, drug, vaccine, nutritional supplement). In a setting, where access to
quality health care can be limited, a public health intervention would, in addition to the
clinical action itself, have to take into account different geographic, socioeconomic and
cultural barriers to uptake and adherence, as well as health system management factors
affecting implementation. Though an intervention may be known to be efficacious in
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ideal settings, contextual and confounding influences might obscure the evidence of its
effect when implemented in a population setting. Interventions may fail to achieve
significant reductions in mortality at a population level due to factors such as
incomplete or patchy coverage, low uptake among some groups, limited diagnostic
accuracy, ineffective application of interventions, or low adherence to treatment.
Strategies that enable communities to benefit more efficiently from existing evidence-
based interventions have the potential to achieve large reductions in mortality. For
example, one study of malaria treatment in Burkina Faso reported that although the
treatment drug was 85% effective, the true community-effectiveness was only 3%, due
to factors such as low uptake of health services in case of illness (21%), poor diagnosis
and management by clinicians (31% sufficient history taken, 69% complete
examination, 81% correct dosage prescribed), and patient adherence (68% took drugs as
prescribed) (227). Addressing barriers to uptake of such services is essential, alongside
the necessary improvements in clinical skills.
Coverage and access
Reviews have suggested that effective interventions for maternal and neonatal health
exist, and large reductions in mortality could be achieved by increasing their coverage
(60, 138). But coverage is a complex issue and many factors must be considered in
order to improve it. These include, widening the provision or distribution of
services/interventions, increasing uptake and use of interventions and ensuring
consistent and optimal use (138, 219). Provision and distribution of services and
interventions is usually the responsibility of health care providers, and depends on
personnel, training, infrastructure and consumables, which make up the ‘supply-side’ of
intervention coverage. On the other hand, uptake and use of services and interventions
depend on a host of community factors such as distance, cost, acceptability and culture,
which make up the ‘demand-side’ of intervention coverage. Improving coverage
therefore requires understanding of both the supply-side and demand-side barriers, and
consideration of mechanisms to address each.
Many public health interventions have the potential to achieve a high coverage at a
relatively low cost – such as vaccinations, comprehensive antenatal care (including iron
folate and antimalarial prophylaxis). Alternatively, interventions can target specific
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diseases that cause high morbidity or mortality, or target particular population groups
(e.g. the poorest, or the furthest from health facilities) who are at higher risk of disease.
Packages of care that tackle multiple risk factors (e.g. antenatal care, skilled delivery
care, or community-based women’s groups) and have a high coverage amongst the
poorest groups, can be more cost-effective than single interventions (60).
Inequalities and barriers to health care
Better coverage does not necessarily happen evenly across a population (136). The
inverse care law described in the 1960s in the UK states that, ““The availability of good
medical care tends to vary inversely with the need for it in the population served.”
(228). This means that the poorest people in society are the ones who are most
vulnerable to health problems but often have least access to appropriate health care.
Inequalities in health exist within and between countries, even in developed countries
(229). Internal variations may be masked by national figures, but large geographic,
economic and social variations exist. Urban-rural differences can be substantial. MMR
is usually higher in rural areas, in part due to large distances between health facilities
and poor transport infrastructure (85). The pattern may be reversed where quality of
health care is poor and urban areas may have more overcrowding and higher
prevalences of HIV and unsafe abortion. In Peru maternal mortality was found to be
more than six times as high in the poorest quintile of the population compared to the
wealthiest (more than 800 per 100,000 compared to less than 130) (58). Part of the
explanation may be differences in uptake of antenatal, delivery and postnatal care
services between rich and poor women, but societal factors and group characteristics
such as ethnicity, caste, race and religion, and individual factors such as marital status,
self-esteem and psychosocial wellbeing are also important pathways through which
disadvantage can exert an effect on health.
Mother and Child Health (MCH) interventions often reach people in better off groups
more frequently and faster than they reach poorer groups, even when they were
intended to benefit primarily the poor (137). The World Bank Reaching the Poor
programme evaluated a sample of interventions to see how their benefits were
distributed across different socio-economic groups. Comparing coverage rates of 8
basic MCH interventions in 56 developing and transition countries, coverage was found
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to be higher in the best-off 20% of the population compared with the poorest 20%.
Government expenditure on health was also shown to benefit the best-off 20% more
than the poorest 20% (230). Approaches that were successful in reaching the poorest
groups included; paying rather than charging poor families for clinic attendance,
targeting interventions at the poorest groups, contracting with NGOs to run rural
primary health services, and targeted bednet distribution in rural areas.
Strategies such as conditional cash transfers, now popular with donors, have been
introduced in an attempt to reach the poorest and reduce the cost barriers for them to
access health care (231). Examples of this have been seen in Mexico, Honduras and
Nepal, where cash transfers are made conditional on a woman delivering at a health
facility. However, women from the most remote areas are still at a disadvantage because
they have the longest distance to travel and may only set off once labour has already
started. These women may deliver en-route to the health facility, where they are
arguably worse off than if they had delivered at home. The financing scheme in Nepal
also provided transport costs in order to further reduce the barriers to health care for the
poorest women, but this was challenging to implement (232).
3.3 Community-based interventions to reduce maternal and neonatal
mortality
In the past most programmes targeting maternal and neonatal health have focused
mainly on improving the quality of health service provision (antenatal care, skilled
delivery care and emergency obstetric care), where quality may have been compromised
by lack of adequately trained health workers, lack of medicines supplies and equipment,
overcrowding and poor hygiene. However, in populations where most mothers deliver
at home and the capacity of health services is severely stretched, the impact of
interventions focusing on skilled attendance and improved obstetric care at facilities
alone is likely be limited.
The rationale for using community-based interventions is based on the fact that many
maternal and neonatal deaths occur at home, and could potentially be avoided by
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changes in antenatal and newborn care practice. Consolidation of the links between
primary health care services and their users – a need spelt out in the Alma-Ata
Declaration (233) – is an essential part of this process, and involves both improving the
quality of the services and creating a demand and awareness among the community to
use them. As described in the previous section, reasons for under-use of existing
services are complex, and in order to increase the uptake of services, not only must
physical barriers to access be removed, but issues of service quality and community
perceptions of service providers must be addressed.
Supply and demand are intimately linked: where users have little say in the design and
management of services, services are unlikely to be successful in meeting their needs.
Creating a demand-driven environment for service delivery therefore, might not only
improve the quality of the services, but also increase uptake. Users who are concerned
and involved with planning service delivery and have an obvious influence are more
likely to use services knowledgeably and appropriately and to pay greater attention to
health messages. In the context of maternal and newborn health, this may mean that
women with high-risk pregnancies and at-risk newborns may be referred more promptly
to the right health facilities.
3.3.1 The importance of community participation in health interventions
The fourth article of the Alma Ata Declaration stated that, “people have the right and
duty to participate individually and collectively in the planning and implementation of
their health care” (233). But even where work to improve health has been done at
community level, decisions have not always been made by the people most affected by
those health issues. Decisions may be made by certain individuals who control
resources, or by people who do not even come from the community. This has generally
been because the interventions have lacked local ownership, there have been different
perceptions of priorities between officials and communities, and because powerful
groups have captured the necessary resources (234-236). Groups most consistently
excluded from decision-making have been women and children.
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Involving groups who have traditionally had little influence in decision-making is very
important for a number of reasons. Firstly, it can lead to better and more appropriate
decisions being made – people in the community have a lot of experience and insight
into what works, what does not work, and why. Secondly, it can increase community
commitment to planned work and thus ensure its sustainability. Thirdly, it can enable
the community to gain some power and control over any planned work and can lead to
their empowerment. Finally, it can increase the resources available for the planned
work, as local materials and manpower can be used
Uninformed community decision-making may lead to inappropriate choices, so
increasing knowledge is also important, but simply providing passive recipients with
interventions or information about health risks is not always enough to change
behaviour (237). Understanding the social context in which behavioural messages are
delivered is extremely important. Experience in Nepal of providing basic information
on infant care and family planning, showed that this did not result in significant changes
in behaviour (23). A review of behaviour-change research in the field of HIV
prevention also found that impact on only one in four participants on average can be
expected through individually focused behavioural interventions (238). Recent cluster
randomised trials in Tanzania, Zimbabwe and South Africa found no effect of school-
based sexual health education interventions on HIV prevalence, though some
knowledge and attitude measures improved (239-241). In the South African study, the
authors concluded that the lack of success may have been in part to do with the inability
of individuals to challenge cultural norms (241).
More success with health promotion and behaviour change has been achieved through
health alliances or partnerships, and the stronger the representation of the community
and the greater the community involvement in the practical activities of the health
promotion, the greater the impact and the more sustainable the gains (238). Campbell
argues that a social change approach that takes the focus away from individuals and
encourages community responsibility for action may have the best chance of success.
Community-based programmes can “help to provide enabling conditions for the
renegotiation of [behaviour] at the collective level, rather than attempting to persuade
people to make an individual decision to change their behaviour by simply providing
them with information about health risks” (242, 243).
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In a review of packages of community-based interventions for neonatal health, it was
found that strategies that used community mobilisation elements reported the highest
declines in perinatal and neonatal mortality (215). Community mobilisation and
empowerment provide fertile ground for facilitating uptake, effectiveness and
sustainability of other beneficial interventions (244, 245). Deployment of private
community members as intervention providers in the absence of community
mobilisation may limit the potential effectiveness of interventions (215).
Despite this evidence, the use of community participatory approaches to improve
mother and child health in Africa has so far been limited. Thus the challenge remains to
develop strategies that encourage the growth of more focused participation of
community members in decision-making about health issues that affect them. Maternal
and child health is potentially a fruitful area for developing such participation.
Community mobilisation, participation and empowerment
Community mobilisation may be perceived to work simply by bringing about changes
in behavioural risk factors such as home care practices and health-care seeking. But as
described above, studies of health education suggest that simply providing key
messages to improve health behaviour do not have the biggest impact, and processes
that engage communities may be more successful.
Community mobilisation and participation are closely related concepts and may be used
to describe processes along a continuum with communities participating passively in
health initiatives implemented by governments or organisations at one end, or actively
as priority-setters and decision-makers at the other (237, 246). Greater active
community engagement with the problem-posing and problem-solving process leads to
recognition that community members could collectively change their circumstances,
and thus leads to greater community empowerment. According to Freire’s theory of
cultural action, new interventions, technologies and information may be insufficient to
change behaviours, unless they are introduced in conjunction with changes in the
existing systems of power and control (247).
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Community mobilisation may be defined as: “a capacity-building process through
which community individuals, groups, or organisations plan, carry out, and evaluate
activities on a participatory and sustained basis to improve their health and other needs,
either on their own initiative or stimulated by others” (237).
3.3.2 Model strategies for participatory, community-based interventions
Studies in Bolivia, India, Nepal, Bangladesh and Ethiopia have shown that it is possible
to achieve significant reductions in mortality using cost-effective community-based
interventions that reach the poorest people (20, 22, 24, 25, 195, 218). These approaches
emphasise the importance of active community participation in tackling health
problems, rather than achieving high coverage of interventions in populations through
more passive means. The design and results of these studies are shown in Table 3.3 and
Table 3.4.
The Warmi experience (Bolivia)
The Warmi Project – introduced in a rural area of Bolivia with little health
infrastructure and widespread poverty – was the first published account of a community
participatory intervention to improve perinatal care (24). It employed participatory
planning methods and community action cycles focused on mother and infant care. The
cycles began with the development of groups in which women worked together to
identify key maternal and neonatal health problems (autodiagnosis) (248). The
women’s groups went on to prioritise the problems and develop local strategies to
address them (planning together) (249). These strategies were aired in the wider
community and adopted after a process of further planning. Within three years, the
Warmi Project had achieved a substantial decrease in PMR, from 117 to 44 per
thousand. However, this study lacked a control group and had relatively low power, so
the quality of evidence it provides is limited.
The SEARCH experience (India)
The work of the SEARCH group in Gadchiroli, a poor rural district of Maharastra State,
India, has also achieved wide recognition (195). The group carried out a controlled
study with a population of about 80,000. At baseline, almost half of newborn infants
encountered high-risk morbidity, of which over half was ascribed to sepsis. Village
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heath workers were therefore trained to visit newborn infants at home, identify warning
signs and manage sepsis with a combination of injectable and oral antibiotics. The case
fatality rate was 17% before training and 2.8% afterward. By the third year of the
intervention, the NMR was 26 per thousand births in the intervention areas and 60 per
thousand in the control areas.
Follow up some years later found that the neonatal mortality rate had increased slightly
in control areas between 1993–1995 and 2001–2003, but fell by 70% in intervention
areas (250). Early neonatal mortality decreased by 64%, late neonatal mortality by 80%,
and infant mortality by 57%. The stillbirth rate decreased by 49% and perinatal
mortality by 56%. Cause-specific neonatal mortality for sepsis decreased by 90%
(1995–1996 vs 2001–2003), for asphyxia by 53%, and for prematurity by 38%.
These findings suggest a large impact of community-based sepsis management on
neonatal outcomes, though some caution is required in interpretation and generalisation
of the findings from this study. The study had a control group but was not randomised,
and the intervention involved workers paid and tightly managed by the SEARCH team,
outside the government system and covering a population in which numerous previous
community interventions may have sensitised them to more rapid behavioural change
(195). The contribution of community mobilisation to the mortality reductions is
difficult to estimate.
Community groups in Tigray (Ethiopia)
A community-based approach to malaria management was developed in Tigray,
Ethiopia, to overcome the limitations of the existing community health worker
approach, which had limited coverage and low of uptake amongst the youngest and
most vulnerable children (20). Mother coordinators were selected and trained to teach
all mothers to recognise and treat the symptoms of malaria, and this strategy was
evaluated through a cluster randomised controlled trial. Under-five mortality was
reduced by 40% in intervention areas (95% CI 29·2–50·6, p<0·003). Verbal autopsy
data suggested cause-specific mortality reductions related to malaria, with 13 out of 70
(19%) of deaths in intervention areas being consistent with possible malaria compared
with 68 out of 120 (57%) control areas.
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This study supports the evidence for the effectiveness of participatory, community-
based interventions, though did not include any data on maternal, neonatal or infant
outcomes.
The MIRA Makwanpur experience (Nepal)
The MIRA Makwanpur study is the main operational model for this study – a cluster
randomised, controlled trial of a community-based participatory intervention to improve
the health of pregnant mothers and their newborn infants in Makwanpur district, central
Nepal (22). MIRA built on experiences in Nepal and the studies mentioned above to
examine the potential of community action cycles to bring about real improvements in
perinatal health outcomes. They demonstrated a 30% reduction in neonatal mortality in
intervention clusters compared with controls over a two-year period (adjusted odds ratio
0·70 (95% CI 0·53–0·94)). Maternal mortality was reduced by 78% (adjusted odds ratio
0·22 (0·05–0·90)), though this was not a specified a priori primary outcome of the trial.
Secondary outcomes included changes in patterns of home care, health seeking and
referral, and showed small, but significant improvements.
The intervention used trained local facilitators as change agents to assist mothers’
groups to bring about perinatal care behaviour change. Each facilitator worked within
one Village Development Committee (VDC) covering an average population of 7500.
She facilitated the activities of women's groups within the VDC as they addressed the
issues of pregnancy, childbirth and newborn health, using an action-learning cycle. The
first cycle of the facilitation process was completed in 12 intervention VDCs and 12
control VDCs in October 2003. Married women of reproductive age (15-49 years)
within the study area were identified and were visited monthly by study personnel. All
pregnancies occurring within the cohort were followed until at least six weeks after
delivery to determine the outcome of birth.
The Projahnmo experience (Bangladesh)
The Projahnmo trial in, Sylhet district, Bangladesh, compared neonatal mortality rates
in home-care, community-care and control arms of a cluster-randomised controlled trial
(218). In the home-care arm, female community health workers made two antenatal and
postnatal home visits to promote birth and newborn-care preparedness, to assess
newborns and refer or treat sick neonates. In the community-care arm, female and male
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community mobilisers held group sessions for birth-preparedness and newborn-care,
and promotion of health-care seeking. There was no effect on neonatal mortality in the
community-care arm (adjusted relative risk 0·95 (95% CI 0·69–1·31)), but a 34%
reduction (0·66 (0·47–0·93)) was noted in the home-care group in the last 6 months of
the programme.
These results are in contradiction with the Makwanpur findings, which showed strong
effects of community mobilisation. Cause-specific mortality data is not available from
either study to assess whether aetiological differences may explain the differing
findings. Intervention differences may explain some of the discrepancy, as the
community mobilisation components of the two interventions differed. Community
mobilisation in Projahnmo was less intensive than in Makwanpur, with only one
meeting every four months, and the communities were involved in a more passive role,
rather than being involved with priority-setting and decision-making. This is not in line
with the definition of community mobilisation given in the previous section. The
investigators of the Projahnmo study also noted that “Availability of referral services
and a strong supervisory system were crucial to this intervention and would be a
necessary feature of scaling up the intervention.”
The Shivgarh experience (India)
The Shivgarh study in Uttar Pradesh, India, investigated the effect of an intensive
behaviour-change programme involving community meetings and home visits by a new
cadre of paid, non-governmental community workers (217). Their cluster-randomised
controlled trial showed a 54% reduction in neonatal mortality (relative risk 0·46, 95%
CI 0·35–0·60) compared to control areas receiving usual care. They also showed
changes in home-care practices related to birth-preparedness, hygiene and thermal care,
but no real change in care-seeking behaviour.
This intervention was community-based and participatory in the sense that the
community was the setting for change and community members were the targets of the
intervention (251), but it did not involve community mobilisation, capacity building or
empowerment. As such the community was not the agent and did not own the process,
and this intervention once again was not in line with the definition of community
mobilisation given in the previous section.
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The Ekjut experience (India)
The Ekjut study from three districts in Jharkand and Orissa in northern India was an
attempt to replicate the MIRA Makwanpur findings in a different setting. It was a
cluster-randomised trial involving 36 clusters and an estimated population of 228,000.
A similar women’s group cycle to the one used in Nepal reduced neonatal mortality by
32% (adjusted odds ratio 0.68 (95% CI 0.59-0.78)) and had a large but non-significant
effect on maternal mortality. There was an even larger (45%) reduction in neonatal
mortality in the second and third years (0.55(0.46-0.66)) (25).
The PCP experience (Bangladesh)
Another recent attempt to replicate the Nepal findings in Bangladesh did not show such
major changes (252). In this study 18 clusters from three rural districts were randomised
to two interventions (women’s groups and TBA resuscitation training) in a population
of 500,000 After three years there was a non-significant difference between intervention
and control areas of 7% (risk ratio 0.93, 95% CI 0.80-1.09). The authors suggest that
this may have been due to limited coverage of community activities, with only one
women’s group per 1,414 of the population, and 9% of women of reproductive age
attending.
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Table 3.3: Design of studies using community-based women’s groups to change behaviour and mobilise communities to reduce neonatal mortality
Study
(primary
author)
Publication
date
Study design Setting Population
of study
area
Total
number of
clusters
Coverage of
women’s groups
Number of live births Number of neonatal
deaths
Number of maternal
deaths
Intervention Control Intervention Control Intervention Control
*O’Rourke 1998 (24) Case-control
studies before
and after
intervention
Rural Bolivia,
Inquivisi
15,000 - - 708 639 31 75 - -
Manandhar 2004 (22) Cluster
randomised
controlled trial
Rural Nepal,
Makwanpur
170,000 24 - 1 group per 778
population
- 37% pregnant
women attended
2,899 3,226 76 119 2 11
Tripathy 2010 (25) Cluster
randomised
controlled trial
Rural India,
Jarkhand and
Orissa
228,186 36 - 1 group per 468
population
- 55% pregnant
women attended
(year 3)
9,388 8,819 397 518 49 60
Azad 2010 (252) Cluster
randomised
controlled trial
with factorial
design
Rural
Bangladesh,
Bogra,
Faridpur, and
Moulavibazar
503,163 18 - 1 group per 1,414
population
- 3% pregnant
women attended
15,153 14,736 515 557 55 32
*Since this used a case-control before and after design, data are for post-intervention and pre-intervention, not intervention and control for this study. Outcomes are ‘perinatal’ deaths (from 28 weeks of pregnancy to 28
days after birth), not neonatal deaths.
Table 3.4: Results from studies using community-based women’s groups to change behaviour and mobilise communities to reduce neonatal mortality
Study
(primary
author)
Publication
date
NMR MMR Adjusted odds ratio
for impact on NMR
(95% CI)
Adjusted odds ratio for
impact on MMR
(95% CI)
Antenatal care
attendance
Institutional delivery
Intervention Control Interventio
n
Control Intervention Control Intervention Control
*O’Rourke 1998 (24) 4.4 11.7 - - - - 63% 48% 31% 34%
Manandhar 2004 (22) 26.2 36.9 69 341 0·70 (0·53–0·94) 0·22 (0·05–0·90) 55% 30% 7% 2%
Tripathy 2010 (25) 42.3 58.7 521.9 680.3 0·68 (0·59–0·78) 0·70 (0·46–1·07) 74% 75% 14% 20%
Azad 2010 (252) 33.9 36.5 388.9 189.1 0·90 (0·73–1·10) 1·74 (0·97–3·13) 59% 65% 15% 16%
*Since this used a case-control before and after design, data are for post-intervention and pre-intervention, not intervention and control for this study. Outcomes are ‘perinatal’ deaths (from 28 weeks of pregnancy to 28
days after birth), not neonatal deaths.
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3.4 Complex evaluations of complex interventions in complex
populations – the importance of effectiveness trials
Summarising the previous few sections, we can see that single interventions are not
sufficient to deal with the complex problems faced in public health, and packages
combining several interventions, delivered at high levels of coverage to whole
populations or communities are likely to be more effective. Evidence for the impact of
such strategies at population-level is essential, but is so far limited (60, 138, 142). In
order to make appropriate decisions, policy-makers need evidence from studies of
complex public health interventions in complex whole populations, and better
understanding of the barriers to achieving universal coverage. Thus a process of moving
from focusing on testing ‘efficacy’ (how interventions work in ideal trial situations) to
testing ‘effectiveness’ (how interventions can be delivered in real world settings) is
required (206).
Most of the estimates of intervention impact reviewed in earlier sections were efficacy
studies and did not take into account the demand-side factors involved in assuring
effectiveness at community level. It may not always be appropriate to use evidence for
the efficacy of individual interventions in planning population-level strategies. An
intervention that is effective for an individual might not be effective as a public health
strategy (141). There is little reliable population data to inform these estimates that
explores coverage, uptake and use of interventions as well as the related impact of these
on mortality. The challenge then is to collect such community-effectiveness data and
use it to improve our understanding of what the barriers are to achieving better coverage
of existing interventions. Quantifying the evidence for the impact of community
mobilisation approaches can be particularly challenging because they address a broad
range of issues simultaneously (215), and use a multiplicity of definitions of community
participation (246).
Evidence on the effectiveness of national public health strategies often relies on health
information systems, and where these are weak, the available data are inadequate and
unreliable. Knowledge on the benefits of many public health interventions currently in
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use comes from observational studies, demographic surveillance and case studies,
though cause-effect relationships are difficult to establish with these types of research.
Randomised controlled trials using communities as the unit of intervention can be used
to evaluate the benefits of public health interventions in whole populations (253). They
inherently take into account losses of effectiveness due to incomplete coverage or
imperfect implementation and adherence, and provide data on population-level
indicators of impact, such as mortality rates.
Context-specific evidence for the benefit of an intervention is also important, as
contextual factors are often important in the success or failure of an intervention in
different settings (57). In evaluating the success of interventions, randomised controlled
trials are appropriate where the causal chains are simple, but in public health
interventions the causal chains may be complex and results may be subject to effect
modification (254). In cases such as clinical efficacy trials of single drug treatments,
contextual factors make little difference, but with many public health interventions, the
delivery of the intervention can have as much to do with its success as the actual clinical
nature. Because it is impossible to perfectly replicate contextual delivery factors from
one study to another it is difficult to compare studies that use reportedly the same
intervention, but do not discuss in detail the possible contextual factors that contributed
towards the success or failure of the intervention.
Randomised controlled trials of complex public health interventions are rarely sufficient
by themselves (254). However, randomised controlled trials with integral process
evaluations can generate more reliable results (255), and plausibility arguments (such as
investigations of confounding and effect modifying factors, reasons for and effects of
diversions from protocol, and biological and behavioural processes on the causal
pathway) strengthen the findings of statistical analysis (254). Process evaluation can
help to distinguish between interventions that are inherently faulty (failure of
intervention concept or theory) and those that are badly delivered (implementation
failure) (255). Information about cost and feasibility are also essential to policy-makers.
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3.5 Rationale for the MaiMwana trial
In resource-limited settings such as Malawi, where the health service is under extreme
pressure due to lack of qualified personnel and resources, community-based approaches
may be an effective first step in reducing mortality while longer-term strategies are
developed to address institutional weaknesses.
There is remarkably little research in rural Africa on the potential for sustainable
community-based interventions to reduce maternal and neonatal mortality. A study of
promotion of community-based IMCI activities in Ethiopia showed some impact on
infant mortality and other behavioural outcomes, though neonatal outcomes were not
reported, and results are difficult to interpret as background mortality increased over the
course of observation and the study was only in one intervention and one control district
(256). A community-based study in Kenya reported a substantial reduction in deaths
amongst infants under six-weeks old following introduction of hygienic delivery packs
(171), and a cluster-randomised trial of community-based treatment for malaria showed
a significant reduction in under-five mortality (20). Though several large trials
specifically targeting neonatal health have now been conducted in Asian countries (22,
25, 195, 217, 218, 252), no other randomised controlled trial of a community-based,
participatory intervention in neonatal health in a rural African setting was found.
Studies are currently under-way in Ghana and Guinea Bissau to evaluate the impact of
community-based interventions on neonatal outcomes, but results from these are not yet
available (257, 258).
This study was established in order to provide policy-relevant answers to key questions
about strategies to improve mother and newborn health in Malawi and the region.
Appropriate maternal and neonatal care for Malawi requires a holistic and integrated
programme of interventions at various levels. Ideally, these interventions should not
only include health-related measures that have a direct bearing on maternal and neonatal
outcomes but other equally important indirect measures. These measures include
poverty alleviation, improved opportunities for female education, and improvements in
women’s social status, empowerment and decision-making power. Family size and
interpregnancy intervals are also critical factors in perinatal health.
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Given that almost half of all births occur at home in Malawi (1), there is a large
proportion of the population for whom health systems strengthening alone will provide
no immediate benefit. There is a need to improve community perception and demand
for health services and increase health service utilisation and coverage. Household and
community care practices can also provide benefits, and a key question is whether
behaviour-change activities at community-level can improve maternal and neonatal
outcomes even without large investments in improving current health services.
Community-based interventions with health-worker home visits have rarely achieved
adequate coverage, quality, or effectiveness when taken to scale, (259). In contrast,
participatory community groups have the advantage of being able to achieve higher
coverage, reach the poorest, are scalable at low cost, and produce potentially wide-
ranging and long-lasting effects (25). As described in section 3.3, there is growing
evidence that community mobilisation though women’s groups is an effective strategy
for improving maternal and neonatal health. Reductions in neonatal mortality were
shown in two Asian settings and one in South America (22, 24, 25). Women’s groups
are community-based, and in the context of low service utilisation they have shown
promise in increasing the demand for services. In addition to improving uptake of health
services, the groups facilitate behaviour change in the home and community,
particularly for preventive behaviours related to hygiene and nutrition. Through the use
of a participatory approach for identifying and solving problems, the solutions identified
are more sustainable than if they were introduced by external organisations. They do
not rely on complicated technology or resources that are difficult to obtain, and they do
not rely on the availability of highly trained health workers. Finally, the process of
mobilising communities to take action for their own health is empowering, and can
encompass the indirect measures of poverty reduction, female education and women’s
decision-making power (237).
It is on this basis that MaiMwana Project in Malawi was founded, in order to evaluate
the impact of two community-based interventions on maternal and neonatal mortality.
Both interventions have previously been tested in other countries and settings, but this is
the first time that they have been tested in rural Africa. The first intervention uses
community mobilisation to address maternal and neonatal health issues through
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women’s groups. The second intervention uses volunteers who make home visits and
provide information and support about breastfeeding.
Women’s groups were successfully used by Warmi Project to address mother and child
health issues in a remote, hilly area of Bolivia. They achieved a 60% reduction in
perinatal deaths over a period of three years (24). This project was not designed as a
research study and did not have a comparison group or baseline socio-economic survey,
however based on the activities described, it suggests that the intervention was
successful in reaching illiterate women in remote areas. The MIRA Makwanpur project
in Nepal replicated this project with a rigorous research design, and was able to
demonstrate a 30% reduction in neonatal mortality and 78% reduction in maternal
mortality over a two-year period (22). Cost-effectiveness analyses show that the
intervention cost $0.75 per capita per year to run, and $111 per life-year saved.
Although facility-based delivery only increased from 3% to 9% during the study period,
significant reductions in mortality were achieved at community-level through improved
hygiene practices at home deliveries, recognition of danger signs and early care-
seeking. At the time of planning the MaiMwana trial in 2003 and 2004, data from the
other studies reviewed in section 3.3 were not yet available.
Home-based infant feeding promotion has been tested in a number of different settings
using different strategies. Randomised controlled trials in Mexico, Bangladesh and
India demonstrated success in increasing rates of exclusive breastfeeding, using
community-based strategies (21, 260, 261). In Mexico and Bangladesh individual
home-based counselling visits were made, while in India counselling sessions were
more opportunistic and could be made by several different cadres of health worker. The
Mexico and Bangladesh studies focused on urban populations, but the study in India
showed a high coverage and acceptance amongst the rural poor. This was the main
model for the development of the volunteer infant feeding counselling intervention in
this study (21).
MaiMwana will evaluate these interventions using a full population-level effectiveness
design, using a cluster-randomised controlled trial, in order to evaluate the potential for
their inclusion in future Malawi national health strategies. Integral process and
economic evaluations will be conducted alongside the main impact evaluation to have a
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more complete understanding of the strengths and weaknesses of the interventions and
to explore the plausibility and validity of effects (254, 255). An added justification for a
rigorously evaluated community-effectiveness trial is that there is a need to improve
information on the magnitude and causes of maternal and neonatal mortality in Malawi
and the southern African region. Data collected through this research will provide vital
information for policy-makers.
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Chapter 4 : Methods
4.1 Background to MaiMwana Project
MaiMwana Project was registered in Malawi as a charitable trust in October 2003 and is
directed by Dr Charles Mwansambo, Dr Peter Kazembe and Professor Anthony
Costello. Its main objective as outlined in the constitution is “to reduce maternal and
newborn morbidity and mortality”, through health facility and community-based
interventions. The organisation is managed locally, with input and guidance from the
Centre for International Health and Development (Institute of Child Health, London,
UK). The emphasis is on local ownership, building links with local government and
non-government stakeholders and maximising the participation of communities in
decision-making processes. The main funders are Saving Newborn Lives (Save the
Children US), Department for International Development (British Government) and
Wellcome Trust (UK).
The project has a main office and a sub-office in the district administrative centre, and
four nodal offices in smaller trading centres around the district. The senior MaiMwana
Project field team was recruited between September and October 2003 and oriented to
the main aims of the trial. Three weeks in-house staff training were carried out from 3rd
to 21st November 2003 and the topics covered included: study design; qualitative and
quantitative research skills; facilitation techniques; participatory interventions; skills for
working in the community, skills for supervisors, team building, consent and ethics,
safe motherhood and antenatal care and prevention of mother to child transmission of
HIV.
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4.2 Objectives
4.2.1 Objectives of MaiMwana Project
Goal
To improve the survival and health of mothers and infants in rural communities in
Mchinji, Malawi.
Purpose
To test the effectiveness of two community-based health promotion interventions for
improving mother and child health and reducing mortality.
Objectives
To test the impact of an intervention using community mobilisation through women’s
groups on:
a) Care practices and health care seeking behaviour for mothers and infants.
b) Maternal and neonatal morbidity.
c) Maternal, infant, neonatal and perinatal mortality.
To document and evaluate the process and costs of implementing the intervention for
potential replicability and sustainability.
To test the impact of an intervention delivering health education through volunteer peer
counsellors on:
a) Exclusive breastfeeding rates, other care practices and health care seeking behaviour.
b) Neonatal and infant morbidity.
c) Infant mortality.
To document and evaluate the process and costs of implementing the intervention for
potential replicability and sustainability.
Outcomes
The women’s group and peer counselling interventions are described in section 4.4.3,
and the primary and secondary study outcomes are summarised in Table 4.1.
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Table 4.1: Study outcomes
Women’s groups Volunteer infant feeding and care
counsellors
Primary
outcomes
 Maternal mortality
 Perinatal mortality
 Neonatal mortality
 Infant mortality
 Rates of exclusive breastfeeding (EBF)
in the first six months
 Infant mortality
Secondary
outcomes
 Changes in caretaker practices:
hygiene behaviours, use of insecticide
treated nets (ITNs), early and
exclusive breastfeeding and decreased
use of pre-lacteal feeds
 Changes in care-seeking behaviour:
antenatal care (use of malaria
prophylaxis in pregnancy, tetanus
toxoid), delivery (facility-based,
skilled attendant, use of safe delivery
kit), uptake of PMTCT, postnatal care
(check-ups for mother and baby,
infant vaccinations).
 Maternal and infant morbidity (breast
problems, fever, diarrhoea, etc.)
 Changes in caretaker practices: EBF
(duration of EBF, time to first feed,
use of pre-lacteals, time to weaning),
management and treatment of breast
problems, family planning (including
use of condoms)
 Changes in care-seeking behaviour:
uptake of PMTCT (awareness, VCT,
expressing breastmilk), uptake of
vaccination services (3 doses
pentavalent and 4 doses polio by 6
months
 Neonatal mortality
 Maternal and infant morbidity (breast
problems, fever, diarrhoea, growth
etc.)
4.2.2 Specific objectives of this PhD
The MaiMwana Project study is a large and complex one, with many impact and
process outcomes. The scope of the research in this PhD was confined to looking at the
impact of the women’s group intervention only, as well evaluating the methods of
surveillance and analysis. The primary research question for this thesis is:
Will community mobilisation through women’s groups reduce perinatal, neonatal,
infant and maternal mortality rates through changes in care practices and health-seeking
behaviour?
This Chapter will focus on aspects of methodology and study design that are relevant to
this question, and will not go into the details of other areas.
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4.3 Study design
This research is part of an ongoing study run by MaiMwana Project in Mchinji District,
Malawi (262). The MaiMwana study is using a cluster-randomised controlled trial
design to evaluate the impact of two community-based interventions in reducing
maternal and neonatal mortality. The first intervention uses women’s groups to address
maternal and neonatal health issues through participatory health education and
community mobilisation (263). The second intervention uses female, community-based
volunteers who make home visits and provide information and support about
breastfeeding (264). A cluster-randomised design was chosen because the allocation
and loci of delivery of the interventions (community clusters) are groups rather than
individuals, and it is the gold-standard for evaluating the effectiveness of public health
interventions (253). 48 study clusters were defined and randomly allocated to one of
four possible intervention combinations using a two-by-two factorial design (Figure
4.1) (265). The whole district population benefited from basic health service
strengthening activities for mother and child heath at all health facilities.
Figure 4.1: Study design – showing two-by-two factorial design and zone allocation
Infant feeding
12 zones
No infant feeding
12 zones
Women's groups
24 zones
Infant feeding
12 zones
No infant feeding
12 zones
No women's groups
24 zones
Study area - 48 zones
(150,000)
Health service strengthening
(Whole district)
Mchinji District
(375,000)
For the purposes of this thesis, the impact only of the women’s group intervention will
be evaluated. The final impact analysis of the MaiMwana study as a whole, requires
complete data on both interventions, so this evaluation will focus on the details of the
implementation and impact of the women’s group intervention only. The primary
outcomes for this intervention are maternal, perinatal, neonatal and infant mortality
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rates and the secondary outcomes are morbidity rates and health behaviours such as use
of health services and home care practices (Table 4.1).
The focus of the women’s group intervention activities is on maternal and newborn
care, and maternal and neonatal mortality are primary outcomes of the study. As early
neonatal deaths are sometimes difficult to distinguish from stillborn infants that died
during labour (34), perinatal mortality has also been included as a primary outcome.
Furthermore, as neonatal deaths make up a large proportion of infant deaths (5), this
was the main focus of the intervention, but intervention activities go beyond the
newborn period and some impact on post-neonatal mortality may be seen. As such,
infant mortality is another important primary outcome. Secondary outcomes were
chosen as measures of behaviour change that might lead to impact on mortality rates
(58, 60, 142). These were home care behaviours such as hygiene, malaria prevention
and breastfeeding, as well as health-care seeking behaviours such as uptake of antenatal,
delivery and postnatal services and seeking treatment in the case of illness. Outcomes
will be compared between intervention and control areas in order to evaluate the impact
of the interventions.
The time-line for the main phases of data collection and activities have been outlined in
Appendix 2 – Background and Orientation, Phase I, Phase II and Phase III. The
Background and Orientation phase included an in-house training workshop, community
entry and consent, orientation to Mchinji, a participatory census, piloting for mapping
and enumeration, zone demarcation and cluster definition. Phase I included formative
qualitative research, mapping and enumeration of study clusters and population, and
random allocation of clusters to interventions. Phase II was the design and
implementation of a prospective surveillance system, including development of the
research tools, recruitment and training, and coordination and management of data
collection. Phase III was a re-census of all households in the study areas, and involved
piloting, training and data collection and management. These phases will be described
in detail in the following sections.
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4.3.1 Primary research question
Will community mobilisation through women’s groups reduce maternal, perinatal,
neonatal and infant mortality rates through changes in care practices and health-seeking
behaviour?
4.3.2 Hypothesis
Community mobilisation through women’s groups will lead to: reductions in maternal,
perinatal, neonatal and infant mortality, reductions in maternal and infant morbidity,
and increases in recognition of high-risk symptoms, increased health-care seeking
behaviour and changes in care-taker practices.
4.3.3 Study endpoints and outcomes
The study endpoints are shown in Table 4.1. The interventions were planned to run for
two years from the date when they were hypothesised to start having an effect. We
hypothesised that benefits of the intervention would start to be seen nine months after
the start of intervention activities, such that newly pregnant mothers would have had the
benefit of exposure to interventions throughout their entire pregnancy.
4.4 Methods
4.4.1 Setting
Mchinji district is one of nine administrative districts in the Central Region of Malawi
(Figure 4.2). Topographically, the Central Region of Malawi is mainly a plateau, over
1000m high, and is the country's main agricultural area. Mchinji district lies to the west
of Lilongwe and has international borders with Zambia and Mozambique. It covers an
area of 3356 sq km and had a population of approximately 375,000 in 2004 and 457,000
in 2008 with a growth rate of 2.4 percent per annum (according to projections from
1998 census data) (61, 266). The district administrative centre is Mchinji Boma, the
site of the MaiMwana Project office, but about 90% of the population of Mchinji live in
rural areas and make a living through subsistence farming. The main crops cultivated
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are maize, tobacco and groundnuts, though periods of drought in previous years have
led to episodes of acute food shortage.
The geo-political organisation of Mchinji District is outlined in Figure 4.3. As of
October 2004 the district has 7 Traditional Authorities (TA) and 2 Sub-Traditional
Authorities (STA). Of the 9 TAs and STAs, 3 are Ngoni and 6 are Chewa. Within each
TA or STA there are several Village Development Committees (VDCs), each governed
by a Group Village Headman (GVH). 61 VDCs are officially registered with the
District Commissioner. Each GVH is responsible for overseeing several villages. 447
villages are officially registered with the DC. Each village is led by a Village Headman.
The main ethnic group in Mchinji are the Chewa (90%). Other tribes found in smaller
numbers are Ngoni (7%), Senga (2%) and Yao (2%). The national language used
throughout Malawi is Chichewa, and this is the main language spoken in Mchinji. The
predominant religion in Mchinji is Christianity (92%), but there are a smaller number of
Muslims (3%) and followers of other religions (3%), mainly based in trading centres,
and a small number who follow no religion (2%) (61).
Maternal and perinatal health care is provided by personnel from one government
district hospital (a first referral and secondary health facility), four rural community
hospitals (one government and three mission hospitals), one maternity unit, six health
centres providing maternity care, and two dispensaries and two private clinics offering
antenatal care. In 2004, Mchinji District Hospital was recognised as a Baby Friendly
Hospital, and in January 2005, it benefited from the Global Fund expanded access to
ARV programme. Services for Prevention of Mother to Child Transmission of HIV
(PMTCT), including Voluntary Counselling and Testing (VCT) and Nevirapine (NVP),
were introduced from 2005 and by 2008 basic PMTCT services had been expanded to
all health facilities. Quality of the health service in Mchinji is compromised by a severe
shortage of personnel, low morale, and irregular drug supplies (94). Traditional Birth
Attendants (TBAs) are available and were used in all localities during the trial (although
in 2009 the government banned TBA attended deliveries). At the start of this project,
data from the 1995 Malawi Social Indicators survey suggested that 95% of women in
Mchinji attended antenatal care at least once during their pregnancy, but less than 40%
of women delivered at a health facility (267).
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Figure 4.2: Map of Malawi showing Mchinji District
Figure 4.3: Geo-political organisation of Mchinji District
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Table 4.2 shows how the population in Mchinji compares to the rest of Malawi on a
number of key indicators.
Table 4.2: Socioeconomic and health indicators in Mchinji and Malawi
Mchinji Malawi
Poverty
Human Development Index (out of 182 countries)
GNP per capita (US$)
Percent below $2 per day
-
-
-
160
690
90%
Education
Female literacy (over 5 years of age)
Educational attainment – primary
– secondary
46%
60%
5%
51%
59%
8%
Health
Access to improved water source
Access to sanitation
Total fertility rate (births per woman)
Crude birth rate (per 1,000 population)
Maternal mortality ratio (per 100,000 live births)
Infant mortality rate (per 1,000 live births)
Neonatal mortality rate (per 1,000 live births)
46%
66%
7.6
55
-
65
24
45%
53%
6.5
50
807
72
33
Sources: Malawi Population and Housing Census, 1998, Malawi DHS, 2004, World Bank 2006, State of
the World’s Newborns report 2001, UNDP 2009, MICS 2006
4.4.2 Target group and eligibility criteria
The target population for this study were rural communities with the least access to
health services, who might benefit most from community-based interventions to
improve maternal and child health. The district administrative centre was excluded
because it is more urbanised than the rest of the district and therefore not comparable to
other clusters. The target group for participation in both of the interventions was women
of childbearing age (WCBA), between the ages of 15 and 49 years, and particularly
pregnant mothers. Girls aged between 10 and 15 years were also monitored and
encouraged to participate in interventions in order to identify and support early teenage
mothers. Older women who were no longer childbearing were also encouraged to
attend, as they influence decision-making around pregnancy, childbirth and childcare,
and have valuable experiences to share (268).
All women aged 10 to 49 years (inclusive) who agreed to take part, were enrolled into
the study, regardless of whether they were married or not. Women who had no
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possibility of conceiving during the study period were enumerated but did not appear in
the final sample, as they did not become pregnant (for example women who had
hysterectomies or terminal family planning procedures). Participation in intervention
activities was voluntary, and women’s groups were free to establish their own
membership criteria.
A cohort of 44,000 women aged between 10 and 49 years was defined during the
baseline phase of the study, and each was visited monthly by study personnel. From the
beginning of the study period all pregnancies, births and deaths occurring within the
cohort of WCBA were identified, with follow-up until at least one year after delivery.
The cohort members were listed in a master document to which new names could be
added: the cohort is open and new participants were enrolled during the study period if
they moved into the study area, or if they reached 15 years of age.
4.4.3 Intervention activities
The main activities and elements of the interventions are summarised in Table 4.3.
Further details of the peer infant feeding counselling intervention are available in
Appendix 3.
Table 4.3: Summary of activities in women’s group and infant feeding and care counselling interventions
Women’s groups Volunteer infant feeding and care counsellors
Specific objectives
Follow a participatory community mobilisation
process to improve maternal and perinatal care
Make individual home visits to promote exclusive
breastfeeding
Elements of the interventions
The activities of 24 Zonal Facilitators (ZFs) are
the key to this intervention. Each facilitator works
within one zone, covering an average population
of 3,000. She facilitates the activities of women’s
groups within the zone as they address the issues
of pregnancy, childbirth, newborn and infant
health. Each women’s group will move through a
participatory planning cycle of assessment,
sharing experiences, planning, action and
reassessment, with the aim of improving essential
maternal and newborn care.
The activities of 72 Volunteer MaiMwana
Counsellors (VMCs) are the key to this
intervention. Three VMCs work within one zone,
covering an average population of 1,000 each.
Each VMC visits all pregnant mothers in her area
5 times – once before birth and four times after
birth – to discuss the importance of exclusive
breastfeeding, and to give support and advice on
mother and child health. She also helps to identify
any breastfeeding problems and refers them to a
health facility.
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The women’s group intervention
The women’s group intervention seeks to build the capacities of communities to take
control of the mother and child health issues that affect them (263). The intervention is
community based in that it defines the community as the agent of change (251). To
achieve this, 24 local female facilitators (ZFs), one per cluster, were recruited and
trained. The facilitators formed between six and 12 groups in their clusters and invited
all women of childbearing age to attend. They guided the groups of women through a
four-phase community mobilisation action cycle developed to be appropriate, accessible
and feasible for the Malawian context from similar models in Bolivia and Nepal (Figure
4.4) (140, 269). In the first phase, consisting of eight meetings, the groups identified
and prioritised the mother and child health problems they felt were most important and
discussed what may contribute to these problems and how they might be prevented and
managed. In the last meeting of this phase they shared their discussions with men in the
community. In the second phase, consisting of four meetings, the groups planned
locally feasible strategies to address the problems they had prioritised. In the last
meeting of this phase they shared their discussions with the whole community. In the
third phase, consisting of four meetings, the membership of the groups expanded to
include all community members, including men, working together to implement the
strategies that had been identified. In the fourth phase, four meetings, the groups
evaluated what they had done and planned for the future. The facilitators received
minimal health training but used participatory rural appraisal tools and picture cards to
facilitate discussions and enable groups to access their collective knowledge and
capacities. With these capacities the groups took increasing control of the intervention
over the course of the cycle and did not receive any resources from MaiMwana Project
except the guidance of the facilitator supported by four trained supervisors and a senior
supervisor, employed by MaiMwana project.
A film called ‘Umodzi’ (Together) was made in 2009, in which women and other
community members in Mchinji explain the women’s groups in their own words. A CD
with a copy of this film has been included in the jacket of this thesis.
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Figure 4.4: Women’s group community mobilisation action cycle
Health service strengthening
This component was not evaluated through the RCT design described above as it was
considered a requirement for all facilities in the District and not only those in
intervention areas. Furthermore, as both interventions sought to increase demand for
health services the supply of these services needed to be at an adequate level in order to
have an overall improvement in health (175). Therefore strengthening of health service
delivery was applied across the whole district and as a result is being evaluated
separately through repeated health service audits. Health service strengthening was
implemented in collaboration with the District Health Office. Health workers have been
trained in Safe Motherhood, Essential Newborn Care and PMTCT by project staff and
national facilitators, and a PMTCT programme was established at Mchinji District
Hospital in 2004. From 2005, PMTCT services were extended to Kapiri, Mkanda,
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Kochilira and Nkhwazi health facilities. By 2008, the services were also extended to
the remaining health facilities at Guillime, Kapanga, Tembwe, Ludzi, Kaigwazanga,
Mikundi and Chiwosha as well as ITES private clinic. Community-based volunteers
will also be trained by national and district trainers to provide pre-test counselling with
funding from the National AIDS Commission.
4.4.4 Sample size
The sample size for the cluster randomised controlled trial was arrived at by comparing
statistical power for different estimates of population parameters related to primary
outcomes. Parameters estimated included baseline mortality rates, the projected size of
the reduction in maternal, neonatal and infant mortality and increase in exclusive
breastfeeding rates due to the interventions, the number of births in each cluster over the
trial period; the number of clusters in the intervention and control groups, the statistical
power of the study, and the inter-cluster coefficient of variation (a measure accounting
for the fact that people from within a cluster may be more similar to each other than
people picked at random from across the study area) (253). Realistic values of some of
these parameters were difficult to estimate, as few population-level mortality data were
available at the start of the study, especially at district and sub-district level. The
sources of data and values for these estimates are summarised in Table 4.4. We aimed
to achieve the smallest sample size that would allow adequate power to detect an impact
within a reasonable time-frame and would be logistically feasible to implement.
Initial sample size estimates were made using national estimates of crude birth rates
from the Malawi DHS for 2000, subsequently revised after the results for the 2004 DHS
survey were released (1, 2). Estimates were made with 80% power, a two-sided 5%
significance level and an inter-cluster coefficient of variation (k) of between 0.15 and
0.30, using the methodology laid out by Hayes et al (Equation 1) (270) (271-273). An
estimate of k=0.25 came from work on interventions to reduce HIV incidence rates
(274), and later from work in Makwanpur, Nepal (22). We assumed that variability in
neonatal, infant and maternal mortality between clusters would be less in rural Malawi,
due to fairly uniform exposure to risk factors such as poor hygiene and poor quality or
absent delivery care and endemic malaria. In addition, we reduced potential
heterogeneity by excluding the main district administrative centre, as it was felt to be
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socio-economically and demographically different from rural villages. In recognition of
the lack of certainty for this estimate, sample sizes were calculated for a range of values
of k.
Equation 1: c  1 (z
 /2  z )
2[ 0 (1  0 ) / n  1(1 1 ) / n  k
2 ( 0
2
  1
2 )] / ( 0  1)
2
(Where c is the number of clusters required, /2 and  are standard normal distribution
values corresponding to upper tail probabilities of /2 and  respectively, and 1 and 0
are the true (population) proportions in the presence and absence of the intervention,
respectively.)
Using available estimates of crude birth rates and mortality rates, it was initially
estimated that a sample size of 72 clusters with 150 births per cluster over two years
(assuming a crude birth rate of 50 per 1000 population), would allow us to detect a 28-
31% reduction in PMR, a 26-30% reduction in NMR, and an 18-24% reduction in IMR.
On the basis of a reduction in NMR of 30% in a study in Nepal (22), this was felt to be
a reasonable effect size for this study. However, in May 2004, after completing some
background research into community size and organisation, it was decided to use 48
larger clusters rather than 72 smaller ones. The original plan had been to use VDCs as
the unit of randomisation, but there were only 61 in the district, and they were of
differing sizes. For logistical convenience and statistical efficiency, 48 equal-sized
clusters were chosen instead (253). On this basis, the sample size calculations were
revised, and maternal mortality was included as a primary outcome as evidence of the
potential impact of women’s groups on maternal outcomes was emerging (22). After
starting the trial, sample size calculations were reviewed again in 2006, when the
Malawi DHS report for 2004 containing new mortality estimates was released. (Revised
parameter estimates and effect sizes are shown in Table 4.4.)
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Table 4.4: Parameters used to estimate sample size, and the estimated effect sizes that would be
detectable
Parameter Source of estimate Original
proposal
(2002)
Revised
design
(2004)
Revised parameter
estimates
(2006)
Number of clusters Geopolitical subdivisions
and logistical efficiency
72 48 48
Population per cluster (Calculated) 1,500 3,000 3,000
Crude birth rate
(per 1000 population)
National data from MDHS* 50 50 42
Time frame
(years)
Funding period 2 2 2
Births per cluster within
study period
(Calculated) 150 300 252
Inter-cluster coefficient of
variation (k)
Hayes 1995 0.15-0.3 0.15-0.3 0.15-0.3
Statistical power of the
study
Probability of Type I error
Probability of Type II error
0.05
0.2
0.05
0.2
0.05
0.2
Perinatal mortality rate
(per 1000 births)
National data from MDHS* 46 46 34
Size of reduction detectable (Calculated) 28-31% 26-31% 29-34%
Neonatal mortality rate
(per 1000 live births)
National data from MDHS* 42 42 27
Size of reduction detectable (Calculated) 26-30% 24-30% 31-36%
Maternal mortality ratio
(per 100,000 live births)
National data from MDHS* - 1,120 984
Size of reduction detectable (Calculated) - 42-45% 47-50%
Infant mortality rate
(per 1000 live births)
National data from MDHS* 104 104 76
Size of reduction detectable (Calculated) 18-24% 18-26% 21-28%
* Malawi DHS (1) data used is the national estimate, as data were not disaggregated for Mchinji District
Interactions between the women’s group and volunteer infant feeding and care
counselling intervention
Through the two-by-two design, it will be possible to assess the interaction between the
two interventions, though the study is not powered to evaluate the combined impact of
the interventions on mortality compared to single interventions alone, as this would
have required an unfeasibly large sample. We will explore qualitatively and
quantitatively whether or not there is a synergistic relationship between the two
interventions, resulting in an effect greater in magnitude than either intervention alone.
We might expect that women in an enabling environment (provided by women’s
groups) would find it easier to discuss health issues and make health-seeking decisions
for themselves and their babies than women in control areas where social barriers to
care-seeking have not been addressed. More specifically, women in areas receiving both
interventions might be more likely to use the Volunteer MaiMwana Counsellor and
recognise the importance of her advice. More of these women may have decided to use
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PMTCT services than those not receiving facilitation, and will therefore be in a better
position to make informed choices about infant feeding and family planning based on
knowledge of their HIV status. Conversely, individual visits made by volunteers to
women in their homes may serve to reinforce messages and issues arising from
women’s group discussions.
4.4.5 Background and orientation
Community entry
Before beginning any work in the community, it was necessary to sensitize the relevant
stakeholders at all levels to the aims and objectives of MaiMwana. The project team did
three levels of sensitization starting with the Mchinji District Executive committee and
Mchinji District Assembly, and followed by Area Development Committees and
Village Development Committees. The main community entry activities took place
during October 2003.
Mchinji District Executive Committee Sensitization Meeting
People from different government sectors and other non-governmental organisations
working in Mchinji District were present at the meeting. The MaiMwana Team was led
by Dr Charles Mwansambo, one of the project directors. The MaiMwana project study
was presented in detail. At the end of this meeting the project was accepted into the
district, and the District Commissioner signed a consent form to document this.
Mchinji District Assembly Committee Sensitization Meeting
The people present during this meeting were from different government sectors, chiefs,
politicians, non-governmental organisations and other interested parties/ members
working in the study district. At this meeting the MaiMwana study was also presented
in detail. At the end of this meeting the project was accepted by the assembly and the
Chairman of Mchinji District Assembly signed a consent form to document this.
Mchinji District Area and Village Development Committee Sensitization Meetings
The ADC and VDC sensitization meetings were done simultaneously, so that whenever
there was a meeting for an ADC, members of the local VDCs were also present. People
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from different community sectors, government sectors, political parties, and other
NGOs within the TA’s catchment area were also present. After each meeting a consent
form was signed by the TA or STA, and also by each of the GVHs in attendance. Hence
the project was accepted into all the communities of the district.
Cluster definition
Combinations of the interventions were to be delivered to whole communities rather
than individuals, with the aim of evaluating their impact on maternal and neonatal
mortality rates and other health indicators. Clusters needed to represent some kind of
natural geo-political division and also be as similar in size as possible. The first in order
to have a cohesive community in which the interventions could work well and potential
communication of information to the surrounding non-study villages would be
minimised, and the second to minimise the coefficient of variation of cluster size and
maximise statistical power (275). In order to define such clusters it was necessary to
collect sub-district level population data. However, data on district population broken
down by geo-political units such as Traditional Authority (TA), Village Development
Committee (VDC) or village was not available from the District Commissioner, and
data from a preliminary MaiMwana participatory census (in which community leaders
were asked to provide village household lists), proved to be inaccurate. Finally, it was
decided that extrapolation from NSO census data might provide the most accurate area-
based population estimates.
A list of villages used for the 1998 census was obtained from the National Statistics
Office (NSO). However, this list of villages did not correspond well to the list of
villages kept by the District Commissioner (DC), and in trying to locate these villages
on the ground it was discovered that many of the villages on both the DC’s list and
NSO list were either no longer in existence, had changed names, had merged with other
villages, or were newly formed (often split from bigger villages) so were not on the
lists. This made it difficult to allocate population information to any particular
geographical area, so instead of using the village-level population data, population data
for the Enumeration Areas (EAs) was used. (Only 9 TA areas exist in Mchinji, so TAs
could not be used as the geo-political unit of randomisation.) Together with a
cartographic NSO map showing TA and EA boundaries, geographical features, roads
and some of the larger villages, 48 areas were demarcated, roughly following the
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boundaries of currently existing VDC areas (equivalent to Group Village Headman
(GVH) areas whose component villages are recorded with the DC).
The total population for the district in 1998 was 324,876 covering 302 EAs and was
estimated to have grown to 376,757 by 2004 (after 1998 population figures had been
adjusted for an estimated population growth of 2.5% per annum (61)). The average
population for an EA was 1,076 in 1998 and was estimated to be 1,248 in 2004. A
population of 13,305 (2004 estimate) from 9 EAs was excluded because they were in
the district administrative centre, which was felt to be socio-economically and culturally
different from the rest of the district. The remaining 293 EAs were then allocated to 48
‘zones’ on the basis of contiguity with other EAs in the zone and the presence of
villages in the EA known to belong to the same VDC as other villages in the zone. Each
of these zones comprised about 6 EAs and covered a population of approximately 7,600
(2004 estimate). Figure 4.5 shows the EAs for Mchinji (thin lines) and the study zones
that were demarcated (thick lines).
After demarcating the zones the next stage was to identify a population of 3,000 in each
zone to make up the study ‘clusters’. Rather than selecting villages at random from each
zone it was decided that a ‘buffer area’ surrounding the perimeter of the zone would be
maintained and only villages at the centre of the zonal area would be eligible for
inclusion in surveillance and intervention activities (Figure 4.6). This was intended to
reduce contamination between study clusters due to interactions between people in
neighbouring villages. Selection of central cluster villages was done by identifying a
village in the centre of the area that appeared both on the NSO map and the DC’s list of
villages, then enumerating the households and population in that village, then going to
the neighbouring village and enumerating it and then continuing to add and enumerate
villages in a spiral around the first village until a total population of approximately
3,000 had been reached. Selection criteria for picking the villages were: proximity to
previously mapped village (as reported by members of the community); falls within the
perimeter of the zone; belongs to the same GVH as the first village. This process left
buffer zones of roughly 4,600 population around each cluster.
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Figure 4.5: Map of Mchinji District showing enumeration areas and demarcation of 48 study clusters
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Figure 4.6: Study villages and buffer areas in three clusters near Mchinji Boma
4.4.6 Phase I – Formative research, mapping and enumeration of study clusters
and random allocation to interventions
Formative qualitative research
Formative qualitative data were collected through semi-structured interviews and focus
groups. These data were collected with the specific purpose of: a) exploring current care
practices to help to develop the structured questionnaires and interviews; and b)
exploring the aims, setting, target population, methods and resources of the
interventions to assist in their development.
Mapping and enumeration
During Phase I (the baseline phase), a baseline census and survey was conducted before
the interventions began in order to define the study population and to make comparisons
between clusters. This also enabled the generation of a list of all women of childbearing
age living in the study areas for use in the prospective pregnancy and birth surveillance.
Enumeration involved mapping the village, numbering each household and then
administering a short questionnaire to identify the total number of household members
and women of childbearing age.
80 Field Interviewers (FIs) were recruited and trained in mapping and enumeration. The
training took place in two groups, with each group attending a residential training
workshop at a rural training centre for two weeks. Interviewers were trained in
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interviewer skills, methods of data collection, mapping, negotiation skills and team
building. In addition to classroom sessions, all interviewers were taken to nearby (non-
study) villages to practice their mapping and interviewing skills. These practical
sessions were observed by a supervisor and technical advisor, and suggestions were
made during feedback sessions afterwards. Questionnaires were also modified to ensure
clarity of questions.
A team of 3 or 4 FIs was allocated to each zone, and supervised by a Monitoring and
Evaluation Officer, based in one of four nodal offices. Each zone was given a number
from 01 to 48 and each village in each zone was given a number from 01 to 34
(depending on how many villages were in the zone). The team of FIs visited each
village, meeting with the village chief and his or her advisors to seek permission to map
the village. A group of between seven and ten villagers was gathered, including
members from different sectors of the village, representing men, women and people of
different age groups. The FIs and villagers drew a sketch map of the village using
participatory rural appraisal techniques and marking major roads, minor roads,
footpaths, rivers, health facilities, schools, bore holes and wells, the chief’s house and
other important features. Boundary features such as rivers or neighbouring villages were
named. The FIs and village members then walked the boundaries of the village together,
and community members acted as guides, helping in the identification of households.
Large villages were divided into sections using footpaths, roads, rivers and gardens as
markers. Each house was assigned an ID number (from 001 to 999, depending on how
many households were in the village), which was marked on the door with chalk. No
objections were made to houses being marked with chalk. The first and last house in a
section and every tenth household was indicated on the map (see map section in Figure
4.7). One FI concentrated on drawing the map, while two other members of the team
followed the mappers through the village and visited each household to collect basic
data on household socio-economic status and household occupants (see Appendix 4 for
an example of the Woman Enumeration Form). This data was then entered into a study
database and used to generate a complete list of all of the women of childbearing age
living in the study clusters.
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Figure 4.7: A detail from a village map drawn during the baseline census
Problems faced during the mapping an enumeration included boundary disputes
between chiefs, transport and allowance arrangements for FIs, fear of witchcraft and
traditional ‘nyau’ secret society members, respondents adding extra household members
(especially females) who were not resident (e.g. moved out and married elsewhere),
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enumerating ‘gowelos’ (boys hostels) twice as if they were two separate households and
using several different names. These issues all led to the possibility of an inflated or
inaccurate number of households and household members.
During the baseline phase some geographic coordinate data was also collected for each
village by the field supervisors, using hand-held global positioning system (GPS) units.
And in addition to the quantitative data, qualitative data was also collected through
focus group discussions and key informant interviews in order to learn more about
existing care practices and community understanding of neonatal care, and to inform
development of the interventions and the structured interview tools. Semi-structured
interviews and focus group discussions were conducted, and some Participatory Rural
Appraisal methods were used to facilitate discussion. Key informant interviews were
held with health workers, TBAs, traditional healers, chiefs, and other NGOs operating
in the district.
Randomisation and allocation
After dividing the district into 48 zones and mapping and enumerating them, these
zones were then randomly allocated to one of four groups; 12 zones receiving infant
feeding counselling and women’s groups, 12 zones receiving women’s groups only, 12
zones receiving infant feeding counselling only, and 12 zones receiving neither
intervention (Figure 4.1). Figure 4.8 shows the geographical pattern of random
allocation according to the 48 zone demarcations. In this way, each intervention was
stratified according to the presence or absence of the other one, in order to balance any
effects of one intervention on outcomes of interest in the other. Random number
generation was done in STATA 7.0. All women aged between 10 and 49 years residing
within the clusters were eligible for inclusion in the interventions and follow-up of
maternal and child health outcomes. Records of a woman’s migrations within and
outside of the study area are recorded in order to allow for standard ‘intention to treat’
analysis (women who were allocated to the intervention), as well as ‘per protocol’
analysis (women who actually received the intervention) and other levels of exposure
(157, 255).
Due to the nature of the interventions, blinding of study participants to their allocation
was not possible (276), though analysts and trial monitors were blinded to the study
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allocation until the definitive analysis was performed. Data was collected independently
from intervention implementation, and no results were fed back to inform the
interventions.
Figure 4.8: Random allocation of zones to four different combinations of intervention
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4.4.7 Phase II – Prospective surveillance
Data on the main primary and secondary outcomes were collected prospectively in
order to reduce the possibility of recall errors and biases affecting the results. Phase II
prospective surveillance data collection started in December 2004 and is still ongoing.
In Phase II, two main types of data are being collected; vital events data and structured
interview data about pregnancy, birth and child care practices. The WCBA list from the
baseline enumeration is used to make monthly ‘registers’ listing all women in each
cluster by village. 48 women enumerators (WEs) were recruited (one WE per cluster),
and trained in the process of identifying and recording any pregnancies occurring within
their cluster. WEs visit each woman of childbearing age (WCBA) in her area once per
month and ask about the menstrual status of each female member of the household and
record it in her register. She also asks about births, deaths and in- and out-migrations. A
weekly summary is submitted to the field interviewer (FI) for that zone for verification,
and a monthly summary is submitted to the nodal supervisor.
Structured interview data is collected from mothers at one month and six months after
delivery. The general content of each questionnaire is outlined in the section below on
Data Collection Tools. The qualitative information collected during the background and
baseline phases was used to develop these structured questionnaires, and questionnaires
were initially piloted by the monitoring and evaluation supervisors, and then piloted
further during the training and orientation of a new group of 48 FIs (one per cluster).
FIs visit each woman at one month and six months after giving birth. They ask a series
of questions relating to antenatal care, delivery care, postnatal care, care of the baby,
breastfeeding practices, sexual health and relationships, and any maternal or neonatal
problems encountered. In the case of a maternal, perinatal or neonatal death, a verbal
autopsy interview is conducted by the monitoring and evaluation supervisors, who were
trained to probe carefully for the details, timing and duration of all signs and symptoms
of illness that led to the death. This data is then sent to a team of physician reviewers to
establish the probable cause of death. (See Appendix 4 for an example of the one-month
questionnaire and perinatal verbal autopsy. Specific data from the maternal verbal
autopsy was not used for this research, apart from date of death.)
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For the purposes of trial follow-up, data was first frozen for review after two years of
intervention - at the end of July 2007 for the infant feeding intervention and the end of
February 2008 for the women’s group intervention.
A summary of the main study procedures is outlined in Table 4.5.
Data collection tools
All data collection tools were extensively researched, and were developed using tools
and experiences from similar studies in Nepal and Malawi (1, 22, 267, 277).
Questionnaires were piloted and modified until data collectors and supervisors were
comfortable with the format, content and flow of questions. Questionnaires were written
in Chichewa, but were back-translated to English by independent staff members to
ensure validity. The first period of questionnaire development and piloting took about
three months. Decisions about when and what to ask affected development of
questionnaires. For example, an interview to expectant mothers at 7-months of
pregnancy was abandoned because it was felt that most of the questions could be asked
at the time of a scheduled 1-month interview, and this would consequently reduce the
number of contacts with participants, and hence the burden on their time. A
comprehensive retrospective survey to collect baseline indicators of mortality and
behaviour was also abandoned because it was not felt necessary given the randomised
design of the study, and the inclusion of a birth history section in the prospective tools.
Prospective data relevant to the evaluation of the women’s group intervention presented
in this thesis were collected in two ways:
1. Neonatal and maternal mortality surveillance
To assess the impact of the interventions on mortality, all women of childbearing age
(WCBA) were visited monthly to identify pregnancies, births, stillbirths and neonatal
and maternal deaths. WCBA were visited by trained women enumerators (WE) once a
month and events were recorded in a register holding an up-to-date list of all women of
childbearing age in the cluster (generated from the baseline survey, plus new residents)
(Table 4.6). One enumerator visited all WCBA in one cluster.
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Table 4.5: Study procedures and time-line
Time Procedure
October 2003 1. Community consent obtained by senior staff members who explained the purpose, procedures, risks and benefits of the proposed study at district andsub-district level meetings
July 2004 2. Baseline census and survey to enumerate all households and WCBA in the study areas and obtain basic demographic and socioeconomic informationwas conducted between July and September 2004
November 2004
3. Random allocation of zones to “women’s group” or “no women’s group” and “infant feeding” or “no infant feeding” was done in November 2004
December 2004
and ongoing
4. New women moving to study area or reaching
10 years of age1 are prospectively enlisted
5. Monthly pregnancy surveillance is carried
out by local Woman Enumerators, who
detect and notify of new pregnancies
(defined by two consecutive missed
menses and two other reported signs of
pregnancy).
6. Birth notification is typically within 1-week of
birth to the Field Interviewers and within 1-
month of birth to the supervisors
7. One-month post-partum interviews are carried out with consenting
women by a trained Field Interviewer, if the mother and infant both
survive until 1-month postpartum, to obtain data on demographic
details, reported health behaviours, health-care seeking and
morbidity and other risk factor data on mothers and their infants
If mother or baby dies:
8. Maternal and stillbirth/neonatal verbal autopsy interviews are conducted
with consenting women or relatives by trained M&E supervisors, if a
mother has died during pregnancy or within 6-weeks of delivery or an
infant is stillborn or dies within 4 weeks of birth, to elicit information that
can aid in discerning causes of death. Two physician reviewers
independently assign primary and contributory causes of death, and discuss
any cases where they have disagreed until a consensus is reached
January 2005 and
ongoing
9. Volunteer MaiMwana Counsellors visit all pregnant women in their zones once before birth and four times after birth to give advice and support on
family planning, PMTCT and birth preparedness, and also offer support regarding breastfeeding problems
May 2005 and
ongoing
10. Women’s groups meet once per month (or less often depending on season) and discuss maternal and neonatal problems, contributing factors, strategies
and actions
June 2005 and
ongoing
11. Six month post-partum interviews are carried out with consenting women by a trained Field Interviewer, if the infant survives until 6-months
postpartum, to obtain information about infant morbidity, feeding practices and health-care seeking and other risk factor data on mothers and their
infants
May/June 2008 12. Re-census of households in study areas to re-enumerate all households and WCBA and collect information on in- and out-migration and births anddeaths of women and children.
April/June 2009 13. Infant follow-ups were carried out for all children born from 1st January 2005 in order to verify their status and collect basic details for children who
have died or moved out. This data will be used for estimates of infant mortality.
1 Surveillance of girls is started from 10-years old as it is an open cohort and new participants can be enrolled as they reach 15-years of age and also so that early
teenage pregnancies can be captured.
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All deaths of women and infants were followed up by a monitoring and evaluation
supervisor (MEO), who verified whether they were stillbirths, neonatal, infant or
maternal deaths or not through a structured verbal autopsy interview conducted between
two and six weeks after the death. This interview sought to elicit the causes and
contributing factors of the deaths (86). There are five supervisors each based at a nodal
office.
Table 4.6: Surveillance tools and content
Tool Administered by Content
Register WE An up-to-date list of all WCBAs in the cluster with space
for WE to write an event code. Events include: pregnancy,
birth, death, transfer out of area, etc
Maternal verbal
autopsy
MEO Questions from 1-month questionnaire (see below) plus:
questions on details of illness, open history and optional
health worker module
Neonatal verbal
autopsy
MEO Questions from 1-month questionnaire (see below) plus:
questions on details of illness, open history and optional
health worker module
2. Morbidity, care practices and behaviours
To assess the impact of the interventions on morbidity, care practices and behaviours,
women who were identified as pregnant were followed up until 6 months after birth by
trained field interviewers (FIs). Interviewers administered one-month and six-month
post-partum interviews to collect detailed information about demographic
characteristics, maternity history, health-seeking behaviours, care behaviours and
maternal and infant morbidity (Table 4.7).
Table 4.7: Health care seeking and health behaviour data collection tools and content
Tool Administered by Content
1-month
questionnaire
FI Mother: Mother and father’s demographic information, birth
history, antenatal care, uptake of PMTCT, delivery details,
maternal illness during pregnancy, delivery and post-
partum, health seeking behaviour, family planning and
relationship history, exposure to interventions
Infant: Birth details, newborn care practices, feeding
history, infant illness, health seeking behaviour
6-month
questionnaire
FI Mother: Use of ITN, uptake of VCT, maternal illness and
breast problems, health seeking behaviour, family planning
and relationships, exposure to interventions
Infant: Vaccinations, feeding history including details of
weaning, infant illness, health seeking behaviour
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4.4.8 – Phase III – Re-census
In order to triangulate and verify prospective mortality data, and collect more complete
information on infant and under-five outcomes, a re-census of all households was
conducted in May and June 2008. An additional 96 FIs were recruited and trained,
giving a total of 144 (3 FIs per zone). Lists of all enumerated households in the study
areas were produced and FIs enumerated any additional households that had been
missed during the previous census and continuing prospective enrolment. They visited
each household and collected information about any members who had migrated into or
out of the household since the last census. Details of ownership of a new set of
household assets were also collected to cover a more comprehensive range than during
the first survey. FIs then generated a list of all female household members, and elicited
further details of any deaths or migrations. Birth histories of all women-of-childbearing
age were collected in order to calculate child mortality rates, and retrospective maternal
mortality data was collected using sisterhood methods (39, 278) in order to compare
rates produced using different methodologies.
4.4.9 Data management, quality control and trial monitoring
Data management
All quantitative data collected was delivered to the main office for data entry in a
relational database management system in Microsoft Access run on a dedicated server
and workstations. Each WCBA was given a unique ID number generated from the
cluster, village and household she comes from. All quantitative data from the mortality
surveillance, morbidity, care practice and behaviour questionnaires was linked to the
WCBAs through this unique ID. After checking and entry, all questionnaires were
archived in a locked room for future reference.
Quality control
One enumerator per cluster identified births and deaths, and each event was
crosschecked by one interviewer. Supervisors made regular field visits to check the
quality of work done by enumerators and interviewers and observe some interviews.
Each supervisor is responsible for between six and ten clusters. Interviewers meet with
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enumerators weekly in order to check on their work and receive updates on births and
deaths in their area. Supervisors meet with interviewers and enumerators fortnightly to
check on their work, discuss problems and provide quality control feedback. A sample
of 200 one-month and six-month interviews was selected to be independently re-done
by the supervisor, in order to be able to estimate recall and interviewer error rates.
Quantitative data was checked in three stages. The first check was performed after
completion of the questionnaire, by the supervisor and a nodal data checker based at
one of the five nodal offices. The second check was done by a team of two data
checkers based at the main office. The last stage of data checking was done at the point
of data entry by the four data entry clerks. Further checks were carried out internally
within the electronic data-handling environment, and measures to ensure the quality of
data entered were taken. Due to the complex nature of the database and practicalities of
handling such a large volume of data, it was not possible to do double-entry of all
questionnaires to check for data entry and key-stroke errors. However, extensive data
cleaning exercises have been done in order to check key variables such as ID numbers
and dates of birth and death. This has mainly involved consistency checks and manual
comparison of records with the original paper questionnaires. Data entered into the
study databases were regularly reviewed for inconsistencies and missing information.
Lists of women interviewed and key fields to be verified were produced, such as ID
numbers, dates of birth, and reported pregnancies, births or deaths that had received no
further follow-up. In the event of errors, omissions or discrepancies in data, a log was
made of the nature of the error and the form was sent back to the data collection person
responsible for verification and correction.
Data is regularly reviewed to check for more general problems. These reviews include:
identification of reported pregnancies, births or deaths that had no further follow-up
with no reason given; identification of infants visited at one-month post-partum but not
visited again at six-months; comparisons of birth rates across all 48 zones to check for
under- or over-reporting by particular field-workers; comparisons of maternal and
neonatal deaths (not rates) across all 48 zones to check for over- or under-reporting by
particular supervisors; comparisons of birth rates and deaths across all villages to make
sure all villages are being visited by field workers; monitoring reporting trends in each
zone over time to check for consistency of reporting; identification of births and deaths
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that received an interview, but had not been reported through the surveillance (to look
for problem areas in surveillance and reporting); average time delays between birth and
interview for each interviewer or death and interview for each supervisor.
Dealing with loss to follow-up
Minimising loss to follow-up is an important aspect of trial conduct. Certain features of
this location and population dynamic needed special attention for outcome tracking: a)
Residents of Mchinji move seasonally to maximise their access to fertile land during the
farming season, both within the district and across international borders into Zambia
and Mozambique; b) Residents of Mchinji may go home for delivery and some time
after birth (to other villages within Mchinji or to other districts); c) Non-residents may
come into Mchinji from other districts for delivery and some time after birth; d)
Families may move after a woman’s death, making it difficult to find respondents who
know the details of what happened; e) High population turnover in trading centres and
commercial farm estates; f) Women being busy working in their gardens, or at
community gatherings such as funerals and chieftainship ceremonies, making them
unavailable for interview; g) Weather conditions making roads impassable and
conducting interviews difficult.
For residents or respondents who are temporarily unavailable, the main strategy is to
keep following up until an outcome is ascertained. All women who have ever lived in
the study areas are maintained in the database, and appear every month in the register.
Any events (such as pregnancy or birth) that are reported but no further details are
known, are selected and lists produced to remind field-workers of the need for follow-
up. In most cases this causes delays in getting complete data, though basic data for
estimating mortality rates are still available. In recognition of the fact that certain data
collected after a long delay will no longer be valid, sections in the questionnaire (such
as infant feeding recall) are skipped.
For residents or respondents who are permanently unavailable, basic information about
dates and timings of events is sought from other community members such as friends or
neighbours.
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Reducing contamination
Contamination may occur when people from one cluster have contact with people from
another. In the rural villages of Mchinji, there are many opportunities for social mixing.
Friends, relatives or neighbours may mix socially, or contact may be made through
travel or migration between intervention and control clusters. There might be direct
participation of residents from control areas in intervention activities, or more likely,
informal discussion of ideas arising from intervention activities – control area residents
may gain some benefit from hearing health messages received by intervention
participants. The usual effect of this kind of contamination would be ‘dilution’ of the
differences between treatment arms (253).
In order to reduce the possibility of contamination, we opted to use clusters of villages
rather than individual villages as the unit of randomisation, thus reducing rates of travel
across cluster boundaries (253). Furthermore, each zone had a defined ‘buffer area’
around the perimeter (Figure 4.6). A population of 3000 in each zone was required to
achieve the desired sample size, but rather than selecting villages at random from each
zone, only villages at the centre of the zonal area were eligible for inclusion in
surveillance and intervention activities. This reduced the possibility of communication
between neighbouring study villages in intervention and control areas.
Women’s group facilitators and volunteer counsellors are residents of the zone in which
they work. This reduces the possibility that they might transfer intervention benefits to
neighbouring communities. For the women’s group trial, whilst health messages are
discussed in group meetings, it is unlikely that neighbouring control communities would
spontaneously mobilise themselves without the presence of a facilitator. So the
hypothesised benefits of community empowerment and social capital are unlikely to
spread beyond intervention areas.
Trial monitoring
An independent Data Safety and Monitoring Board (DSMB) met four times during the
trial to review progress and advise on the conduct of the trial according to the
DAMOCLES statement (Box 1) (279). They first met in June 2007 and assessed
compliance with the protocol, data quality and completeness, recruitment figures,
sample size assumptions and ethical considerations. The DSMB met again in October
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2008, and the panel recommended extending the women’s group trial by an extra year
(to 31st January 2009) in order to allow for completion of intervention activities which
had faced unexpected delays, and re-census data processing. The final review of trial
data was held in March 2010.
Box 1: Aims of Data Safety and Monitoring Board meetings
4.4.10 Statistical analysis
Interim analyses and stopping rules
Interim DSMB meetings did not include analysis of outcome data by intervention
allocation until completion of the trial because the study interventions did not involve
medications and no significant safety issues were implicated, and because unplanned
interim analyses would have reduced the power of the study. Baseline data were
reviewed to evaluate how well balanced the clusters were after randomisation and
suggestions were made for any adjustments that may needed to be made. We did not
foresee any adverse effects of community mobilisation or peer counselling, so we did
not apply stopping rules.
The trial was planned for 3 years, and was powered for a 2-year analysis of birth
outcomes, after allowing a period for the intervention to be established. Analysis was by
intention to treat at cluster and participant levels, and the significance of the
intervention effect on primary and secondary outcomes was tested on the basis of
previously agreed hypotheses.
To independently:
 assess data quality, including completeness
 monitor recruitment figures and losses to follow-up
 monitor compliance with the protocol by participants and investigators
 monitor trial conduct – organisation and implementation of trial protocol
 suggest additional data analyses
 advise on protocol modifications suggested by investigators (e.g. to inclusion criteria, trial
endpoints, or sample size)
 monitor planned sample size assumptions and review the plan for analysis of primary and
secondary outcomes
 advise on safety issues
 consider the ethical implications of any recommendations made
 assess the impact and relevance of external evidence
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Sample
Surveillance began in December 2004 and is ongoing. The infant feeding intervention
started in January 2005 and the women’s group intervention started in May 2005, but
the effects of both interventions are not expected to have been apparent immediately.
For the women’s group intervention only births to women who had been exposed to the
intervention for the whole of their pregnancy will be included in the final analysis,
hence, the first months of surveillance are considered as a prospective baseline phase.
Trial end-points for the women’s group and infant feeding interventions are 31st January
2009 and 30th June 2008 respectively.
For the purpose of this thesis, data for all women who were pregnant and gave birth
between January 2005 and February 2009 will be used. For analysis of the impact of the
women’s group intervention, data for births between 1st February 2006 and 31st January
2009 will be included.
Inclusion criteria
All women enrolled in the MaiMwana surveillance system who had pregnancies ending
(with a live birth, stillbirth, neonatal death, infant death or maternal death) between 1st
January 2005 and 31st January 2009 and who agreed to take part in the study.
Exclusion criteria
Women not enrolled in the MaiMwana surveillance system, women who had
pregnancies ending before January 2005 or after January 2009, and women who had
pregnancies ending in miscarriage (but the mother survived). Mothers or infants for
whom month and year of birth and/or death were not known were excluded from
analysis, and mothers or infants who died for whom classification according to the
categories stillbirth, neonatal death, infant death or maternal death was not possible due
to missing details in verbal autopsy were excluded from analysis of specific mortality
outcomes. Infants were not classified according to exclusive breastfeeding status if data
were collected more than 2-weeks after the scheduled time, as feeding recall data were
considered unreliable.
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Datasets used
Several datasets were used for the purposes of the analyses in this thesis. They are
described in Table 4.8 below. Data collected for the first six months of the surveillance
system, before the intervention started, was used to provide baseline estimates of
mortality and other behavioural characteristics. This dataset, collected between 1st
January 2005 and 30th June 2005 is known as the ‘prospective baseline’.
Table 4.8: Datasets used for analyses presented in this thesis
Dataset Use for PhD Source Data collection
phase
Baseline
household census
To explore variability in
demographic and socioeconomic
characteristics between zones
before the interventions started in
order to evaluate success of
randomisation
Baseline survey July to September
2004
Newly
enumerated
households
To explore variability in
demographic and socioeconomic
characteristics between zones
before the interventions started in
order to evaluate success of
randomisation
Prospectively
enrolled households
1st January 2005 to
present
Prospective
baseline data
To explore variability in primary
and secondary outcomes between
zones before the interventions
started in order to evaluate the
success of randomisation
Prospective
surveillance system
1st January 2005 to
30th June 2005
Trial period
mortality data
To evaluate impact of the
intervention on maternal, perinatal
and neonatal mortality
Prospective
surveillance system
1st February 2006 to
31st January 2009
Trial period
secondary
outcome data (1-
month outcomes)
To evaluate impact of the
intervention on secondary process
and behavioural outcomes at 1-
month postpartum
Prospective
surveillance system
1st February 2006 to
31st January 2009
Trial period
secondary
outcome data (6-
month outcomes)
To evaluate impact of the
intervention on secondary process
and behavioural outcomes at 6-
months postpartum
Prospective
surveillance system
1st February 2006 to
31st January 2009
Re-census data To evaluate impact of the
intervention on infant mortality
Retrospective re-
census survey
May to June 2008
Cluster-level
characteristics
To adjust for cluster-level
characteristics and imbalances
Survey of field
workers and
cluster-level
medians, means or
proportions derived
from other datasets
1st January 2005 to
present
Baseline comparisons
Descriptive statistics were used to present baseline demographic and socioeconomic
characteristics of the study population. Principal components analysis (PCA) of
household asset data was done for the dataset containing all households enrolled in the
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study, and each household was given a socioeconomic score which was then used to
divide the sample into quintiles (280).
The prospective baseline dataset was used make crude comparisons between
intervention and control areas on several key socioeconomic and demographic
characteristics, baseline mortality rates and baseline behavioural and process outcomes.
Numbers, rates and proportions were derived, but statistical tests of significance were
not performed as the null hypothesis must be true at baseline, and any differences are
either due to chance or flawed randomisation (52). This was done in order to describe
the characteristics of the trial participants to assess generalisability of the results, to
check that the randomisation had led to balanced groups and to identify variables that
might be strongly related to the outcomes.
Maternal and stillbirth/neonatal verbal autopsies were reviewed independently by two
paediatricians. They assigned a cause of death, as well as any indirect or underlying
causes of death using classification systems adapted from the Neonatal and Intrauterine
death Classification according to Etiology (NICE) and Wigglesworth (for perinatal and
neonatal deaths) and WHO (maternal deaths) (28, 281-284). They indicated whether or
not the death could have been prevented, and named any ‘avoidable’ factors. Available
data on causes and timing of death was explored, although cause-specific data was not
available for maternal deaths. Exposure to the women’s group intervention and factors
related to participation were also explored.
Intervention impact
Primary and secondary outcomes were defined prior to analysis by intervention
allocation. These are outlined in Table 4.1 and definitions are given in Appendix 1. All
analyses were conducted in Stata (version 11.0 for Mac), MLwiN (version 2.18) and
SPSS (version 18.0 for Mac), and impact was measured using odds ratios with 95% CIs.
Descriptive analysis
After data cleaning, range checks, consistency checks and removal of severe outliers,
data collected during the trial period were explored through descriptive analyses
looking at distributions of exposure and outcome variables, and trends in means and
standard deviations. Univariate analyses were carried out in order to examine the
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relationship between the primary mortality outcomes and each exposure of interest. This
was done using simple two-by-two tables, and cross-tabulation (52). Univariate logistic
regression with random effects (to adjust for clustering of data by zones) on individual-
level data was done to explore the association between exposures and outcomes. In
particular, relationships between primary mortality outcomes and maternal age,
education, marital status and socioeconomic quintile were explored.
Unadjusted analysis
The association between the main exposure (allocation to women’s group intervention
or not), was explored through univariate logistic regression with random effects on
individual-level data, adjusting only for clustering and stratification by the infant
feeding intervention) (253, 265, 285). Analysis was done by intention-to-treat at cluster
and individual levels, where a woman’s exposure group was assigned according to the
allocated intervention in the place of residence at the time of delivery.
Adjusted analysis
Multivariable logistic regression with random effects was used to estimate the impact of
women’s groups after adjusting for potential confounding variables. Confounding
variables were selected on the basis of previous evidence of their association with study
outcomes, and their inclusion in the model was explored to investigate their effects in
this population (52). Exploratory analyses considered the effects of including individual
and cluster-level socioeconomic variables, distance from health facility, maternal age,
education, literacy, parity, tribe, religion and occupation (5, 25, 73, 94). The effects of
including baseline values were also explored to adjust for any imbalance between study
arms at baseline (253). Factors that were on the causal pathway, (e.g. health behaviours
such as health facility delivery) were not adjusted for (52). Analysis of outcomes only
in years 2 and 3 was also conducted in order to make the potential impact more
concentrated by excluding data from the first year when the intervention was just being
rolled out, although this was not an a priori analysis plan. The number of individuals
differed slightly for each analysis because of missing data for particular variables.
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Sub-group analysis
The women’s group intervention may have had a greater or lesser impact in certain sub-
groups, particularly those who were simultaneously exposed to the infant feeding
intervention at the same time. It was also possible that there might have been a dose-
response effect, with greater impact in those women who were more exposed to the
intervention (i.e. attended a greater number of women’s group meetings). Anecdotal
evidence during the implementation of the intervention, suggested that certain groups of
women might have benefitted more from the intervention. Thus, effect-modification of
intervention group, exposure level, and socioeconomic quintile was explored (52, 285).
P-values for the inclusion of the term rather than individual sub-groups are presented.
It is recommended that sub-group analyses are conducted with caution, as a small p-
value in one subgroup may arise due to a larger number of observations in the group
even if it has an identical treatment effect as in another group with smaller numbers
(52). Analyses by intervention group and exposure level were planned, but analysis by
socioeconomic quintile can be seen as an exploratory (post hoc) analysis to generate
hypotheses for future testing, rather than to provide definitive results in this study.
4.4.11 Ethical issues
Approvals
Ethical permission for this study was granted by the Malawi National Health Sciences
Research Committee in January 2003 (Ref: MED/4/36/I/167) (Appendix 5), and the
ethics committee of the UCL Institute of Child Health and Great Ormond Street
Hospital. It is registered with ISRCTN06477126.
Community consultation
Verbal and written consent was received from community leaders after full consultation
and discussions. The regional, district and village leaders, and local health and
development professionals had ongoing access to the research programme and will be
the first to be briefed on study findings and outcomes through written and verbal
reports.
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Individual consent
Before each instance of data collection, the process and advantages and disadvantages
of taking part were explained to all participants. Verbal consent was obtained, and
participants informed that they could stop taking part at any time. Participation in
intervention activities was voluntary, and women could choose to start or stop as they
wished.
Benefits to the control communities
The study is designed to test the community effectiveness of two community-level
initiatives to reduce maternal, perinatal, neonatal and infant mortality in rural Malawi.
Encouraging community action for maternal and newborn care alone will not grant
success. For health promotion interventions to work, the supply side of health care
services must reach a minimum standard. The study team considered it unethical to
strengthen services only in intervention and not control areas. Control communities
benefitted from low-cost improvements in equipment, supplies and training at all
primary level facilities in the district in intervention and control areas.
Treatment of illness in participating communities
When the study workers identified minor or chronic illness in mothers or infants in
either intervention or control areas they encouraged referral to the appropriate health
facility.
Confidentiality of information
All information will remain confidential. Access to information is limited to
interviewers and their supervisors at sites of collection, to auditors and data feeders at
the collation point and thence to the senior data management officers and principal
investigators. No analyses or reports will include the names of participants. Paper files
are kept in locked rooms and electronic data is kept in password-protected files.
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4.4.12 Role of the investigator
This thesis is based on prospective data collected as part of MaiMwana Project between
1st January 2005 and 31st January 2009, as well as background and baseline information
collected before that. This project is the result of efforts by a large multidisciplinary
team, involving many people, who made different contributions according to their skills
and knowledge. Most activities could not have been implemented by one person alone,
and benefitted from inputs from a wide range of people. As an epidemiologist and
technical advisor to this project since its inception I have been based in Malawi from
2003 to 2009 and have been involved in all aspects of the study. The main academic
areas of work that I coordinated were: designing the study and developing the study
protocol; random allocation of study clusters; sample size calculation and monitoring of
sample size requirements; coordinating mapping, enumeration and census of the study
area; designing, translating and piloting the data collection tools; recruiting and training
the Monitoring and Evaluation team; managing the data collection, checking and entry
processes; developing the study databases; cleaning and checking data and statistical
analysis and presentation of the data. In addition, I helped to develop the original grant
proposal to Saving Newborn Lives and was a principal investigator on the application
for a second phase of the same funding. I coordinated the qualitative data collection
during the baseline phase of the study that was used for tool development and
intervention design, and was involved in discussions about the continued development
of both of the interventions. I have co-authored several papers and conference
presentations both nationally and internationally using findings from the study (262-
264, 286).
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Chapter 5 : Results
5.1 Participation in baseline census and prospective data collection
5.1.1 Baseline census and prospective enumeration
Between 1st July and 30th September 2004 28,339 households were visited for mapping
and census, agreed to be included in the study and were interviewed. This represented a
total population of 146,623, of which 43,719 were women aged between 10 and 49
years. Over the following months and years up to 31st January 2009, 8,965 additional
households with 11,576 women aged between 10 and 49 years were enrolled, giving a
total population of 182,944 from 36,321 households, of whom 55,295 are women aged
10-49. Over the study period 3,830 women and families moved out of the study areas,
61 refused to participate and 1,290 died. All households and women interviewed were
included in the datasets looking at socioeconomic and demographic composition, as
they were eligible for inclusion at some time during the study. These details are shown
in Table 5.1.
Table 5.1: Composition of baseline and prospectively enumerated population sample
Households Women aged 10-49 years Total population
Total enumerated 37,304 55,295
11,875 (10-14 years)
43,247 (15-49 years)
6 (over 49 years)
167 (age unknown)
182,944
Interviewed during baseline 28,339 43,719
10,763 (10-14 years)
32,956 (15-49 years)
146,623
Added prospectively 8,965 11,576 36,321
Died - 1,290 -
Refused enumeration - 61 -
Moved out - 3,830 -
5.1.2 Prospective trial enrolment
The women’s group intervention trial period ran from 1st February 2006 to 31st January
2009. The database was formally frozen on 31st January 2009, and the trial profile
(using CONSORT guidelines (287)) in Figure 5.1 shows progress on study accrual from
1st February 2006 to 31st January 2009. Pregnancies are only included in this dataset if
they have had their outcomes (i.e. pregnancy completed due to miscarriage, stillbirth or
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live birth) by the 31st January 2009. No zone or village refused to participate and only
87 (0.4%) of pregnant women refused or were not allowed to participate in interviews.
Though numbers were small, there were twice as many refusals in control areas as in
intervention areas, and there were almost twice as many reported but unverified births
in intervention areas.
Between February 2006 and January 2009 20,066 pregnancies were reported, resulting
in 18,340 live births, 362 stillbirths, 434 neonatal deaths and 73 maternal deaths. 594
women miscarried before seven completed months, and 910 pregnant women were lost
to follow-up due to moving out of the study area, declining to take part, having
incomplete data or the data not having been fully verified. Retrospectively collected
data included 11,450 live births, and 484 infant deaths. Overall mortality rates for this
sample were 398 maternal deaths per 100,000 live births, 19.4 stillbirths per 1,000
births, 23.7 neonatal deaths and 42.3 infant deaths per 1,000 live births. Of the infants
that died during the neonatal period, 310 died within the first seven days, giving a
perinatal mortality rate of 35.9 per 1,000 births.
Of the questionnaires received at the office, all were included in datasets estimating
process outcomes. Seven verbal autopsy questionnaires were not included in the dataset
enumerating the numbers of births and deaths by zone and by intervention because the
exact timing of death was not known, so it was not possible to categorise (e.g. whether
an infant was stillborn or born alive but died soon after).
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Figure 5.1: Trial profile (CONSORT diagram)
1 Pregnancies reported in monthly registers but not followed up with an interview could include
women who moved out permanently, declined, were temporarily out, reporting errors as well as
some missed interviews. Some may be pregnancies that resulted in miscarriage, but the
miscarriage was not reported.
0 clusters excluded
All villages in buffer area of each
cluster excluded
48 clusters randomly allocated to intervention
692 villages included
182,944 estimated population
3,811 mean cluster population (range: 3,059 – 4,852)
24 clusters allocated no intervention
18,931 households
28,129 cohort members (women 10-49 years)
24 clusters received no intervention
24 clusters allocated intervention
18,373 households
26,993 cohort members (women 10-49 years)
24 clusters received intervention
0 total clusters lost to follow-up
9887 total pregnancies reported
60 participants moved out of study area
29 participants declined/not allowed
8 participants with incomplete data
409 participants unverified births1
506 total participants lost to follow-up
308 participants miscarried before 7 m
0 total clusters lost to follow-up
10179 total pregnancies reported
64 participants moved out of study area
58 participants declined/not allowed
10 participants with incomplete data
272 participants unverified births1
404 total participants lost to follow-up
286 participants miscarried before 7 m
Analysed for mortality outcomes
9537 infants born
167 stillbirths
9370 live births
219 neonatal deaths
39 maternal deaths
Analysed for process outcomes
9489 pregnancies
9540 infants born
5987 infants followed up at 6m
5164 infants with 6m breastfeeding data
Analysed for mortality outcomes
9165 infants born
195 stillbirths
8970 live births
215 neonatal deaths
34 maternal deaths
Analysed for process outcomes
9073 pregnancies
9169 infants born
5653 infants followed up at 6m
4889 infants with 6m breastfeeding data
48 clusters defined using census data
Analysed for infant mortality (from re-census)
5989 live births
255 infant deaths
Analysed for infant mortality (from re-census)
5461 live births
229 infant deaths
around each
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5.2 Characteristics of the study population and participants
5.2.1 Socioeconomic and demographic characteristics of the whole study
population
The socioeconomic and demographic characteristics of all enumerated households and
women of childbearing age are described in Table 5.2 and Table 5.3. Most families
lived in dwellings with a mud floor, a grass roof, a well for drinking water and a
traditional pit latrine. Very few households have electricity or own a motorcycle, car or
oxcart, but most did own a paraffin lamp and over half owned a radio or a bicycle. The
mean age of women in the study population was 23.3 years and the median was 21.0
years. Most women were married, from the Chewa tribe and Christian. Most had been
to primary school, but many had no education. The majority made their living through
farming.
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Table 5.2: Basic information about households in the study areas
Basic information about households N %
37,304
Type of flooring 37,107
Dirt/sand/dung
Cement
Wood/plank/tiles/other
33,660
3,314
133
90.7
8.9
0.4
Type of roofing 37,110
Natural
Iron sheets
Other
32,360
4,569
181
87.2
12.3
0.5
Use of agricultural land 37,071
Own or family land
Rented or someone else’s land
No agricultural work
33,470
2,993
608
90.3
8.1
1.6
Source of drinking water 37,099
Piped water (house)
Piped water (yard)
Piped water (public)
Protected well/borehole
Traditional well
River/canal/surface water
171
61
2,201
17,810
15,701
1,155
0.5
0.2
5.9
48.0
42.3
3.1
Toilet 37,099
Flush
Traditional pit latrine
VIP pit latrine
Bush/field
Other
184
29,571
596
6,604
144
0.5
79.7
1.6
17.8
0.4
Household members (average per household) 182,944 4.9
Sleeping rooms (average per household) 72,731 1.9
Household density (i.e. members per sleeping room) (average per
household)
2.5 2.8
Assets 37,304
Electricity
Radio
Bicycle
Motorcycle
Car
Paraffin lamp
Oxcart
Domestic worker
225
23,512
18,918
232
159
34,715
1,545
1,266
0.6
63.0
50.7
0.6
0.4
93.1
4.1
3.4
Data are number (%), unless otherwise specified.
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Table 5.3: Basic information about women living in the study areas
Basic information about women aged 10 to 49 years N %
Women aged 10-49 years
10-14 years
15-49 years
55,122
11,875
43,247
-
24.6
75.3
Mean age (SD)
Median age (range)
23.3
21.0
9.8
10-49
Marital status 55,063
Married
Never married
Divorced
Separated
Widowed
32,034
19,702
1,205
1,257
865
58.2
35.8
2.2
2.3
1.6
Tribe 55,055
Chewa
Ngoni
Senga
Yao
Tumbuka
Lomwe
Other
48,923
3,351
1,175
831
288
339
148
88.9
6.1
2.1
1.5
0.5
0.6
0.3
Religion 55,049
Christian (catholic)
Christian (other)
Moslem
Aaron
Pagan
Other
25,923
27,234
928
60
233
671
47.1
49.5
1.7
0.1
0.4
1.2
Education 55,055
None
Primary
Secondary
Tertiary
12,702
38,674
3,584
95
23.1
70.2
6.5
0.2
Occupation 55,047
Farming
Casual worker
Salaried worker
Small business
Rural artisan
Student
No work
32,773
572
563
2,205
62
15,738
3,134
59.5
1.0
1.0
4.0
0.1
28.6
5.7
Data are number (%), unless otherwise specified.
5.2.2 Principal Components Analysis for socioeconomic status
Principal components analysis of household assets was used to generate socioeconomic
scores for each household in the study area. The distribution of these scores is shown in
Figure 5.2. As can be seen in the figure, most values were clustered together in the
lower range of scores. Cluster analysis showed that 80% of households fell within the
cluster for the lowest socioeconomic group, and the first principal component accounted
for 15% of the total variation. This ‘truncation’ makes it difficult to differentiate
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between the poor and the very poor in this sample. Most households in rural Mchinji do
not own durable assets, are built of the same materials and have similar levels of access
to utilities. Such skewed distributions, with short tails to the left (poorer end) and long
tails to the right (wealthier end), are often found for variables measuring concepts such
as income and wealth (288).
Further exploration of socioeconomic scores by zone showed that households with the
highest socioeconomic scores tended to be clustered in several zones, which had much
higher mean and median scores than other zones. Mean and median socioeconomic
scores were calculated for each cluster, and Figure 5.3 shows box-plots for the
distribution of cluster-level scores by intervention allocation. Zone 17 (Kamwendo
trading centre) in particular was far wealthier than any of the other zones, and is
represented by the biggest outlier in Figure 5.3. It is interesting that the variability in
terms of cluster-level socioeconomic scores is bigger in intervention areas, with both
high and low outliers (beyond the whiskers of length 1.5 times the interquartile range
from the box edge (289)), and a wider box (representing the 25th and 75th percentiles).
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Figure 5.2: Frequency distribution of household socioeconomic scores
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Figure 5.3: Box-plots showing distribution of cluster-level mean and median socioeconomic scores
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5.2.3 Socioeconomic and demographic characteristics of pregnant women during
prospective baseline
Comparisons of socioeconomic and demographic characteristics by intervention
allocation are described in Table 5.4, using ‘prospective baseline’ data (collected
between January and June 2005). This gives a picture of the characteristics of pregnant
women in this population before the intervention started. Little difference was apparent
between intervention and control areas at baseline. The mean household socioeconomic
score was slightly higher in women’s group compared to control areas, though the
medians were almost identical. In both groups, the median was a lot lower than the
mean, reflecting the skewed nature of the data described earlier (Figure 5.2). Looking at
the quintiles of socioeconomic scores, there were a slightly higher proportion of
households in both the poorest and the least poor quintiles in women’s group areas,
reflecting the presence of large trading centres as well as the most remote areas in the
women’s group zones.
Characteristics such as age, education, occupation, marital status and parity were very
similar. The main differences seemed to be related to the distribution of different tribal
groups between intervention and control areas, with more Ngoni, Senga and other tribes
falling in intervention areas and a larger proportion of Chewa in control areas. The
distribution of more Ngoni and Senga in the intervention areas is as a result of many
those zones lying along the border with Zambia where these tribes are concentrated.
There are also fewer Catholics, but more other Christian denominations and Muslims in
the intervention group. Religious affiliation is partly a result of the denomination of the
nearest church, though more diversity may reflect the presence of more trading centres
in intervention areas. Overall, the intervention and control groups are very comparable
on baseline socioeconomic and demographic characteristics.
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Table 5.4: Comparison of socioeconomic and demographic characteristics by intervention allocation for
women who became pregnant during the prospective baseline phase
Prospective baseline
January – June 2005
Women’s group
n (%)
Control
n (%)
Household characteristics 1465 1537
Socioeconomic score mean (SE)
median
-0.040 (0.025)
-0.32
-0.087 (0.022)
-0.31
Socioeconomic
quintile
1 = poorest
2
3
4
5 = least poor
304 (21.1)
275 (19.1)
307 (21.3)
272 (18.9)
283 (19.6)
304 (20.1)
282 (18.7)
346 (22.9)
330 (21.9)
248 (16.4)
Woman characteristics 1465 1537
Age mean (SE)
median
26.3 (0.17)
25.00
26.1 (0.16)
25.00
Tribe Chewa
Ngoni
Senga
Other
1235 (85.2)
124 (8.6)
48 (3.3)
43 (3.0)
1425 (93.3)
66 (4.3)
8 (0.5)
28 (1.8)
Religion Catholic
Other Christian
Muslim
Traditional
Other
585 (40.3)
807 (55.7)
32 (2.2)
2 (0.1)
24 (1.7)
782 (51.2)
709 (46.4)
15 (1.0)
3 (0.2)
18 (1.2)
Education None
Primary
Secondary or higher
294 (20.1)
1065 (72.9)
122 (7.1)
337 (22.0)
1076 (70.1)
122 (8.0)
Occupation Farmer
Ganyu
Salaried
Business
Student
No work
1217 (83.9)
18 (1.2)
11 (0.8)
79 (5.5)
54 (3.7)
71 (4.9)
1260 (82.5)
12 (0.8)
18 (1.2)
99 (6.5)
59 (3.9)
79 (5.2)
Marital status Married
Never married
Divorced/Widowed
1365 (94.2)
32 (2.2)
52 (3.6)
1292 (93.8)
108 (2.0)
49 (4.2)
Parity Ever previously pregnant
Never previously pregnant
1213 (82.9)
251 (17.1)
1248 (80.8)
297 (19.2)
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5.2.4 Primary (mortality) outcomes for mothers and infants during prospective
baseline
Prospectively collected surveillance data, using registers documenting monthly visits to
women of childbearing age (section 4.4.7), was used to calculate mortality rates in areas
allocated to women’s group and control at baseline, before the women’s group
intervention had started. The comparisons and combined mortality rates are shown in
Table 5.5 below. Large differences were found between intervention and control areas,
with infant, neonatal and perinatal mortality 62%, 42% and 64% higher respectively in
intervention than control areas during this baseline phase. The number of maternal
deaths during the six-month period was small, with only 14 deaths, but the maternal
mortality ratio was also slightly higher in intervention areas (6%).
Table 5.5: Prospective baseline mortality rates by intervention allocation
Prospective baseline
January – June 2005
Births and deaths Women’s groups Control Total
Births
Live births
Stillbirths (FSB and MSB)
1488
1445
43
1564
1538
26
3052
2983
69
Neonatal deaths
Early (0-6 days)
Late (7-28 days)
46
32
14
34
22
12
80
54
26
Infant deaths*
(retrospective live births)
82
(1307)
61
(1576)
143
(2883)
Maternal deaths 7 7 14
Mortality rates
Stillbirth rate
per 1000 births 28.9 16.6 22.6
Perinatal mortality rate
per 1000 births 50.4 30.7 40.3
Early neonatal mortality rate
per 1000 live births 22.1 14.3 18.1
Late neonatal mortality rate
per 1000 live births 9.7 7.8 8.7
Neonatal mortality rate
per 1000 live births 30.9 21.7 26.2
Infant mortality rate*
per 1000 live births 62.7 38.7 49.6
Maternal mortality ratio
per 100,000 live births 484 455 469
*Using retrospectively collected birth and death data for the same period, from the re-census conducted
in June 2008
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5.2.5 Secondary (behavioural and process) outcomes for mothers and infants
during prospective baseline
Prospectively collected data from one- and six-month postpartum interviews during the
six-month baseline phase before the women’s group intervention had started, was used
to calculate the prevalence of certain key health behaviours in areas allocated to
women’s group and control. The comparisons are shown in Table 5.6 below.
Table 5.6: Prospective baseline secondary outcomes by intervention allocation
Prospective baseline
January – June 2005
Women’s group
n (%)
Control
n (%)
Pregnancies 1465 1537
Any antenatal care at a health facility
Four or more antenatal care visits
Any iron and folic acid
More that 90 days iron/folate
Any tetanus toxoid immunisation
Adequate tetanus toixoid1
Any sulphadine-pyrimethamine (SP)
Two or more doses of SP
Bednet use night before interview
Bednet used every night in pregnancy
Any HIV testing at antenatal care visit
Any perceived antenatal, delivery or postnatal maternal
problem
1336 (91.2)
417 (30.0)
1199 (87.9)
232 (17.0)
1174 (86.1)
822 (61.2)
1261 (91.6)
564 (44.8)
625 (42.6)
686 (48.0)
164 (11.8)
822 (56.4)
1410 (91.7)
517 (35.2)
1334 (92.0)
360 (24.8)
1189 (82.2)
885 (61.9)
1375 (93.4)
559 (41.1)
688 (44.5)
751 (50.4)
201 (14.0)
750 (48.8)
Births 1488 1564
Institutional deliveries
Birth attended by skilled provider
Birth attended by a TBA
Attendant washed hands/wore gloves
536 (36.1)
535 (35.9)
611 (41.0)
1163 (91.7)
682 (43.7)
663 (42.4)
586 (37.5)
1266 (91.7)
Live births 1445 1538
Baby wrapped within 30 min
Baby bathed after 24hrs
Postnatal care at a health facility
Infant received BCG
Infant received polio immunisation
Any perceived infant problem (cough, fever or diarrhoea)
1330 (93.4)
454 (32.0)
344 (25.0)
641 (44.6)
532 (37.1)
597 (45.3)
1355 (88.7)
553 (36.5)
454 (31.5)
643 (41.9)
570 (37.3)
637 (45.8)
Infants with follow-up data at 6m 830 934
Infant received BCG by 6-months
Infant received any polio vaccine doses by 6-months
Infant received 4 polio vaccine doses by 6-months
Infant received any pentavalent vaccine dose by 6-months
Infant received 3 pentavalent vaccine doses by 6-months
799 (96.3)
803 (96.8)
50 (6.0)
752 (90.7)
456 (55.0)
891 (95.4)
890 (95.4)
164 (17.6)
878 (94.1)
537 (57.6)
Infants with 6m of breastfeeding data 778 844
Infant exclusively breastfed to 6m
Initiated breastfeeding within 1 hr
Use of prelacteals
Any breastfeeding problem
137 (17.6)
604 (79.5)
111 (14.3)
20 (2.6)
91 (10.8)
621 (75.3)
186 (22.0)
31 (3.7)
1 Adequate tetanus toxoid immunisation is 2 doses in pregnancy, or having completed the whole course of 5 doses over preceding
years
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Differences were seen between women’s group and control areas, with many health
indicators being worse in intervention areas. There were fewer health facility deliveries
and fewer postnatal care visits in women’s group areas, and more maternal antenatal,
delivery and postnatal problems were reported. Combined with the fact that all primary
mortality outcomes were worse in intervention areas (Table 5.5), there is some evidence
that women and children in women’s group areas had poorer health than those in
control areas at baseline, suggesting that randomisation did not create balanced groups,
and baseline values would have to be adjusted for in analysis of intervention impact
(253).
5.2.6 Main cause and time of death
Data on cause and time of death are from all those records with available data, and do
not exactly represent the study period. Less than 10 physician reviews assigning causes
of maternal deaths were available at the time of writing, and will not be discussed here.
Physician reviews of perinatal and neonatal deaths were also not complete at the time of
writing, but data for 194 (53%) neonatal deaths and stillbirths out of 367 collected
during the course of the baseline and inception phases of the study before the evaluation
period started were available. There may have been differences between those included
and not included, but cause-specific mortality was not a main focus of this research, and
available data are presented here in order to provide a picture of the aetiology.
There were 17 macerated stillbirths, 62 fresh stillbirths, 17 undifferentiated stillbirths,
and 98 neonatal deaths. Table 5.7 summarises the causes of all perinatal and neonatal
deaths, and Figure 5.4 shows the distribution of causes of neonatal deaths. The most
common cause of neonatal death was severe infection, accounting for more than half of
all neonatal deaths. This is a much higher proportion than the WHO regional estimates
for Africa shown for comparison in Figure 5.5, where severe infection accounts for just
over one quarter of neonatal deaths (53). Birth asphyxia accounted for almost one third
of deaths in both cases, but prematurity and tetanus were much more common in the
WHO estimate.
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Table 5.7: Causes of neonatal death and stillbirth
Cause N %
Stillbirths 96 49.5
Macerated stillbirth
Fresh stillbirth
Undifferentiated stillbirth
17
62
17
17.7
64.6
17.7
Neonatal deaths 98 50.5
Congenital malformation
Birth asphyxia
Infectious causes
Sepsis and meningitis
Tetanus
Diarrhoea
Pneumonia
Prematurity
Hypoglycaemia/hypothermia
Sudden infant death
Unspecified
2
29
55
41
0
1
13
6
2
2
2
2.0
29.6
56.1
41.8
0
1.0
13.3
6.1
2.0
2.0
2.0
Of 640 neonatal deaths for whom data on dates of birth and death were available (for
the whole study period including baseline), 253 (39.5%) happened on the first day, and
455 (71.1%) were within the first week of life. Figure 5.6 shows the distribution of day
of death for neonatal deaths.
Of 82 maternal deaths for whom data on stage of pregnancy was available, 10 (12.2%)
happened before seven completed months of pregnancy, 22 (26.8%) happened after
seven completed months but before the onset of labour, and 50 (61.0%) happened
during or after delivery. Of those that happened during or after delivery, 16 (32%) were
on the first day, and 29 (58%) were within the first week. Figure 5.7 shows the
distribution of maternal deaths.
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Figure 5.4: Causes of neonatal death from 98 neonatal deaths in Mchinji, Malawi
(98 neonatal deaths from baseline and year 1)
Severe infection includes the sepsis and meningitis, and pneumonia categories
Figure 5.5: Causes of neonatal death for Africa from WHO estimates for 2000-2003 (53)
Severe infection includes pneumonia, meningitis, sepsis/septicaemia
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Figure 5.6: Day of death for 640 neonatal deaths
Figure 5.7: Day of death for 82 maternal deaths
NB: Deaths during pregnancy, before the onset of labour, are included as those less than day 0.
Deaths during delivery are counted as day 1.
During
pregnancy
During or after
delivery
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5.2.7 Socioeconomic and demographic characteristics related to primary and
secondary outcomes
Section 2.2 describes some of the socioeconomic and demographic characteristics
known to be related to maternal and neonatal mortality and coverage of health-care
interventions. The relationship between risk factors and adverse health outcomes was
explored in this study population. Mortality rates and health-care seeking differed
according to maternal age, education and socioeconomic status, as well as maternal
parity and marital status. Given the collinearity between some of these variables, the
independent effects of each will not be described fully here. This section presents data
showing primary mortality outcomes and three key secondary outcomes by maternal
age, educational level, marital status and socioeconomic group.
Maternal age
Figure 5.8 shows the proportion of births resulting in infant, maternal, neonatal and
perinatal deaths for different maternal ages. Mortality was higher amongst the youngest
and oldest groups of mothers. For neonatal and perinatal deaths, the relationship is
clearly not linear, and is better represented by a quadratic, curved line. The relationship
between infant death and maternal age is less curved, but still clearly quadratic. We
would expect to see a similar quadratic relationship between maternal age and maternal
death because first pregnancies at young ages and late pregnancies are known to have
higher risks associated with them (290, 291), but this pattern is less obvious in this
dataset, though is still best described statistically by a curve than a straight line.
Age reporting is inaccurate, as many women do not know their age or date of birth, and
ages for women in the older age groups particularly, may be misclassified. However,
the outlying points for the youngest and oldest ages represent only a small number of
women, so for the bulk of the dataset (for the purposes of statistical modelling) we can
consider age as quadratic for mortality outcomes.
As coefficients and odds ratios from quadratic terms in models are difficult to interpret,
further exploration of differential effects of the intervention by age was done using four
age groups. Table 5.8 shows how mortality rates and key health-care seeking indicators
vary by age-group, confirming the clear pattern of higher mortality in the youngest and
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oldest age groups for perinatal and neonatal mortality, and a less clear pattern for infant
and maternal mortality.
Figure 5.8: Proportion of births resulting in infant, maternal, neonatal and perinatal death by maternal age
Process outcomes, such as antenatal care, skilled birth attendance and postnatal care did
not follow a quadratic relationship (Figure 5.9). For most health-care seeking variables,
older women were less likely to seek care than younger women. Thus for secondary
outcomes, a linear age term was included in regression models. Table 5.8 again shows
significantly lower health-care seeking in the older age groups.
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Figure 5.9: Proportion of mothers receiving antenatal care, skilled birth attendance and postnatal care by
maternal age
Educational level
There appears to be a pattern of reduced risk of maternal death with higher level of
maternal education (Table 5.8), but the pattern is less clear for perinatal and neonatal
mortality. There is a significantly higher risk of perinatal death amongst women with
primary education compared to those with no education, and women with primary
education are also at highest risk of neonatal death.
The pattern of health-care seeking with maternal education is much clearer. Antenatal
care, skilled birth attendance and postnatal care are significantly higher amongst women
with primary education, and higher still amongst women with secondary education,
compared to women with no education.
Marital status
Marital status is closely related to age, with most of the never married women being
found in the youngest age group. Women who have never been married (corresponding
to the youngest age group), are at significantly higher risk of perinatal, neonatal and
maternal death when they become pregnant, than women who are currently married
165
(Table 5.9). Divorced or widowed women are also at significantly higher risk of
perinatal and neonatal death, and they also have significantly lower uptake of antenatal
care, skilled birth assistance and postnatal care. Antenatal care is significantly lower
amongst never married women, perhaps because of fear of the stigma associated with
being a young, unmarried mother, but skilled birth attendance is significantly higher
amongst unmarried women.
Socioeconomic status
Poverty is a well-documented determinant of poor health as described in section 2.2,
and it was important to explore the magnitude of health inequalities in this study
population. Figure 5.10 shows that mortality rates tend to decrease with increasing
socioeconomic status. The relationship is not as strong for infant mortality, and in fact
mortality increases with increasing socioeconomic status when zone 17 (a
socioeconomic outlier described in section 5.2.2 and Figure 5.3) is included.
Figure 5.10: Infant, maternal, neonatal and perinatal mortality rates by cluster-level socioeconomic score
Scatter of cluster-level mortality rates against mean cluster-level socioeconomic score
Line of best fit to all points
Line of best fit to all points excluding zone 17 (outlier with mean socioeconomic score above 1.0)
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The non-normal distribution of household socioeconomic scores (Figure 5.2) makes its
coefficient difficult to interpret in regression models, and without a suitable
transformation it was more informative to create a categorical variable by dividing
individual household scores into quintiles (292). The magnitude of the difference in
mortality between the poorest and the least poor quintiles is greatest for peinatal and
neonatal mortality, which is more than 30% higher in the poorest quintile compared to
the least poor. For maternal mortality this difference is less than 10% (Table 5.9). For
maternal, perinatal and neonatal mortality, the highest mortality rates are found in the
lowest quintile, but the lowest mortality rates are not found in the highest quintile.
Instead the lowest mortality is found in the fourth quintile for perinatal and neonatal,
and the third quintile for maternal mortality. For maternal mortality in Malawi, as
described in section 2.2.3, this flattening of the socioeconomic gradient, as well as the
loss of the ‘urban advantage’ has previously been attributed to HIV (77, 85).
Odds ratios show that there is a significant relationship between perinatal mortality and
socioeconomic group, with the highest mortality amongst the poorest women (reference
group). For neonatal and maternal mortality, the relationship is not significant, but is
similar, and appears to be greater in all other socioeconomic groups compared to the
poorest quintile.
For infant mortality, the pattern is quite different. Infant mortality is just over 20%
higher in the poorest compared to the least poor quintile, but the highest mortality rate is
in the third quintile, the lowest is in the least poor quintile, and the second lowest in the
poorest quintile.
The relationship between health-care seeking rates and socioeconomic status is much
clearer and more consistent (Figure 5.11), and coverage rates for antenatal care, skilled
birth attendance and postnatal care increase with socioeconomic status. The relationship
between socioeconomic quintile and health-care seeking is highly significant (Table
5.9). Similar patterns are seen with most other secondary outcome variables.
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Figure 5.11: Percentage of mothers receiving antenatal care, skilled birth attendance and postnatal care by
cluster-level socioeconomic score
Scatter of cluster-level mortality rates against mean cluster-level socioeconomic score
Line of best fit to all points
Line of best fit to all points excluding zone 17 (outlier with mean socioeconomic score above 1.0)
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Table 5.8: Primary mortality outcomes and selected secondary outcomes by age group and educational level
Age group Educational level
Rate by group
N/total (rate)
Odds ratio
Years 1-3*
p value
(Wald)
Rate by group
N/total (rate)
Odds ratio
Years 1-3*
p value
(Wald)
Primary outcomes
Perinatal mortality rate
(per 1000 births)
10-19 years
20-29 years
30-39 years
40 years and over
93/2317 (40.1)
320/10431 (30.7)
174/4913 (35.4)
41/847 (48.4)
-
0.76 (0.60-0.96)
0.87 (0.67-1.13)
1.20 (0.83-1.76)
0.012
None
Primary
Secondary or higher
111/3669 (30.3)
495/13364 (37.0)
50/1594 (31.4)
-
1.26 (1.02-1.56)
1.12 (0.80-1.58)
0.08
Neonatal mortality rate
(per 1000 live births)
10-19 years
20-29 years
30-39 years
40 years and over
68/2275 (29.9)
212/10260 (20.7)
106/4812 (22.0)
23/822 (28.0)
-
0.69 (0.52-0.91)
0.72 (0.53-0.98)
0.94 (0.58-1.52)
0.042
None
Primary
Secondary or higher
79/3669 (21.5)
320/13364 (23.9)
27/1594 (16.9)
-
1.13 (0.88-1.46)
0.84 (0.54-1.32)
0.25
Infant mortality rate
(per 1000 live births)
10-19 years
20-29 years
30-39 years
40 years and over
23/562 (40.9)
268/6289 (42.6)
131/3463 (37.8)
42/787 (53.4)
-
1.06 (0.69-1.65)
0.95 (0.60-1.50)
1.37 (0.81-2.31)
0.26
None
Primary
Secondary or higher
NA NA NA
Maternal mortality rate
(per 1000 live births)
10-19 years
20-29 years
30-39 years
40 years and over
11/2315 (475)
24/10343 (232)
27/4856 (556)
1/836 (120)
-
0.49 (0.24-1.00)
1.17 (0.58-2.36)
0.25 (0.03-1.95)
0.009
None
Primary
Secondary or higher
16/3627 (441)
52/13267 (392)
4/1577 (254)
-
0.89 (0.51-1.56)
0.58 (0.19-1.72)
0.61
Secondary outcomes
Any antenatal care
(%)
10-19 years
20-29 years
30-39 years
40 years and over
2240/2313 (96.8)
9878/10328 (95.6)
4574/4851 (94.3)
737/836 (88.2)
-
0.75 (0.58-0.97)
0.57 (0.44-0.75)
0.27 (0.20-0.39
<0.0001
None
Primary
Secondary or higher
3256/3620 (89.9)
12724/13253 (96.0)
1552/1577 (98.4)
-
2.37 (2.05-2.74)
5.70 (3.76-8.63)
<0.0001
Skilled birth attendance
(%)
10-19 years
20-29 years
30-39 years
40 years and over
1376/2318 (59.4)
5342/10437 (51.2)
2345/4916 (47.7)
343/847 (40.5)
-
0.72 (0.66-0.80)
0.65 (0.59-0.73)
0.49 (0.42-0.59)
<0.0001
None
Primary
Secondary or higher
1342/3671 (36.6)
6897/13373 (51.6)
1180/1594 (74.0)
-
1.74 (1.61-1.89)
4.34 (3.78-4.99)
<0.0001
Postnatal care attendance
(%)
10-19 years
20-29 years
30-39 years
40 years and over
825/1965 (42.0)
3528/8783 (40.2)
1507/4176 (36.1)
196/706 (27.8)
-
0.98 (0.88-1.10)
0.84 (0.75-0.95)
0.57 (0.46-0.70)
<0.0001
None
Primary
Secondary or higher
817/3116 (26.2)
4447/11232 (39.6)
804/1379 (58.3)
-
1.65 (1.50-1.82)
3.35 (2.89-3.88)
<0.0001
* Adjusted for clustering and stratification only.
NA: Maternal education data were not available with the retrospective infant outcome dataset.
P-values have not been adjusted for multiple testing as these are exploratory analysis rather than hypothesis testing
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Table 5.9: Primary mortality outcomes and selected secondary outcomes by marital status and socioeconomic quintile
Marital status Socioeconomic quintile
Rate by group
N/total (rate)
Odds ratio
Years 1-3*
p value
(Wald)
Rate by group
N/total (rate)
Odds ratio
Years 1-3*
p value
(Wald)
Primary outcomes
Perinatal mortality rate
(per 1000 births) MarriedNever married
Divorced/widowed/other
585/17411 (33.6)
21/395 (53.2)
44/648 (67.9)
-
1.71 (1.09-2.69)
2.05 (1.49-2.83) <0.0001
1 – Poorest
2
3
4
5 – Least poor
169/3694 (45.7)
122/3531 (34.6)
140/3977 (35.2)
109/3915 (27.8)
104/3057 (34.0)
-
0.77 (0.61-0.98)
0.80 (0.63-1.01)
0.63 (0.49-0.81)
0.80 (0.61-1.03)
0.009
Neonatal mortality rate
(per 1000 live births) MarriedNever married
Divorced/widowed/other
372/17093 (21.8)
18/386 (46.6)
31/625 (49.6)
-
2.41 (1.48-3.93)
2.24 (1.53-3.27) <0.0001
1 – Poorest
2
3
4
5 – Least poor
105/3600 (29.2)
80/3468 (23.1)
86/3904 (22.0)
82/3857 (21.3)
66/2999 (22.0)
-
0.81 (0.60-1.09)
0.77 (0.58-1.04)
0.75 (0.56-1.02)
0.78 (0.57-1.08)
0.32
Infant mortality rate
(per 1000 live births) MarriedNever married
Divorced/widowed/other NA NA NA
1 – Poorest
2
3
4
5 – Least poor
95/2370 (40.1)
107/2318 (46.2)
117/2514 (46.5)
106/2347 (45.2)
59/1790 (33.0)
-
1.12 (0.84-1.49)
1.12 (0.84-1.48)
1.08 (0.81-1.45)
0.77 (0.55-1.08)
0.17
Maternal mortality rate
(per 1000 live births) MarriedNever married
Divorced/widowed/other
65/17263 (377)
6/396 (1515)
1/641 (156)
-
4.07 (1.75-9.45)
0.41 (0.06-2.98)
0.003
1 – Poorest
2
3
4
5 – Least poor
17/3658 (465)
12/3502 (343)
10/3930 (286)
15/3889 (386)
13/3036 (428)
-
0.74 (0.35-1.54)
0.55 (0.25-1.19)
0.83 (0.41-1.66)
0.92 (0.45-1.90)
0.62
Secondary outcomes
Any antenatal care
(%) MarriedNever married
Divorced/widowed/other
16424/17245 (95.2)
363/396 (91.7)
587/639 (91.9)
-
0.46 (0.31-0.67)
0.55 (0.41-0.74)
<0.0001
1 – Poorest
2
3
4
5 – Least poor
3368/3649 (92.3)
3287/3493 (94.1)
3740/3928 (95.2)
3741/3881 (96.4)
2940/3028 (97.1)
-
1.21 (1.00-1.47)
1.46 (1.20-1.78)
1.90 (1.53-2.36)
2.44 (1.89-3.14)
<0.0001
Skilled birth attendance
(%) MarriedNever married
Divorced/widowed/other
8813/17421 (50.6)
244/396 (61.6)
289/648 (44.6)
-
1.28 (1.02-1.59)
0.77 (0.65-0.92) 0.001
1 – Poorest
2
3
4
5 – Least poor
1435/3695 (38.8)
1675/3532 (47.4)
1942/3977 (48.8)
2080/3916 (53.1)
2020/3059 (66.0)
-
1.23 (1.11-1.36)
1.36 (1.24-1.51)
1.61 (1.46-1.78)
2.63 (2.36-2.93)
<0.0001
Postnatal care attendance
(%) MarriedNever married
Divorced/widowed/other
5731/14838 (38.6)
149/340 (43.8)
171/509 (33.6)
-
0.95 (0.75-1.21)
0.80 (065-0.98)
0.09
1 – Poorest
2
3
4
5 – Least poor
934/3111 (30.0)
1108/2986 (37.1)
1278/3365 (38.0)
1312/3283 (40.0)
1256/2612 (48.1)
-
1.17 (1.04-1.32)
1.31 (1.17-1.47)
1.41 (1.25-1.58)
2.05 (1.82-2.32)
<0.0001
* Adjusted for clustering and stratification only.
NA: Marital status data were not available with the retrospective infant outcome dataset.
P-values have not been adjusted for multiple testing as these are exploratory analyses rather than hypothesis testing.
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5.2.8 Exposure to the intervention
Of the 7,705 women in intervention areas interviewed at one-month post-partum during
the three-year period covered by this analysis, and who had data available on women’s
group attendance, 4120 (53%) had ever attended a women’s group. Of those who
attended, 1179 (29%) had only been once or twice, 919 (22%) had been three or four
times, and 2022 (49%) had been five or more times (Figure 5.12). The coverage of
women’s groups per zone (defined as the percentage of women who had ever attended)
ranged from 33% to 82% (Figure 5.13), and the cluster mean was 49% (95% CI 40-58).
78 women (1%) of women in control areas reported ever having been to a women’s
group meeting. The proportion of women per zone in control areas who had ever
attended ranged from 0% to 5%.
Figure 5.12: Distribution of the number of women’s group meetings attended by those who had ever
attended at least once
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Figure 5.13: Distribution of percentage coverage of women’s groups in intervention zones
5.2.9 Socioeconomic and demographic characteristics related to exposure to the
intervention
Table 5.10 presents data for exposure to the women’s group intervention (defined as
reporting ever having attended a group) in different sub-groups of the study population
in women’s group intervention areas. Looking at exposure by age-group, there was an
increasing trend with age in the proportion of women who had ever attended a women’s
group (also see Figure 5.14). Similarly, exposure increased with parity, with only 28%
of women who had no previous pregnancy ever attending a group, and 56-63% of
women with one or more previous pregnancies attending. Exposure by socioeconomic
quintile was similar across the first four quintiles (54-58%), but in the least poor
quintile attendance was lower (44%). Perhaps reflecting a similar underlying
phenomenon, a smaller proportion of women with secondary education or higher
attended groups (44%) compared to those with primary or no education (54-57%).
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Table 5.10: Exposure to women’s group intervention by sub-group
Population in this
group N (%)
Proportion attending women’s
groups %
Age group
10-19 years
20-29 years
30-39 years
40 and over
2315 (13)
10343 (56)
4856 (26)
836 (5)
30
54
63
66
Socioeconomic quintile
Poorest
2
3
4
Least poor
3658 (20)
3502 (19)
3930 (22)
3889 (22)
3036 (17)
58
54
56
55
44
Allocation to peer counselling
Women’s groups + peer
counselling
Women’s groups alone
Peer counselling alone
No intervention
4461 (24)
4612 (25)
4566 (25)
4903 (26)
57
50
1
1
Tribe
Chewa
Ngoni
Senga
Other
16386 (90)
1026 (6)
379 (2)
408 (2)
55
49
42
37
Married
Married
Never married
Divorced, widowed, other
17263 (94)
396 (2)
641 (4)
55
21
41
Education
None
Primary
Secondary or higher
3627 (20)
13267 (72)
1577 (9)
57
54
44
Study year
1
2
3
6280 (34)
6061 (33)
6201 (33)
51
54
55
Parity
No previous pregnancy
1 or 2
3 or 4
5 or more pregnancies
3367 (18)
6658 (36)
4259 (23)
3987 (22)
28
56
59
63
Attendance varied by tribe, with Chewa having the highest proportion attending (55%),
and ‘other tribes’ having the smallest proportion (37%). However, other tribes were in a
minority, only reflecting 2% of the overall population, and are likely to be from highly
mobile groups such as traders and estate workers. The presence of peer-counsellors in
the same area seemed to have a small effect on women’s group attendance, with slightly
higher attendance in areas where both women’s groups and peer-counsellors were
operating (57%) compared to areas with women’s groups alone (50%). But
interestingly, there was more evidence that women’s groups increased counsellor
coverage, with a greater proportion of women in areas with both peer-counsellors and
173
women’s groups being counselled by a volunteer (65%) than in areas with counsellors
only (47%).
Figure 5.14: Proportion of women who ever attended a women’s group by age, intervention,
socioeconomic and tribal groups
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5.3 Intervention impact
5.3.1 Impact on primary (mortality) outcomes
As shown in Table 5.5, all mortality rates were higher in intervention areas at baseline.
Figure 5.15 and Table 5.11 show trends for decreasing mortality rates in women’s
group areas, and no consistent trend in control areas. Similarly, although overall
perinatal and neonatal mortality rates for the three-year study period were slightly
higher in intervention than control areas, percentage change scores from baseline show
consistent, large reductions in all mortality outcomes of over 20%, whereas no
consistent patterns are seen in control areas, and some mortality rates are higher than
they were at baseline (Table 5.12). Unadjusted odds ratios for each of the mortality
rates, and odds ratios adjusted for baseline values and socioeconomic and demographic
factors are shown in Table 5.12. Baseline skilled birth attendance was used to adjust for
initial imbalance rather than baseline mortality, because in univariate and descriptive
analyses it correlated better with all mortality outcomes except infant mortality, and had
a much stronger effect in regression models. In years 1-3, both adjusted and unadjusted
odds ratios show no difference between women’s group and control areas in terms of
mortality. Post hoc analysis comparing the odds in years 2-3 only shows evidence of a
pattern of reduced mortality in women’s group areas, but none of these reductions has
yet reached a level of statistical significance.
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Figure 5.15: Trends in infant, maternal, neonatal and perinatal mortality from baseline to study year 3
Women’s group areas
Control areas
(NB: Year 3 data for infant mortality using re-census data is only for five-months, from 1/2/08 to
30/6/08)
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Table 5.11: Births, deaths and mortality rates in intervention and control clusters at baseline and during trial
Baseline Year 1 Year 2 Year 3 Years 1-3
Intervention Control All Intervention Control Intervention Control Intervention Control Intervention Control All
Births and deaths
Births
Live births
Stillbirths
1488
1445
43
1564
1538
26
3052
2983
69
3053
2970
83
3289
3224
65
3073
3006
67
3039
2986
53
3039
2994
45
3209
3160
49
9165
8970
195
9537
9370
167
18702
18340
362
Neonatal deaths
Early (0-6 days)
Late (7-28 days)
46
32
14
34
22
12
80
54
26
86
59
27
74
52
22
76
56
20
84
55
29
53
38
13
61
50
11
215
153
60
219
157
62
434
310
122
Infant deaths
(retrospective births)*
82
(1307)
61
(1576)
143
(2883)
97
(2181)
102
(2443)
101
(2565)
107
(2772)
31
(715)1
46
(774)1
229
(5461)
255
(5989)
484
(11450)
Maternal deaths 7 7 14 17 14 8 15 9 10 34 39 73
Mortality rates
Stillbirth rate
per 1000 births 28.9 16.6 22.6 27.2 19.8 21.8 17.4 14.8 15.3 21.3 17.5 19.4
Perinatal mortality rate
per 1000 births 50.4 30.7 40.3 46.5 35.6 40.0 35.5 27.3 30.9 38.0 34.0 35.9
Early neonatal mortality rate
per 1000 live births 22.1 14.3 18.1 19.9 16.1 18.6 18.4 12.7 15.8 17.1 16.8 16.9
Late neonatal mortality rate
Per 1000 live births 9.7 7.8 8.7 9.1 6.8 6.7 9.7 4.3 3.5 6.7 6.6 6.7
Neonatal mortality rate
per 1000 live births 30.9 21.7 26.2 29.0 23.0 25.3 28.1 17.7 19.3 24.0 23.4 23.7
Infant mortality rate
per 1000 live births 62.7 38.7 49.6 44.4 41.8 39.4 38.6 43.3 59.4 41.9 42.6 42.3
Maternal mortality ratio
per 100,000 live births 484 455 469 572 434 266 502 301 316 379 416 398
*Using retrospectively collected birth and death data from the re-census in June 2008
1 Year 3 data for infant mortality is only for five-months, from 1/2/08 to 30/6/08
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Table 5.12: Women’s group impact on mortality rates
Intervention
N (rate)
% change from
baseline
Control
N (rate)
% change from
baseline Years 1-3* p value
Years 1-3† p value Years 2 and 3† p value
Stillbirth rate
per 1000 births
195/9165 (21.3) -26.3 167/9537 (17.5) +5.4 1.20 (0.94-1.53) 0.14 1.07 (0.85-1.34) 0.56 0.90 (0.67-1.21) 0.50
Perinatal mortality rate
per 1000 births
348/9165 (38.0) -22.6 324/9537 (34.0) +10.7 1.09 (0.84-1.42) 0.50 0.98 (0.79-1.22) 0.87 0.85 (0.64-1.13) 0.27
Early neonatal mortality rate
per 1000 live births
153/8970 (17.1) -22.6 157/9370 (16.8) +17.5 1.01 (0.67-1.52) 0.97 0.90 (0.62-1.32) 0.60 0.78 (0.48-1.29) 0.33
Late neonatal mortality rate
per 1000 live births
60/8970 (6.7) -30.9 62/9370 (6.6) -15.4 1.02 (0.68-1.54) 0.91 0.99 (0.66-1.49) 0.98 0.84 (0.51-1.36) 0.47
Neonatal mortality rate
per 1000 live births
215/8970 (24.0) -22.3 219/9370 (23.4) +7.8 1.05 (0.76-1.46) 0.76 0.95 (0.71-1.28) 0.95 0.82 (0.55-1.22) 0.33
Infant mortality rate
per 1000 live births
229/5461 (41.9) -33.2 255/5989 (42.6) +10.1 1.03 (0.76-1.40) 0.84 ‡ 0.88 (0.65-1.20) 0.43 ‡ 0.86 (0.58-1.27) 0.45
Maternal mortality ratio
per 100,000 live births
34/8970 (379) -21.7 39/9370 (416) -8.6 0.91 (0.57-1.44) 0.68 0.94 (0.56-1.61) 0.84 0.68 (0.33-1.41) 0.30
Data are odds ratio (95% CI). *Adjusted for stratification (by other factorial intervention) and clustering only. † Adjusted for stratification, clustering, cluster-level baseline skilled birth attendance,
socioeconomic quintile, maternal age (quadratic term), and education. ‡ Adjusted for stratification, clustering, cluster-level baseline infant mortality, socioeconomic quintile and age (quadratic term). Education
data was not available with the retrospective infant outcome dataset.
Adjustments for multiple testing have not been made because none of the p-values were close to significance.
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Due to the social processes involved, the full impact of women’s groups may take time
to achieve, and the inclusion of data for year 1 may have diluted the effect seen. The
apparent increase in effect size for all mortality outcomes when looking at years 2 and 3
only, prompted further post hoc exploration into the impact in year 3 alone. There were
a relatively small number of observations in this dataset, and regression for maternal
outcomes could not be run. For perinatal and neonatal outcomes, little difference was
seen between year 3 alone and years 2 and 3 together. However, for infant mortality, the
effect in year 3 alone was more pronounced, though not statistically significant
(adjusted odds ratio 0.53 (95% CI 0.21-1.35). The lack of statistical significance is not
surprising given that data for only the first 5-months of year 3 were available, but it
suggests that the magnitude of mortality reduction may increase with time.
Zone 17 was an extreme outlier for cluster-level socioeconomic score and its effect on
the results was considered here (Figure 5.3 and Figure 5.10). Analyses were repeated
excluding zone 17, but this did not make a large difference on any variable. The largest
effect was for infant mortality (adjusted odds ratio for years 1-3 0.85 (95% CI 0.62-
1.15)), but this was still not significant.
Baseline mortality rates were not highly correlated with mortality outcomes (with the
exception of infant mortality), and their inclusion in the models in order to adjust for
baseline imbalances was not significant. However, baseline skilled birth attendance was
highly correlated with all mortality outcomes (with the exception of infant mortality),
and was included instead to adjust for baseline differences. The possible reasons for the
lack of correlation between baseline and study mortality rates might be that the period
of data collection for baseline was short and produced highly variable mortality
estimates. Furthermore, the surveillance system was newly established during this phase
and may have been more prone to error. Infant mortality would not be expected to be so
highly correlated with skilled birth attendance given the high burden of post-neonatal
illness in this setting.
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5.3.2 Impact on secondary (behavioural and process) outcomes
Data were collected prospectively from one-month postpartum interviews and were
used to calculate the prevalence of certain key health behaviours in women’s group and
control areas. The comparisons are shown in Table 5.13 below. Many secondary
outcomes improved in both intervention and control areas. Odds ratios for any antenatal
care, births attended by TBAs, and four polio doses by 6-months of age, adjusted for
baseline values, socioeconomic quintile, maternal age and education, show significant
improvements in women’s group areas compared to control areas. The unadjusted odds
ratio for exclusive breastfeeding shows a significant 79% improvement in women’s
group areas, and there is still and increase after adjusting for socioeconomic and
demographic factors, but this is no longer significant. The adjusted odds ratio for three
pentavalent vaccine doses suggested a detrimental effect of women’s groups, but given
the large number of tests performed here, the validity of these significant results needs
to be interpreted with caution, as some may have occurred just by chance.
Many adjusted odds ratios showed non-significant improvements in intervention areas
compared to control areas, but there were improvements for increased health-care
seeking and reduced maternal and infant morbidity in control arms as well. This could
be due to secular trends, or possibly the effects of the infant feeding intervention, which
was present in half of zones in both women’s group and control areas, and had similar
outcomes (especially uptake of antenatal HIV-testing, childhood immunisations and
exclusive breastfeeding). In recognition of the fact that there were some imbalances
between intervention and control areas at baseline, percentage change from baseline
scores have been calculated (Table 5.13). Larger improvements in health-care seeking
were seen in women’s group areas compared to control areas for uptake of HIV-testing,
skilled attendance at delivery, delayed infant bathing, post-natal care and complete
infant polio immunisation. Greater reductions were also seen in reported maternal
problems (especially antenatal problems) and deliveries attended by TBAs.
Coverage of some of the secondary outcome indicators was already very high at
baseline: antenatal care, use of any SP, clean delivery (washing hands with soap or
wearing gloves), early wrapping and any BCG, polio and pentavalent immunisation
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were all over 90%. This may have left relatively little room for improvement, making it
unlikely that the study would detect large, significant effects on these outcomes.
In most cases, the effect of adjusting for baseline values was to increase the effect size,
however for many of the secondary outcome variables (two or more doses of SP, bednet
used the night before interview and dipped, birth attendant washed hands or wore
gloves, baby wrapped within 30 minutes, any infant diarrhoea, any BCG vaccination by
6-months (years 2 and 3), any polio dose, initiated breastfeeding within 1 hour, use of
prelacteals, and any breastfeeding problem), the cluster-level baseline values did not
predict the outcome well, so may be part of the reason why adjusting for baseline values
made no difference.
The effect of adjusting for baseline values may have had special implications for
exclusive breastfeeding outcomes. The infant feeding intervention, which promoted
exclusive breastfeeding, may have had some early effects during the baseline phase, as
it had already started during this period. Adjusting for baseline breastfeeding outcomes
may remove some of the effect of the infant feeding intervention, since it was not a true
baseline measure (in the absence of any intervention) for this outcome. Adjusting for
socioeconomic and demographic variables but not baseline exclusive breastfeeding rates
shows a significant increase of around 82% in women’s group areas compared to
control areas (adjusted odds ratio 1.82 (95% CI 1.07-3.08)).
As was done with the mortality outcomes, the effect of excluding zone 17 from these
analyses because of its atypical socioeconomic score was explored, but it made little
difference.
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Table 5.13: Women’s group impact on process indicators and secondary outcomes
Intervention
N (%)
% change from
baseline
Control
N (%)
% change from
baseline
Odds ratio (95% CI)
for years 1-3*
Odds ratio (95% CI)
for years 1-3†
Odds ratio (95% CI)
for years 2 and 3†
Pregnancies 9073 9469
Any antenatal care at a health facility
Four or more antenatal care visits
Any iron and folic acid
More than 90 days iron/folate
Any tetanus toxiod immunisation
Adequate tetanus toxoid1
Any sulphadine-pyrimethamine (SP)
Two or more doses of SP
Bednet use night before interview
Bednet used every night in pregnancy
Any HIV-testing at antenatal care
Any perceived antenatal, delivery or postnatal maternal problem
8657 (95.7)
2564 (29.3)
7692 (88.9)
1587 (18.3)
7600 (87.8)
5831 (68.2)
8288 (92.7)
4031 (48.8)
4978 (54.9)
4964 (55.1)
4522 (50.4)
4345 (48.1)
+4.9
-2.3
+1.1
+7.6
+2.0
+11.4
+1.2
+8.9
+28.9
+14.8
+427.1
-14.7
8926 (94.4)
2703 (29.7)
8160 (90.3)
1362 (15.1)
7504 (83.3)
6298 (71.1)
8664 (92.7)
4398 (50.8)
5363 (56.6)
5090 (54.1)
4989 (53.2)
4255 (45.1)
+2.9
-15.6
-1.8
-39.1
+1.3
+14.9
-0.7
+23.6
+27.2
+7.3
+380.0
-7.6
1.44 (0.89-2.34)
0.91 (0.63-1.34)
0.93 (0.57-1.52)
1.26 (0.67-2.38)
1.40 (0.94-2.09)
0.83 (0.57-1.20)
1.05 (0.72-1.54)
0.80 (0.42-1.50)
0.91 (0.66-1.27)
1.02 (0.69-1.51)
0.79 (0.42-1.48)
1.02 (0.59-1.78)
1.46 (1.00-2.13)
1.03 (0.73-1.44)
1.11 (0.72-1.69)
1.67 (0.99-2.82)
1.20 (0.83-1.75)
0.83 (0.63-1.09)
1.17 (0.89-1.54)
0.75 (0.40-1.39)
0.97 (0.74-1.26)
1.07 (0.76-1.51)
0.87 (0.52-1.45)
0.79 (0.54-1.18)
1.33 (0.89-1.98)
0.96 (0.66-1.40)
1.13 (0.66-1.94)
1.89 (1.07-3.34)
1.16 (0.80-1.70)
0.80 (0.61-1.06)
1.16 (0.87-1.55)
0.76 (0.39-1.49)
0.98 (0.72-1.35)
1.14 (0.76-1.72)
0.77 (0.38-1.55)
0.80 (0.52-1.24)
Infants with 1m follow-up data 9169 9540
Institutional deliveries
Birth attended by skilled provider
Birth attended by a TBA
Attendant washed hands/wore gloves
Baby wrapped within 30 min
Baby bathed after 24hrs
Postnatal care at a health facility
Infant received BCG
Infant received polio immunisation
Any perceived infant problem (cough, fever or diarrhoea)
4599 (50.3)
4670 (50.9)
2700 (29.4)
6864 (90.1)
8635 (97.9)
4925 (56.2)
2933 (37.9)
4660 (60.1)
4143 (52.3)
2794 (37.5)
+39.3
+41.8
-28.3
-1.7
+4.8
+75.6
+51.6
+34.8
+41.0
-17.2
4734 (49.7)
4792 (50.2)
3267 (34.2)
8137 (92.9)
9093 (98.3)
5334 (58.0)
5132 (39.3)
4823 (55.9)
4608 (51.8)
2868 (37.3)
+13.7
+18.4
-8.8
+1.3
+10.8
+58.9
+24.8
+33.4
+38.9
-18.6
0.99 (0.63-1.56)
1.00 (0.64-1.55)
0.78 (0.48-1.27)
0.70 (0.39-1.24)
1.04 (0.53-2.07)
0.95 (0.34-2.65)
0.85 (0.49-1.48)
1.20 (0.70-2.07)
1.03 (0.59-1.77)
1.04 (0.67-1.62)
1.24 (0.92-1.68)
1.20 (0.89-1.62)
0.71 (0.51-0.97)
0.67 (0.38-1.16)
1.01 (0.50-2.06)
1.20 (0.54-2.66)
1.11 (0.76-1.61)
1.14 (0.77-1.68)
1.05 (0.66-1.67)
1.04 (0.72-1.48)
1.22 (0.86-1.72)
1.16 (0.82-1.64)
0.69 (0.48-0.99)
0.54 (0.30-0.97)
0.92 (0.45-1.88)
1.32 (0.55-3.21)
1.24 (0.81-1.89)
1.22 (0.76-1.96)
1.00 (0.55-1.85)
1.15 (0.76-1.73)
Infants with follow-up data on vaccinations received by 6m 5653 5987
Any BCG
Any polio dose
4 polio doses
Any pentavalent dose
3 pentavalent doses
5421 (96.5)
5468 (97.4)
433 (7.7)
5065 (90.2)
2940 (52.4)
+0.2
+0.6
+28.3
-0.6
-4.7
5752 (97.0)
5764 (97.2)
817 (13.8)
5681 (95.9)
3780 (63.8)
+1.7
+1.9
-21.6
+1.9
+10.8
0.67 (0.31-1.47)
0.86 (0.39-1.92)
0.86 (0.39-1.92)
-
0.60 (0.26-1.39)
0.61 (0.29-1.28)
0.81 (0.38-1.72)
2.52 (1.07-5.96)
0.85 (0.45-1.61)
0.60 (0.33-1.10)
0.67 (0.25-1.78)
1.17 (0.51-2.67)
2.62 (0.89-7.69)
1.03 (0.50-2.10)
0.45 (0.21-0.96)
Infants with 6m of breastfeeding data 4889 5164
Infant exclusively breastfed to 6m
Initiated breastfeeding within 1 hr
Use of prelacteals
Any breastfeeding problem
902 (18.4)
4081 (84.2)
332 (6.8)
76 (1.6)
+4.5
+5.9
-52.4
-38.5
591 (11.4)
4056 (79.3)
496 (9.6)
58 (1.1)
+5.6
+5.3
-56.4
-70.3
1.79 (1.05-3.05)
1.32 (0.48-3.60)
0.76 (0.48-1.20)
1.34 (0.68-2.64)
1.29 (0.84-1.98)
1.26 (0.50-3.16)
0.84 (0.53-1.33)
1.33 (0.66-2.68)
1.27 (0.79-2.04)
1.10 (0.39-3.08)
0.91 (0.58-1.43)
1.30 (0.58-2.94)
Data are N (%) and odds ratio (95% CI), unless otherwise indicated. *Adjusted for stratification (by other factorial intervention) and clustering only. † Adjusted for stratification, clustering, baseline values, socioeconomic
quintile, maternal age and education.
1 Adequate tetanus toxoid immunisation is 2 doses in pregnancy, or having completed the whole course of 5 doses over preceding years.
NB: Denominators for calculating percentages do not include missing data, which differs for each variable, so percentages presented are not directly calculable from the table.
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5.3.3 Variation in exposures and outcomes between clusters by study arm
Outcomes of interest and exposure to risk factors or protective factors were not
uniformly distributed across zones within study arms (between cluster variability), and
individuals within clusters tend to be more similar to each other than individuals
selected at random across a population (within cluster variability), and this reduces the
variability of responses in a sample. When the ratio of between-cluster variability to
within-cluster variability increases (as measured by the intracluster correlation
coefficient (ICC)), the power to detect statistical differences between study arms is
reduced. Figure 5.3 and Figure 5.13 illustrate the between-cluster variability for cluster-
level summary scores of socioeconomic index and the proportion of women attending
women’s groups. Figure 5.16 further shows how infant, maternal, neonatal and perinatal
mortality and skilled birth attendance and postnatal care attendance vary by zone and
intervention arm.
Figure 5.16: Distribution of mortality and process outcomes by intervention allocation
Despite restricting the study areas by excluding the main urban centre in Mchinji, there
is still considerable variability. Primary mortality outcomes tended to follow a slightly
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skewed distribution, with a longer positive tail, caused by a few clusters having very
high mortality rates. Secondary outcomes tended to be more normally distributed. As
Taljaard (2008) and Campbell (2005) point out, ICCs for process measures (such as
number of antenatal visits) tend to be larger than for outcome measures (in their case
measures such as number of births or birthweight). A similar pattern can be seen here,
with ICCs for all 48 clusters for mortality outcomes ranging from <0.00001 to 0.0096,
and those for process outcomes ranging from 0.037 to 0.17 (Table 5.14) (ICC estimates
for more outcomes are provided in Appendix 6). This effect may also be partly
explained by the fact that ICCs tend to increase with higher prevalences (Taljaard
2008). However, the most likely explanation is the fact that ICC is dependent on the
scale of the variable. Intercluster coefficients of variation (k) are not dependent on scale,
and these show similar ranges: from <0.05 to 0.47 for mortality outcomes and from 0.04
to 0.52 for process outcomes.
Table 5.14: Intracluster correlation coefficients and intercluster coefficients of variation for primary and
key secondary outcomes
Intra-cluster correlation coefficient (SE) Intercluster coefficient of variation (SE)
All clusters
(48)
Control
clusters (24)
True control
clusters (12)
All clusters
(48)
Control
clusters (24)
True control
clusters (12)
Perinatal mortality rate
per 1000 births
0.0050
(0.0016)
0.0031
(0.0017)
0.00076
(0.0014) 0.368 0.297 0.140
Neonatal mortality rate
per 1000 live births
0.0049
(0.0016)
0.0058
(0.0025)
0.0027
(0.0022) 0.449 0.491 0.309
Infant mortality rate
per 1000 live births
0.0096
(0.0029)
0.015
(0.0056)
0.022
(0.011) 0.467 0.581 0.656
Maternal mortality ratio
per 100,000 live births
<0.00001
(0.00054)
<0.00001
(0.00075)
0.00060
(0.0013) <0.05 <0.05 0.349
Antenatal care attendance
(%)
0.037
(0.0079)
0.032
(0.0099)
0.019
(0.0065) 0.044 0.043 0.056
Skilled birth attendance
(%)
0.12
(0.02)
0.13
(0.03)
0.16
(0.06) 0.348 0.352 0.449
Postnatal care attendance
(%)
0.17
(0.03)
0.19
(0.05)
0.24
(0.08) 0.520 0.544 0.691
Ever attending women’s group
(%)
0.41
(0.051)
0.09
(0.025)*
0.07
(0.030)** 1.048 0.281 0.265
*Women’s group areas and women’s group plus infant feeding areas
**Women’s group only areas
ICCs are presented for all clusters (48), control clusters for the women’s group trial (24
clusters having no women’s groups), and true control clusters (12 clusters having no
intervention at all). With interventions impacting on the outcomes and increasing
difference between intervention and control areas, you might expect that ICCs for all
clusters combined would be larger (more between-cluster variability) than for women’s
group control or true control clusters, and this is the case for perinatal mortality and
antenatal care attendance. However, this is not the case for most other variables, ICCs
for infant mortality, skilled birth attendance and postnatal care increase as the number
184
of clusters gets smaller. There may be different effects on overall variability, depending
on whether the intervention reduces the variability of outcomes in women’s group areas
(thus reducing the overall variability), as well as increasing or reducing the overall
proportion or rate. This effect may differ depending on the outcome in question. For
example, the effect on mortality may be greater in zones with higher baseline mortality,
and thus reduce the variability in mortality rates in intervention areas (i.e. it brings the
positive tail in).
5.4 Sub-group analysis and effect modification
5.4.1 Impact according to intervention group
As both women’s groups and infant feeding counsellors work to improve mother and
child health, the presence of both interventions in an area has the potential to create a
synergistic or even antagonistic effect, resulting in greater or smaller effects
respectively than either intervention alone. The interaction between the women’s group
(WG) and infant feeding (VMC) interventions was explored descriptively, and also by
inclusion of an interaction term (WG*VMC) in regression models. This was an a priori
planned analysis. Interaction plots of primary mortality outcomes against intervention
allocation showed that there did appear to be interaction between women’s groups and
infant feeding counselling for perinatal, neonatal and maternal mortality outcomes, but
not for infant mortality (Appendix 7). The significance of adding an interaction term to
the regression model was evaluated using likelihood ratio tests, but was non-significant
for any models, except exclusive breastfeeding. However, given the limited power of
this analysis, it is not surprising that interactions were not significant, and non-
significant results do not rule out the possibility that there was some interaction between
the two interventions (265, 293). Adding the interaction term affected the model so that
the effects for WG and VMC interventions alone changed in magnitude and sometimes
direction, making the impact of the WG intervention alone stronger (less than 1.00).
The odds ratios for the WG*VMC variable were close to 1.00 for perinatal, neonatal
and maternal mortality, suggesting that there was no difference in mortality rates
between control areas (with neither intervention) and areas with both WG and VMC.
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This further supports the idea that there may have been an interaction between the two
interventions, but that there is insufficient power for this to reach statistical significance.
A null or possibly slightly negative effect of both interventions together was
unexpected, and highlighted the importance of understanding how the two interventions
work together and separately. Further exploration was made into the impact in each of
the four arms of the study. This data is presented in Table 5.15.
For maternal, perinatal and neonatal mortality, analysing outcomes according to the
four intervention groups revealed an effect size in women’s group only areas that was
more pronounced than in the earlier analysis (Table 5.12), but close to 1 (no effect) in
women’s group and infant feeding areas combined (WG+VMC). Thus the apparent lack
of effect in the earlier analysis that compare 24 women’s group areas (WG and
WG+VMC) with 24 control areas (VMC and no intervention), may have arisen because
the impact in areas with women’s groups alone is obscured by the lack of impact in
areas with both interventions. For infant mortality the picture was different; the effect
again became more pronounced in women’s group only areas when including all four
intervention groups in the model, but was even larger in areas with both interventions.
For infant, neonatal and perinatal mortality, the lowest mortality rates are in areas with
infant feeding intervention only, and unadjusted odds ratios show larger effects in this
group. For maternal mortality, the lowest mortality rate (and corresponding unadjusted
odds ratio) is in areas with only women’s group intervention. After adjusting for
baseline differences and other covariates, the biggest reduction in maternal mortality is
still seen in women’s group only areas, followed by infant feeding alone. And after
adjustment, the biggest effects in perinatal and neonatal mortality are now seen in areas
with women’s groups only, highlighting the confounding of the relationship between
intervention allocation and mortality, and this was mostly due to baseline imbalances. In
women’s group only areas in post hoc exploratory analysis of year 2 and 3 data, the
effect on perinatal mortality is significant, and the effect on neonatal mortality is close
to significant (reflecting 36% and 41% reductions respectively). Very little effect on
perinatal, neonatal or maternal mortality is seen in areas with both interventions in
analysis for years 1-3 and in years 2 and 3 only. The exception to this is an apparent
large effect on maternal mortality in years 2 and 3. After adjustment, there were
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borderline effects for infant mortality in women’s group plus infant feeding and infant
feeding only areas in years 1-3.
Figure 5.17 shows trends in unadjusted mortality rates over the study period by
intervention group. Mortality rate estimates broken down both by year and by
intervention group are likely to be imprecise due to the small numbers in each group,
and the bounds of uncertainty are wide. However, for all four mortality outcomes
shown, rates are lower in year 3 than they were at baseline for women’s group and
women’s group plus infant feeding areas, but this is not the case for infant feeding alone
and control areas.
Consistent with the mortality outcomes, the adjusted effects on antenatal care, tetanus
immunisation, taking SP, maternal antenatal problems, skilled birth attendance and
postnatal care attendance were all highest is women’s group only and women’s group
plus counselling areas, though these were also not statistically significant (Table 5.15).
Little effect on antenatal care and postnatal care was seen in infant feeding only areas,
but a stronger effect on reported infant illnesses was seen. Maternal morbidity was
reduced by 33% in areas with both interventions, while little effect was seen in areas
with either intervention alone. When broken down by the four intervention groups, the
effects on exclusive breastfeeding are much higher in women’s group plus infant
feeding areas, and after adjusting for covariates, there is very little effect in areas with
women’s group alone or infant feeding alone.
It is important to remember that many comparisons have been made here, and
significant effects should be interpreted with caution. It was not felt necessary to adjust
p-values for multiple testing given the overall lack of significance seen for all primary
outcomes, and tests for years 2 and 3 were post hoc and should be considered as
exploratory. Part of the reason for the lack of significant effect may be the lower power
to detect differences by four intervention groups rather than just two. In summary, it is
difficult to draw firm conclusions about the effects of the interaction between the
women’s group and peer counselling interventions, though patterns of effects suggest
that a qualitative interaction does exist (265).
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Table 5.15: Comparison of primary and secondary outcomes by four intervention groups
Rate by intervention group
N/total (rate)
Years 1-3* p value
(Wald)
Years 1-3† p value
(Wald)
Years 2 and 3† p value
(Wald)
Primary outcomes
Perinatal mortality rate (per 1000 births)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
185/4941 (37.4)
155/4661 (33.3)
139/4595 (30.3)
193/4500 (42.9)
-
0.84 (0.59-1.21)
0.78 (0.54-1.12)
1.12 (0.79-1.59)
0.20
-
0.84 (0.62-1.13)
0.89 (0.65-1.21)
1.04 (0.78-1.38)
0.47
-
0.64 (0.44-0.94)
0.88 (0.60-1.29)
1.00 (0.70-1.43)
0.09
Neonatal mortality rate (per 1000 live births)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
133/4851 (27.4)
98/4577 (21.4)
86/4518 (19.0)
117/4390 (26.7)
-
0.77 (0.49-1.19)
0.67 (0.43-1.05)
0.98 (0.64-1.51)
0.23
-
0.77 (0.52-1.15)
0.78 (0.52-1.19)
0.94 (0.64-1.39)
0.50
-
0.59 (0.34-1.03)
0.89 (0.51-1.54)
1.00 (0.60-1.68)
0.22
Infant mortality rate (per 1000 live births)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
152/3127 (48.6)
129/2758 (46.8)
103/2862 (36.0)
100/2703 (37.0)
-
0.96 (0.64-1.47)
0.69 (0.45-1.06)
0.77 (0.50-1.17)
0.26
-
‡ 0.79 (0.52-1.20)
‡ 0.67 (0.45-1.00)
‡ 0.67 (0.44-1.01)
0.16
-
‡ 0.84 (0.50-1.41)
‡ 0.73 (0.44-1.22)
‡ 0.65 (0.38-1.11)
0.41
Maternal mortality rate (per 100000 live births)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
24/4903 (489)
12/4612 (260)
15/4566 (329)
22/4461 (493)
-
0.53 (0.26-1.06)
0.67 (0.35-1.28)
1.01 (0.56-1.80)
0.19
-
0.60 (0.28-1.31)
0.71 (0.33-1.54)
1.07 (0.56-2.07)
0.42
-
0.51 (0.19-1.36)
0.52 (0.18-1.51)
0.54 (0.22-1.37)
0.39
Secondary outcomes
Any antenatal care (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
4576/4896 (93.5)
4371/4601 (95.0)
4350/4558 (95.4)
4286/4448 (96.4)
-
1.32 (0.67-2.60)
1.16 (0.59-2.27)
1.84 (0.93-3.64)
0.35
-
1.38 (0.81-2.35)
0.94 (0.56-1.60)
1.47 (0.85-2.53)
0.26
-
1.43 (0.82-2.49)
1.05 (0.61-1.83)
1.30 (0.74-2.29)
0.55
Mother received any Tetanus Toxoid Vaccine (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
3756/4657 (80.7)
3828/4385 (87.3)
3748/4354 (86.1)
3772/4267 (88.4)
-
1.73 (0.99-3.03)
1.63 (0.93-2.85)
1.84 (1.05-3.21)
0.13
-
1.41 (0.84-2.36)
1.19 (0.70-2.02)
1.23 (0.71-2.14)
0.64
-
1.33 (0.79-2.24)
1.23 (0.72-2.10)
1.24 (0.71-2.17)
0.74
Mother received any SP (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
4429/4831 (91.7)
4182/4542 (92.1)
4235/4512 (93.9)
4106/4397 (93.4)
-
1.08 (0.63-1.85)
1.29 (0.75-2.21)
1.31 (0.77-2.25)
0.70
-
1.13 (0.78-1.63)
1.11 (0.77-1.62)
1.37 (0.94-1.99)
0.45
-
1.00 (0.68-1.47)
1.05 (0.71-1.56)
1.45 (0.97-2.16)
0.23
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Rate by intervention group
N/total (rate)
Years 1-3* p value
(Wald)
Years 1-3† p value
(Wald)
Years 2 and 3† p value
(Wald)
Always used bednet during pregnancy (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
2480/4884 (50.8)
2434/4580 (53.1)
2610/4532 (57.6)
2530/4426 (57.2)
-
1.06 (0.61-1.84)
1.44 (0.82-2.50)
1.41 (0.81-2.46)
0.44 -
0.89 (0.55-1.45)
1.07 (0.65-1.76)
1.40 (0.86-2.26)
0.32 -
0.94 (0.52-1.68)
0.95 (0.52-1.73)
1.35 (0.76-2.40)
0.59
Maternal morbidity (antenatal, delivery or postnatal
problem) (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
2194/4891 (44.9)
2460/4596 (53.5)
2061/4555 (45.3)
1885/4442 (42.4)
-
1.46 (0.67-3.15)
1.07 (0.49-2.31)
0.77 (0.35-1.66)
0.44
-
0.93 (0.54-1.62)
0.98 (0.57-1.69)
0.67 (0.39-1.15)
0.43
-
1.00 (0.54-1.85)
1.07 (0.59-1.95)
0.69 (0.38-1.26)
0.48
Skilled birth attendance (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
2184/4943 (44.2)
2404/4664 (51.5)
2608/4597 (56.7)
2266/4505 (50.3)
-
1.21 (0.65-2.25)
1.53 (0.83-2.84)
1.26 (0.68-2.34)
0.60
-
1.23 (0.81-1.88)
1.14 (0.74-1.74)
1.32 (0.87-2.02)
0.60
-
1.24 (0.77-2.01)
1.16 (0.71-1.89)
1.25 (0.77-2.02)
0.78
Postnatal care attendance (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
1419/4213 (33.7)
1394/3911 (35.6)
1733/3815 (45.4)
1539/3835 (40.1)
-
0.92 (0.42-2.00)
1.60 (0.73-3.49)
1.27 (0.58-2.78)
0.49
-
1.08 (0.64-1.80)
0.97 (0.57-1.65)
1.12 (0.67-1.87)
0.95
-
1.23 (0.68-2.21)
0.93 (0.51-1.70)
1.17 (0.65-2.10)
0.79
Infant morbidity (cough, fever or diarrhoea) (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
1749/4009 (43.6)
1501/3768 (39.8)
1119/3686 (30.4)
1293/3675 (35.2)
-
0.92 (0.49-1.72)
0.52 (0.28-0.97)
0.61 (0.32-1.14)
0.12
-
0.94 (0.57-1.55)
0.65 (0.39-1.09)
0.75 (0.45-1.25)
0.33
-
0.96 (0.54-1.71)
0.62 (0.35-1.12)
0.85 (0.47-1.53)
0.39
Exclusive breastfeeding rate (%)
No intervention
Women’s groups only
Infant feeding only
Women’s groups + infant feeding
258/2641 (9.8)
231/2606 (8.9)
333/2521 (13.2)
671/2282 (29.4)
-
0.86 (0.43-1.74)
1.03 (0.51-2.09)
3.78 (1.89-7.57)
<0.001
-
0.81 (0.46-1.44)
0.86 (0.48-1.53)
1.82 (0.98-3.39)
0.04
-
0.93 (0.49-1.76)
0.94 (0.49-1.82)
1.69 (0.84-3.42)
0.28
Data are odds ratio (95% CI). *Adjusted for stratification clustering only. † Adjusted for clustering, cluster-level baseline values, socioeconomic quintile, maternal age (quadratic term) and education. ‡ Adjusted for
clustering, cluster-level baseline values, socioeconomic quintile and maternal age (quadratic term). Education data was not available with the retrospective infant outcome dataset.
Adjustments for multiple testing have not been made because none of the p-values for primary outcomes were close to significance.
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Figure 5.17: Trends in unadjusted infant, maternal, neonatal and perinatal mortality from baseline to
study year 3 by intervention group
Control areas
Women’s group areas
Infant feeding areas
Women’s group plus infant feeding areas
5.4.2 Impact according to level of exposure
The main analysis was performed by intention-to-treat, with all women, regardless of
whether they attended groups or not, being classified as exposed to the intervention
according to the zone they were allocated to (Table 5.12). Coverage of women’s groups
was just over 50% in intervention areas, so 50% of women allocated as exposed to
women’s groups may in fact not have been exposed at all. The nature of the intervention
as a community mobilisation approach means that even if women did not attend groups,
they may have benefited from changes in their community and discussions they had
with women who did attend groups, however, we might still expect that women who
attended groups would have better outcomes than those who did not. Indeed, in a crude
comparison of mortality rates according to whether women had ever attended a group, it
was found that neonatal mortality rates were higher amongst women who had never
attended a group but lived in a women’s group area (28.7 per 1000 live births),
compared to those who had ever attended (23.3).
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Furthermore, one of Bradford Hill’s criteria for assessing the evidence of a causal
association is ‘biological gradient’, or ‘dose-response’, meaning that greater exposure to
a causative factor should generally lead to a larger effect (294). Thus outcome effects
were explored according to level of exposure to the intervention in a ‘per protocol
analysis’ (according to who got the intervention) as an addition to the main intention-to-
treat analysis. This analysis is presented in Table 5.16 below.
Individual data on attendance of women’s groups was not available for infant mortality
data using the retrospective re-census dataset. It was also not possible to analyse
maternal mortality in this way, as many respondents were not able to provide
information about women’s group attendance for their deceased wife or relative, so
there was a lot of missing data. However, data from other prospective datasets did show
significant trends for lower neonatal and perinatal mortality as group attendance
increased. Women who never attended women’s groups, but lived in women’s group
areas had the highest mortality rates (higher than in control areas), and this was used as
the reference group. Odds ratios and adjusted odds ratios for perinatal and neonatal
mortality showed significantly decreasing risk of mortality with increasing number of
times women’s groups were attended.
For all health-care seeking variables (except tetanus toxoid immuisation), coverage rates
significantly increased with women’s group ‘dose’ level, and women’s group dose
effects on exclusive breastfeeding were also significant. Reported maternal antenatal
and delivery problems decreased with increasing women’s group ‘dose’, though not
significantly. Reporting of maternal problems did not have a clear dose-response effect,
but infant morbidity appeared to increase with women’s group ‘dose’ level, and women
who attended groups 11 or more times reported significantly more infant problems. It is
not clear whether this is due to higher incidence of problems, or higher reporting.
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Table 5.16: Comparison of primary and secondary outcomes by exposure level
Rate by exposure group
N/total (rate)
Years 1-3* p value
(Wald) ‡
Years 1-3† p value
(Wald) ‡
Years 2 and 3† p value
(Wald) ‡
Primary outcomes
Perinatal mortality rate (per 1000 births)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
304/7759 (39.2)
178/3619 (49.2)
103/2537 (40.6)
36/1269 (28.4)
6/409 (14.7)
0.72 (0.52-0.99)
1.00
0.72 (0.56-0.94)
0.51 (0.35-0.74)
0.26 (0.11-0.59)
0.0001
0.76 (0.56-1.01)
1.00
0.69 (0.53-0.90)
0.48 (0.33-0.71)
0.21 (0.09-0.53)
0.0001
0.77 (0.52-1.14)
1.00
0.53 (0.36-0.77)
0.38 (0.22-0.63)
0.18 (0.06-0.51)
<0.0001
Neonatal mortality rate (per 1000 live births)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
204/7602 (26.8)
104/3523 (29.5)
70/2479 (28.2)
25/1250 (20.0)
2/403 (5.0)
0.81 (0.54-1.21)
1.00
0.84 (0.54-1.21)
0.59 (0.37-0.93)
0.15 (0.04-0.62)
0.02
0.88 (0.60-1.29)
1.00
0.86 (0.62-1.19)
0.59 (0.37-0.95)
0.16 (0.04-0.66)
0.04
0.92 (0.55-1.55)
1.00
0.73 (0.47-1.15)
0.46 (0.25-0.84)
0.08 (0.01-0.58)
0.02
Infant mortality rate (per 1000 live births) NA NA NA NA NA NA NA
Maternal mortality rate (per 1000 live births) (Not enough values in some groups even after collapsing last 2 groups)
Secondary outcomes
Any antenatal care (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
7236/7684 (94.2)
3411/3584 (95.2)
2398/2500 (95.9)
1207/1256 (96.1)
394/405 (97.3)
0.83 (0.51-1.36)
1.00
1.32 (1.01-1.72)
1.27 (0.90-1.80)
1.66 (0.88-3.16)
0.09
0.87 (0.58-1.30)
1.00
1.42 (1.08-1.87)
1.35 (0.95-1.92)
2.24 (1.11-4.54)
0.01
1.10 (0.70-1.74)
1.00
1.87 (1.28-2.73)
1.57 (1.00-2.48)
2.67 (1.17-6.11)
0.005
Mother received any Tetanus Toxoid Vaccine (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
6061/7356 (82.4)
3051/3425 (89.1)
2071/2389 (86.7)
1058/1212 (87.3)
327/391 (83.6)
0.61 (0.43-0.87)
1.00
0.80 (0.68-0.95)
0.86 (0.70-1.07)
0.65 (0.48-0.89)
0.005
0.73 (0.51-1.02)
1.00
0.90 (0.75-1.07)
1.01 (0.81-1.26)
0.84 (0.62-1.16)
0.27
0.76 (0.53-1.10)
1.00
0.98 (0.78-1.23)
1.05 (0.80-1.37)
0.74 (0.52-1.07)
0.27
Mother received any SP (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
7010/7603 (92.2)
3226/3540 (91.1)
2297/2466 (93.2)
1168/1243 (94.0)
386/401 (96.3)
1.14 (0.79-1.63)
1.00
1.47 (1.20-1.81)
1.49 (1.13-1.96)
2.32 (1.35-3.99)
0.0001
1.07 (0.82-1.40)
1.00
1.56 (1.26-1.81)
1.57 (1.19-2.08)
2.62 (1.49-4.62)
<0.0001
1.07 (0.77-1.48)
1.00
1.66 (1.23-2.25)
1.46 (1.01-2.11)
2.20 (1.14-4.26)
0.003
Always used bednet during pregnancy (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
4069/7656 (53.2)
1884/3569 (52.8)
1375/2484 (55.4)
732/1256 (58.3)
264/403 (65.5)
1.01 (0.74-1.36)
1.00
1.27 (0.92-1.73)
1.28 (0.92-1.73)
1.49 (1.02-2.19)
<0.0001
1.01 (0.76-1.36)
1.00
1.23 (1.09-1.38)
1.23 (1.06-1.42)
1.48 (1.16-1.88)
0.0004
0.74 (0.51-1.09)
1.00
1.22 (1.05-1.41)
1.21 (1.01-1.45)
1.45 (1.09-1.91)
0.002
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Rate by exposure group
N/total (rate)
Years 1-3* p value
(Wald) ‡
Years 1-3† p value
(Wald) ‡
Years 2 and 3† p value
(Wald) ‡
Maternal morbidity (antenatal, delivery or postnatal
problem) (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
3465/7680 (45.1)
1732/3580 (48.4)
1256/2499 (50.3)
540/1252 (43.1)
171/403 (42.4)
1.23 (0.83-1.83)
1.00
1.11 (0.99-1.25)
1.04 (0.90-1.21)
1.22 (0.97-1.54)
0.23
1.48 (0.85-2.58)
1.00
1.09 (0.97-1.22)
1.00 (0.86-1.17)
1.17 (0.92-1.50)
0.32
1.04 (0.48-2.26)
1.00
1.11 (0.96-1.29)
1.03 (0.86-1.24)
1.19 (0.90-1.56)
0.59
Skilled birth attendance (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
3841/7762 (49.5)
1901/3621 (52.5)
1203/2538 (47.4)
638/1270 (50.2)
250/409 (61.1)
0.91 (0.65-1.28)
1.00
0.92 (0.83-1.03)
1.05 (0.91-1.21)
1.33 (1.06-1.68)
0.03
0.87 (0.67-1.15)
1.00
0.99 (0.88-1.11)
1.19 (1.03-1.39)
1.47 (1.16-1.87)
0.002
0.90 (0.65-1.24)
1.00
1.05 (0.90-1.22)
1.21 (1.01-1.46)
1.32 (1.01-1.75)
0.09
Postnatal care attendance (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
2920/7564 (38.6)
1337/3490 (38.3)
909/2455 (37.0)
428/1242 (34.5)
177/394 (44.9)
1.18 (0.80-1.75)
1.00
1.05 (0.94-1.19)
1.08 (0.92-1.26)
1.22 (0.96-1.55)
0.47
1.08 (0.78-1.48)
1.00
1.13 (1.00-1.28)
1.21 (1.03-1.42)
1.37 (1.07-1.76)
0.03
0.93 (0.64-1.37)
1.00
1.14 (0.98-1.34)
1.17 (0.96-1.41)
1.23 (0.93-1.63)
0.25
Infant morbidity (cough, fever or diarrhoea) (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
2734/7317 (37.4)
1271/3368 (37.7)
897/2368 (35.1)
423/1204 (35.1)
151/389 (38.8)
0.87 (0.61-1.24)
1.00
1.01 (0.90-1.14)
0.95 (0.82-1.11)
1.28 (1.01-1.24)
0.22
0.73 (0.42-1.25)
1.00
1.05 (0.93-1.19)
1.02 (0.87-1.19)
1.35 (1.06-1.73)
0.09
0.58 (0.28-1.21)
1.00
1.18 (1.01-1.38)
1.03 (0.84-1.24)
1.53 (1.15-2.02)
0.005
Exclusive breastfeeding rate (%)
Control areas
WG area never attended
Attended 1-5 times
Attended 6-10 times
Attended 11 or more times
538/4957 (10.9)
352/2201 (16.0)
387/1542 (18.6)
189/841 (22.5)
72/263 (27.4)
0.59 (0.37-0.93)
1.00
1.00 (0.82-1.21)
1.31 (1.04-1.65)
1.48 (1.06-2.06)
0.002
0.75 (0.50-1.13)
1.00
1.00 (0.82-1.22)
1.28 (1.01-1.62)
1.39 (0.50-1.13)
0.03
0.87 (0.55-1.38)
1.00
0.93 (0.72-1.20)
1.45 (1.09-1.92)
1.35 (0.92-1.98)
0.01
Data are odds ratio (95% CI)., and all models , use women in intervention areas who never attended groups as the reference category. *Adjusted for stratification clustering and stratification only. † Adjusted for
clustering, stratification, cluster-level baseline values, socioeconomic quintile, age (quadratic for mortality outcomes, linear for process outcomes) and education. Education data was not available with the retrospective
infant outcome dataset.
‡ Unadjusted p-values are presented, but after adjustment for multiple testing using the Holm correction (295), p-values for primary outcomes are still significant at the 5% level.
NA – Data not available on women’s group attendance for infant mortality using retrospective dataset
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5.4.3 Impact according to socioeconomic status
The purpose of the analysis presented in this section was to explore whether or not there
were differential effects of the intervention in different socioeconomic groups. This was
a post hoc analysis, and was done to see whether low effects in some sub-groups may
have masked larger effects in other groups. For example, it has been reported that many
public heath interventions disproportionately benefit the better off (138), so if poorer
women represented a larger proportion of women’s group attenders (Table 5.10) but
received less of the benefits of the intervention, the effects in other groups may not be
apparent.
Table 5.17 shows rates and odds ratios exploring the effects of the interaction between
the women’s group intervention and socioeconomic status on primary and secondary
outcomes. Regression models exploring the interaction between women’s group and
socioeconomic quintile were built, and women in the lowest quintile in control areas
were used as the reference group. No significant interaction effects for primary
mortality outcomes were found, though the study was not powered to look at these
interactions. However, there are patterns that are suggestive of some degree of
interaction. Odds ratios for the 2nd, 3rd, 4th and 5th quintiles all showed greater reductions
in neonatal mortality when compared to the poorest quintile, suggesting that the
women’s group intervention may have had most impact amongst the least poor women
and less impact amongst the poorest women. However, the opposite is true for perinatal,
infant and maternal mortality, and the effect of women’s groups on reducing the risk of
adverse outcome is lower in the wealthier quintiles when compared to the poorest.
For health-care seeking outcomes, most showed lower effects of women’s groups in the
wealthier quintiles (2nd to 5th) compared to the poorest quintile, though they were not
large or significant effects. Bednet use showed the least effect amongst the poorest
group. A large, significant effect of women’s groups on increasing rates of exclusive
breastfeeding was seen in the 2nd quintile, and the smallest effect was seen in the least
poor quintile. The effects on maternal and infant morbidity are not significant, though
women reported significantly more maternal problems in the 3rd and 4th quintiles
compared to the 1st.
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Due to the number of tests carried out and the low of power to detect statistical
differences between sub-groups, it is difficult to draw any firm conclusions about
whether women’s group effects were stronger in different socioeconomic groups.
Overall, it seems that there may have been stronger effects of women’s groups amongst
the poorest women for infant and maternal mortality and health-care seeking outcomes,
suggesting that the intervention did not disproportionately benefit better off women.
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Table 5.17: Effects of interaction between women’s group intervention and socioeconomic quintile on primary and secondary outcomes
Rate by intervention group
N/total (rate)
Years 1-3* p value
(Wald)
Years 1-3† p value
(Wald)
Years 2 and 3† p value
(Wald)
Primary outcomes
Perinatal mortality rate (per 1000 births)
1 – poorest
2
3
4
5 – least poor
169/3694 (45.7)
122/3531 (34.6)
140/3977 (35.2)
109/3915 (27.8)
104/3057 (34.0)
-
1.20 (0.74-1.94)
0.98 (0.61-1.55)
1.29 (0.78-2.13)
0.97 (0.58-1.62)
0.73
-
1.23 (0.74-2.04)
0.95 (0.59-1.54)
1.25 (0.75-2.09)
1.06 (0.63-1.79)
0.79
-
1.09 (0.58-2.06)
1.25 (0.67-2.35)
1.18 (0.61-2.30)
1.11 (0.57-2.18)
0.97
Neonatal mortality rate (per 1000 live births)
1 – poorest
2
3
4
5 – least poor
105/3600 (29.2)
80/3468 (23.1)
86/3904 (22.0)
82/3857 (21.3)
66/2999 (22.0)
-
0.74 (0.40-1.35)
0.70 (0.38-1.26)
0.84 (0.46-1.54)
0.42 (0.21-0.80)
0.12
-
0.88 (0.47-1.65)
0.69 (0.38-1.27)
0.95 (0.51-1.75)
0.50 (0.26-0.98)
0.26
-
0.40 (0.17-0.96)
0.67 (0.30-1.49)
0.68 (0.31-1.50)
0.45 (0.19-1.06)
0.23
Infant mortality rate (per 1000 live births)
1 – poorest
2
3
4
5 – least poor
95/2370 (40.1)
107/2318 (46.2)
117/2514 (46.5)
106/2347 (45.2)
59/1790 (33.0)
-
‡1.62 (0.91-2.88)
‡1.71 (0.97-3.02)
‡1.42 (0.79-2.54)
‡1.57 (0.79-3.09)
0.39
-
‡1.64 (0.90-2.98)
‡1.67 (0.93-3.00)
‡1.40 (0.77-2.55)
‡1.64 (0.82-3.28)
0.42
-
‡1.53 (0.70-3.32)
‡1.49 (0.67-3.30)
‡1.44 (0.65-3.18)
‡1.86 (0.74-4.67)
0.73
Maternal mortality rate (per 1000 live births)
1 – poorest
2
3
4
5 – least poor
17/3658 (465)
12/3502 (343)
10/3930 (286)
15/3889 (386)
13/3036 (428)
-
3.79 (0.80-17.93)
4.08 (0.79-21.10)
3.67 (0.85-15.76)
1.56 (0.34-7.24)
0.27
-
5.12 (0.91-28.93)
3.70 (0.62-22.27)
2.80 (0.62-12.59)
1.53 (0.29-8.12)
0.34
-
5.62 (0.67-47.44)
1.76 (0.10-31.21)
4.74 (0.58-38.74)
1.94 (0.11-34.40)
0.51
Secondary outcomes
Any antenatal care (%)
1 – poorest
2
3
4
5 – least poor
3368/3649 (92.3)
3287/3493 (94.1)
3740/3928 (95.2)
3741/3881 (96.4)
2940/3028 (97.1)
-
0.80 (0.54-1.18)
0.97 (0.65-1.44)
0.87 (0.56-1.35)
0.88 (0.53-1.49)
0.83
-
0.80 (0.54-1.20)
1.02 (0.68-1.54)
0.89 (0.57-1.39)
0.99 (0.58-1.67)
0.79
-
1.19 (0.70-2.02)
1.22 (0.70-2.13)
1.14 (0.63-2.07)
1.33 (0.62-2.87)
0.93
Mother received any Tetanus Toxoid Vaccine (%)
1 – poorest
2
3
4
5 – least poor
2882/3414 (84.4)
2856/3310 (86.3)
3198/3750 (85.3)
3243/3756 (86.3)
2458/2923 (84.1)
-
0.76 (0.58-1.01)
0.79 (0.60-1.03)
0.97 (0.73-1.29)
0.97 (0.73-1.30)
0.16
-
0.77 (0.57-1.02)
0.80 (0.61-1.06)
0.98 (0.73-1.30)
0.96 (0.71-1.29)
0.23
-
0.77 (0.54-1.12)
0.86 (0.61-1.23)
1.14 (0.79-1.65)
0.95 (0.65-1.39)
0.31
Mother received any SP (%)
1 – poorest
2
3
4
5 – least poor
3223/3589 (89.8)
3165/3447 (91.8)
3604/3892 (92.6)
3634/3843 (94.6)
2842/3006 (94.5)
-
0.91 (0.65-1.27)
1.06 (0.76-1.47)
0.84 (0.58-1.21)
1.10 (0.74-1.64)
0.67
-
0.84 (0.60-1.19)
1.03 (0.74-1.45)
0.81 (0.56-1.18)
1.10 (0.74-1.66)
0.49
-
0.95 (0.60-1.50)
1.00 (0.62-1.63)
1.00 (0.60-1.68)
1.28 (0.73-2.26)
0.89
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Rate by intervention group
N/total (rate)
Years 1-3* p value
(Wald)
Years 1-3† p value
(Wald)
Years 2 and 3† p value
(Wald)
Always used bednet during pregnancy (%)
1 – poorest
2
3
4
5 – least poor
1669/3627 (46.0)
1740/3482 (50.0)
2159/3911 (55.2)
2284/3869 (59.0)
1917/3016 (63.6)
-
1.15 (0.95-1.40)
1.14 (0.94-1.38)
1.18 (0.97-1.44)
1.12 (0.91-1.39)
0.50
-
1.16 (0.95-1.42)
1.14 (0.94-1.38)
1.18 (0.97-1.44)
1.14 (0.92-1.42)
0.50
-
1.05 (0.82-1.35)
1.10 (0.86-1.41)
1.10 (0.86-1.41)
0.97 (0.73-1.27)
0.83
Maternal morbidity (antenatal, delivery or postnatal
problem) (%)
1 – poorest
2
3
4
5 – least poor
1652/3644 (45.3)
1618/3490 (46.4)
1893/3920 (48.3)
1800/3880 (46.4)
1363/3025 (45.1)
-
1.11 (0.91-1.37)
1.24 (1.02-1.52)
1.31 (1.07-1.61)
1.06 (0.85-1.32)
0.05
-
1.12 (0.91-1.38)
1.25 (1.02-1.53)
1.31 (1.07-1.61)
1.08 (0.87-1.35)
0.07
-
1.31 (1.01-1.69)
1.29 (1.00-1.66)
1.43 (1.11-1.85)
1.13 (0.85-1.49)
0.05
Skilled birth attendance (%)
1 – poorest
2
3
4
5 – least poor
1435/3695 (38.8)
1675/3532 (47.4)
1942/3977 (48.8)
2080/3916 (53.1)
2020/3059 (66.0)
-
1.12 (0.91-1.37)
0.94 (0.77-1.15)
0.99 (0.81-1.20)
0.83 (0.67-1.03)
0.10
-
1.10 (0.89-1.35)
0.93 (0.76-1.14)
0.99 (0.81-1.20)
0.85 (0.68-1.06)
0.21
-
1.10 (0.86-1.35)
0.89 (0.70-1.15)
0.89 (0.70-1.15)
0.82 (0.62-1.09)
0.23
Postnatal care attendance (%)
1 – poorest
2
3
4
5 – least poor
934/3111 (30.0)
1108/2986 (37.1)
1278/3365 (38.0)
1312/3283 (40.0)
1256/2612 (48.1)
-
0.90 (0.71-1.14)
0.86 (0.68-1.08)
0.88 (0.70-1.11)
0.78 (0.61-0.99)
0.37
-
0.89 (0.70-1.14)
0.86 (0.68-1.09)
0.88 (0.69-1.11)
0.78 (0.61-1.00)
0.41
-
1.05 (0.78-1.40)
0.85 (0.64-1.13)
0.94 (0.70-1.25)
0.75 (0.55-1.02)
0.21
Infant morbidity (cough, fever or diarrhoea) (%)
1 – poorest
2
3
4
5 – least poor
1101/2965 (37.1)
1074/2877 (37.3)
1231/3241 (38.0)
1188/3157 (37.6)
908/2512 (36.2)
-
1.07 (0.85-1.34)
1.01 (0.81-1.26)
0.89 (0.71-1.11)
1.12 (0.88-1.43)
0.34
-
1.11 (0.88-1.40)
1.03 (0.82-1.28)
0.91 (0.72-1.14)
1.15 (0.90-1.47)
0.31
-
1.12 (0.84-1.49)
1.05 (0.79-1.39)
0.92 (0.69-1.23)
0.98 (0.72-1.34)
0.72
Exclusive breastfeeding rate (%)
1 – poorest
2
3
4
5 – least poor
280/1949 (14.4)
283/1883 (15.0)
324/2197 (14.8)
325/2166 (15.0)
277/1729 (16.0)
-
1.48 (0.99-2.19)
0.98 (0.67-1.44)
1.01 (0.69-1.48)
0.83 (0.55-1.24)
0.07
-
1.49 (1.00-2.22)
0.96 (0.66-1.40)
0.98 (0.67-1.44)
0.79 (0.53-1.18)
0.04
-
1.45 (0.89-2.36)
0.90 (0.57-1.44)
1.02 (0.63-1.63)
0.83 (0.50-1.38)
0.23
Data are odds ratio (95% CI). *Adjusted for stratification clustering and stratification only. † Adjusted for clustering, stratification, cluster-level baseline values, age and education. ‡ Adjusted for clustering, cluster-
level baseline values, socioeconomic quintile and age. Education data was not available with the retrospective infant outcome dataset.
P-values have not been adjusted for multiple testing as these are exploratory analyses rather than hypothesis testing, and none of the p-values for primary outcomes were close to significance.
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Chapter 6 : Discussion – impact of the women’s group
intervention
The fundamental question addressed in this thesis is whether women’s groups had an
impact on perinatal, newborn, infant and maternal mortality rates and health-care
seeking outcomes, and whether the groups were primarily responsible for any
differences observed between intervention and control areas, or whether other factors
may have caused variability between clusters and study arms. This chapter will review
the evidence for the first possibility, as well as exploring other explanatory factors.
6.1 Key findings
6.1.1 Summary of findings
The MaiMwana trial results demonstrated that the women’s group intervention led to
significant improvement in antenatal care attendance, reduced the number of births
attended by TBAs (accompanied by a non-significant increase in skilled birth
attendance), and improved complete infant polio immunisation (four doses by six-
months). There was no significant impact on pre-specified mortality outcomes or other
process indicators after three years of the intervention being in place.
Other studies have shown a significant impact of women’s groups on neonatal mortality
(22, 24, 25), but while potentially important in improving individual women’s and
community empowerment, community mobilisation through women’s groups may not
have been sufficient to reduce mortality among mothers and infants over this time-scale
and in this setting. However, there is some evidence that implementation and
methodological factors may have obscured the results, and these will be discussed
further in below.
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6.1.2 Mortality
The intervention did not show a significant impact on any of the primary mortality
outcomes, though the adjusted odds of mortality showed consistently lower risk in
women’s group areas than control areas, particularly in years 2 and 3. Adjusted odds
ratios (and 95% CIs) for perinatal, neonatal, infant and maternal mortality for years 2
and 3 were 0.85 (0.64-1.13), 0.82 (0.55-1.22), 0.86 (0.58-1.27) and 0.68 (0.33-1.41)
respectively (Table 5.12). Mortality rates were much higher in intervention areas at
baseline, and from these high starting values, Figure 5.15 shows that all of the mortality
rates in women’s group areas have now crossed below those in control areas, and Table
5.12 shows reductions in women’s group areas of over 20% for all mortality outcomes
between baseline and the study period, and smaller reductions or increases in mortality
in control areas. It will be interesting to see how this trend continues after more time,
and when complete infant mortality data is available for year 3.
In general, mortality rates were lower than the most recent national estimates from DHS
and MICS surveys discussed in section 2.2.1 (Table 2.7 and Table 2.8) (1, 63). The
overall maternal mortality rate during the study was 398 per 100,000 live births, which
is less than half of that estimated in the DHS and MICS surveys (984 and 807 per
100,000 live births respectively), and decreased from a baseline rate of 469 per 100,000
live births. This is still much lower than DHS and MICS estimates, but closer to other
reported estimates, particularly those using prospective methods (Table 2.2). It is also
closer to recent WHO model estimates for 2008, which give an estimate of 510 per
100,000 live births for Malawi (37). The maternal mortality ratio was slightly higher in
intervention areas at baseline, and slightly lower at the end of the study period, but the
number of maternal deaths was relatively small, with only 73 deaths, and with wide
confidence intervals this makes accurate comparison between groups and over time
difficult. Infant mortality estimates were also lower than other reported estimates (DHS
76 and MICS 72 per 1000 live births), with 49.6 per 1000 live births at baseline, and
42.3 during the study period. The overall neonatal mortality rate at baseline (26.2 per
1000 live births), was similar to recent DHS and MICS estimates (27 and 33 per 1000
live births respectively), but decreased below this level to 23.7.
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There could be several reasons for the lower mortality rates in this study, such as: a
general, secular trend towards reduced mortality rates, with these estimates reflecting a
more recent period (mid-point 2007) than those in DHS and MICS surveys that are
centred on a point three years before the survey (DHS mid-point 2002, MICS mid-point
2004); differences in the methodology and definitions used (especially the inclusion of
all pregnancy-related deaths in DHS and MICS – see Section 2.1); impact of the
MaiMwana interventions; and impact of the surveillance system itself. Mchinji may
also have lower mortality rates than the national average. The MICS survey shows
lower maternal mortality in rural than in urban areas, and in the northern and central
regions (Table 2.8), so perhaps this rural, central region population is at lower risk than
the national average. Indeed, they do report that neonatal and infant mortality is lower
in Mchinji compared to other districts and to the national average (Table 2.8) (63).
6.1.3 Behaviour
The intervention showed some impact on secondary behavioural and process outcomes
(Table 5.13). The proportion of women attending antenatal care and infants immunised
with four polio doses by 6-months of age significantly increased (adjusted odds ratio
1.46 (95% CI 1.00-2.13) and 2.52 (1.07-5.96) respectively), and the proportion of
women delivering at a TBA significantly decreased (0.71 (0.51-0.97)). Although they
did not reach statistical significance, improvements were also seen in iron folate, tetanus
toxoid vaccination and SP in pregnancy, institutional deliveries, delayed infant bathing,
post-natal care visits and exclusive breastfeeding rates compared to control areas
(increases of 67%, 20%, 17%, 24%, 20%, 11%, and 29% respectively). And there were
a reduced proportion of women reporting any maternal antenatal, delivery or postnatal
problems (21% reduction). The lack of significant effects detected may in part be due to
the fact that coverage of many secondary outcome indicators was already very high at
baseline, and this may have left relatively little room for improvement.
Antenatal care and skilled delivery care coverage at the end of the trial were similar to
national estimates reported in DHS and MICS surveys (Table 2.7 and Table 2.8) (1, 63).
The proportion of women reporting any postnatal care visits was slightly higher than
national estimates in this study, but similar to estimates for Mchinji in the MICS survey.
Both skilled delivery and postnatal care attendance rates were much lower than the
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national average at baseline, and rose in both women’s group and control areas, though
by a greater amount in women’s group areas (skilled delivery increased by 39% and
postnatal care by 51% (Table 5.13)). Many health-care seeking indicators improved in
control areas during the course of the study, but generally less than in women’s group
areas. The reasons for increased uptake of health services could be secular trends, partly
as a result of national campaigns and increased donor funding in the wake of
international calls for action (221) and national priority-setting following the large
increase in maternal mortality between 1992 and 2000 DHS estimates (1, 296). There
may also be some effects of the peer counselling intervention, which was present in half
of the control areas, and also encouraged use of antenatal, delivery and postnatal health
services.
The reporting of maternal and infant problems decreased in both intervention and
control areas between baseline and the study period, but reported maternal problems
decreased by a much larger amount in women’s group areas and this was largely due to
a reduction in reported antenatal problems. It is difficult to interpret the effects of the
intervention on morbidity. The interventions may prevent some types of problems from
occurring (e.g. postpartum and neonatal sepsis, anaemia), but cannot prevent others
(e.g. obstructed labour, postpartum haemorrhage). We might actually expect higher
reporting of some sorts of problems, because with raised awareness they may have been
better identified (140). To fully understand the impact of the intervention on maternal
morbidity it would be necessary to explore more about what the problems reported
actually were. Health-care seeking rates in the event of a problem, might be a more
useful indicator of intervention impact.
6.1.4 Sub-group analysis
A number of sub-group analyses were carried out in order to explore any differential
intervention effects within specific groups of the study population. It appears that the
intervention may have had more impact in areas with only the women’s group
intervention than in areas with both interventions, on women who were more exposed to
the intervention (i.e. attended more groups), and among poorer women. The sub-group
effects on health-care seeking were clearer than for mortality outcomes, but the overall
patterns were similar.
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Interaction between the two interventions and analysis by four intervention groups
The interaction between the women’s group and infant feeding intervention was not
statistically significant for primary outcomes, but it did appear that there was some
interaction such that the effects of each intervention were affected by the presence of
the other intervention – a ‘qualitative’ interaction. This qualitative interaction may have
complicated the interpretation of the analysis of main effects, and in this case the sub-
group effects may provide less misleading results (265).
Looking at the four intervention groups (no intervention, women’s group alone, peer
counselling alone, both interventions), adjusted odds ratios for women’s groups alone
compared to no intervention at all (12 clusters versus 12 clusters) showed much larger
effects (MMR 0.60, PMR 0.84, NMR 0.77, IMR 0.79) than for the comparison of
women’s groups alone and both interventions with infant feeding alone and no
intervention (24 clusters versus 24 clusters) that was presented in the main analysis
(MMR 0.94, PMR 0.98, NMR 0.95, IMR 0.88) (Table 5.15 and Table 5.12).
Intervention effects on maternal, perinatal and neonatal mortality were most pronounced
in women’s group areas alone, and little effect was seen in areas with both
interventions, but the effect on infant mortality appeared to be slightly larger in areas
with both interventions.
Overall, the less pronounced effect of the women’s group intervention seen in the main
comparison in Table 5.12 compared to the sub-group comparison in Table 5.15 may
have been due to several factors, including mortality reduction as a result of peer
counselling in half of the comparison areas in the main analysis, and lack of effect in
the areas with both interventions. Thus, looking at the magnitude of differences between
main analysis and sub-group analysis, it appears that observed effects of the women’s
group may have been diluted by between 10 and 36% due to the inclusion of the peer
counselling intervention in the design and analysis.
Mortality reduction in control areas as a result of peer counselling cannot adequately
explain the lack of effect in the main comparison, as there was little or no observed
reduction in overall mortality rates in control communities over the same period (Figure
5.15, Table 5.11 and Table 5.12). The lack of effect on maternal, perinatal and neonatal
mortality in areas with both interventions is surprising, and based on accruing evidence
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from the process evaluation it seems more likely to be due to cluster characteristics or
implementation factors rather than an antagonistic effect of the two interventions (297).
The slight increase in coverage of each intervention in the presence of the other (section
5.2.9 and Table 5.10) is not consistent with an antagonistic interaction, such as
community members tiring of the commitment to two simultaneous interventions.
The interaction between the women’s group and peer counselling interventions was not
significant for any secondary outcomes except for exclusive breastfeeding. Exclusive
breastfeeding rates were much higher in areas with both women’s groups and peer
counselling, which corresponds with the reduced infant mortality in those areas, but is
different to the pattern seen for other mortality outcomes.
Dose-response effect and analysis by different levels of exposure
A dose-response relationship is one of the Bradford-Hill criteria for evidence of
causation (294). The results showed an apparent ‘dose-response’ effect for perinatal and
neonatal mortality, with odds ratios decreasing significantly with higher numbers of
women’s group meetings attended (adjusted odds ratios and 95% CIs for NMR in
women attending 1-5 times, 6-10 times and 11 or more times were 0.86 (0.62-1.19),
0.59 (0.37-0.95), 0.16 (0.04-0.66)) (Table 5.16). Mortality rates and odds ratios were
highest for women in women’s group areas who did not attend groups, and lowest for
women who attended 11 or more times. Similarly, there was a strong dose-response
effect on health-care seeking, with antenatal (ANC), delivery (SBA) and postnatal
(PNC) care attendance all increasing significantly with number of meetings attended
(adjusted odds ratios and 95% CIs for ANC, SBA and PNC in women attending 11 or
more times were 2.24 (1.11-4.54), 1.47 (1.16-1.87), 1.37 (1.07-1.76)). About half of
women who had ever attended a women’s group attended five or more meetings
(section 5.2.8), and this suggests that larger effects might have been achieved if more
women had attended a higher number of meetings.
Although this dose-response effect is interesting, it may not be causal. Better outcomes
amongst women who attended more groups might result from the self-selecting effect of
healthier women attending more groups rather than attending more groups causing
women to be healthier. For example, women with better health and more interest in
being involved in community activities may choose to attend groups more frequently (a
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healthy volunteer effect (298, 299)). Furthermore, being a more frequent group attender
might affect the way women answered behaviour questions, as their knowledge about
what the ‘right’ answers were increased. Some self-reported morbidity outcomes seem
to get worse with the number of groups attended, particularly maternal postnatal
problems and infant morbidity, but again this could be because women are more aware
of and more able to identify and report important illnesses the more they attend groups.
Since mortality rates decreased with exposure level, it doesn’t make sense that
morbidity would increase. Exploration of the specific morbidities reported would be
needed in order to understand better whether there is a pattern of increasing serious
problems such as postpartum haemorrhage, or greater reporting of minor illnesses. Also,
problems such as anaemia may not be identified unless a woman went to a health
facility, so if skilled birth attendance increases with women’s group ‘dose’ level, the
likelihood of a problem being identified would have increased.
Socioeconomic inequality and analysis by socioeconomic quintiles
Assessing the ‘focus’ and ‘coverage’ of the intervention is an important way of
understanding how much inequality there might be between socioeconomic groups, and
whether the intervention is reaching the most disadvantaged women (230). Higher
attendance of women’s groups amongst the poorest women (Table 5.10) suggests that
there was no inequality in terms of coverage or intervention reach (230). Looking at the
proportion of benefits of the intervention in each socioeconomic group tells us about the
focus or ‘benefit-incidence’, and this was explored by looking at the interaction
between the intervention and socioeconomic quintile.
No significant interactions between impact of the women’s group intervention and
socioeconomic quintile were seen for primary mortality outcomes, although there were
some patterns suggesting differential effects, with poorer women disproportionately
benefitting from reductions in maternal and infant mortality (adjusted odds ratios and
95% CIs for least poor compared to poorest were 1.53 (0.29-8.12) and 1.64 (0.82-3.28)
respectively) (Table 5.17). The only secondary outcome with a significant interaction
between intervention and socioeconomic quintile was exclusive breastfeeding, which
had the strongest effect in the 2nd quintile and the weakest effect in the 5th quintile when
compared to the poorest quintile. Effects on health-care seeking outcomes tended to be
stronger in the poorest quintile, though these were not large or statistically significant.
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Low power limited the scope of this analysis to detect statistically significant interaction
effects. If a larger impact of the intervention is seen after it has been running for longer,
it may be important to re-visit this analysis in future and explore how equitably the
impact has been distributed.
6.2 Did the study address the research hypothesis?
The primary hypothesis of the study was that women’s groups would lead to behaviour
changes including uptake of health services, and these would in turn lead to reductions
in maternal, perinatal, neonatal and infant mortality. Through the measurement of
mortality rates in trial communities, this study was able to compare rates in
communities with and without women’s groups. In addition, this study measured the
impact of women’s groups on other secondary and process outcomes, such as use of
routine antenatal, delivery and postnatal health services and maternal and infant
morbidity.
It was hypothesised that women’s groups would empower women and communities to
take actions to improve their own health. The processes involved in running women’s
groups and the ‘how’ and ‘why’ of their success or failure have been investigated in a
parallel process evaluation, but this has not been presented here. In-depth understanding
of reasons for intervention success or failure is beyond the scope of this thesis, though
some possible explanations will be explored.
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6.3 Strengths and limitations of the study design and methods
6.3.1 Strengths
The study design had a number of strengths. A randomised controlled trial is the gold
standard for evaluating the impact of health interventions (253), and using community
clusters as the unit of randomisation allowed the effectiveness of this intervention to be
evaluated at population level. The factorial design of the MaiMwana study allowed the
effects of two interventions to be evaluated simultaneously, thus reducing the cost of
running two separate studies and increasing logistical efficiency (265). The use of a
control group to compare mortality rates with, rather than making comparisons in the
same population over time, means that secular trends would affect both groups equally
and could not be the cause of any effects seen. The random allocation of clusters to
intervention groups should have meant that potential confounding factors were evenly
distributed between groups, and any significant differences between intervention and
control arms would be likely to be due to intervention effects. ‘Buffer areas’ around
study villages reduced the possibility of contamination of control areas with benefits of
the intervention (253). A particular strength of the design was that primary outcomes
were objective mortality outcomes rather than only subjectively reported health
behaviour and morbidity outcomes, which are more prone to measurement bias.
Data on the main study outcomes was collected prospectively to further reduce the
possibility of recall errors and biases (Table 2.1). In addition, the inclusion of a 6-month
baseline period before the intervention started, and the repeat cross-sectional census
survey towards the end, allowed estimation of outcomes for comparison at baseline and
endline, as well as the main comparison between intervention and control groups.
Baseline values could also be used to adjust for imbalances between clusters after
randomisation. The repeat census provided the opportunity to triangulate data and verify
the accuracy of prospective mortality data from each cluster. Robust data on infant
outcomes had not been collected from the outset with the prospective surveillance
system, so retrospective census data provided more complete data for the estimation of
infant outcomes in the analysis in this thesis.
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6.3.2 Limitations
Cluster-randomised trials are being increasingly used to evaluate health interventions,
but there are considerable challenges in their implementation, and issues of internal and
external validity must be properly addressed (57, 300, 301). Internal validity may be
affected by sample selection, bias and appropriateness of analytical approaches.
External validity refers to the extent to which results can be generalised to other
individuals and settings. This section will discuss some of the limitations to data
collection and analysis affecting the validity of this study.
Sample selection
The sampling frame for the study was the whole of Mchinji District, which was divided
into 48 roughly equal sized clusters, with the exclusion of the district administrative
centre at Mchinji Boma. As this was a population-based study, all births and deaths in
the study areas were eligible for inclusion, and thus strictly speaking sampling error
does not arise. However, there is still inherent uncertainty and variability in the
estimates due to random fluctuations over time, and the observed outcomes in the study
population can be considered to be ‘one realisation of events sampled by nature’.
Although the study was population-based, selection forces may have acted at any of
four main stages; selection of villages, selection and enumeration of households and
women of childbearing age, identification of pregnancies, and loss to follow-up of study
outcome. Some different selection forces may also have acted during the retrospective
re-census. At any of these stages, a systematic exclusion of a particular type of
participant could have produced a biased or unrepresentative sample (302).
The first stage of selection was selection of villages for inclusion within the defined
clusters. Villages were sampled from the centre of each cluster, and could have
introduced selection bias if central villages differed systematically from those on the
edges of cluster areas. Systematic difference is unlikely, as cluster boundaries used
NSO census enumeration area boundaries rather than roads or geographic features, so
villages in the centre were not further away from health facilities or transport routes
than those on the edges.
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The second stage of selection was enumeration of households for enrolment in the study
cohort. Research participants were initially identified through a house-to-house census,
which was a good way of identifying stable residents of the study communities. It is
unknown how many households refused to take part or were missed, and no information
is available on the characteristics of ‘non-responders’. Interviewers were instructed to
re-visit households three times if respondents were not available on the first visit, but
some households were still missed. The baseline household census was conducted in the
months of June to September, which is not a busy farming time, but respondents who
were not available for interview may have been more likely to be seasonal workers (e.g.
on commercial farms and tobacco estates), small business traders or have other mobile
professions. During continued enumeration of in-migrants to study areas, people with
mobile professions or those who only stayed for a short time (especially in trading
centres or estates), may have been missed.
The third stage of selection was identification of pregnancies to be followed up, which
involved monthly visits to all women of childbearing age by field-workers. It is
unknown how many pregnancies were not reported, or the characteristics of these
women. It is likely that unreported pregnancies included those ending in early
miscarriage or termination, and those arising during a period of absence such as farming
or school. In some cases, distance from the field-worker’s home may have been a factor
related to how frequently she visited households, and more distant villages may have
been visited less. It is not clear what effect this might have had, but exploration of birth
rates by village may help to identify areas where this happened. The fourth stage of
selection, losses to follow-up of study outcomes, is discussed further in the next section.
Any selection biases introduced through village selection or household selection are
unlikely to have differed between intervention and control areas because these were
done before random allocation to study arms, and the main effect would be related to
reduced generalisability of the findings. There is a possibility that pregnancy
identification could have been affected by intervention allocation, such that pregnancies
were easier to identify in intervention areas, where the presence of women’s groups or
peer counsellors sensitised communities to pregnancy-related issues. Interaction
between the intervention and data collection is discussed further below.
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Losses to follow-up of study outcome and attrition
There are considerable challenges of longitudinal population follow-up in resource-poor
settings with no vital registration infrastructure (302). This study was successful in
identifying and following up 18,709 infants to one-month post-partum, though there
were some losses to follow-up that may have affected the findings.
Once pregnancies were identified, coverage of data for primary outcomes and most
secondary process outcomes was very high. Only 681 (3%) of pregnancy outcomes
were not verified (Figure 5.1). Six-month follow-up data and data on exclusive
breastfeeding were less complete. Of 18,275 infants with data available and alive at
one-month, only 11,640 (64%) also had data available at six-months, and only 10,053
(55%) had breastfeeding data (Table 5.13). Thus loss to follow-up of primary outcome
was very low and unlikely to have caused substantial selection bias, though losses to
follow-up of some secondary outcomes (such as exclusive breastfeeding and
immunisation) were higher and characteristics of those followed and not followed
should be explored further in future analysis. Losses to follow-up among infants alive at
one-month were 35% in both intervention and control areas, and would have affected
generalisability rather than biasing the results.
The sample of live births from the retrospective sample (11,450 live births) was 38%
lower than the prospectively collected data (18,340 live births) (Table 5.11). It is
important to remember that the retrospective sample represents a period of two years
and five months, while the prospective sample represents three years. After adjusting
for this time difference (assuming recapture rates remain the same), the retrospective
sample is still 22% smaller than the prospective sample. This is likely to be due to a
combination of recall error in the retrospective survey, as well as missing data on dates
of birth and death, which resulted in exclusion of data from the sample. It is unlikely
that under-reporting of births and deaths differed systematically between intervention
and control areas, because the proportion of live births identified retrospectively is
similar in each arm (61% intervention areas, 64% control areas), but under-reporting
may have systematically differed between live and dead infants. There is some evidence
from other surveys in Malawi that respondents tend to under-report dead infants, and
they are also more likely not to remember their dates of birth (1). This appears to have
been the case in this study, as perinatal and neonatal mortality rates estimated from the
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retrospective sample (31.9 per 1000 births and 17.9 per 1000 live births respectively)
were lower than prospectively estimated rates for years 1 to 3 (35.9 per 1000 births and
23.7 per 1000 live births). Retrospective neonatal mortality estimates were similarly
27% lower than prospective estimates in a population-based study in Nepal (303, 304).
Other reasons for losses to follow-up at six-months or during the retrospective survey
might include permanent or seasonal internal migration, out-migration, changing of
names, or changing household living arrangements. Migration within the district is
usually from villages to larger trading centres, although there is also seasonal migration
between villages and farming areas during cultivation periods, and movements from one
village to another following marriage, divorce or widowhood. Such migration may have
the effect of increasing loss-to-follow-up at one-month, six-month and retrospective
survey visits, if mothers were out of their usual village at the scheduled time. Permanent
or temporary migration across international borders also occurs frequently in Mchinji,
for business, family visits and farming, and it was not possible to trace these
participants. 3,830 women (7% of women enumerated) moved out of the study area
permanently during the follow-up period, and 124 of them were pregnant (1% of
pregnancies identified).
Another particularly challenging aspect of follow-up was the lack of any identifying
documents such as passports or driving licenses, the lack of a street address, and the use
of several different names by study participants. Women may be known by different
names to different people and at different times. They often have a Chichewa name as
well as an English name, a husband’s first name or surname may be used as a surname,
or a father’s name may be used, and clan names and nicknames are also used frequently.
The names used for tracing women were the first name, surname and alternative names
listed at the time the household was enumerated (either during the baseline survey or
prospectively). Most women did not know their exact dates of birth, but rough ages, and
names and dates of birth of children were also used in an effort to trace the correct
woman. Women whose details changed were the most difficult to follow up. No
information was available to assess how these women might have differed from those
who were easier to trace, but proportions of pregnant women lost-to-follow-up due to
unverified births in intervention and control arms were similar (4% and 3%
respectively).
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Losses to follow-up arose due to recall error or under-reporting, in- and out-migration
and inability to trace the correct respondent. These did not appear to differ
systematically between intervention and control areas, and are unlikely to have biased
analysis comparing intervention and control areas. However, the effects of in- and out-
migration may be that the proportion of women exposed to women’s groups amongst
those followed up (particularly during the retrospective census) is lower than the
proportion of the population who actually attended.
Generalisability
In order to take the lessons learned from this study and apply them to other settings, it is
important to know if and how the study population may have differed from other rural
populations in Malawi and sub-Saharan Africa.
Mchinji District is close in proximity to the capital, Lilongwe, and this may give it
infrastructural and economic advantages compared to other more remote districts. Many
districts in Malawi have international borders with Zambia, Mozambique or Tanzania,
and Mchinji is not unusual in having international borders with Zambia and
Mozambique. However, one of the major road transport routes to Zambia passes
through the district, and this may create a special socioeconomic environment along its
course. Another feature that is not unique to Mchinji, but perhaps more developed
compared to other districts, is the presence of many commercial tobacco estates,
especially in the northern part of the district. Cross-border trade, estate work and truck
driving are all occupations associated with a high prevalence of HIV in Malawi, and
though Mchinji is not a particularly high prevalence district overall, certain areas such
as roadside trading centres and estates may have higher levels of HIV (95).
Due to the exclusion of the main trading centre in Mchinji, the selected study area
reflects a mainly rural population that is reliant on subsistence farming. This population
may not be representative of the Malawian population as a whole, although at a national
level 85% of the population lives in rural areas (305). Mortality rates in rural areas tend
to be higher than in urban areas (apart from maternal mortality), and it is surprising that
the mortality rates found in this study (particularly maternal and infant mortality) were
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so low compared to DHS and MICS national estimates for rural areas (Table 2.7 and
Table 2.8) (1, 63).
The selection forces and losses to follow-up described above may also have acted to
create a study population that differed from the general population in certain ways. In
particular, mobile women may have been under-represented, and they may be at higher
or lower risk of adverse outcomes than the general population of pregnant and
postpartum women from which they came. This might limit the ability to extrapolate the
findings of this study to other settings in Malawi. Although overall, socioeconomic,
demographic and behavioural characteristics (such as health-care seeking rates) derived
from this study population were similar to national estimates (1, 63), and sample
selection doesn’t seem to have affected generalisability too greatly.
Imbalance after randomisation
Randomisation should eliminate selection bias (301), and data on socioeconomic and
demographic characteristics of the study population at baseline suggest that study arms
were relatively well balanced in terms of socioeconomic status, age, education,
occupation, marital status and parity after randomisation (Table 5.4). Tribe and religion
were not so evenly balanced, with fewer Chewa and Catholic women than in control
areas. In spite of the apparent overall balance, data on mortality rates and process
outcomes were not well balanced (Table 5.5 and Table 5.6). Perinatal, neonatal, infant
and maternal mortality rates at baseline were 54%, 47%, 62% and 6% higher in
women’s group areas respectively, compared to control areas. Skilled attendance at
delivery was 14% lower and postnatal care attendance was 20% lower in women’s
group areas compared to control areas, though antenatal care attendance was identical.
It is unclear what the cause of these imbalances in primary and secondary outcomes
could be, given the relative balance of socioeconomic and demographic factors. Such
large imbalances are unlikely to be due to the tribal and religious differences observed,
and must be due to some other unmeasured confounding factors. Perhaps the
imbalances can be explained by a randomisation pattern that resulted in a combination
of both the poorest and the least poor communities in women’s group areas, such that
the overall average is similar to control areas, but there is more variability between
women’s group zones. This is reflected by the wider distribution of cluster-level
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socioeconomic scores in women’s group areas shown in Figure 5.3. The five zones
furthest from a health facility, with a walking time of three hours or more, were all
women’s group areas. Conversely, the three largest trading centres were all in women’s
group areas. Data show that mortality rates are higher in both the poorest and the least
poor quintiles for perinatal, neonatal and maternal mortality (Table 5.17). Lower access
to health services may be largely responsible for higher mortality in the poorest quintile,
while factors such as high HIV prevalence and unregulated private health service
providers might contribute to higher mortality in the least poor quintile (74, 82, 85).
Thus average socioeconomic characteristics were similar in intervention and control
areas, but mortality risks may have been higher in intervention areas due to more areas
at the extremes of the socioeconomic distribution.
Although cluster-level baseline values were included in adjusted regression models,
adjustment for baseline differences may have been insufficient and still resulted in
dilution of the effects. Analysis of cluster-level percentage change scores would be less
statistically efficient, but may be more robust under these conditions (253).
Sources of measurement error and bias in measures of exposure to the intervention
Error or bias in measuring or assigning exposure status may result in incorrect or
inaccurate conclusions about the relationship between exposure and outcome. Error or
bias in measures of actual exposure to the women’s group intervention may have arisen
in several ways: dilution through inclusion of new in-migrants to study cohort, dilution
through not following out-migrants beyond study areas, ‘contamination’ of control
areas through internal migration, and variability in intensity of exposure between
individuals, communities and over time.
In the main impact analysis, intervention exposure was assigned by ‘intention-to-treat’,
such that any women living and enumerated in clusters allocated to the women’s group
intervention at the time of the birth of their infant and subsequent interviews were said
to be exposed to this intervention, even if they did not attend any women’s group
meetings. In drug trials, the intention-to-treat approach has the advantage that it allows
for any effects of selective withdrawal from the intervention after allocation that may be
related to the outcome of interest. However, in this community-randomised trial,
selective withdrawal due to intervention exposure is unlikely. More likely is that not all
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women assigned to the intervention would be able to access it. It was not feasible for
every woman of childbearing age to attend all of the women’s group meetings, and less
than 100% coverage was expected from the outset. Women who migrated seasonally
and were absent from the village for long periods, also had less opportunity to attend
meetings, though the number of women who migrated seasonally is unknown. The
nature of the intervention being one that mobilises community-wide social capital
means that even without attending groups, women may still have experienced some
benefits, but we might expect these to be less than for those who attended more
frequently. Indeed, analysis by level of exposure to the intervention suggests that there
were greater benefits with greater attendance (Table 5.16).
The fact that the study population was an ‘open cohort’ (enumerating new community
members as they moved into the area), may have accentuated the diluting effect of the
intention-to-treat analysis in this study. In-migrants were included in the study cohort,
even though they may have had little time to be exposed to the intervention. Due to
logistical constraints, out-migrants who moved out of the study areas while pregnant
were not followed, even though they may have been exposed to the intervention. High
levels of in- and out-migration may have been a problem particularly in areas with a
high population turnover, such as trading centres and tobacco estates. But although
there were more trading centres and tobacco estates in intervention areas, the cohort
grew by similar amounts in both study arms (25% increase in intervention areas and
27% in control areas). Migration may also have been a particular problem for infant
mortality estimates derived from retrospective data, as infants born in the three year
period preceding the survey, as identified through birth histories, were included even if
they were born before their mother had moved into the area and could not have attended
groups at that time. Although migration data has been collected, it was not available for
the analysis presented here. In future, an analysis confined only to women who were
resident in study areas at baseline may reduce some of the diluting effects of this
problem.
Population movements resulting in ‘contamination’ of control areas with intervention
messages may also have occurred, resulting in further dilution of study effects.
Contamination appears to have been low, as only 78 women (1%) of women in control
areas interviewed at one-month postpartum reported ever having attended a women’s
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group. To reduce the potential for contamination, communities in the study were
separated from each other by ‘buffer zones’, and this appears to have been effective.
Community interventions like the women’s groups may take time to achieve their full
potential as they follow a slow process of building social capital and changing
behaviours. Intensity of exposure to the intervention elements most potent in changing
behaviours changed over the course of the study. For example, the impact of the
women’s groups in the first year of the intervention is unlikely to have been at its
highest level, as this was a phase of discussion and planning. Implementation of chosen
strategies did not happen until later in the second and third years of the trial. Thus
inclusion of all three years of follow-up data may have diluted the full potential effects
of women’s groups. Looking only at the impact in years 2 and 3 shows more consistent
and pronounced effects on all mortality outcomes than when year 1 data is also included
(Table 5.12).
Variability in intensity of exposure between communities may also have arisen due to
implementation factors. Intention-to-treat analysis can lead to false conclusions about
intervention impact if, for example, there was poor delivery of the intervention (255)
(255, 306). Limitations of intervention implementation will be discussed further in
section 6.4.2.
Overall, assignment of exposure status according to allocation to women’s group
intervention area was a crude measure of exposure. In fact there was considerable
variation in exposure, coverage and delivery of the intervention between individuals and
clusters. Assigning exposure by intention-to-treat meant that many women were
assigned as exposed when in fact they may have received very little or no benefit from
the intervention. The main effect was to overestimate exposure levels, which may have
led to false conclusions about the impact of the intervention, in particular an
underestimation of its effects. Although evaluation of public health interventions
through effectiveness trials should not try to reproduce coverage levels only attainable
in ideal study situations (254).
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Sources of measurement error and bias in measures of exposure to other risk factors
In order to be able to adequately control for potential confounding factors or effect
modification, accurate data on these is required. The main additional explanatory factors
included in the model were cluster-level baseline values, household socioeconomic
quintile, maternal age and education, and these will be considered in turn.
First, as discussed in the section above on imbalance after randomisation, there were
important differences between intervention and control areas at baseline that needed to
be adjusted for in the analysis. Cluster-level baseline values were generated from data
collected during the prospective baseline period (1st January to 30th June 2005).
Baseline values for secondary outcomes were highly correlated with outcomes during
the study period. However, apart from infant mortality, baseline mortality rates were not
highly correlated with mortality during the study period. This may have been because
the period of prospective baseline data collection was only six-months, and mortality
rates estimated were likely to be imprecise. This was also the time when the
surveillance system was newly established, and may have been more prone to error.
Instead of baseline mortality rates therefore, baseline skilled birth attendance rates were
used to adjust for baseline imbalances in mortality (for all mortality outcomes except
infant mortality), and these correlated well. This may not have adequately adjusted for
the confounding effects.
A second important factor adjusted for in the analysis was household socioeconomic
status. Socioeconomic scores produced by principal components analysis were highly
skewed with a long positive tail, but the majority of scores being clustered at the lowest
end of the range (Figure 5.2 and Figure 5.3). Such truncation may reflect the fact that
most rural households are homogenously poor. In this analysis, socioeconomic quintile
groups were used rather than continuous scores, in order to avoid problems associated
with non-normal data. However, inaccurate conclusions about associations may still be
drawn if the principal components do not predict socioeconomic status well (i.e. no
internal coherence) (307). In future analysis, new lists of household assets collected
during the re-census in 2008 could be used to better capture inequality between the
poorest households and broaden the distribution (280). These included additional asset
variables that may vary more between households, such as ownership of cellphones,
mattresses, table and chairs, and sofa sets. Cellphone ownership in particular has
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become much more common over the course of the study. Though data collected on
assets is usually less prone to measurement error than income, consumption or
expenditure data as a way of estimating household socioeconomic status, there was
some evidence that respondents denied ownership of certain assets such as radios or
bicycles because they had misunderstood the purpose of the project and thought they
would receive one. Onwujekwe 2006 similarly found test-retest and inter-rater
reliability not to be high resulting in differences of classification of households into
different socioeconomic groups (307). Univariate relationships between socioeconomic
quintile still showed the expected socioeconomic gradients, with poor health and lower
health-care seeking amongst the poorest women (Figure 5.11), but these may have been
attenuated due to imprecision estimating socioeconomic status.
Finally, the other factors adjusted for in the analysis were maternal age and education.
One third of women did not know their year of birth, though most were able to give
their age in years when probed about events that happened around the time they were
born. Imprecise age data is likely to have resulted in some imprecision in estimating
relationships between age and outcomes, widening the ranges of uncertainty, and may
have caused some bias if older or less well-educated women were less likely to know
their age. Educational attainment was more easily reported, and was only categorised
into three groups: no education, primary education and secondary or higher education.
Significant misclassification of educational level is unlikely.
Overall, misclassification of other risk factors is unlikely to have differed between
intervention groups or to have caused bias or confounding, so the overall impact would
be imprecision, and thus underestimation of their effect. Most importantly, inaccurate
measurement of baseline outcome measures would reduce their strength in adjusting for
baseline imbalances in the analysis.
Sources of measurement error and bias in outcome measures
The primary outcomes in this study were objective mortality outcomes, which are less
prone to error and bias than subjective outcomes such as self-reported behaviour and
morbidity. However, errors and biases could still have affected mortality rate estimates.
The main sources of error and bias in this study were missing or unclear information on
dates of birth and death or signs of life for infants immediately after birth, incomplete
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identification and reporting of pregnancies, loss to follow-up with a questionnaire or
verbal autopsy, misclassification of cause and timing of deaths, and interaction of the
surveillance system with the intervention. These are described below.
In both prospective and retrospective datasets, records with missing data on date of birth
were excluded because it was not possible to say whether or not they had been born
during the baseline or study periods. This particularly affected retrospective data, with
1,417 (12%) records being discarded due to lack of date of birth data. Similarly,
neonates, infants and mothers were excluded from analysis when missing date of death
information made it impossible to say whether or not they had died within 28, 365 or 42
completed days respectively (i.e. within the defined neonatal, infant or maternal
periods). Seven (1%) records without clear details of peripartum events were also
excluded from analysis of stillbirth and neonatal outcomes because it was not possible
to tell whether the infant had died during labour or soon after birth. Though these were
still included in analysis of perinatal outcomes.
As described earlier, identification and reporting of pregnancies may not have been
complete, and this may have led to errors or biases in estimating mortality rates. As
described above in the section on losses to follow-up, the follow-up rate for reported
pregnancies was very high, but it is impossible to know the number of pregnancies that
were never reported at all. Incomplete reporting may have been a particular problem in
areas with high population turnover, such as trading centres and commercial tobacco
estates, or high seasonal migration. Furthermore, fieldworkers were not all equally
diligent in visiting all households or villages, and some may have visited the remotest
villages in their zone less frequently, thus under-reporting pregnancies there. The extent
of this is not known at present, though further data quality checks will be made. It is
unlikely that this would have differed between study arms.
Losses to follow-up with a one-month and six-month questionnaire have been described
above, but loss to follow-up with verbal autopsy may also have occurred and caused
error or bias. In order to avoid misclassification of miscarriages, stillbirths and early
neonatal deaths, which have confusing and overlapping names in the local language,
these were not classified by fieldworkers themselves, but through complete verbal
autopsy by a supervisor. Though the requirement for verbal autopsy as the basis for
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classification brought in its own source of bias, as supervisors were not equally diligent
in following these up. Some were less willing to travel to the furthest zones, meaning
that deaths may have been more under-reported in the remotest zones, making their
mortality rates lower than expected. This may have led to overall underestimates of
mortality rates. There may have been some imbalance in this effect between study arms
as they were not evenly distributed between supervisors, but again, the extent of this is
not known at present.
Definitions of miscarriage, stillbirth, neonatal, infant and maternal death occasionally
caused confusion amongst fieldworkers, despite repeated training and monthly review
meetings. There was also some evidence from management feedback that several
fieldworkers may have over-classified stillbirths and under-classified neonatal deaths in
an attempt to avoid the longer interview required for neonatal deaths, and this happened
more in control areas. In the first three years of surveillance, maternal deaths were
reported by fieldworkers and followed up with verbal autopsy by a supervisor.
However, it was observed that fieldworkers might have been misclassifying maternal
deaths that occurred several weeks after delivery because they did not consider these to
be maternal, and reporting them as non-maternal. As a result of this, in October 2007, a
list of all women of childbearing age reported to have died during the study was
generated, and followed up with a short interview to the relatives about timing of the
death in relation to pregnancy and description of events leading to the death. This
process uncovered at least 10 (14%) maternal deaths that had originally been
misclassified as non-maternal deaths among women of childbearing age, and this
misclassification was slightly more common in control areas. Most were subsequently
followed up, but where relatives had moved out of the area, follow-up with an interview
was not possible.
Finally, there is some evidence that there may have been interaction between data
collection through the surveillance system and the women’s group intervention,
potentially causing bias. Early findings from the process evaluation suggest that with
heightened community awareness of mother and child health issues in women’s group
areas, pregnancies, births and deaths are easier to identify than in control areas (297). In
some cases female interviewers and enumerators also attended women’s groups.
Fieldworkers in women’s group areas reported that it was easier to interview women
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about their pregnancy and birth experiences than in control areas, and there were twice
as many refusals in control areas, though numbers were small (Figure 5.1). In addition,
due to financial constraints, monitoring and evaluation supervisors shared a motorbike
with women’s group supervisors, and this may have made them more likely to follow
up verbal autopsies in intervention than control areas. Anecdotal evidence from project
management sources confirms this (128). The size of effect is not presently known,
though this may mean that deaths were more under-reported in control areas, which
may have reduced the magnitude of difference seen between intervention arms.
Secondary outcomes were more prone to error or bias as they were self-reported
behaviour and morbidity. Recall of behaviours such as diet (e.g. infant feeding recall) or
signs of illness may be particularly prone to error. In order to try and reduce recall error,
data for classification of breastfeeding outcomes were not included if collected four
weeks or more after the scheduled visit time. Accurate classification of exclusive
breastfeeding was limited by the fact that data were only collected at two points in time
(308, 309). The fact that neither women interviewed nor data collectors were blind to
the study allocation meant that there was a possibility of ‘best behaviour bias’ or
‘interviewer preference’, where answers may have been influenced by knowledge of
which study group the respondent was in. In order to reduce this, interviewers were
instructed not to read out lists of possible answers, but wait for respondents to answer
spontaneously. They also asked women to bring their health passports, if available,
which contained information recorded by health workers at antenatal, delivery and
postnatal visits, as well as visits for vaccinations or illness. Given the lack of significant
impact on most of the secondary behaviour and morbidity outcomes, it seems unlikely
that differential recall bias was a major problem.
As with the measurement of other risk factors discussed above, the question of whether
the measures chosen adequately capture the underlying concept is important. Death is
an objectively verifiable event, but the periods defined as neonatal, infant and maternal
are somewhat arbitrary (see section 2.1.1), and it is possible that they did not capture the
periods most affected by the intervention. For example, death rates amongst women
continue to be higher than background mortality rates for several months after birth in
Malawi (14). In light of this, in September 2006, the follow-up with verbal autopsy of
maternal deaths was extended to one year after delivery (i.e. late maternal deaths), and
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future analysis of this data will be interesting. However, since many of these late
maternal deaths may be HIV-related, and women’s groups did not put major focus on
HIV-related problems (286), there may not have been large impact of the intervention
on these. Women’s groups focused largely on obstetric maternal problems, so analysis
of data only on direct maternal deaths may show a bigger impact than including all
maternal deaths. Evidence suggests that failure to differentiate between direct and
indirect causes of maternal death may lead to misleading estimates of the success of
failure of an intervention (78). For infant outcomes, the opposite applies, with women’s
groups focusing on problems arising within a broader time period but the outcome
measure being linked to a shorter time period. Women’s groups did not focus solely on
health problems affecting neonates, but ranged into problems that affect older children
more, such as malaria and diarrhoea (310). Focusing analysis only on neonates and
infants may miss some important effects on older children. Future analysis of data on
under-five mortality will be important.
In summary, non-differential errors or exclusions in classifying outcomes may have led
to imprecision in estimating the impact of the intervention, and errors or exclusions that
were more pronounced in intervention or control arms may have led to bias, and
incorrect conclusions about the impact.
Data quality and internal validity
Data on most of the study outcomes were collected through face-to-face interviews and
visits. Interpretation of the findings depends to what extent the data are valid, reliable
and unbiased. There is inherent uncertainty in the measurement of human characteristics
(292), and some sources of error and bias have been described in the previous sections.
In order to make data more reliable, supervisors were required to check completed
questionnaires and make spot visits to study areas to observe interviews. Re-interviews
were also done on a sub-sample of 100 one-month and 100 six-month questionnaires.
This data is not yet available, but in future this may allow calculation of test-re-test and
inter-rater reliability scores, which would help to understand the influence of
measurement errors on the results seen.
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There is natural variability in health-care seeking and mortality between zones, but
some of the variability seen in the data may also be due to variability in data quality
between zones. In large surveys there are inevitable differences between interviewers in
their technique, in spite of rigorous and systematic training (302). There were some
‘extreme’ values in cluster-level summary data for secondary outcomes that seemed not
to correspond with other variables for that cluster, raising questions about internal
validity for some secondary outcome measures. A few cluster outliers due to poor data
quality may not affect the overall direction of the relationship between exposure and
outcome, and inaccuracies may be equally distributed between intervention and control
areas, but it does suggest that some of the errors and biases discussed above may be
influencing the results. During the re-census, to try and make the quality of the data less
dependent on the individual assigned to each zone, two additional interviewers were
recruited. Future investigations of the re-census data will allow interviewer effects on
variability of data to be explored.
Statistical methods
Logistic regression with random effects to take account of between-cluster variation in
outcomes is the recommended way to analyse individual-level data from cluster-
randomised trials with more than 20 clusters (253). However, there are ways in which
the statistical analysis was limited in this study due to design factors, such as lack of
stratification for imbalances at baseline, imperfect statistical adjustment of baseline
differences, and lack of power to explore interaction between the two interventions and
other complications of the factorial design (265). Further elements of the analysis that
could be improved would be to increase precision by including fewer additional
explanatory variables, and more complete exploration of multilevel data structure and
sources of variation.
Randomisation was performed after the baseline survey data was collected, but before
data entry had been completed. This prevented exploration of potential imbalances
between clusters that could have been used as a basis for stratification. Stratifying by
cluster-level socioeconomic scores might have reduced baseline imbalances between
intervention and control arms. Better still would have been to wait until after the
prospective baseline phase, and use baseline mortality rate estimates to stratify or match
clusters. Having said this, neither cluster-level socioeconomic scores nor baseline
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mortality rates were strong predictors of primary outcomes, and stratification may have
reduced the power of the study without providing great advantage (293).
Given that there was a large imbalance between clusters at baseline, adjustment for
baseline values in the analysis was necessary. Adjusting mortality outcomes for baseline
mortality rates, by including cluster-level baseline mortality variables in regression
models, did not prove effective. Instead perinatal, neonatal and maternal mortality were
adjusted for baseline imbalances by including cluster-level baseline skilled birth
attendance rates as a variable in the model. This may still not adequately have
accounted for imbalances at baseline, resulting in underestimation of the impact of the
intervention. Adjustments for baseline imbalances were also made at cluster-level rather
than individual-level, because individual-level baseline data on mortality is not possible,
and this may not have been a sufficiently precise measure of the initial imbalance
between study participants. Imprecision again resulting in underestimating the effect
size. A future analysis of cluster-level changes in mortality would be less statistically
efficient, but might be a better way of adjusting for differences at baseline (253).
Cluster randomised trials are a robust means of evaluating the benefits of public health
interventions, but logistical constraints often limit the number of clusters leading to
limited statistical power (253). There was inadequate statistical power to provide
definitive answers about the interaction between the women’s group and peer
counselling interventions. Exploratory analysis showed some evidence of interaction for
perinatal, neonatal and maternal mortality outcomes, but not for infant mortality. Infant
mortality and exclusive breastfeeding were the primary outcomes of the peer
counselling intervention, and primary and secondary outcomes respectively of the
women’s group intervention. This means that activities to reduce infant mortality and
increase exclusive breastfeeding were happening in half of the control areas included in
the main analysis, and this may have masked some of the impact of the women’s group
intervention. The factorial design made it difficult to disentangle the separate effects of
the two interventions in main effects analysis (Table 5.12), and though lacking power,
sub-group analyses are important in the presence of a qualitative interaction (265).
Baseline values, household socioeconomic quintile, maternal age and education were all
included as explanatory variables in adjusted analysis, as well as the presence of the
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peer counselling intervention. The inclusion of so many additional variables may have
resulted in some loss of precision in estimating effects, especially as there may have
been some collinearity, such as between age and education, and between education and
socioeconomic status. In linear and logistic regression without random effects to control
for clustering, stepwise methods can be used to select variables for inclusion in
regression models. This was not possible for random effects logistic regression, and
explanatory variables were selected on the basis of their known association with the
outcomes, as well as strength of association in bivariate analysis (52). Furthermore, a
standard model was applied across all primary and secondary outcomes for ease of
presentation, but in fact relationships with other explanatory variables may have been
different for different outcomes. Records with missing values for covariates (such as
socioeconomic score or maternal age) were excluded in adjusted analyses. For example
48 (11%) records for neonatal deaths and 996 (6%) for live infants were excluded in
analysis of neonatal outcomes. Imputation of missing data may be important if records
with missing data differ systematically from those without in ways related to other
outcomes or risk factors (311).
Finally, the analysis presented in this thesis was limited to random effects or variability
between clusters (i.e. a random intercept model), but did not allow the effect of the
intervention in each cluster to vary (i.e. a random coefficient model). Further
exploration of sources of variability might prove fruitful in understanding the nature of
the relationship between the intervention and outcome. It might also allow for more
detailed understanding of how intervention impact varies between clusters, and the
influence of individual-level and cluster-level contextual factors in intervention success
or failure (292).
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6.4 Limitations of the intervention
One explanation for the lack of significant impact may have been weaknesses in the
design or implementation of the intervention.
6.4.1 Intervention design
This was a well thought out intervention that was developed from similar interventions
in Bolivia and Nepal that had showed beneficial effects. The adaptation of the
intervention to the Malawian context was carefully considered after formative research
to explore issues of accessibility, acceptability and feasibility (263). The intervention
had a number of constraints due to the Malawian context, and the requirement that it
should be sustainable, relatively low cost and easy to scale-up by government or other
local partners. Some limitations of the intervention design may include the staffing and
supervision structure, coverage and reach, lack of health information content as a basis
for decision-making, promotion of health-care seeking without concomitant
improvements in the health services, and narrow neonatal focus of materials.
Staffing and supervision structure
Consideration of cost-effectiveness and sustainability were the main limiting factors on
the staffing and supervision of the intervention. There was one paid facilitator per
cluster, and one paid supervisor for every six clusters. Each facilitator formed between
eight and 10 groups, and due to demand, facilitators were running between four and 12
groups by the end of the trial. The distances between villages where groups were held
were quite large in some cases, and limited the frequency with which meetings could be
held. Similarly, distances covered by supervisors when visiting zones for supervision
could be up to 20km, and the time and cost of fuel involved limited the number of
supervisory visits that could be made.
In addition to human resource limitations, there were some limitations on capital
equipment available. The fact that women’s group and surveillance supervisors had to
share motorbikes limited the frequency and intensity of supervision that each was able
to provide, particularly to the most remote areas.
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Coverage and reach
With one facilitator running an average of 9 groups per cluster, there were limitations to
the coverage of the intervention. With a total population of between 3,100 and 4,900 per
cluster, this means about one group per 350-550 people. There were an average of 900
women aged 15 to 49 years per cluster, meaning roughly one group per 100 women.
Data show that 53% of women interviewed postpartum had ever attended a women’s
group, and this corresponds well to a successful women’s group interventions in India
(one group per 468 population and 55% attendance by pregnant women) (25), and is
slightly higher than a successful intervention in Nepal (one group per 778 population
and 37% attendance by pregnant women) (22). If all women of childbearing age had
attended in this study, group sizes would have been unmanageable. But not all women
of childbearing age did attend, and though no longer childbearing, a large number of
older women attended. Through social networks, women’s group messages may have
reached beyond those who actually attended groups (238), though there is some
evidence that women who attended more meetings themselves did have health
advantages over those who did not (Table 5.16). In order to increase coverage in future,
in a second phase of women’s group activities starting in 2010, after the study period,
chairwomen of existing groups were trained in facilitation skills and run the groups as
volunteers. New groups have been established in villages that did not have their own
group, and are facilitated by the original paid facilitators.
In terms of how equitable the coverage was, data showed good uptake amongst the
poorest and least well-educated women (Table 5.10). Groups that were less well
reached were young, unmarried women, with no previous pregnancies, as well as
wealthier, more educated women. Groups were allowed to choose their own
membership criteria, and young girls who had never been pregnant, or who were
pregnant for the first time, were sometimes prevented from attending. 153 (74%) of
groups specified pregnancy status as a criteria for group membership. During a mid-
term review, concern was expressed at the lack of older grandmothers present at groups
because of their important in influential role in decision-making around pregnancy,
birth and child-care. In fact, no groups excluded older women, though some older
women chose not to attend because they felt that the discussions were no longer of
benefit to them.
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Lack of health information content as a basis for decision-making
Facilitators were not trained in health education themselves, so were not able to provide
specific information on diseases, and strategies to prevent and treat them. Instead
communities were encouraged and empowered to seek health information and care from
existing sources. As such they did successfully organise 369 health education talks with
their local health extension workers (HSAs), and established five mobile antenatal, and
21 under-five clinics. A weekly mother and child health programme was also broadcast
on local radio in a collaboration between the MaiMwana women’s group team, the
District Health Office and community-based listening groups. However, as these
activities were all part of the implementation phase (phase 3), the new knowledge
gained was not available to the groups at the time of problem identification,
prioritisation and planning. Health education was the most commonly identified and
implemented strategy and this shows how disadvantaged communities had initially felt
in relation to health knowledge.
In Nepal and India, there was perhaps more implicit knowledge transfer in the groups
about home care behaviour, hygienic delivery practices and being prepared for
emergencies than was the case in Malawi, and significant reductions in both neonatal
and maternal mortality were achieved without high levels of health facility deliveries in
the intervention group (22, 25). The intervention was described as ‘participatory
learning and action’ and facilitators were trained in ‘participatory learning skills’ in
Nepal and India. In all cases, there was consideration of how to strike a balance between
facilitators being supportive and being directive of group processes (140). In Malawi,
the women’s group intervention was developed with a conscious decision about the
importance of community empowerment as a beneficial outcome in itself, and aimed for
processes that were community driven for collective community action (237), while
transfer of health information was not explicitly included in the process, unless the
groups identified the need and planned it themselves. Heath education on hygienic
home delivery practices was considered to be less important, given that a larger
proportion of women delivered in facilities to begin with, and that government policy
strongly discourages home delivery in Malawi. Furthermore, the picture card game
adapted for use in Malawi was more of a planning tool than a learning tool, and picture
cards were only shown after a problem had been identified and used to stimulate and
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guide discussion, rather than for role-playing during the process of problem
prioritisation.
It seems that overall, the women’s group process in Malawi was more focused on
capacity building to enable communities to take control of their own health issues (245,
247). The process did not suggest any pre-prepared solutions to the problems identified
by the groups, and as such, some of the strategies chosen may not have been the most
effective way of addressing the problems, and some were chosen to address broader
underlying problems and may have an effect in the longer term. Direct comparison of
the three trials is difficult given the differences in community context, health system
factors and other disease determinants, but it seems likely that there were also
differences in the concept and design of the intervention in the different settings that
may have contributed to the impact observed. The main difference may have been in the
way community participation was conceptualised and achieved (246), and the main
effect of this may have been that the time-scale of the change process was longer in
Malawi, because learning and action was driven more by communities identifying the
need for it themselves.
Increasing demand for health services without improving quality
As stated in the section on ethics in 4.4.11, it was felt to be unethical to increase
demand for health services without improving their quality. Therefore, simple, low-cost
health service strengthening activities were undertaken, but it is not clear to what extent
these were effective. Health facility audits in 2004 and 2007 found that communication
systems and infection prevention had improved (Mchinji was awarded national
Infection Prevention and Reproductive Health shields during this period), but drug
supply systems were still inadequate, antenatal syphilis testing was unavailable, and
most of the staff that were trained in essential newborn care had transferred out of the
district (312).
In a maternal death review in Malawi, Kongnyuy 2009 shows that major avoidable
factors in institutional maternal deaths are health-worker related and that provision of
care in cases of maternal death was inadequate and delayed (6). Poor quality care may
have limited the impact of strategies that increased uptake of health services. No
refresher or replacement training was carried out, and continued MaiMwana support for
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supervision systems and service provision were difficult to maintain, and did not
happen for a large part of the study period. Renewed effort has been put into this more
recently. Collaborative work on rolling out services for PMTCT was more successful.
Coverage was improved greatly, from services being almost non-existent when the
project started, to currently operating basic services (antenatal HIV testing, single-dose
Nevirapine, referral for longer-term ART, and postnatal cotrimoxizole prophylaxis for
exposed infants) in all health facilities. Further analysis by place and cause of death, and
exploring avoidable factors might elucidate whether or not limited health service quality
had played a significant role in lack of impact in this study.
A sense of fatalism and inevitability of adverse outcomes may impede health-care
seeking (140), and without obvious improvements to the quality of services, these
attitudes are unlikely to change. The concept that people possess equal rights to health,
education and social services is key in increasing demand for services and for better
allocation of resources, and this must be coupled with greater community participation
in planning and decision-making processes to ensure services meet their own health
care needs (238, 313). Many groups did engage in advocacy activities with their local
health facility to address cases of poor quality care and advocate for better coverage of
outreach services, and 67 groups (34%) successfully lobbied for community health
workers to be stationed in their area rather than in a more distant trading centre.
Constructive dialogue between communities and providers will increase demand for
services that better meet the needs of the users, but this is likely to be effective over a
longer period of time than that covered this study.
Narrow neonatal focus of materials
The women’s group intervention and materials were developed using manuals and
documents from Warmi, Bolivia, and MIRA, Nepal. As well as maternal outcomes,
these focused on perinatal and neonatal outcomes because of the important contribution
of these to child mortality in Asian and South American settings (314). However, in
sub-Saharan Africa a smaller proportion of child and infant mortality is due to perinatal
and neonatal complications. In sub-Saharan Africa post-neonatal mortality from
malaria, pneumonia, diarrhoea and HIV is generally high. Though infant mortality was
a primary outcome of the intervention, and all groups discussed infant health problems,
women’s group materials focused more on the neonatal period. Therefore the design of
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the women’s group intervention in Malawi may have been tailored towards an aspect of
child survival with smaller and less immediate gains to be made than in the Asian and
South American settings. It is difficult to gauge the contribution of HIV to maternal and
child deaths in Malawi, but WHO estimates that 32% of maternal deaths in Malawi are
HIV-related (37), and other authors have also highlighted the importance of tackling
HIV in order to achieve reductions in maternal and infant mortality (14, 74, 76, 82).
6.4.2 Intervention implementation
Although implementation problems reflect real-world public heath challenges, it is still
important to understand why the intervention may have had less impact than expected,
and whether there were any contextual and implementation factors that could be
addressed differently in order to achieve greater impact. Therefore, in evaluating the
potential of the women’s group intervention as a future public health strategy for
mother and child health, it is important to ask whether the intervention was well-
implemented in this study. Lack of significant impact may be a result of poor or
incomplete implementation (255). A parallel process evaluation has been carried out to
explore implementation factors in depth, and the findings from this will provide further
important information for interpretation of the impact analysis. A number of factors
may have led to sub-optimal implementation, including delays in implementation,
particular implementation problems with certain meetings, and particular
implementation problems in certain areas.
A further feature, which was both a benefit and a limitation of the way the intervention
was designed and implemented, was the freedom of communities to choose their own
strategies. Although this is likely to have resulted in increased social capital,
empowerment and greater sense of ownership of the activities (313), the freedom to
choose also resulted in groups finding it difficult to implement certain strategies, a
diversity of strategies being chosen having diverse effects, and strategies being chosen
to address broader underlying social problems but lacking maternal and infant focus
(140).
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Delays in implementation
Community interventions take time to implement, particularly while ensuring active
participation at all stages. However, there were some disruptions to the implementation
of intervention activities that caused additional delays, and may have caused delays in
evidence of overall intervention impact. In June 2006, five of the senior personnel
involved in coordinating the project, including the senior facilitation officer in charge of
the intervention, were involved in a serious road traffic accident. Project activities in all
departments were affected for at least 18 months after this. Lack of guidance at the top
trickled down to fieldworkers, resulting in lower motivation and delays in holding
scheduled meetings, and reduced frequency and intensity of supervision. An additional
factor causing low morale during the same period was a significant delay of funds,
meaning that many activities such as meetings and refresher trainings had to be
postponed or cancelled. Secure funding was only re-established in mid-2007. The
average timing of each meeting is shown in Figure 6.1, as well as the range of dates. As
can be seen, there is some skew, with most groups holding the meeting around the
expected time, but some lagging behind.
Annual seasonal delays also occurred during busy farming seasons as it became difficult
to convene all group members. Similarly, delays occurred during the rainy season
(December to March) because it was difficult to find a sheltered meeting location in
some areas. Other reasons for unexpected delays were funerals, weddings and other
community gatherings that required participation of the entire community.
As described below, some of the meetings caused delays, and some strategies chosen by
communities to address the problems they identified were difficult to implement. After
reviewing some process evaluation data in 2008, the Data Safety and Monitoring Board
panel recommended extending the follow-up of the women’s group intervention beyond
the original two-year period to allow for complete implementation of the intervention
and collection of more complete data, especially on infant mortality. Even by January
2009, the final end-date of the trial, although 176 (89%) of groups had completed the
whole women’s group cycle, some had not, and a small number had not managed to
implement any strategies. The average time for the start of strategy implementation was
July 2007, which is the mid-point of the study period. Although individual behaviour
change may have occurred much earlier, some of the biggest effects of the intervention
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would not have started to be seen until half way through the evaluation period. Indeed,
data from years 2 and 3 alone show greater impact than when year 1 is also included
(adjusted odds ratios and 95% CIs for NMR were 0.82 (0.55-1.22) and 0.95 (0.71-1.28)
respectively) (Table 5.12). Longer follow-up, into years 4 and 5, will allow continuing
effects to be observed.
Implementation problems with certain meetings
Confusion and disagreement over the role of men in the women’s group intervention
process resulted in delays in holding meeting eight (where men were first invited). The
average length of the delay between meeting seven and meeting eight was around eight
months (Figure 6.1).
‘Male championship’ has become a fashionable catchphrase amongst development
workers in Malawi and the international community (315), and male involvement was
incorporated into MaiMwana PMTCT activities from the outset. However, male
involvement in ‘women’s groups’ was a more complicated issue, and there were many
misunderstandings and disagreements about how and whether this should be done.
Many groups took a long time to organise meeting eight because they thought that it
was compulsory, so scheduled and re-scheduled the meeting until men attended, but in
the process got de-motivated because men did not immediately attend (297). Arguably,
part of the benefit of being a member of a women’s group is the sense of individual
empowerment and confidence gained by the women themselves through an increasing
sense of decision-making power in relation to their health (316). When groups did
become open to male membership this may have influenced the way in which women
participated, and indeed it was observed that in the presence of men women did tend to
talk less and take on more traditional deferential roles in relation to male members. And
although there was always higher representation of women in decision-making roles,
men also began to take on roles such as secretary or chairperson of the groups. On the
other hand, many men were very involved in the implementation of the chosen
strategies, and were particularly helpful in relation to resource mobilisation and
advocacy (297).
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Figure 6.1: Implementation of meetings 2 to 12 (M2 to M12) and the start of the implementation phase (IMP) – showing average and range of times, and timing of strategies
Average and range of time of holding meeting
t=0 is the time of the first group meetings, t=9 is nine months later when the intervention evaluation period began (i.e. from 1st February 2006), t=33 is the original
end of the evaluation period after two years of intervention (i.e. to 31st January 2008)
1 = Bicycle ambulances donated, 2 = 400 ITN distributed & first clinics established, 3 = 100 ITN distributed, 4 = 300 ITN distributed, 5 = more clinics established
1 2 3 4 5
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There was also a delay between the implementation phase and the start of the evaluation
phase (between meetings 16 and 17). This was a planned delay because groups were
encouraged to implement strategies for at least nine months before they started
evaluation.
Implementation problems in certain areas
Implementation of women’s groups in some types of communities raised particular
problems. Trading centres and tobacco estates were particularly difficult. It was
sometimes difficult for groups to find a quiet place to meet, but more importantly, many
women were too busy with business or work commitments to be able to attend
meetings. Individual or community attitudes about not spending time on intervention
activities that did not provide ‘hand-outs’ such as farming inputs or loans were
particularly common in these areas. They were both less likely to attend at all, as well as
less regular in their attendance. This is reflected in the group attendance data (Table
5.10), which shows that wealthier and more educated women were less likely to have
ever attended a group.
Remote areas also raised challenges. Facilitators and supervisors visited less frequently,
and the groups had less access to resources than in areas closer to trading centres and
health facilities. Difficulty accessing the necessary resources for implementing some
strategies led to failure to implement strategies and consequently de-motivation. It was
difficult to recruit and retain staff at the most remotely located nodal office, and there
was a high staff turnover, with four different supervisors being recruited over the study
period. Finally, in some specific areas, chieftainship conflicts also resulted in parts of
communities being prevented from attending groups.
Diversity of strategies chosen, with diverse implementation problems
In phases 2 and 3 of the women’s group cycle, groups chose and implemented strategies
to address mother and child health problems (Figure 4.4), and 197 groups managed to
implement strategies. Some of the strategies chosen by the groups were difficult to
implement due to external factors. The most commonly identified strategy (by 96% of
groups), was health education, and 134 groups (68%) managed to organise health talks
in their community, though these were generally delivered by the lowest cadre of
health-worker, with only 8-weeks of training. 120 (61%) groups also set up radio-
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listening clubs and listened to weekly broadcast mother and child health education
shows. The next most commonly identified strategy was bicycle ambulances (88% of
groups), but due to the cost and difficulty in obtaining bicycle ambulances locally, only
40 were donated and had to be shared between 95 groups (48%) in neighbouring
villages. The third most commonly identified strategy was TBA training (71% of
groups). A government ban on TBA deliveries in 2009 meant that none of the groups
who identified TBA training as a key strategy were successful in implementing it. 60%
of groups identified the need for better access to insecticide-treated bednets (ITN), and
collected funds to buy and distribute low-cost ITNs, but a change in government policy
meant that they could no longer organise their own access to nets outside of government
sources. When new government supplies finally arrived, an agreement was signed with
the district hospital so that women’s groups could be community-based distributors of
nets to all women with children under five years old. 130 groups (66%) distributed a
total of 247 ITNs. Lack of success with planned strategies led to frustration.
Having said this, groups went on to identify a wide range of other strategies that they
successfully implemented. More groups who identified dimba vegetable gardens
(identified by 61%, implemented by 69% of groups), mobile clinics (identified by 48%,
implemented by 44%), small-scale income-generating activities (identified by 37%,
implemented by 33%), distribution of oral rehydration solution (identified by 7%,
implemented by 17%), and group funds (identified by 3%, implemented by 52%) were
successful in implementing them. In addition, many groups implemented other
strategies that were not originally identified in phases 1 and 2: 11 groups (6%)
established literacy clubs, 96 groups (49%) dug pit latrines, 108 groups (55%) treated
drinking water with chlorine, 12 groups (6%) lobbied for forestry training and inputs,
and two groups (1%) established child care centres.
Figure 6.1 shows how strategies such as bicycle ambulances, ITN distribution and
mobile clinics were implemented towards the end of the second year of the original
evaluation period.
Diversity of strategies chosen, with diverse effects
The fact that groups were free to choose their own strategies, and that they all chose
different strategies, means that the effects may also be heterogeneous. Different
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strategies might affect maternal, perinatal, neonatal and infant mortality to greater or
lesser extents, resulting in different effects in each cluster depending on what strategies
had been implemented.
Strategy selection was not evidence-based, and some strategies chosen may not in fact
have been very effective in reducing mortality in the short term. For example, use of an
insecticide treated bednet during pregnancy is reported to be 23% effective in reducing
low birth weight (Table 3.1), and 22% effective at reducing all-cause infant mortality
(144, 317). The 22% reduction in mortality was achieved with a level of bednet use of
83%. In this study bednet use increased from 42.6% at baseline to 54.9% during the
follow-up period (a 29% increase). Low birth weight is an underlying factor in
approximately 30% of neonatal deaths, so the effectiveness of bednets as a strategy to
reduce neonatal mortality (assuming similar conditions to the other studies) would be
about 7% (0.3 x 0.23). So even with almost complete coverage with bednets, the
maximum likely impact on neonatal and infant mortality would have been around 7%
and 22% respectively. However, the benefits of ‘co-coverage’ with several interventions
of low effectiveness can add up to a larger effect overall (60, 318).
Diversity of strategies chosen, with lack of maternal and infant focus
The process of community mobilisation has achieved a great deal in terms of solidarity,
confidence and community problem solving capacities. Many of the most direct and
obvious gains have been more closely related to general household livelihoods than to
maternal and infant health. As described above, small businesses, group loans, dimba
vegetable gardens, farming inputs and advice, water and sanitation projects were some
of the most successfully implemented strategies. A smaller number of the successfully
implemented strategies were directly related to maternal and infant health outcomes.
We can consider the MaiMwana women’s group intervention according to the model of
maternal and neonatal health strategies described in Figure 3.1, with a package of
interventions, delivery mechanism and target population (106). In the development of
this intervention, the means of distribution and target population were given
considerable thought – the means of distribution was the women’s group process
facilitated by a trained facilitator, and the target population was women of childbearing
age in rural areas. However, the single interventions in the package through which
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mortality reductions would be achieved were not specified. This was left to the groups
to decide for themselves, in line with the paradigm of community decision-making and
empowerment followed (237, 238, 313).
As they were free to choose, communities may have incorrectly identified the most
important causes of maternal and infant mortality, and/or incorrectly identified the most
suitable interventions to address these problems, thus making the ‘package of
interventions’ less powerful. Some important causes of maternal and infant deaths that
were not directly identified or tackled were HIV, maternal sepsis and meningitis (286,
310). Birth asphyxia was also not highly prioritised. However, communities may also
have taken a longer-term view to solving their health problems, and considered the
underlying causes of poor health, such as poverty and illiteracy more than specific quick
fixes. As described earlier, many communities did choose more general strategies
related to poverty-reduction, nutrition and literacy. Whilst these strategies may also
have beneficial effects on mother and child health, it is likely that their impact will be
seen after a much longer period of time (313), further adding to the delay in seeing an
impact of the intervention. A parallel evaluation looking at benefits of the intervention
for household wealth and investment in the health and education of other children in the
family is also being conducted, but analysis of this data is still in progress, and will be
completed in 2011.
237
6.5 Alternative explanations for the results
In light of the methodological and intervention limitations, it is important to consider
whether there may be other explanations for the observed effect that differences in
primary mortality outcomes between intervention and control areas were not significant.
The three main alternative explanations to consider are chance, bias and confounding.
6.5.1 Chance
Random errors affect intervention groups equally, and can result in chance findings.
Imprecision in measuring the association between exposure and outcome makes it more
likely to underestimate the strength of the relationship. The effects of random error can
be reduced by and increasing sample size, but as with most community-based trials, the
power of this study was limited by the relatively small number of clusters used as the
unit of randomisation. With 48 clusters, the study was planned with adequate power to
detect a reduction in neonatal, infant and maternal mortality of 31-36%, 21-28% and
47-50% respectively (Table 4.4). It was clear after estimating mortality rates during the
prospective baseline period, that these were much lower than predicted, and the actual
power of the study to detect an impact would be reduced.
Apart from the number of clusters, which was fixed once the study had started, other
factors affecting the power of the study were size of clusters (number of births per
cluster), baseline mortality rates and intercluster variability. The number of births per
cluster was higher than expected, after following up for three years, but mortality rates
were much lower, and intercluster variability was somewhat higher than expected, and
this resulted in an overall loss of power. Using birth rates, mortality rates and
intercluster coefficients calculated from the study data, the size of reduction in mortality
that would have been detectable at 80% power at a 5% significance level was 34-42%
for neonatal mortality, 40-49% for infant mortality, and around 60% for maternal
mortality. Reductions in mortality of this magnitude were not achieved, even with data
from years 2 and 3 alone. Even with mortality reductions of the magnitude seen in years
2 and 3, the study only had 22%, 22%, 14% and around 30% power, at the 5%
significance level, to detect a significant effect on perinatal, neonatal, infant and
maternal mortality respectively. Thus there is a high probability of making a ‘Type II
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error’, and failing to reject the null hypothesis, when it is in fact false (52). With the
inclusion of other covariates and sub-groups in regression models, the power to detect
statistically significant differences was even further reduced. Even a 41% reduction in
neonatal mortality in women’s group only areas in years 2 and 3 was only of borderline
significance (adjusted odds ratio 0.59 (95% CI 0.34-1.03)).
As described earlier, in section 6.3.2, error and imprecision in measuring exposures and
outcomes that did not systematically differ between intervention arms may have led to
an underestimation of the impact of the intervention.
6.5.2 Bias
Systematic error is error that affects intervention groups unequally, and can lead to a
false understanding about the differences between treatment groups, or an inaccurate
estimate of the relationship. There may seem to be an effect where none exists, or no
effect where one does exist. Possible sources of the two main types of bias – selection
bias and measurement bias – have been described in section 6.3.2.
Losses to follow up may lead to selection bias in two ways. Firstly, if people followed
up or data are not missing at random, but differ systematically from those who were
followed up or have complete data, then the study sample may be different from the
general population, and this may affect the generalisability of the findings. Secondly, if
people not followed up or missing data differ systematically between intervention and
control groups, then this may bias the observed association (301). In this study, people
lost to follow-up at different stages of the study may have been more mobile than those
not lost to follow-up, and these women may have been at higher or lower risk of
adverse pregnancy outcomes. There may also have been some bias as a result of
differential follow-up of women in intervention and control groups, with slightly more
refusals in control areas. The overall impact of selection bias on the findings is likely to
be minimal as follow-up was very high for most outcomes, and the number of births per
woman of childbearing age in each arm was similar (Figure 5.1).
Measurement bias may have arisen through differential misclassification, such that
exposure status affected the probability of a death being classified. For example, as
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described in section 6.3.2, if communities were more sensitised about maternal and
child health in intervention areas and supervisors visited them more frequently, deaths
may have been more completely reported than in control areas. Or there may have been
recall bias, or ‘best behaviour bias’, with unequal recollection of behaviour or disease
between intervention groups, particularly as respondents were not blinded to
intervention allocation. Finally, there is a possibility of observer bias, with interviewers
perhaps tending to seek information or interpret it differently according to their
knowledge of exposure status. Data handling and analyses were carried out blind to
intervention allocation, and are unlikely to have affected the results.
The overall impact of measurement bias on the findings is difficult to tell. Raised
community awareness accompanying intervention activities and shared transport
between intervention and data collection staff may have resulted in more complete
death reporting in intervention areas, and biased mortality rates upwards. However,
recall and observer bias would tend to bias secondary outcome estimates in the opposite
direction, making them better than control areas. Primary and secondary outcome data
does not seem to reflect this scenario, with consistent non-significant improvements
being seen in both (Table 5.12 and Table 5.13).
6.5.3 Confounding
Problems arise when a confounding factor (that is independently related to both the
exposure and the outcome), is unequally distributed between intervention groups (52).
This may lead to misunderstanding of the relationship between exposure and outcome if
not taken into consideration. Randomisation should have prevented this from
happening, as known and unknown confounding factors should be evenly distributed
between intervention and control arms. However, trials randomised by clusters have
small numbers and the potential for imbalance is greater. There does appear to have
been some initial imbalance in the way the clusters were allocated to intervention
groups in this study, and primary and secondary outcomes were worse in intervention
areas at the start of the intervention (Table 5.5 and Table 5.6). Even with adjustment for
baseline values, this imbalance may have masked some of the effects of the
intervention. A few of the clusters were unlike the majority, having more, large,
periurban trading centres or large commercial tobacco estates. Balanced distribution of
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these clusters would not have been possible unless they were matched or stratified at the
design stage. Thus, clusters were allocated to intervention areas in such a way that they
had a combination of the most remote rural areas (where mortality was much higher to
start with) plus the wealthiest trading centres (where women’s groups didn’t work as
well, but HIV may have been higher), and this might have led to dilution of the effect.
Other factors known to be related to an increased risk of mortality include poverty,
maternal age and parity and low education. There did not appear to be any imbalance in
these risk factors between intervention arms (Table 5.4), but they were adjusted for in
the statistical analyses anyway. It is unlikely that they have biased the results and
masked any effects of the intervention. Other unknown confounding factors must be
responsible for differences in mortality at baseline, and these factors have not been
adjusted for. One possible unmeasured confounding variable might be HIV. Female
cross-border traders and estate workers were found to be at higher than average risk of
HIV infection in Malawi (95). Further exploration of imbalances between study arms in
terms of such HIV-related risk factors would be useful.
Another possibility is that exposure to other health interventions in the district may not
have been balanced between intervention arms resulting in bias or masking of effects.
Data on presence of other interventions has been collected, but was not available for
this analysis. Anecdotal data on other NGOs working in the district suggests that few of
them were working specifically in the field of mother and child health, and their
activities were either mainly in health facilities, or in only a small number of villages in
one TA. Though not formally measured, access to television and newspapers are
unlikely to differ between intervention arms. Data on ownership of radios show that
63% of households overall own a radio (Table 5.2), 62% in women’s group areas and
64% in control areas. MaiMwana, in partnership with the District Health Office, started
a community radio programme about pregnancy and child health in 2009, after the
study end-point. Coverage of this programme was across the whole district, though
introduction of radio listener groups in women’s group areas may have meant that they
had better access to these health messages.
Clusters with large trading centres and tobacco estates were more difficult to collect
information in, more difficult to implement the intervention in, and likely to have higher
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prevalences of HIV. Three of the most problematic zones (zones 15, 17 and 23) were
allocated by chance to the arm with both women’s group and infant feeding
interventions. This could possibly partly explain why the arm with both interventions
appears to have had the least impact on maternal, perinatal and neonatal mortality.
6.6 Evidence for a causal association between intervention and outcome
In investigating causal associations in epidemiology, Bradford Hill noted that a small
association does not mean that there is not a causal effect, though the larger the
association, the more likely that it is causal (294). Apart from the strength or magnitude
of association, some of the other criteria that Bradford Hill suggested as a guideline for
assessing causal relationships were: consistency with other findings, temporal
relationship between exposure and effect, biological gradient, plausible mechanism,
experimental evidence, and analogy with similar factors.
6.6.1 Consistency
The evidence reviewed in section 3.3.2 suggested that women’s groups have the
potential to reduce perinatal and neonatal mortality, and there is also some evidence for
reduction in maternal mortality. The studies in Bolivia, Nepal and India all found large
reductions in perinatal and neonatal mortality (Table 3.3) (22, 24, 25). In Nepal there
was a large, significant reduction in maternal mortality, and in India a large, but non-
significant reduction in maternal mortality. However, a similar study in Bangladesh
found no effect of women’s groups on perinatal, neonatal or maternal mortality (252). A
possible reason cited for the lack of success of the Bangladesh study was low coverage
of the intervention, especially among newly pregnant women.
The findings from all the women’s group studies so far are not unequivocal, though
suggestive of a beneficial effect overall. In this context, the new data from this trial in
Malawi suggest a smaller impact of women’s groups at this stage, but one that could
increase further with time.
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Part of the reason for the difference between studies may be contextual factors that
facilitate or hinder the intervention. Such contextual factors may be environmental,
socio-cultural or epidemiological. Measurement of observable environmental factors
such as degree of urbanisation and distance from health facilities may be easier than for
socio-cultural and epidemiological influences that might not be easy to identify.
Obvious differences exist in epidemiological contexts between the Asian study settings
and Malawi, such as much higher prevalence of malaria and HIV in Malawi. The ability
of a community mobilisation intervention using women’s groups to tackle these
diseases may be limited, or require a longer time to be effective. If the attributable risk
of HIV is high, maternal and infant mortality may not be substantially reduced without
directly addressing HIV. In addition, health behaviours differ between the settings, with
much higher usage of health services in Malawi than in other settings. As such, large
reductions in mortality as a result of changes in pre-existing practices at community-
level may have been less likely. Antenatal care, clean delivery (gloves or hand-washing
with soap), early newborn care (early wrapping and early breastfeeding), and
immunisation were all around 80-90% at baseline.
Though not statistically significant, most results were internally consistent. All primary
outcomes showed trends in a positive direction, and key secondary outcomes, including
antenatal care, skilled birth attendance and postnatal care, also showed positive trends.
6.6.2 Temporality
If a relationship is causal, the effect must occur after exposure to the intervention. Data
show very clear declining mortality rates for perinatal, neonatal and infant mortality that
start to occur after exposure to the intervention, when women’s groups started (Figure
5.15). The trend in maternal mortality reduction is less clear, perhaps due to inaccuracy
in estimating yearly rates with small numbers, but still shows an overall decline. Trends
in mortality rates in control areas are not so clear, and some increased slightly during
the course of the study Table 5.12. Health-seeking behaviours increased in both
intervention and control areas over the course of the study, though improvements
tended to be greater in intervention areas. Change over time cannot be seen as definitive
proof that the women’s group process caused the behaviour changes (294).
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General improvements could be partly due to secular trends, especially with
government initiatives and other NGOs being active in the area, and reducing maternal
mortality currently being prominent on the national agenda. It might also be that women
changed their behaviour just as a result of being monitored – the Hawthorne effect (319)
– either reporting more desirable outcomes as they became more aware of what the
‘right’ answers were, or actually changing their behaviours. Changes in reporting are
unlikely to explain the whole effect, as mortality rates were also reduced, and these
could not be subject to the same kind of reporting bias. In an attempt to minimise the
possibility that observation might itself change behaviour, interviews were conducted at
the end of the neonatal period, after most outcomes would already be determined.
Community awareness of mother and child issues is likely to have increased over time,
even in control areas, through being part of a community-based study in which women
were visited every month to identify pregnancies, local stakeholder meetings were held,
and as many as 6 local people were employed in MaiMwana activities per zone.
Evidence of a temporal association must also be viewed in light of any expected delays
between cause and effect, such that the effect should start to occur after the period of
these delays. There is an inherent delay expected between exposure to community
mobilisation through women’s groups and an effect on mortality, as community
empowerment approaches can take considerable time to show effects (313). Various
additional delays in complete implementation of the intervention (see section 6.4.2),
mean the full benefits may not yet have been seen, and we would expect these to
emerge after continued exposure. The continuing downward trend from years 2 to 3,
with no sign of levelling out, suggests that the intervention has not yet achieved its full
potential.
On an individual level, it would be important to explore the timing of exposure to
women’s groups in relation to pregnancy and study outcomes. Complete data are not
available to explore this further, though available data were collected at one-month
postpartum, so for those that attended groups, it is known that attendance occurred
before neonatal outcomes were measured. Many women stopped attending groups
during the later stages of pregnancy and early postpartum period for practical reasons,
but it is probable that attendance continued after the time of the one-month interview.
Data on later group attendance has not been collected through the surveillance system,
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but measurement at the time of the six-month postpartum interview would have given a
better idea of complete exposure. Attendance figures for women beyond one-month
postpartum may show higher coverage than when only considering this period.
6.6.3 Biological gradient
There does appear to be evidence of a ‘dose-response’ relationship, or biological
gradient, such that greater exposure to women’s groups (more meetings attended)
results in lower mortality and higher rates of health-care seeking (Table 5.16). This was
discussed in sections 5.4.2 and 6.1.4. It would also be interesting to explore this
relationship at a cluster level, using women’s group coverage as a measure of dose
6.6.4 Plausible mechanism
Data on changes in cause-specific mortality were not yet available for this study. Data
from other studies of women’s group interventions did not show evidence of changes in
the proportion of neonatal deaths due to different causes (22, 25). As such, it is not clear
what the biological mechanisms underlying reductions in mortality may be.
The effects in Nepal and India were achieved without large improvements in
institutional deliveries (7% and 14% of births respectively in intervention
communities). The most significant effects on process outcomes were related to
hygienic home delivery practices. In India the proportion of institutional deliveries was
slightly lower than control areas. It seems plausible that much of the impact on neonatal
mortality observed in Nepal and India was due to more hygienic home delivery and
neonatal care, although cause-specific early neonatal mortality data in India did not
show differences in the proportion of septicaemia deaths between intervention and
control areas. However, the Gadchiroli study in India provides compelling evidence for
the benefits of community management of neonatal sepsis in reducing neonatal
mortality, suggesting that infection prevention could have similar large effects (195).
Since the intervention in Malawi emphasised institutional delivery, hygienic home
delivery practices were not discussed in detail in groups, and unlike the Asian settings,
clean home delivery kits were not used and have not been developed anywhere in
Malawi. Given the Malawi government ban on TBA attended deliveries, it is unlikely
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that clean home delivery kits will be introduced in future. Deliveries in which attendants
washed their hands or wore gloves were high – around 90% in both intervention and
control areas – and rates were similar at baseline. Data on hygienic cord care have not
yet been coded, and may provide evidence of more hygienic practices in intervention
areas. Early and exclusive breastfeeding, and better identification and care-seeking for
problems might be other possible mechanisms, but require further investigation.
6.6.5 Experimental evidence
This is an experimental study design. Three of the women’s group studies reviewed
used cluster randomised controlled trial designs, the gold standard for providing
evidence of causal associations, and two of these showed strong effects of women’s
groups on reducing neonatal mortality.
6.6.6 Analogy
It is difficult to know how to explore the effect of interventions similar to women’s
groups on maternal and infant outcomes, as data on similar interventions is limited.
Interventions that build individual confidence and capacity to make choices have been
widely applied in the field of HIV research, and some have shown beneficial effects on
attitudes and behaviour, though effects on biological outcomes have been more difficult
to prove (239-241). It has been argued that in addition to building the confidence and
voice of disadvantaged individuals and groups, the promotion of receptive social
environments for change may be important (207). The effects of some of the individual
elements promoted by the intervention have been investigated and proven, such as
insecticide-treated bednets, PMTCT, skilled birth attendance, breastfeeding and
immunisations (Table 3.1). Evidence for the benefits of other elements, such as
antenatal care, is less clear. In general, increasing coverage of known effective
interventions would be expected to have an overall benefit.
As mentioned earlier, in section 6.4.2, apart from promotion of health service
utilisation, the effectiveness of some of the strategies chosen by groups to reduce
maternal and infant mortality is not known. Evidence suggests that improving social
capital and reducing inequality improves health (136, 229, 313), but no study has been
conducted that shows the effects of increasing social capital on mortality outcomes.
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Chapter 7 : Conclusion
As described in Chapter 2, maternal and neonatal mortality rates are high in Malawi (1,
63). Some progress has been made in recent years in improving the survival of mothers
and children, but greater efforts will need to be made to reach the Millennium
Development Goal target of reducing maternal mortality by three quarters and under-
five mortality by two thirds between 1990 and 2015. A greater proportion of children
die in rural than urban areas in Malawi (Table 2.7 and Table 2.8), and a large proportion
of deaths in children under five years old occur in the neonatal period (20%). Women’s
groups in rural areas, that mobilised communities to tackle maternal and neonatal health
problems, were chosen as a means to tackle maternal and child health issues at the point
of greatest potential impact.
Section 7.1 will summarise the results and discussion covered in the previous chapters,
Section 7.2 will make recommendations for further research based on these findings,
and Section 7.3 will discuss the implications of the findings for policy-makers.
7.1 Summary and interpretation of the main findings
The women’s group intervention did not show significant impacts on any primary
mortality outcomes, but was consistent in showing decreasing trends and non-
significant effects, which were larger in years 2 and 3. If rates continue to decline we
may see bigger, and possibly statistically significant, effects with follow-up into years 4
and 5. Significant increases in antenatal care uptake and polio immunisation were seen,
and a significant reduction in the proportion of TBA attended deliveries was also seen.
Non-significant improvements were seen in several elements of antenatal care, skilled
assistance at delivery, postnatal care and exclusive breastfeeding.
There appears to have been some interaction between the two interventions, with
attenuated effects in areas with both women’s groups and peer counselling. However, it
is not clear whether this is a true interaction, or a spurious effect caused by imbalance of
confounding factors after randomisation. Some evidence of a dose-response relationship
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adds weight to the idea that there may be a causal relationship between intervention and
most primary and secondary outcomes, even though it is not yet strong enough to reach
statistical significance.
Returning to the main question of the thesis, as to whether women’s groups were
responsible for reductions in perinatal, neonatal, infant and maternal mortality through
changes in care practices and health-seeking behaviour, it is difficult to draw firm
conclusions. Comparisons between study arms do not suggest reductions in mortality as
a result of the intervention, but comparisons over time show much greater reduction in
women’s group areas. The intervention and study design were complex, and careful
consideration of process and contextual factors is important when interpreting the
results (255, 306). The lack of an overall significant effect may have been a true
finding, demonstrating the ineffectiveness of the women’s group intervention in this
setting. But the lack of impact seen may also have been due to implementation factors
that limited the intervention in this study, or due to methodological factors that reduced
the ability to detect significant effects. These have been summarised in Table 7.1 and
Table 7.2.
There were some limitations to the design and implementation of the intervention
(Table 7.1). An intervention that is sustainable and feasible to deliver through existing
community-development and health infrastructure was always likely to be delivered
imperfectly and with variable quality (57, 255). The intervention was constrained by its
staffing and supervision structure, coverage and reach, and availability of resources,
which were kept low in order to try and make the intervention cost-effective and
feasible to scale up. Coverage was similar to other successful women’s group studies
(22, 25), but uptake among young women was low and not all women attended all
meetings, which may have limited the benefits. The intervention focused more on
community empowerment than transfer of health knowledge, and this may have delayed
some knowledge, attitude and behaviour changes compared to women’s group studies
in other settings (22, 25, 313). The success of an intervention that promotes uptake of
health services may also have been limited by the quality of the services available.
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Table 7.1: Factors that limited the effectiveness and impact of the intervention in this study
Factor Type of effect Likely magnitude and direction of effect
Design factors limiting effectiveness
Limited by costs of staff and equipment Achieved similar levels of coverage as other successful interventions
 Probably not a major limiting factor
Significant dose-response effect on many primary and
secondary outcomes
Not all eligible women attended all groups
 May have reduced the potential to achieve greater impact
Coverage
Lower uptake amongst younger women Low coverage amongst younger women, who are at higher risk of poor outcomes
 May have reduced the potential to achieve greater impact
Lack of health information content in the intervention Women identified the need to know more about health issues, and organised health education
sessions themselves. Community radio programme came after the study period.
 May have resulted in less immediate behaviour change than in other studies
Increasing demand without improving quality of health
services
Women seek more health care but not have better outcomes
 Ineffective mechanism through which to reduce mortality
Focus on neonate Post-neonatal contributions to infant mortality are higher in sub-Saharan Africa than Asian settings
 Focusing discussions mainly on newborn care would have smaller impact on infant outcomes
Design
Community empowerment takes time Empowerment and social change processes take time to work
 Study time-frame may have been too short
Implementation factors limiting the impact seen in this study
Delayed
implementation
Unexpected programmatic delays and problems with
specific meetings
Strategies implemented late in follow-up period meaning intervention has not yet reached its
maximum capacity to impact health outcomes
 May have reduced the size of effect seen in this study
Problems in trading centres and tobacco estates Women’s groups were difficult to run in these areas, were fewer, had fewer members and met less
frequently
 May have limited the effectiveness of the intervention in these areas
Incomplete
implementation
Difficulty implementing some chosen strategies due to
external factors such as government policy
Strategies such as TBA training, bednet distribution and bicycle ambulances were difficult to
implement
 May have limited the effectiveness of the intervention for groups who chose these strategies
Diversity of effects not captured in single mortality and
process outcomes
Many strategies chosen within and between groups having heterogeneous effects
 Effects may be spread out between many pre-specified mortality and process outcomes
Address broader underlying factors such as poverty,
nutrition and illiteracy
Broader societal changes will take longer to achieve
 May have limited the impact seen over this time scale
Choice of strategies was not evidence-based Strategies chosen and implemented may not have been the most effective ways to reduce mortality
 Limited impact of the intervention
Choice of strategies
Strategies may not have targeted areas of maternal and
child health with highest population attributable risk
Groups did not address issues such as HIV that contribute to maternal and child mortality
 Limited impact of the intervention
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Table 7.2: Factors affecting ability to see significant effects
Factor Type of effect Likely magnitude and direction of effect on results
Study design and methods
Interaction between
women’s group and peer
counselling interventions
No interaction for IMR, possible non-significant
interaction for PMR, NMR, MMR
Large effect in areas with women’s groups only masked by little effect in areas with both
interventions
 Effect dilution in main analysis by 10-36%
Household selection
Identification of pregnancies
Magnitude unknown, though likely small, and similar selection processes in intervention and
control areas so unlikely to cause bias
 May affect generalisability if different from those included
Losses to follow-up for 1-month outcomes (due to
permanent and temporary migration, lack of identifying
documents)
Losses to follow-up similar in both arms (5% in intervention and 4% in control) so unlikely to
cause bias
 May affect generalisability if different from those followed up
Selection bias
Losses to follow-up at 6-month and retrospective census
interviews (due to recall errors and missing data,
permanent and temporary migration, lack of identifying
documents)
Losses to follow-up similar in both arms so unlikely to cause bias (both 35% at 6-months, and 39%
and 36% for intervention and control areas respectively for retrospective)
 May affect generalisability if different from those followed up
Inclusion of in-migrants to study cohort and not
following out-migrants
Dilution of exposure (particularly in trading centres and tobacco estates, and for infant mortality
estimates)
 Effect dilution
Contamination Little exposure of women in control areas to the intervention
 Negligible effect on results
Measurement bias
(exposure)
Variable intensity of exposure (over time and between
areas)
 Imprecision in estimating exposure levels
 Effect dilution
Measurement bias (other
risk factors)
Misclassification of risk level Unlikely to have differed between study arms
 Imprecise estimates of risks factors reduce their power to adjust for confounding (especially
baseline disadvantage)
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Factor Type of effect Likely magnitude and direction of effect on results
Non-differential misclassification of outcome category
(due to missing dates and details, misunderstanding of
definitions and loss to follow-up)
Similar misclassification in both study arms (1% perinatal/neonatal, 14% maternal)
 Imprecision
 May result in random error making results less precise and wider confidence intervals
Differential misclassification of outcome category
(greater misclassification of NNDs as SBs in control
areas, greater loss to follow-up of deaths in control areas)
Unknown magnitude, warrants further investigation
Measurement bias
(outcomes)
Differential misclassification of outcome category (best
behaviour bias and/or interviewer preference in
intervention areas)
Doesn’t seem to have produced any large or significant effects
Low statistical power Imprecision in estimating effect 70-86% chance of failing to indentify an effect if one exists
Due to imbalance in levels of disadvantage after
randomisation
Mortality rates much higher (6-62%) and health-care seeking lower (14-20%) in intervention areas
at baseline
Large reductions in mortality rates seen in intervention areas, but baseline mortality rates not
strongly correlated with outcomes in regression
 Imperfect adjustment of baseline imbalance
 Effect dilution
Confounding
Due to other demographic and socioeconomic factors These were balanced between groups and unlikely to have confounded the results
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Delays and problems in implementation of the intervention arose due to delays in
funding, seasonal conditions, confusion about how to involve men, and high mobility
and lack of group cohesion in trading centres and tobacco estates. The largest delay was
seen in mid-2006 (about eight months), and may have prevented the intervention from
achieving its maximum impact during the time-frame of the study. In addition,
community empowerment and social change processes take time show to effects, and
the length of follow-up may have been insufficient to see effects (313).
There were some limitations in study design and methodology that may have affected
the results (Table 7.2). The factorial design led to an apparent interaction between
women’s group and peer counselling interventions that was difficult to disentangle, and
may have masked the impact seen in areas with women’s groups only. There was low
loss-to-follow-up for most primary and secondary outcomes, but higher loss-to-follow-
up for six-month and retrospective infant mortality data. This was largely due to
seasonal migration, out-migration and missing date or birth and death data. Losses to
follow-up of pregnancies and births were balanced between study arms, and may have
affected generalisability, but are unlikely to have biased the results. There may have
been some dilution of effect by including new in-migrants with little exposure to the
intervention as ‘intention-to-treat’ in the study cohort, and not following out-migrants
who were exposed to the intervention. Misclassification of other explanatory factors,
such as baseline levels of mortality, may have reduced the strength of these variables to
adjust for the large baseline imbalances. Misclassification of outcomes due to
interaction between the surveillance system and the intervention may have biased
mortality rates upwards in intervention areas, resulting in a further reason for
attenuation of the observed impact on mortality outcomes.
Neither chance, bias nor confounding can be completely ruled out as possible
alternative explanations for the findings. The study had much lower statistical power
than expected to detect large reductions in mortality, and this combined with
imprecision due to random error in measuring outcomes, may have resulted in an effect
of smaller magnitude that did not reach statistical significance. There was also
inadequate statistical power to explore the interaction between women’s group and peer
counselling interventions, and there is need for further investigation into why there
seems to be a lack of effect on perinatal, neonatal and maternal mortality in areas with
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both interventions. Selection biases and losses to follow-up did not differ between study
arms, but the main bias that could potentially have affected the magnitude of the results
seen was differential misclassification of mortality outcomes (measurement bias). The
size of this problem is unknown, but further investigation would show whether it has
made a substantial difference to the results.
Some uncontrolled confounding is likely, due to the large imbalance between study
arms at baseline, which may not have been adequately adjusted for in the analysis by
using baseline values. Further confounding may have resulted from imbalances between
study arms in other unknown and unmeasured factors, such as HIV or other health
programmes active in the area.
Although the effect of the intervention on primary outcomes was not significant, some
of the Bradford Hill criteria still support the idea of a causal association. Other studies
of women’s groups have shown positive impacts (22, 24, 25), and this intervention
shows a smaller effect in the same direction. By nature of the experimental design, it
was possible to see that cause preceded effect, and there is a pattern of continuing
reduction in mortality over time in intervention areas. There also seems to be a
biological gradient, with effects increasing with higher exposure to women’s group
meetings. Evidence for the biological mechanism is unclear, but process evaluation data
from this and other studies provides a plausible explanation of the social mechanism for
the effects observed.
Non-significant trends in mortality reduction and increased health-care seeking suggest
there may be some emerging benefits of the women’s group intervention that have been
obscured by implementation-related and methodological factors. However, it is also
possible that women’s groups did not have as large a benefit in this setting as in other
settings due to ‘impact-related’ factors. In a multi-country review of the Integrated
Management of Childhood Illness strategy (214), implementation-related and impact-
related factors were identified that confounded the relationship between delivery of the
intervention and its impact, and explained variability of impact between settings (57).
Implementation-related factors included characteristics of delivery systems such as
skills of implementers and availability of materials, and these approximate to factors in
this study outlined in Table 7.1. Impact-related factors included baseline levels and
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patterns of child mortality. Therefore, differences seen between the studies in Bolivia,
Nepal, India and Malawi may also reflect differences in the underlying epidemiology
and health system factors (22, 24, 25).
7.2 Recommendations for further research
7.2.1 Further analysis of existing data
The dataset collected during this study is large and complex, and the analysis presented
here was restricted to the main impact of the women’s group intervention. However,
there are other ways that the data could have been analysed that will be explored further
over time. Many of the areas of further research relate to investigating the limitations
outlined in Table 7.1 and Table 7.2 more thoroughly, and understanding their
contribution to the lack of significant effect seen on mortality rates and most secondary
outcomes.
Exploratory analysis
One exploratory analysis that merits further attention is to investigate the relationship
between uptake of the intervention and various demographic and socioeconomic
characteristics. This would highlight possible barriers to attendance and suggest ways in
which it could be better targeted to the most high risk women, like to the poorest
women and young women experiencing their first pregnancy (320).
Another useful exploratory analysis would be to use the data to predict the probability
of maternal, neonatal or infant death for ‘ideal’ or ‘typical’ individuals in this
population – for example a woman who goes for antenatal care, gets adequate iron
folate, tetanus toxoid immunisation and antimalarial treatment, sleeps under a bednet
during pregnancy, delivers with a skilled birth attendant and goes for a postnatal check-
up. The probability of death in different scenarios could be used to build predictive
models to test the potential effects of different approaches to improving maternal and
infant survival (176, 220). We could also identify the most potent points of intervention
for future studies, and this information could be combined with research evidence to
make ‘intentional packages’ of interventions (215).
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Impact analysis
Due to the concerns raised earlier (section 6.3.2) about dilution of effects due to
inclusion of new in-migrants, an important addition to the impact analysis presented
here would be to re-analyse data excluding women who had moved into the area after
randomisation. A more pure ‘intention-to-treat’ analysis may be achieved by not
including women who were not allocated to the intervention at the start of the
intervention in the study cohort. Kirkwood et al 2010 compare effects of vitamin A
supplements on maternal mortality using several different intention-to-treat definitions,
and a similar strategy could be followed here (157). We might also analyse data for all
deaths reported, rather than only those with verbal autopsy, to reduce the possibility of
differential loss to follow-up rates between study arms as discussed in section 6.3.2.
Future analysis should also include complete infant mortality data for year 3 to allow
better assessment of the effects of women’s groups on this outcome. Longer follow-up
of all outcomes into years 4 and 5, would allow evaluation of longer term effects,
especially in light of the delays in implementation described earlier (section 6.4.2).
Though not an a priori primary outcome, further exploration of the retrospective re-
census survey data would permit the analysis of impact of women’s groups on under-
five mortality. Given the lack of distinction made by women’s group participants
between the arbitrary childhood categories of ‘neonatal’, ‘infant’ and ‘under-five’, and
the subsequent diversity of strategies implemented, (many addressing broader health
issues as well as underlying factors contributing to poor health), we might expect to see
reductions in mortality amongst older children (321). Increased use of bednets,
improvements in hygiene and sanitation, better immunisation coverage, and reduced
poverty and illiteracy should all contribute to reductions in under-five mortality, and the
benefits of the intervention may have been distributed across a larger age-group than
focused in young infants alone. With a larger under-five mortality rate, this analysis
would also have greater statistical power than for neonatal and infant mortality
outcomes. Retrospective re-census data would allow analysis of the impact of women’s
groups at different stages of childhood. Infancy has already been broken down into
early neonatal, neonatal and infant, but post-neonatal and child mortality could also be
presented in order to look at the contribution of each to the overall effect. Furthermore,
classification of all neonatal, infant and maternal verbal autopsies to assign cause of
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death and estimate cause-specific mortality rates, would allow better understanding of
the mechanism through which the intervention works. Distinction between impact of
women’s groups on direct and indirect maternal deaths would provide a more complete
picture of intervention effectiveness. Avoidable factors could also be explored to give a
practical understanding of where things are still going wrong, and where the best points
of intervention would be in future.
Full exploration of intervention effects on maternal and infant morbidity would also
contribute to better understanding of the mechanism of action. Coding of maternal
morbidity data according to what the antenatal, delivery and postnatal problems were
would be important. Conversely, infant morbidity data is already coded according to
any reported episodes of cough, fever or diarrhoea, but could be combined into a single
infant morbidity variable to look at the impact on overall morbidity.
To better understand reasons for variation between and within clusters, and explore
variation in impact between clusters, a multilevel modelling approach should be used.
More detailed exploration of the influence of contextual factors will be an important
part of this. A village-level survey will be conducted in the next few months, and data
from this will provide general contextual information to explore reasons for variability
in mortality and other outcomes between areas, and will also provide information on
limiting and facilitatory factors to intervention success in certain communities, such as
local access to health services, local access to resources, other NGOs working in the
area, community attitudes and leadership, and social capital. Exploration of effects by
village and not only by cluster may be important, as not every village in a cluster had its
own group, and it may be that villages without groups benefitted less as women had to
attend groups in neighbouring villages and may have had less influence over decision-
making processes in their own village than women whose village hosted the group and
could draw in locally influential people to discussions. Exploration of whether the
inclusion of group village headmen and traditional authority’s own villages within a
cluster influenced the ease with which groups were able to bring about change will also
be interesting, and this will be possible using data from the village-level survey.
Multilevel modelling can be conducted to explore the causes of variation between and
within clusters in terms of outcomes, as well as intervention impact, in order to
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understand where and how effects may be occurring. Considering the influence of
contextual factors is important in understanding why the intervention may have worked
better or worse in some areas. Factors related to data quality may also be partly
responsible for variability between clusters. Specific questions that could be explored
with multilevel modelling include:
– Do the relationships between intervention, group attendance and exposure level
vary across zones?
– Is the effect on mortality greater in zones where a larger proportion of women
attend groups?
– Is the effect on mortality greater for women in the lowest socioeconomic group?
– Is the effect on mortality less in estates and trading centres than in rural villages?
– Is the effect on mortality less in zones that are furthest from a health facility?
– Is the effect on mortality greater in zones with higher baseline mortality?
– Is the effect on mortality greater in zones that implemented bednet distribution
as a strategy?
– Is the effect on mortality more or less for second pregnancies in the study
period?
– Is the effect more or less for infants born during the rainy season?
– Is zone X different from other zones in the sample in its effect?
– Is village X different from other villages in the zone in its effect?
– How has the intervention affected variability in mortality?
– Are intervention or control zones more or less variable in their mortality rates?
– Does the effect of women’s groups reduce the variability in mortality rates as
compared to baseline?
Some of these multilevel analyses may help to uncover reasons why effects on
maternal, perinatal and neonatal mortality seem to be less in areas with both
interventions. This, alongside data from the process evaluation, will help us better
understand whether and how the two interventions might be interacting. However,
multilevel analysis may have limited power and will be used for hypothesis generation
rather than definitive tests of effect.
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Analysis to explore data quality
Some sources of imprecision or inaccuracy in the data may have contributed towards
attenuation of the observed intervention impact. Further analysis exploring issues
related to data quality would help to better understand how this might have influenced
the results. Exploring variability of outcomes and intervention effects by field-worker
(enumerator, interviewer or supervisor) would be one way to do this. Another would be
to link births and deaths from prospective and retrospective datasets and estimate
recapture rates according to who collected the data. Performance of the zonal
interviewers collecting prospective data could be compared with the two additional
short-term interviewers per zone during the re-census. Exploration of birth rates by
village, to see whether more remote villages have fewer reported births per capita,
would be one way to investigate the potential for incomplete pregnancy reporting by
enumerators.
More emphasis will also be placed on following up infant outcomes prospectively. This
process is ongoing, and this data might provide more robust estimates of infant
mortality, with lower attrition (303). With the current dataset, detailed exploration of
the characteristics of women lost to follow-up at six-months or during the retrospective
survey would show whether or not there was any selection bias introduced in this way.
And analysis of the re-interview data collected from a sample of women at one-month
and six-months would allow estimates of test-retest and inter-rater reliability on
interview questions for secondary outcomes.
Different analysis approaches could also be compared to see how they affect the results,
as different methods may give divergent results (285). Random effects logistic
regression was used in this analysis, but generalised estimating equations could have
been used, providing population-average estimates (253). Since most of the mortality
distributions are slightly skewed, transformation could also be done, or non-parametric
methods used on cluster-level data. Analysis of cluster-level data would also enable
calculation of difference scores (between baseline and study) for each cluster, and
though less efficient and flexible for exploring effects of covariates, these might better
account for the imbalances seen at baseline between study arms (253).
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7.2.2 Further data collection and processing from this study population
Alongside the main impact evaluation described in this thesis, a process evaluation and
economic evaluation were carried out. Data from these has either not yet been
completely collected or fully analysed, but will form an important basis for
understanding the strengths and weaknesses of the intervention and understanding the
‘how’ and ‘why’ of intervention success and failure. Many factors that may have
affected the findings have already been discussed, but systematic analysis of process
evaluation data, including large qualitative datasets, is required to fully understand what
worked, what did not work and why, and how contextual factors may have influenced
the results.
The economic evaluation will assess the potential replicability and scalability of the
intervention, and the potential for it to be adopted as a larger scale public health
intervention in Malawi. The cost per maternal, infant, neonatal and perinatal death
averted can be estimated, with appropriate sensitivity analyses to explore the
implications of uncertainty of any assumptions. The cost of scaling up the interventions
at national level can be estimated in order to explore cost-saving opportunities and to
investigate issues of generalisability beyond the trial context and beyond domestic
boundaries.
In addition, to the integral process and economic evaluations, a parallel study,
conducted in collaboration with researchers from the Institute of Fiscal Studies in
London, will explore the non-health benefits of the intervention to households, and how
these further benefit older children and other family members.
During the re-census, sibling survival data was collected for all women of childbearing
age in order to estimate maternal mortality ratios using the sisterhood method used in
DHS surveys. This will enable comparison of estimates using different methodologies
within the same population over the same time period, and provide a basis for making
comparisons with sisterhood data collected in the DHS. Data on late maternal deaths
and other women of childbearing age can be used to estimate background adult female
mortality in this population, and understand how maternal mortality fits into the
demographic patterns. Because women’s groups may be more effective at reducing
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direct maternal deaths, analysis excluding deaths due to indirect causes could reveal
more effect (31, 78).
The peer counselling intervention promotes family planning, but there is anecdotal
evidence to suggest that the women’s group intervention, and even the surveillance
system itself may have affected fertility rates. Women attending groups, and women
visited monthly by an enumerator reported being more aware of the importance of child
spacing for their own and their other children’s health. Data on birth histories has been
collected for all women who were interviewed postpartum during this study. It would be
interesting to generate a variable for time since last birth in each case, and compare this
between intervention and control areas, and over time. Process evaluation data may also
allow exploration of how and why effects on fertility may have occurred, as well as
giving better understanding of interactions between women’s group and peer
counselling interventions, and between interventions and surveillance.
Further use of collected but as yet unprocessed data could be made by coding of open-
ended questions for inclusion in quantitative analysis. These include questions related to
umbilical cord care, which may reveal important newborn care behaviour changes.
Other questions are about barriers to desired behaviours. When a respondent answered
“No” to a question such as “Did you attend antenatal care during this pregnancy?”, this
question is followed up by asking “Why not?”. Analysis of this data would provide a
picture of the relative importance of factors that prevent health-care seeking or
intervention uptake, such as lack of money, lack of transport, needing permission and
attitudes and beliefs. Comparison of perceived barriers could also be compared between
women’s group and control areas.
Household asset data collected in the 2008 re-census can be processed and analysed to
see whether it provides a less truncated distribution of socioeconomic scores. Full
analysis and comparison of data from health facility audits in 2004 and 2007 can also be
done. This would enable better evaluation of the extent, reach and quality of health
service strengthening activities that might have impacted on mortality, or limited
intervention effectiveness.
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Finally, in a new phase of the intervention, women’s groups have begun a second cycle
of community mobilisation, and new groups have been started in the same intervention
areas in villages that previously did not have their own group. Exploration of future
impact with this new, higher level of coverage, but facilitated by community volunteers,
will perhaps address some of the limitations described in section 6.4, and be both more
effective and more sustainable.
7.2.3 Further studies
An important study, after complete analysis and publication of the results from this
study, will be to conduct a meta-analysis of data from all the women’s group studies
that have been conducted to date. Perhaps more powerful as an exploratory approach,
would be multilevel modelling, including data on important contextual factors in each
location. This would enable investigation into the possible reasons for the differences in
impact seen in different settings.
7.3 Implications for policy-makers
Data from the process evaluation, non-health benefits evaluation and cost-effectiveness
evaluation will provide important information for policy-makers about how useful and
feasible it would be for the government or other partners to scale up the intervention. At
this stage, without a large, significant impact, the cost of the intervention is less
important than proving its effectiveness. If the intervention does prove to be effective
after running for a longer period of time, it will be important to separate the set-up costs
and running costs. With such a long lead-in phase before effects start to be evident, it
may seem that the intervention could not be cost-effective. However, if well-
established, women’s groups can become a self-sustaining community structure that
may eventually need little government input (313). In Mchinji, zonal committees, nodal
committees and a district committee have already been established, representing
women’s group members from across the district. These structures provide a means of
organising on a larger scale, which can have even more powerful effects and potential
for collective action than disconnected groups in villages, as they are a form of
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‘bridging’ social capital – that is they create social networks between heterogeneous
groups that can be mutually beneficial (322-324). Microfinance projects have shown
benefits for social capital and health in other settings (325), and the district women’s
group committee in this study has opened a bank account from which they can pay out
loans to community groups, and into which they can receive donations and loan re-
payments. This account was opened after the trial period for the analysis in this study,
but has so far been used to give out small loans totalling MK1.2 million (£5000). The
district committee also provides a stronger voice for advocacy to health providers in the
district, as well as a forum for writing proposals to local organisations to apply for funds
for activities such as building clinics.
Lessons learned from the implementation of this women’s group intervention have
already been used in developing women’s group programmes in two other settings in
Malawi, which started before this trial had been completed. They both use a lower cost
system, that might be more sustainable by government and other partners, and feasible
as a model for scale-up. One, in a population of 98,000 in Ntcheu District, uses
government Health Surveillance Assistants to facilitate groups. They are paid an
additional allowance by the programme for the meetings they hold, rather than a
monthly salary, and the intervention is more closely integrated into the district health
infrastructure. The other, in a population of 312,000 in Lilongwe, Salima and Kasungu
districts, uses local volunteers to facilitate groups. They are also unpaid, but receive
allowances for meetings held. The Lilongwe, Salima, Kasungu programme is using a
version of the women’s group manual and cycle that has been shortened to try and
reduce the implementation period.
In anticipation of positive findings, and in light of the broader non-health and social
benefits, plans are being developed for scale-up of MaiMwana women’s groups. The
first element of scale-up has been to introduce groups in villages in existing intervention
areas that did not previously have their own group. The original groups have started a
second cycle of the women’s group process, and to keep the costs low, this is facilitated
by trained volunteers. With benefit of experience, this second cycle has been shortened,
and explicit discussion of under-five and infant health problems has been included.
Should this model prove attractive to donors, the next phase would be to introduce
groups to control areas, and then into non-study, buffer areas in Mchinji.
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Even though specific effects of women’s groups on maternal and neonatal mortality
rates have been difficult to show, findings from the evaluation of the non-health benefits
of the intervention may show beneficial effects. In considering the ultimate usefulness
of this intervention as a pubic health strategy, the whole range of benefits will need to
be taken into account.
Geographic and cultural diversity between regions, different epidemiology, different
health system capacities and different usage patterns should be taken into consideration
in adapting interventions to different settings (215), and may partly explain the differing
results between studies (22, 25, 252). The women’s group intervention could be better
tailored to the Malawian context by more consciously including elements that address
HIV and malaria, as well as the fact that uptake of health services is higher than in
many Asian settings and can be built upon.
7.4 Concluding remarks
In conclusion, it is disappointing that a significant impact of a women’s group
intervention on perinatal, neonatal, infant and maternal mortality has not been observed
in this study by the time this dataset was analysed. However, there were promising signs
of sustained mortality reduction and increased health-care seeking over the course of the
intervention. The results of longer-term follow up studies will be important, as well as
studies of the non-health benefits of the intervention, such as household livelihood and
community empowerment. Fuller contextual information will also be required in
making a final assessment of the impact and broader benefit of women’s groups as a
strategy for consideration by policy-makers in Malawi to achieve Millennium
Development Goals for maternal and child health.
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Appendices
Appendix 1 – Glossary of terms and definitions of outcomes
1.1 Primary outcomes
Live birth
The complete expulsion or extraction from its mother of a product of conception,
irrespective of the duration of the pregnancy, which after such separation, breathes or
shows any other evidence of life, such as beating of the heart, pulsation of the umbilical
cord, or definite movement of voluntary muscles, whether or not the umbilical cord has
been cut or the placenta is attached; each product of such a birth is considered a live-
born. (ICD-10) (28)
Stillbirth
The death prior to the complete expulsion or extraction from its mother of a product of
conception, after 28 completed weeks of pregnancy; the death is indicated by the fact
that after such separation the foetus does not breathe or show any other evidence of life,
such as beating of the heart, pulsation of the umbilical cord or definite movement of
voluntary muscles. (ICD-10) (28)
Macerated stillbirth
A stillborn baby who may have died some time before labour started and whose body
and skin appeared pulpy/puffy/mushy/swollen.
Fresh stillbirth
A stillborn baby who died immediately before or during delivery and whose body and
skin did not appear pulpy/puffy/mushy/swollen.
Early neonatal death
A neonatal death occurring during the first seven completed days of life (0-6 days).
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Perinatal death
A stillbirth or early neonatal death.
Late neonatal death
A neonatal death occurring after the seventh day but before the completion of the 28th
day of life (7-28 days).
Post-neonatal death
A death arising after the 28th day but before completion of the first year of life.
Infant death
A death arising within the first year of life.
Maternal death
The death of a woman while pregnant or within 42 days of termination of pregnancy,
irrespective of the duration and site of the pregnancy, from any cause related to or
aggravated by the pregnancy or its management but not from accidental or incidental
causes. (ICD-10) (28)
Late maternal death
The death of a woman from direct or indirect obstetric causes more than 42 days but
less than one year after termination of pregnancy. (ICD-10) (28)
Pregnancy-related death
The death of a woman while pregnant or within 42 days of termination of pregnancy,
irrespective of the cause of death. (ICD-10) (28)
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1.2 Secondary outcomes
Outcome Definition
1. Any antenatal care at a health
facility
Answered ‘yes’ to the question “Did you go for an antenatal
check-up during this pregnancy?”, and gave the name of a health
facility or outreach clinic to the question “Where did you go?”
2. Four or more antenatal care
visits
Answered ‘yes’ to the question in 1, and a number greater than 3
to the question “How many times did you go altogether during
this pregnancy”
3. Any iron and folic acid Answered ‘yes’ to the question “During this pregnancy were you
given, or did you buy any iron tablets or iron syrup?”
4. More than 90 days iron/folate Answered ‘yes’ to the question in 3, and a number of days greater
than 90 to the question “During the whole pregnancy, for how
many days did you drink the tablets or syrup?”
5. Any tetanus toxiod
immunisation
Answered ‘yes’ to the question “Did you have a Tetanus Toxoid
Vaccine (TTV) injection in the arm during this pregnancy?”
6. Adequate tetanus toxoid Either answered ‘yes’ to the question in 5 and ‘2’ or ‘3’ to the
question “During this pregnancy, how many times did you get
this injection?”, or answered ‘yes’ to the question “Have you
received all the five injections?”
7. Any sulphadine-
pyrimethamine (SP)
Answered ‘SP/Fansidar/Novidar’ to the question “During this
pregnancy did you take any drugs in order to prevent you from
getting malaria?”
8. Two or more doses of SP Answered ‘2’ or ‘3’ to the question “During this pregnancy did
you take any drugs in order to prevent you from getting malaria?”
(in which they were also asked to specify how many times each
type of medicine was taken)
9. Bednet use night before
interview
Answered ‘self’ to the question “Did anyone sleep under a
mosquito net last night? If yes, who?”
10. Bednet used night before and
dipped
Answered ‘self’ to the question in 9, ‘yes’ to the question “Since
you got the mosquito net, was it ever soaked or dipped in
chemicals to repel mosquitoes or insects?”, and a number between
1 and 6 to the question “When was the last time the net was
soaked or dipped in these chemicals?”
11. Bednet used every night in
pregnancy
Answered ‘every night’ to the question “During this pregnancy,
how often did you sleep under the mosquito net?”
12. Any HIV-testing at antenatal
care
Answered ‘yes’ to the question “I do not want to know the result,
but have you ever been for VCT?”, and ‘yes’ to the question “Did
you collect your results?”
13. Any reported antenatal
problem
Answered ‘yes’ to the question “Were you sick or did you have
any serious problems during the recent pregnancy?”
14. Any reported delivery
problem
Answered ‘yes’ to the question “Were you sick or did you have
any serious problems during this delivery?”
15. Any reported postnatal
problem
Answered ‘yes’ to the question “Were you sick or did you have
any serious problems after this delivery, including problems
related to breastfeeding?”
16. Institutional deliveries Answered with the name of a health facility to the question
“Where was (NAME) born?”
17. Birth attended by skilled
provider
Answered ‘doctor/nurse/clinical officer/midwife’ to the question
“Who helped with the delivery?”
18. Birth attended by a TBA Answered ‘TBA’ to the question “Who helped with the
delivery?”
19. Attendant washed hands/wore
gloves
Answered ‘yes’ to the question “Did the person who helped wash
his/her hands with soap before the delivery?”, or ‘yes’ to the
question “Did the person who helped wear gloves during the
delivery?”
20. Baby wrapped within 30 min Answered with a time between 1 and 30 minutes to the question
“How long after birth was (NAME) wrapped up?”
21. Baby bathed after 24hrs Answered with a time greater than 24 hours to the question “How
long after birth was (NAME) bathed?”
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22. Postnatal care at a health
facility
Answered ‘yes’ to the question “After the baby was born, did a
health professional or a traditional birth attendant check on your
or your baby’s health?”, and gave the name of a health facility or
outreach clinic to the question “Where did this check first take
place?”
23. Infant received BCG (by one-
month)
Answered ‘yes’ to the question “Has (NAME) had a BCG
immunisation (injection on left arm)?”
24. Infant received polio
immunisation (by one-month)
Answered ‘yes’ to the question “Has (NAME) received a polio
immunisation?”
25. Any infant cough Answered ‘yes’ to the question “Has the bay had a cough?”
26. Any infant fever Answered ‘yes’ to the question “Has the baby had a high fever?”
27. Any infant diarrhoea Answered ‘yes’ to the question “Has the baby had diarrhoea more
than 3 times a day?”
28. Any BCG (by six months) Answered ‘yes’ to the question “Has (NAME) had a BCG
immunisation (injection on left arm)?”
29. Any polio dose (by six
months)
Answered ‘yes’ to the question “Has (NAME) ever received a
polio immunisation?”
30. 4 polio doses (by six months) Answered with the number ‘4’ to the question “How many times
did (NAME) receive polio immunisation after they were born?”
31. Any pentavalent dose (by six
months)
Answered ‘yes’ to the question “Has (NAME) ever received a
tetanus (5-in-1) immunisation in the leg?”
32. 3 pentavalent doses (by six
months)
Answered ‘3’ to the question “How many times did (NAME)
receive tetanus (5-in-1) immunisation after they were born?”
33. Infant exclusively breastfed to
6m
Defined as exclusively breastfed to 6-months if the first food
swallowed was breastmilk, no prelacteal feeds or water was
given, no other liquids or foods were given according to 24-hour
recall and 7-day recall for the first week, and age of introducing
porridge was 6-months or more.
34. Initiated breastfeeding within
1 hr
Answered with a time of 60 minutes or less to the question “How
long after birth did you first breastfeed the baby/put (NAME) to
the breast?”
35. Mean time to first breastfeed Cluster-level mean time to first breastfeed
36. Use of prelacteals Defined as not given prelacteal feeds if the first food swallowed
was breastmilk, and no other liquids or foods were given before
initiating breastfeeding.
37. Mean age of starting porridge Cluster-level mean time to starting to give porridge
38. Any breastfeeding problem Answered ‘yes’ to the question “Have you had any problems with
breastfeeding?”
39. Seeking help for breast
problem
Answered ‘yes’ to the question in 38, and ‘went without referral’
or ‘was referred’ to the question “Did you go, or were you refrred
to a health facility because of these problems?”
1.3 Mortality rates and ratios
Stillbirth rate
The number of stillbirths during a given time period per 1000 births during the same
period.
Perinatal mortality rate
The number of perinatal deaths during a given time period per 1000 births during the
same period.
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Neonatal mortality rate
The number of neonatal deaths during a given time period per 1000 live births during
the same period.
Infant mortality rate
The number of infant deaths during a given time period per 1000 live births during the
same period.
Maternal mortality ratio
The number of maternal deaths during a given time period per 100 000 live births
during the same time-period.
Maternal mortality rate
The number of maternal deaths in a given period per 100 000 women of reproductive
age during the same time-period. It is also sometimes given as the number of maternal
deaths per 1000 person-years of exposure (29).
Lifetime risk of maternal death
The probability of dying from a maternal cause during a woman’s reproductive lifespan.
Lifetime risk of maternal death = (1-(1-maternal mortality rate)35) (35).
Adult lifetime risk
The probability that a 15-year old female will die eventually from a maternal cause.
Adult lifetime risk of maternal mortality = (T15 – T50 / l 15) × maternal mortality rate
(Where l 15, T15 and T50 are quantities from a life table for the female population
during the period in question (l 15 equals the probability of survival from birth until age
15, and (T15 – T50)/l15 equals the average number of years lived between ages 15 and
50 – up to a maximum of 35 years – among survivors to age 15). (36)
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Appendix 2 – Time-line of activities and achievements to date
Activities from October 2003 – September 2004
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
BACKGROUND AND ORIENTATION
In-house training workshop
Community entry and consent
Mchinji orientation and TA visits
Zone definition
Participatory census
Participatory census data entry
Mapping and enumeration piloting
Chapter 8
PHASE I – baseline survey
Formative qualitative research
FI recruitment and training
Mapping and enumeration – first 24 zones
Mapping and enumeration – second 24 zones
Randomisation
Refinement of baseline database
PHASE II – prospective surveillance
1-month questionnaire design
295
Activities from October 2004 – September 2005
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
PHASE I – baseline survey
Formative qualitative research
Data entry of basic baseline data
Refinement of baseline database
Data entry of remaining baseline data
Data cleaning
Preliminary analysis of baseline data
PHASE II – prospective surveillance
1-month questionnaire design
1-month questionnaire piloting
FI recruitment and training
WE recruitment and orientation
Pregnancy and birth surveillance
1-month questionnaires in use
Maternal Verbal Autopsies in use
Perinatal Verbal Autopsies in use
Data checking and feedback
Development of 1-month questionnaire database
6-month questionnaire design
6-month questionnaire piloting
FI refresher training
6-month questionnaire in use
Entry of register data
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Activities from October 2005 – September 2006
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
PHASE II – prospective surveillance
Pregnancy and birth surveillance
1-month questionnaires in use
6-month questionnaires in use
Maternal Verbal Autopsies in use
Perinatal Verbal Autopsies in use
Data checking and feedback
Entry of WCBA register data
Development of 1-month questionnaire database
Entry of 1-month questionnaire data
Development of maternal verbnal autopsy database
Development of perinatal verbal autopsy database
Development of 6-month questionnaire database
Entry of verbal autopsy data
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Activities from October 2006 – September 2007
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
PHASE II – prospective surveillance
Pregnancy and birth surveillance
1-month questionnaires in use
6-month questionnaires in use
Maternal Verbal Autopsies in use
Perinatal Verbal Autopsies in use
Data checking and feedback
Entry of WCBA register data
Development of 1-month questionnaire database
Entry of 1-month questionnaire data
Development of maternal verbnal autopsy database
Development of perinatal verbal autopsy database
Development of 6-month questionnaire database
Entry of verbal autopsy data
Data preparation for DSMB meeting
DSMB meeting
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Activities from October 2007 – September 2008
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
PHASE II – prospective surveillance
Pregnancy and birth surveillance
1-month questionnaires in use
6-month questionnaires in use
Maternal Verbal Autopsies in use
Perinatal Verbal Autopsies in use
Data checking and feedback
Entry of WCBA register data
Development of 1-month questionnaire database
Entry of 1-month questionnaire data
Development of maternal verbnal autopsy database
Development of perinatal verbal autopsy database
Development of 6-month questionnaire database
Entry of verbal autopsy data
Data preparation for DSMB meeting
PHASE III – re-census
Re-census development, piloting and training
Re-census data collection
Re-census database development and pilot entry
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Activities from October 2008 – September 2009
ACTIVITY MONTH
Oct Nov Dec Jan Feb Mar Apr May June July Aug Sept
PHASE II – prospective surveillance
Pregnancy and birth surveillance
1-month questionnaires in use
6-month questionnaires in use
Maternal Verbal Autopsies in use
Perinatal Verbal Autopsies in use
Data checking and feedback
Entry of WCBA register data
Development of 1-month questionnaire database
Entry of 1-month questionnaire data
Development of maternal verbnal autopsy database
Development of perinatal verbal autopsy database
Development of 6-month questionnaire database
Entry of verbal autopsy data
Data preparation for DSMB meeting
DSMB meeting
PHASE III – re-census
Re-census data entry
Infant outcome verification
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Appendix 3 – Details of the infant feeding and care counselling
intervention
Primary research question
Will volunteer infant feeding and care counselling for pregnant and breastfeeding
mothers in their homes reduce infant mortality through changes in knowledge and
practices regarding exclusive breastfeeding, family planning and other care practices
and health-seeking behaviours?
Hypothesis
Infant feeding and care peer counselling sessions will lead to: reductions in neonatal
and infant mortality, reductions in maternal and infant morbidity, increases in exclusive
breastfeeding rates in the first six months, increases in health-care seeking behaviour,
and changes in care-taker practices.
The infant care and feeding intervention is based on studies in Mexico, Bangladesh and
India (21, 260, 261) and uses training materials and manuals adapted and developed
from WHO manuals and national guidelines. The volunteer counselling intervention
seeks to change the behaviour of individuals in relation to care and care-seeking for
mothers and children (264). The intervention is community based in that it defines the
community as the target of change (251). In particular, the intervention seeks to provide
health education to raise the awareness, change the attitudes and build the self-efficacy
of mothers in relation to exclusive breastfeeding. To achieve this, 72 volunteer
counsellors were identified by local communities and trained in nutrition and
breastfeeding counselling. The volunteer counsellors identify pregnant women and visit
them at home at five key times in pregnancy and after birth (see table). They provide
support and advice on breastfeeding, family planning, PMTCT and birth-preparedness,
and also support women when they have problems with breastfeeding. Women are also
supported and counselled about when to start complementary feeding, and which foods
are most nutritious. The volunteer counsellors received minimal health training but used
a picture book to facilitate learning. The volunteer counsellors were supervised by 24
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government Health Surveillance Assistants and the intervention was coordinated by one
supervisor employed by MaiMwana project.
Infant feeding and care counselling intervention visit guide
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5
Pregnancy After birth
3rd trimester 1st week 1 month 3 months 5 months
*Introduction
*Early BF
*Exclusive BF
*PMTCT
*Birth-
preparedness
*Family planning
and condoms
*Attachment &
positioning
*Exclusive BF
*Vaccinations
*Warmth
*Hygiene
*Danger signs
*Family planning
and condoms
*Advice on BF
problems
*Attachment &
positioning
*Exclusive BF
*Vaccinations
*Warmth
*Hygiene
*Danger signs
*Discuss weaning
at 6m
*Advice on BF
problems
*Attachment &
positioning
*Exclusive BF
*Vaccinations
*Warmth
*Hygiene
*Danger signs
*Discuss weaning
at 6m
*Advice on BF
problems
*Attachment &
positioning
*Exclusive BF
*Vaccinations
*Warmth
*Hygiene
*Danger signs
*Discuss weaning
at 6m
*Discuss weaning
foods
*Advice on BF
problems
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Appendix 4 – Example data collection forms
1. Woman enumeration form – for collection of household socio-economic data and
demographic data for all female household members
2. One-month questionnaire – for collection of information during interview at one-
month post-partum about:
 demographic characteristics
 antenatal care
 use of bednets
 use of HIV counselling and testing services
 problems during antenatal, delivery and post-partum periods
 care-seeking for those problems
 family planning and sexual relationships
 exposure to interventions
 birth details
 newborn care
 breastfeeding and feeding recall
 infant illness and care-seeking
3. Perinatal verbal autopsy – for collection of information during interview at least two
weeks after the termination of a pregnancy or the death of a newborn infant. The section
of the one-month questionnaire relating to maternal behaviour is administered (Sections
A to F – Questions 1.1 to 10.11), and additional information is collected in the perinatal
verbal autopsy about:
 birth details
 a description of what happened in the respondent’s own words
 signs and symptoms of illness
 newborn care
 breastfeeding
 feeding recall
 infant illness and care-seeking
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Woman Enumeration form MaiMwana Project
TA ID Zone ID Village name ……………………… Village ID Household ID
Interviewer ID Interview date / /
Data checker ID Data checking date
Data entry ID Data entry date
Name of head of household ………………………………………………… Name of respondent ………………………………………………..
Look at the house… Ask the resident…
1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8
What is the main type
of flooring?
What is the main
type of roofing?
Do you or members
of your HH work on
agricultural land?
What is the main HH source of
drinking water?
What is the main type of
toilet facility used by
members of your HH?
Number of
members of
the HH
Number of
sleeping
rooms
In your HH is there…
(Y/N)
1 = Dirt, sand or dung
2 = Wood or plank
3 = Cement
4 = Tiles
5 = Other
1 = Natural material
(e.g. grass)
2 = Iron sheets
3 = Iron and tiles
4 = Asbestos
5 = Cement
6 = Other
1 = Mainly on own
or family’s land
2 = Mainly on
rented or someone
else’s land
3 = Do not do
agricultural work
1 = Piped water inside house
2 = Piped water into yard or plot
3 = Public tap (piped)
4 = Protected well/borehole
5 = Traditional public well
6 = River, canal or surface water
1 = Own flush toilet
2 = Shared flush toilet
3 = Traditional pit toilet
4 = VIP pit latrine
5 = Bush or field
6 = Other
(including
those sleeping
in boys + girls
hostels)
(including
boys + girls
hostels)
Electricity? ___
A radio? ___
A bicycle? ___
A motorcycle? ___
A car? ___
A paraffin lamp? ___
An oxcart? ___
A domestic worker not related to the
head of the HH? ___
Original village: (Village/GVH/TA/District) ………………………………………
…………………………………………………………………………………………….…….
…………………………………………………………………………………………….…….
Identified: 1 = New woman come into previously enumerated house? Q2.1
2 = New woman came into a house not previously enumerated?
3 = The woman has stayed in the village for a long time, the door
has been numbered, but the house isn’t in the register?
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Please complete the following table for all females who usually live in the household (include those attending school or doing short-term business away from the village):
2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11
First name Surname Alternative names a. Age in years
b. Year of birth
c. Age group
Marital Status Tribe Religion Education Main Occupation
(apart from
housework)
Has she ever
been pregnant
before?
(Y/N)
Is she pregnant
now?
(Y/N)
a
b
c
a
b
c
a
b
c
a
b
c
a
b
c
a
b
c
a
b
c
a
b
c
a
b
c
c. Age group
1 = Less than 15 yrs
2 = 15 to 49 yrs
3 = Above 49 yrs
1 = Married
2 = Never married
3 = Divorced
4 = Separated
5 = Widowed
1 = Chewa
2 = Ngoni
3 = Senga
4 = Yao
5 = Tumbuka
6 = Lomwe
7 = Other
1 = Catholic
2 = Christian
3 = Moslem
4 = Aaron
5 = Pagan
6 = Other
1 = None
2 = Primary
3 = Secondary
4 = Tertiary
1 = Farming
2 = Casual worker
3 = Salaried worker
4 = Small business
5 = Rural artisan
6 = Student
7 = No work
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BEFORE STARTING OFF FOR THE INTERVIEW – COMPLETE THIS SECTION USING THE INFORMATION FROM THE WCBA REGISTER. IF
THE WOMAN YOU ARE GOING TO INTERVIEW DOES NOT APPEAR IN THE WCBA REGISTER AND DOES NOT HAVE A WCBA_ID
NUMBER, PLEASE COMPLETE A HOUSEHOLD ENUMERATION FORM WHEN YOU ARRIVE, BEFORE STARTING THE ONE-MONTH
INTERVIEW AND LEAVE THIS SECTION BLANK.
WCBA names from register:
WCBA ID from register: |__|__|-|__|__|-|__|__|__|-|__|
PLEASE TICK AS APPROPRIATE:
WCBA ALREADY APPEARS ON REGISTER |__|
HOUSEHOLD ENUMERATION FORM COMPLETED |__|
ON ARRIVING AT THE RESPONDENT’S HOUSE – GREET THE RESPONDENT. ASK FOR A PRIVATE PLACE TO SIT AND CHAT, AWAY
FROM OTHER PEOPLE. ASK THE RESPONDENT TO BRING HER HEALTH PASSPORT AND TTV CARD, IF SHE HAS ONE. CHAT A LITTLE
BIT, TO HELP THE RESPONDENT TO FEEL RELAXED.
ASK FOR CONSENT – My name is ______________. I am working with MaiMwana Project. MaiMwana is trying to improve the health of mothers
and babies in Mchinji. We are doing a survey of women who have recently given birth, in order to learn about their experiences.
We assure you that everything you tell us will be kept confidential, and will only be used for study purposes. You do not have to take part in this
research if you do not want to. If you do not wish to take part, this will not affect your right to take part in other MaiMwana activities in the future. If
there are any questions that you do not want to answer, you do not have to answer them. There are no wrong answers to these questions. We just
want to know about the experiences of pregnant women. If you do not understand a question, please ask me to explain it again.
This interview will take about one hour. Do you agree to take part?
Yes |__|
No |__|
AFTER GAINING CONSENT – COMPLETE A HOUSEHOLD ENUMERATION FORM IF NECESSARY, THEN FILL IN THE DETAILS BELOW. IF
THE RESPONDENT APPEARS ON THE WCBA REGISTER, BUT SHE LIVES IN A DIFFERENT ZONE, VILLAGE OR HOUSE FROM THE ONE IN
THE WCBA REGISTER, OR USES ANY DIFFERENT NAMES, PLEASE WRITE THESE DETAILS BELOW.
Zone ID: |__|__| Village ID: |__|__| Village name: Household ID: |__|__|__|
WHERE DID THE RESPONDENT LIVE BEFORE THIS/WHICH VILLAGE DID THEY COME FROM?
Zone ID: |__|__| Village ID: |__|__| Village name: Household ID: |__|__|__|
District/country: TA name: VDC/GVH name:
Names used by WCBA that are not on the register: First name Surname
Interviewer ID: |__|__| Date of interview: |__|__|/|__|__|/|__|__| Time started interview: __ __ : __ __
FOR OFFICE USE ONLY
Supervisor’s signature: Date received in nodal office: |__|__|/|__|__|/|__|__|
Data Checker ID: |__|__| Date checked: |__|__|/|__|__|/|__|__|
Data Entry ID: |__|__| Date entered: |__|__|/|__|__|/|__|__|
MAIMWANA PROJECT – ONE MONTH QUESTIONNAIRE
One-month Questionnaire MaiMwana Project
|__|__|-|__|__|-|__|__|__|-|__| WCBA ID 306
Part A: Personal Details of Mother and Father
First I would like you to tell me about yourself and the father of your baby
Mother
1.1 How old are you? Age (years) |__|__|
Day/Month/Year |__|__|/|__|__|/|__|__|
1.2 What is the highest level of school you attended?
FOR PRIMARY AND SECONDARY ALSO PUT HIGHEST STANDARD
OR FORM REACHED
1 = None
2 = Primary |__|
3 = Secondary |__| 
4 = Tertiary
Q1.5
1.3 Have you ever participated in a literacy programme or any other
programme that involves learning to read or write (not including primary
school)?
1 = Yes
2 = No
1.4 Can you read this sentence? 1 = Reading with ease
2 = Reading with difficulty
3 = Cannot read
Father
1.5 What is the age of the man who fathered this pregnancy?
IF THE RESPONDENT DOESN’T KNOW THE EXACT AGE, CIRCLE
THE CORRECT AGE GROUP
Age (years) |__|__|
1 = <20 years
2 = 20-29 years
3 = 30-39 years
4 = 40-49 years
5 = >49 years
1.6 What is your relationship to him? 1 = Married
2 = Boyfriend/fiancé
3 = Casual acquaintance 
4 = Relative
5 = Divorced/separated
6 = Widowed 
7 = Other (specify)
Q2.1
Q2.1
Q2.1
1.7 Which of the following best describes your living arrangements with this
man?
READ OUT THE LIST OF STATEMENTS
1 = Live together all of the time
2 = Live together but occasionally apart for work
reasons
3 = Live together but separated for a period
every year for work reasons (i.e.
seasonal/ganyu work)
4 = Live apart but regular/frequent cohabitation
(i.e. return visits)
5 = Live apart, infrequent cohabitation
6 = Never live together
1.8 What is the highest level of school he attended?
FOR PRIMARY AND SECONDARY ALSO PUT HIGHEST STANDARD
OR FORM REACHED
1 = None
2 = Primary |__|
3 = Secondary |__|
4 = Tertiary
Q1.10
1.9 Has he ever participated in a literacy programme or any other programme
that involves learning to read or write (not including primary school)?
1 = Yes
2 = No
1.10 What is his main occupation?
PROBE FOR THE ONE WHICH HE SPENDS MOST TIME DOING
1 = Farming
2 = Casual worker/ganyu
3 = Salaried worker
4 = Small business/artisan
5 = Student
6 = No work
7 = Other (specify _________)
1.11 Does he do any other type of work, apart from that mentioned in Q1.10? If
yes, what type?
1 = No other work
2 = Farming
3 = Casual worker/ganyu
4 = Salaried worker
5 = Small business/artisan
6 = Student
7 = Other (specify _________)
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Part B: Birth History
2.1 Have you ever had a pregnancy before this child, even if it ended early or the baby was a
stillbirth?
1 = Yes
2 = No ---------- ( Q2.9)
Now I am going to ask you some questions about all of the pregnancies you have had during your life before this one. Starting from your first
pregnancy, can you tell me about ALL your pregnancies, even if the pregnancy only lasted a few months, if the baby was born dead, or if it
died soon after birth?
2.2
On what day,
month and year
was the baby born?
PROBE:
“What is his/her
birthday?”
CHECK HEALTH
PASSPORT IF
AVAILABLE
2.3
Was this
pregnancy single
or multiple?
RECORD TWINS
AND TRIPLETS
ON SEPARATE
LINES
2.4
Did this pregnancy end
in a miscarriage, a
stillbirth or a live birth?
FOR STILLBIRTHS,
PROBE FOR SIGNS
OF LIFE AT BIRTH
IF MISCARRIAGE OR
STILLBIRTH, GO TO
NEXT PREGNANCY
2.5
Is (NAME) a
boy or a girl?
2.6
Is (NAME)
still alive?
2.7
How old was (NAME)
at his/her last
birthday?
RECORD AGE IN
COMPLETED YEARS
GO TO NEXT
PREGNANCY
2.8
How old was
(NAME) when
he/she died?
PROBE TO MAKE
SURE YOU GET
THE RIGHT AGE
CATEGORY
01 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
02 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
03 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
04 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
05 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
06 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
07 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
08 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
09 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
10 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
11 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
12 Day/ Month/ Year
__ __/__ __/__ __ |__| |__| |__|
Yes
No ( 2.8) |__|__| years |__|
1 = Single
2 = Multiple
1 = Live birth
2 = Stillbirth
3 = Miscarriage
1 = Girl
2 = Boy
1 = 0-7 days
2 = 8-28 days
3 = 29 days -1yr
4 = >1yr
5 = >2yrs
6 = >3yrs
7 = >4yrs
8 = >5yrs
REMEMBER:
- A MISCARRIAGE IS A PREGNANCY THAT ENDS BEFORE 7 COMPLETED MONTHS
- A STILLBIRTH IS A PREGNANCY THAT ENDS AFTER 7 COMPLETED MONTHS, BUT THE BABY IS BORN DEAD
- A LIVE BIRTH IS A PREGNANCY THAT ENDS WITH A LIVE BABY, EVEN IF THAT BABY ONLY SURVIVES FOR A FEW MOMENTS
 PROBE BY ASKING “APART FROM THE PREGNANCIES YOU HAVE MENTIONED, HAVE YOU HAD ANY OTHERS THAT ENDED
BEFORE 7 MONTHS, OR THAT ENDED AFTER 7 MONTHS BUT WERE BORN DEAD?”
 FOR ANY STILLBIRTHS REPORTED, MAKE SURE YOU ASK “DID THE BABY CRY OR SHOW SIGNS OF LIFE? DID IT MOVE AN ARM
OR A LEG, OR BREATHE FOR A MOMENT?”
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2.9 Have you ever had a pregnancy that ended before 7 completed months?
IF YES, MAKE SURE THESE DETAILS ARE RECORDED IN TABLE 2
1 = Yes
2 = No
2.10 Have you ever had a pregnancy that ended with a dead baby? 1 = Yes
2 = No Q2.12
2.11 Did the baby show any signs of life after it was born? Did it cry or breathe or
move an arm or a leg?
IF YES, RECORD THE BABY AS A LIVEBIRTH IN TABLE 2
IF NO, RECORD THE BABY AS A STILLBIRTH IN TABLE 2
1 = Yes
2 = No
2.12 Have you ever had any children that died at any time after being born?
IF YES, MAKE SURE THESE CHILDREN ARE RECORDED IN TABLE 2
1 = Yes
2 = No
Part C: Details About the Recent Pregnancy
Now I would like to ask you about the details of your recent pregnancy
ANC
3.1 Did you go for an antenatal check-up during this pregnancy? 1 = Yes
2 = No
Q3.3
3.2 Why did you not go to ANC?
Go to

Q3.12
3.3 Where did you go?
PROBE FOR MORE
CIRCLE ALL THAT APPLY
FOR OUTREACH SPECIFY WHERE THE OUTREACH WAS, NOT THE
HEALTH FACILITY THAT IT CAME FROM
1 = Mchinji District Hospital
2 = Kapiri
3 = Kaigwazanga
4 = Kochilira
5 = Mkanda
6 = Guillime
7 = Nkhwazi
8 = Chipumi
9 = Chiwosha
10 = Ludzi
11 = Mikundi
12 = Kapanga
13 = Tembwe
14 = St Gabriel’s
15 = TBA
16 = Outreach (specify _____________)
17 = Other (specify ________________)
3.4 How many months pregnant were you when you first went? |__| months
3.5 How many times did you go altogether during this pregnancy? |__|__| times
3.6 During any of your antenatal visits, did the provider do any of the
following at least once?
EMPHASISE THAT THIS DOES NOT INCLUDE ANY VISITS ONCE
THE LABOUR HAS STARTED
Weigh you?
Measure your height?
Make you lie down and examine your belly?
Measure your BP with a cuff?
Take a sample of your urine?
Take a sample of your blood for tests?
Do a syphilis test?
Perform a vaginal examination?
Give information about VCT/PMTCT services?
Give information on breastfeeding?
Give information on contraception?
Give information on postnatal check?
Give information on danger signs?
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
1 = Yes 2 = No
3.7 Did you have a Tetanus Toxoid Vaccine (TTV) injection in the arm during
this pregnancy?
1 = Yes
2 = No Q3.9
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3.8 During this pregnancy, how many times did you get this injection? |__| times
3.9 Have you received all the five injections?
CHECK TTV CARD OR HEALTH PASSPORT
1 = Yes
2 = No
3.10 During this pregnancy were you given, or did you buy any iron tablets or
iron syrup?
SHOW TABLETS
1 = Yes
2 = No Q3.12
3.11 During the whole pregnancy, for how many days did you drink the tablets
or syrup?
IF ANSWER IS NOT NUMERIC, PROBE FOR APPROXIMATE
NUMBER OF DAYS
|__|__|__| days
3.12 Did you go to anyone else for advice during your pregnancy? 1 = Yes
2 = No Q3.14
3.13 Who did you go to? 1 = TBA
2 = Sing’anga
3 = Grandmother
4 = Other (specify
_____________________)
3.14 During this pregnancy, did you take any drugs in order to prevent
you from getting malaria?
NOT CONSIDERED HERE ARE INSTANCES WHEN YOU TOOK THE
DRUG BECAUSE YOU HAD MALARIA
1 = Yes
2 = No Q3.17
3.15 Which medicines did you take to prevent malaria?
RECORD ALL MENTIONED. AND ASK FOR EACH DRUG CIRCLED
HOW MANY TIMES IT WAS TAKEN DURING THE PREGNANCY
1 = SP/Fansidar/Novidar |__|__|
2 = Other (specify __________) |__|__|
3.16 Did you get the medicine during an antenatal visit, during another visit to
a health facility or from some other source?
1 = Antenatal visit
2 = Another facility visit
3 = Other source (specify
_______________)
3.17 Does your household have any mosquito nets that can be used while
sleeping?
1 = Yes
2 = No Q3.24
3.18 How many mosquito nets does your household have? |__|
3.19 Since you got the mosquito net, was it ever soaked or dipped in
chemicals to repel mosquitoes or insects?
1 = Yes
2 = No
3 = Not sure
Q3.22
Q3.22
3.20 When was the last time the net was soaked or dipped in these
chemicals?
|__|__| months ago
3.21 Did anyone sleep under a mosquito net last night? If yes, who?
CIRCLE ALL THAT APPLY
IF THE NUMBER OF NETS SEEMS LOW FOR THE NUMBER OF
PEOPLE THAT SLEPT IN IT, PROBE TO MAKE SURE THE ANSWER
IS CORRECT
1 = Nobody
2 = Self
3 = Husband
4 = New baby
5 = All other children
6 = Some other children
7 = Other (specify
_____________________)
3.22 During this pregnancy, how often did you sleep under the mosquito net? 1 = Every night
2 = Some nights
3 = Never
Q3.24
3.23 Why did you not sleep under the mosquito net every night?
3.24 Have you ever talked with your husband/partner about ways to prevent
HIV?
1 = Yes
2 = No
3.25 What methods have you ever tried to prevent HIV?
LIST ALL MENTIONED
3.26 Do you know a place that you can go to for HIV testing and counselling?
If yes, name all the ones you know.
CIRCLE EACH NAME MENTIONED
PROBE FOR OTHERS
1 = No
2 = Mchinji District Hospital
3 = Kapiri
4 = Mkanda
5 = St Gabriel’s
6 = Banja La Mtsogolo
7 = MACRO
Q4.1
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8 = Other (specify
_____________________)
3.27 I do not want to know the result, but have you ever been for VCT? 1 = Yes
2 = No
Q3.28
3.28 Why did you not go?
Go to Q4.1
3.28 When did you go for VCT?
READ OUT THE LIST OF RESPONSES
1 = During ANC visit
2 = A separate visit during this pregnancy
3 = Before you were pregnant
4 = After this pregnancy
5 = Don’t know
3.29 Where did you go? 1 = Mchinji District Hospital
2 = Kapiri
3 = Mkanda
4 = St Gabriel’s
5 = Other (specify
_____________________)
3.30 Did you go for testing together with your partner? 1 = Yes
2 = No
3.31 Did you collect your results? 1 = Yes
2 = No
Q4.1
3.32 Why did you not collect your results?
Delivery
4.1 How long did the labour last? 1 = 0 – 6 hours
2 = 7 – 12 hours
3 = 13 – 18 hours
4 = 19 – 24 hours
5 = >24 hours
4.2 How many hours before the baby was born did the waters break? 1 = <24 hours
2 = >24 hours
3 = Don’t know
4.3 How did the waters smell and look? 1 = No odour/normal odour and clear
2 = Foul smell and green
3 = Don’t know
4.4 How long after the baby’s birth did the placenta come out?
IF THE BABY WAS BORN BY C-SECTION, CIRCLE “<1 hour”
1 = <1 hour
2 = >1 hour
4.5 Did you drink ‘mwana mphepo’ medicine to assist labour? 1 = Yes
2 = No Q5.1
4.6 How many spoonfuls did you drink? |__| spoonfuls
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Part D: Problems, Healthcare-seeking and Treatment – Mother
Antenatal problems
5.1 Were you sick or did you have any serious problems during the recent pregnancy? 1 = Yes
2 = No ------------ ( Q6.1)
Now I would like to ask you about ALL the problems you had while you were pregnant this time
5.2
What was the
first/next problem
you had?
PROBE FOR
MORE
PROBLEMS
5.3
Did you
consult
anybody?
5.4
If NO, why not?
SKIP TO NEXT
PROBLEM AT
Q5.2
5.5
If YES, who was
the first/next
person you
consulted?
5.6
What did the person
you consulted do?
WRITE ALL THAT
APPLY
5.7
Did you have to
ask permission
from anyone
before you could
go there? If
YES, who?
5.8
How long was it
from the start of
your illness until
you received
treatment?
5.9
Did you go to anyone else for
help? If YES, were you
referred or did you go of your
own accord?
5.10
Did you
go?
5.11
If NO, why not?
1 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
2 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
3 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
4 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
5 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
6 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
1 = Yes 5.5
2 = No 5.2
(SKIP TO
NEXT
PROBLEM)
1 = Sing’anga
2 = TBA
3 = HSA
4 = Health worker in
Mchinji
5 = Health worker
outside Mchinji
6 = Grandmother
7 = Other relative
8 = Other (specify)
1 = No
2 = Husband
3 = Mother
4 = Father
5 = Mother-in-law
6 = Other relative
7 = Other (specify)
1 = Didn’t go Q5.2 (SKIP TO
NEXT PROBLEM)
2 = Went without referral Q5.5
(START A NEW LINE)
3 = Was referred Q5.10
1 = Yes
2 = No
IF YES,
START AT
Q5.5 WITH
A NEW
LINE
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Delivery Problems
6.1 Were you sick or did you have any serious problems during this delivery? 1 = Yes
2 = No ------------ ( Q7.1)
Now I would like to ask you about ALL the problems you had during this delivery
6.2
What was the
first/next problem
you had?
PROBE FOR
MORE
PROBLEMS
6.3
Did you
consult
anybody?
6.4
If NO, why not?
SKIP TO NEXT
PROBLEM AT
Q6.2
6.5
If YES, who was
the first/next
person you
consulted?
6.6
What did the person
you consulted do?
WRITE ALL THAT
APPLY
6.7
Did you have to
ask permission
from anyone
before you could
go there? If
YES, who?
6.8
How long was it
from the start of
your illness until
you received
treatment?
6.9
Did you go to anyone else for
help? If YES, were you
referred or did you go of your
own accord?
6.10
Did you
go?
6.11
If NO, why not?
1 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
2 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
3 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
4 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
5 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
6 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
1 = Yes 6.5
2 = No 6.2
(SKIP TO
NEXT
PROBLEM)
1 = Sing’anga
2 = TBA
3 = HSA
4 = Health worker in
Mchinji
5 = Health worker
outside Mchinji
6 = Grandmother
7 = Other relative
8 = Other (specify)
1 = No
2 = Husband
3 = Mother
4 = Father
5 = Mother-in-law
6 = Other relative
7 = Other (specify)
1 = Didn’t go Q6.2 (SKIP TO
NEXT PROBLEM)
2 = Went without referral Q6.5
(START A NEW LINE)
3 = Was referred Q6.10
1 = Yes
2 = No
IF YES,
START AT
Q6.5 WITH
A NEW
LINE
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Post-natal Problems
7.1 Were you sick or did you have any serious problems after this delivery, including problems related to breastfeeding? 1 = Yes
2 = No ------------ ( Q8.1)
Now I would like to ask you about ALL the problems you had after this delivery
7.2
What was the
first/next problem
you had?
PROBE FOR
MORE
PROBLEMS
7.3
Did you
consult
anybody?
7.4
If NO, why not?
SKIP TO NEXT
PROBLEM AT
Q7.2
7.5
If YES, who was
the first/next
person you
consulted?
7.6
What did the person
you consulted do?
WRITE ALL THAT
APPLY
7.7
Did you have to
ask permission
from anyone
before you could
go there? If
YES, who?
7.8
How long was it
from the start of
your illness until
you received
treatment?
7.9
Did you go to anyone else for
help? If YES, were you
referred or did you go of your
own accord?
7.10
Did you
go?
7.11
If NO, why not?
1 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
2 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
3 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
4 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
5 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
6 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
1 = Yes7.5
2 = No 7.2
(SKIP TO
NEXT
PROBLEM)
1 = Sing’anga
2 = TBA
3 = HSA
4 = Health worker in
Mchinji
5 = Health worker
outside Mchinji
6 = Grandmother
7 = Other relative
8 = Other (specify)
1 = No
2 = Husband
3 = Mother
4 = Father
5 = Mother-in-law
6 = Other relative
7 = Other (specify)
1 = Didn’t go Q7.2 (SKIP TO
NEXT PROBLEM)
2 = Went without referral Q7.5
(START A NEW LINE)
3 = Was referred Q7.10
1 = Yes
2 = No
IF YES,
START AT
Q7.5 WITH
A NEW
LINE
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Part E: Family Planning and Relationships
Now I would like to ask you some questions about family planning and sexual relationships in your family. I know that many people feel shy talking
about these sorts of things, but I would like to assure you that everything you tell me will be kept in confidence.
Family Planning
8.1 Have you ever used family planning in the past? If yes, which methods?
DO NOT READ THE LIST
CIRCLE ALL METHODS MENTIONED
PROBE FOR MORE ANSWERS
1 = Lactational amenorrhea
2 = Pill
3 = Norplant
4 = Depo (Injection)
5 = Condom
6 = Loop
7 = Chingwe
8 = Traditional medicine
9 = Following cycles
10 = Withdrawal
11 = Abstinence
12 = Others (specify________________)
13 = No
Q8.3
“
“
“
“
“
“
“
“
“
“
“
Q8.2
8.2 If not, why not?
8.3 How many months pregnant were you the last time you had sex before the
delivery?
|__| months
8.4 Did you use condoms during pregnancy or since the baby was born? 1 = During pregnancy
2 = After the birth
3 = Both during the pregnancy and after birth
4 = No Q8.6
8.5 How many times? |__|__| times during pregnancy
|__|__| times after the baby was born
8.6 Do you know of a person or a place where a person can get condoms? 1 = Yes
2 = No Q9.1
8.7 Where is that?
DO NOT READ THE LIST
CIRCLE ALL PLACES MENTIONED
PROBE FOR MORE ANSWERS
1 = Health facility
2 = Grocery
3 = Bar or bottle store
4 = Community workers (e.g. CBDA, Youth
Alert)
5 = Other (specify _________________)
8.8 If you wanted to, could you get yourself a condom? 1 = Yes
2 = No
3 = Don’t know
Relationships
9.1 How many times have you ever been married or in a long-term relationship
(lasting more than 12 months)?
INCLUDE CURRENT RELATIONSHIP IF MARRIED
|__|__| times
9.2 How old were you when you first entered such a relationship? |__|__| years
9.3 What is your marital status now? 1 = Married
2 = Single/never married
3 = Divorced/separated
4 = Widowed 
5 = Other (specify)
Q10.1
Q10.1
Q10.1
9.4 How long have you been in this relationship? |__|__| years
|__|__| months
9.5 Does this man have any wives apart from you? If yes, how many? 1 = Yes |__| wives
2 = No Q9.7
9.6 Are you the first, second, third… wife? |__|__| rank
9.7 How many times has this man ever been married before (including
yourself)?
|__|__| times
9.8 Taken altogether, how many children has this man ever fathered with other
women (not including self, but including co-wives)?
|__|__| children
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Part F: Exposure to Interventions
Now I would like to ask you some questions about community activities that you are involved with in your village
IF YOU ARE WORKING IN ANY OF THE FOLLOWING ZONES PLEASE START AT Q10.4: 4, 5, 6, 13, 18, 19, 21, 26, 30, 39, 44, 48
IF YOU ARE WORKING IN ANY OF THE FOLLOWING ZONES PLEASE START AT Q10.7: 3, 7, 8, 14, 16, 22, 27, 31, 32, 35, 46, 47
IF YOU ARE WORKING IN ANY OTHER ZONE, PLEASE START AT Q10.1
10.1 Have you ever attended a MaiMwana women’s group meeting? 1 = Yes
2 = No Q10.3
10.2 How many times did you go? |__|__| times  Q10.4
10.3 If no, why not?
IF YOU ARE WORKING IN ANY OF THE FOLLOWING ZONES PLEASE GO TO Q10.7: 1, 9, 11, 20, 24, 25, 28, 33, 34, 40, 42, 45
10.4 Have you ever been counselled by a MaiMwana infant feeding counsellor? 1 = Yes
2 = No Q10.7
10.5 How many times were you visited by her in the last 6 months? |__| times  Q10.8
10.6 If no, why not?
10.7 Who have you exchanged ideas with about issues relating to pregnancy and
newborn care in the last 4 months?
CIRCLE ALL THAT APPLY
1 = MaiMwana women’s group members
2 = Other female friends from the village
3 = Other female friends from another village
4 = Female relatives
5 = Husband
6 = Nobody
7 = Other (specify _____________________)
10.8 Who have you exchanged ideas with about issues relating to how to feed a baby
in the last 4 months?
CIRCLE ALL THAT APPLY
1 = MaiMwana infant feeding counsellor
2 = Other female friends from the village
3 = Other female friends from another village
4 = Female relatives
5 = Husband
6 = Nobody
7 = Other (specify _____________________)
10.9 Have you been involved in any other community activities, groups or committees
in the last year? If yes, what were they?
10.10 Do you or your husband hold any of the following positions? 1 = No
2 = Village headman
3 = Group village headman
4 = TBA
5 = Sing’anga
6 = HSA
7 = Member of village health committee
8 = Member of other community group
(specify ___________________________)
10.11 How much control do you feel you have in making important decisions that affect
your and your children’s health?
1 = No control
2 = Control over very few decisions
3 = Control over some decisions
4 = Control over most decisions
5 = Control over all decisions
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WCBA ID: |__|__|-|__|__|-|__|__|__|-|__| WCBA name: first/second/other
Interviewer ID: |__|__| Date of interview: |__|__|/|__|__|/|__|__| Supervisor’s signature:
What is the relationship of the respondent to the infant? 1 = Mother
2 = Father
3 = Mother’s relative
4 = Father’s relative
5 = Neighbour
6 = TBA
7 = Other (specify _______________________________)
Part G: The Newborn Baby
COMPLETE A SEPARATE FORM FOR EACH BABY IF THEY ARE TWINS/MULTIPLE
Now I would like you to tell me about the birth of your baby
Details of the birth
11.1 Is your baby a girl or a boy? 1 = Girl
2 = Boy
11.2 What is your baby’s name?
11.3 What date was (NAME) born on? Day/ Month/ Year
__ __/__ __/__ __
11.4 Was (NAME) born early, late, or at the expected time? 1 = Early
2 = On time
3 = Late
11.5 After how many completed months of pregnancy was (NAME) born? |__|__| months
11.6 Is (NAME) one of twins? 1 = Single 
2 = Twin/multiple
Q11.8
11.7 Was (NAME) the first or second born twin? 1 = First
2 = Second
11.8 How big was the baby? 1 = Very large
2 = Average
3 = Very small
4 = Don’t know
11.9 Was (NAME) weighed at birth? 1 = Yes
2 = No Q12.1
11.10 How much did (NAME) weigh?
CHECK HEALTH PASSPORT
|__|__|__|__| grams
Newborn Care
12.1 Where was (NAME) born? 1 = Mchinji District Hospital
2 = Kapiri
3 = Kaigwazanga
4 = Kochilira
5 = Mkanda
6 = Guillime
7 = Nkhwazi
8 = Chipumi
9 = Chiwosha
10 = Ludzi
11 = Mikundi
12 = Kapanga
13 = Tembwe
14 = St Gabriel’s
15 = TBA
16 = At home
17 = On the way to health facility
18 = Other (specify ________________)
12.2 Was there a fire, stove or any form of heating in the room? 1 = Yes
2 = No
3 = Don’t know
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12.3 Who helped with the delivery?
CIRCLE ALL MENTIONED
1 = Doctor/Nurse/Clinical Officer/Midwife
2 = Other health worker
3 = TBA
4 = Relative/friend
5 = Nobody Q12.6
12.4 Did the person who helped wash his/her hands with soap before the
delivery?
1 = Yes
2 = No
3 = Don’t know
12.5 Did the person who helped wear gloves during the delivery? 1 = Yes
2 = No
3 = Don’t know
12.6 How was the baby delivered? 1 = Normal
2 = Breech
3 = Forceps/vacuum
4 = C-section
12.7 Which part of the baby came out first? 1 = Head
2 = Buttock
3 = Hand/foot
4 = Cord
5 = Don’t know
12.8 What was the cord cut with?
12.9 What was the cord tied with?
12.10 What substances were put on the cord stump after it was cut?
12.11 How long after birth was (NAME) wrapped up? |__|__| hours |__|__| minutes
12.12 How long after the birth was (NAME) bathed? |__|__| hours |__|__| minutes
12.13 What was the first thing the baby swallowed after he/she was born?
12.14 Has (NAME) had a BCG immunisation (injection on left arm)?
CHECK HEALTH PASSPORT AND LOOK FOR SCAR
1 = Yes
2 = No
Post-natal Check-up
13.1 After the baby was born, did a health professional or a traditional birth
attendant check on your or your baby’s health?
THIS DOES NOT INCLUDE CHECKS MADE BY HEALTH WORKERS
IMMEDIATELY AFTER A DELIVERY AT A HEALTH FACILITY
1 = Yes
2 = No
Q13.3
13.2 Why was there not a check?
Go to Q14.1
13.3 How many days after delivery did the first check take place? |__|__| days
13.4 Why did you go? 1 = Normal check-up
2 = Problem for mother
3 = Problem for baby
13.5 Where did this first check take place?
FOR OUTREACH SPECIFY WHERE THE OUTREACH WAS, NOT THE
HEALTH FACILITY THAT IT CAME FROM
1 = Mchinji District Hospital
2 = Kapiri
3 = Kaigwazanga
4 = Kochilira
5 = Mkanda
6 = Guillime
7 = Nkhwazi
8 = Chipumi
9 = Chiwosha
10 = Ludzi
11 = Mikundi
12 = Kapanga
13 = Tembwe
14 = St Gabriel’s
15 = TBA
16 = Outreach (specify _________________)
17 = Other (specify ____________________)
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13.6 Since the delivery, have you received a dose of Vitamin A?
SHOW VITAMIN A TABLET
1 = Yes
2 = No
Now I would like you to tell me about how you fed your baby
Breastfeeding
14.1 Have you ever breastfed (NAME)? 1 = Yes
2 = No Q14.3
14.2 How long after birth did you first breastfeed the baby/put (NAME) to the
breast?
|__|__| hours |__|__| minutes
14.3 What did you give (NAME) to drink in the first three days after delivery,
before your milk began flowing regularly?
PROBE ‘Anything else?’
RECORD ALL FOODS/DRINKS MENTIONED
IF ONLY BREASTMILK WAS GIVEN, GO TO Q14.5
14.4 Why did you give these things?
14.5 Has (NAME) drunk any pharmaceutical medicine since he/she was born?
INCLUDE LIQUID MEDICINES AND LIQUID VITAMINS OR MINERALS
AND COMMERCIAL GRIPE WATER
1 = Yes (specify _______________________)
2 = No Q14.8
14.6 What was the medicine for?
14.7 How many times did (NAME) drink pharmaceutical medicine? |__|__| times
14.8 Has (NAME) drunk any traditional medicine since he/she was born? 1 = Yes (specify _______________________)
2 = No Q14.11
14.9 What was the medicine for?
14.10 How many times did (NAME) drink traditional medicine? |__|__| times
14.11 Has (NAME) drunk any water since he/she was born? 1 = Yes
2 = No Q14.13
14.12 How many times did (NAME) drink water? 1 = Only on the first day
2 = On some days
3 = Every day
4 = Other (specify) _____________________
14.13 Are you still breastfeeding (NAME)? 1 = Yes
2 = No
Q14.15
14.14 Why did you stop breastfeeding?
14.15 Have you had any problems with breastfeeding? 1 = Yes
2 = No Q14.20
14.16 What were they?
14.17 Did you go, or were you referred to a health facility because of these
problems?
1 = Went without referral
2 = Was referred
3 = Didn’t go
14.18 Did you change the way you fed your child during the time you had breast
problems?
1 = Yes
2 = No Q14.20
14.19 What did you do differently?
WRITE ALL CHANGES MENTIONED
14.22 Did you change the way you fed your baby at any time when you or the
baby was sick after the delivery?
CIRCLE ALL THAT APPLY
1 = No
2 = Yes, when I was sick
3 = Yes, when the baby was sick
4 = yes, for another reason (specify
_____________________________________)
Q…
14.23 What did you do differently?
WRITE ALL CHANGES MENTIONED
14.25 Did anyone else (beside yourself) ever breastfed (NAME)? 1 = Yes
2 = No
3 = Don’t know 
Q14.27
Q14.27
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14.26 Why did the other person breastfeed (NAME)?
14.27 Did you ever express your breast milk after (NAME) was born? 1 = Yes
2 = No Q15.1
14.28 Did you give the expressed breast milk to (NAME)? 1 = Yes
2 = No Q14.30
14.29 How did you give the milk to (NAME)? 1 = Cup
2 = Bottle
3 = Other (specify _____________________)
14.30 Did you heat-treat your breast milk? 1 = Yes
2 = No
14.31 Why did you express milk?
14.32 Who explained to you how to express the milk? 1 = Health worker
2 = Sister
3 = Mother
4 = Other family member
5 = Neighbour
6 = MaiMwana IF counsellor
7 = Other (specify _____________________)
Feeding recall
Now I would like you to tell me the details about how you fed (NAME)
First I’m going to ask you about all the things
(NAME) drank during the first week after birth
Now I want to ask you about all the
things (NAME) drank in the last 7 days
15.1 15.2 15.3 15.4 15.5
Before you
gave any
breast milk,
was (NAME)
given…
On the day
he/she was
born, was
(NAME)
given…
Between day 2
and day 7 after
(NAME) was
born, was
he/she given…
Yesterday, was
(NAME) given…
Apart from
yesterday, in the
last week, was
(NAME) given…
01 Breast milk?
02 Other milks?
03 Water/dawale?
04 Home-made gripe water/rice
water/mzuwa?
05 Phala?
06 Other foods or drinks (specify)?
07 Traditional medicines?
08 Pharmaceutical medicines?
09 Other foods or drinks given but she
doesn’t know what they were
1= Yes
2 = No
1= Yes
2 = No
1= Yes
2 = No
1= Yes
2 = No
1= Yes
2 = No
REMEMBER: OTHER MILKS INCLUDE COMMERCIAL FORMULA MILK, FRESH ANIMAL MILK, TINNED OR POWDERED MILK,
FERMENTED OR SOUR MILK, YOGHURT, YOGGIE, CHAMBIKO AND CHEESE
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Part H: Problems, Healthcare-seeking and Treatment – Baby
16.1 Has your baby been sick or had any serious problems, including problems to do with feeding? 1 = Yes
2 = No ------------ ( Q17.1)
Now I would like to ask you about ALL the problems your baby has had
16.2
What was the
first/next problem
(NAME) had?
PROBE FOR MORE
PROBLEMS
16.3
Did you
consult
anybody?
16.4
If NO, why not?
SKIP TO NEXT
PROBLEM AT
Q16.2
16.5
If YES, who was
the first/next
person you
consulted?
16.6
What did the
person you
consulted do?
WRITE ALL THAT
APPLY
16.7
Did you have to
ask permission
from anyone
before you could
go there? If YES,
who?
16.8
How long was it
from the start of
the illness until
(NAME) received
treatment?
16.9
Did you go to anyone else for
help for (NAME)? If YES,
were you referred or did you
go of your own accord?
16.10
Did you
go?
16.11
If NO, why
not?
1 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
2 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
3 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
4 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
5 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
6 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
1 = Yes
16.5
2 = No
16.2 (SKIP
TO NEXT
PROBLEM)
1 = Sing’anga
2 = TBA
3 = HSA
4 = Health worker
in Mchinji
5 = Health worker
outside Mchinji
6 = Grandmother
7 = Other relative
8 = Other (specify)
1 = No
2 = Husband
3 = Mother
4 = Father
5 = Mother-in-law
6 = Other relative
7 = Other
(specify)
1 = Didn’t go Q16.2 (SKIP
TO NEXT PROBLEM)
2 = Went without referral
Q16.5 (START A NEW LINE)
3 = Was referred Q16.10
1 = Yes
2 = No
IF YES,
START
AT Q16.5
WITH A
NEW
LINE
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Illness in Infant
17.1 Has the baby had a cough? 1 = Yes
2 = No Q17.3
17.2 How many days continuously did the cough last? |__|__| days
17.3 Has the baby had any fast breathing for more than 6 hours? 1 = Yes
2 = No
17.4 Has the baby had chest recession? 1 = Yes
2 = No
17.5 Has the baby had difficulty in feeding? 1 = Yes
2 = No
17.6 Has the baby had diarrhoea more than 3 times a day? 1 = Yes
2 = No Q17.9
17.7 For how many days did the diarrhoea last? |__|__| days
17.8 Was there mucus, pus or blood in the stool? 1 = None present
2 = Mucus
3 = Pus
4 = Blood
17.9 Did the baby vomit repeatedly?
THIS DOES NOT INCLUDE REGURGITATION OF MILK
1 = Yes
2 = No
17.10 Has the baby had a high fever? 1 = Yes
2 = No Q17.12
17.11 How many days did the fever last? |__|__| days
17.12 Has the baby had any infection of the umbilical cord?
PROBE ABOUT REDNESS OF DISCHARGE AROUND THE STUMP
1 = Yes
2 = No
17.13 Has the baby had jaundice? 1 = Yes
2 = No
RECORD TIME FINISHED INTERVIEW: __ __ : __ __
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On arriving at the respondent’s house – GREET THE RESPONDENT AND OFFER CONDOLENCES. ASK FOR A PRIVATE PLACE TO SIT
AND CHAT, AWAY FROM OTHER PEOPLE. ASK THE RESPONDENT TO BRING HER HEALTH PASSPORT, IF SHE HAS ONE. CHAT A
LITTLE BIT, TO HELP THE RESPONDENT TO FEEL RELAXED.
Consent – My name is ______________. I am working with MaiMwana Project. MaiMwana is trying to improve the health of mothers and babies
in Mchinji. We are doing a survey of women who have recently given birth, in order to learn about their experiences. The purpose of this interview
is to try and understand why your baby died, so that we can help to prevent other babies from dying in future. I am sorry that I am going to remind
you about the death of your baby. I hope you will allow me to talk about it.
We assure you that everything you tell us will be kept confidential, and will only be used for study purposes. You do not have to take part in this
research if you do not want to. If you do not wish to take part, this will not affect your right to take part in other MaiMwana activities in the future. If
there are any questions that you do not want to answer, you do not have to answer them. There are no wrong answers to these questions. We just
want to know about the experiences of pregnant women. If you do not understand a question, please ask me to explain it again.
This interview will take about one hour. Do you agree to take part?
Yes |__|
No |__|
Zone ID: |__|__| Village ID: |__|__| Village name:
Household ID: |__|__|__| Name of head of household:
WCBA ID: |__|__|-|__|__|-|__|__|__|-|__| WCBA name: first/second/alternative
Interviewer ID: |__|__| Date of interview: |__|__|/|__|__|/|__|__| Supervisor’s signature:
Date received in office: |__|__|/|__|__|/|__|__|
Is the mother still alive? 1 = Yes
2 = No
What is the relationship of the respondent to the infant? 1 = Mother
2 = Father
3 = Mother’s relative
4 = Father’s relative
5 = Neighbour
6 = TBA
7 = Other (specify ___________________________)
MAIMWANA PROJECT – PERINATAL VERBAL AUTOPSY
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|__|__|-|__|__|-|__|__|__|-|__| WCBA ID 323
RECORD TIME STARTED INTERVIEW: __ __ : __ __
Part A: Details of the Birth
First I would like you to tell me the details about the birth of this baby
Details of the birth
1.1 What date was the baby born on? Day/ Month/ Year
__ __/__ __/__ __
1.2 What date did the baby die on? Day/ Month/ Year
__ __/__ __/__ __
1.3 Where did your baby die? 1 = At home
2 = On the way to treatment
3 = At a health facility (specify _____________)
4 = At TBA’s house
5 = At sing’anga’s
6 = Other (specify ______________________)
1.4 Was your baby a girl or a boy? 1 = Girl
2 = Boy
3 = Don’t know
1.5 What was the name of your baby?
IF NOT GIVEN WRITE ‘NO NAME’ AND GO TO Q1.6
1.6 Was the baby born at the expected time? 1 = Early
2 = On time
3 = Late
1.7 After how many completed months of pregnancy was the baby born? |__|__| months
1.8 Was the baby one of twins? 1 = Yes
2 = No Q1.10
1.9 Was the baby the first or second born twin? 1 = First
2 = Second
1.10 How big was the baby? 1 = Very large
2 = Average
3 = Very small
4 = Don’t know
1.11 Was the baby weighed at birth?
CHECK HEALTH PASSPORT
1 = Yes
2 = No Q1.13
1.12 How much did the baby weigh?
CHECK HEALTH PASSPORT
|__||__| kg
1.13 Where was the baby born? 1 = Mchinji District Hospital
2 = Kapiri
3 = Kaigwazanga
4 = Kochilira
5 = Mkanda
6 = Guillime
7 = Nkhwazi
8 = Chipumi
9 = Chiwosha
10 = Ludzi
11 = Mikundi
12 = Kapanga
13 = Tembwe
14 = St Gabriel’s
15 = TBA
16 = At home
17 = On the way to health facility
18 = Other (specify ________________)
1.14 Was there a fire, stove or any form of heating in the room? 1 = Yes
2 = No
3 = Don’t know
1.15 Who helped with the delivery? 1 = Doctor/Nurse/Clinical Officer/Midwife
2 = Other health worker
3 = TBA
4 = Relative/friend
5 = Nobody Q1.18
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1.16 Did the person who helped wash his/her hands with soap before the
delivery?
1 = Yes
2 = No
3 = Don’t know
1.17 Did the person who helped wear gloves during the delivery? 1 = Yes
2 = No
3 = Don’t know
1.18 How was the baby delivered? 1 = Normal
2 = TBA/relative/friend pulled the baby or
pushed on the belly
3 = Health worker used forceps
4 = Health worker did a caesarean section
1.19 Which part of the baby came out first? 1 = Head
2 = Buttock
3 = Hand/foot
4 = Cord
5 = Don’t know
Part B: Open History
Verbal autopsy
2.1 We need to understand how and why your baby died. So please tell me the story of how the death came about, including all of the
problems he/she had, from the beginning to the end.
PROBE UNTIL THEY HAVE TOLD YOU EVERYTHING THEY CAN REMEMBER
Perinatal Verbal Autopsy MaiMwana Project
|__|__|-|__|__|-|__|__|__|-|__| WCBA ID 325
Part C: Details of Illnesses Leading to the Death of the Baby
Congenital abnormalities
3.1 Did the baby have any obvious deformity? 1 = Yes
2 = No Q3.7
3.2 Can you describe it for me?
3.3 Did the baby have a very small head? 1 = Yes
2 = No
3.4 Did the baby have a mass or defect on the back of the head or spine 1 = Yes
2 = No
3.5 Did the baby have a cleft lip or palate? 1 = Yes
2 = No
3.6 Did the baby have abnormal arms or legs 1 = Yes
2 = No
Stillbirth or live birth
3.7 Did the baby have bruises or signs of injury? 1 = Yes
2 = No
3 = Don't know
3.8 Was the baby born alive or dead? 1 = Alive 
2 = Dead
Q4.1
3.9 Was the baby still moving when labour started? 1 = Yes
2 = No
3 = Don't know
Q3.12
3.10 When did you last feel the baby moving? |__|__| Days before labour started
|__|__| Hours before labour started
3.11 Do you think that the baby had died before you went into labour? 1 = Yes
2 = No
Q3.15
3.12 Did the baby ever cry, even a little? 1 = Yes
2 = No
Q4.1
3.13 Did the baby ever move, even a little? 1 = Yes
2 = No
Q4.1
3.14 Did the baby ever breathe, even a little? 1 = Yes
2 = No
Q4.1
3.15 Did the baby look like a normal baby, or had the skin and body changed
and become pulpy/puffy/mushy/swollen?
1 = Yes
2 = No
3 = Don't know
3.16 Was anything done to try to help the baby to breathe at birth? 1 = Yes
2 = No
3 = Don't know 
STOP
STOP
3.17 What was done to try to help the baby to breathe? 1 = Stimulation
2 = Mouth to mouth
3 = Mouth to tube or mask
4 = Bag and mask
STOP
STOP
STOP
STOP
THIS IS THE END OF THE INTERVIEW IF THE BABY WAS A STILLBIRTH. IF YOU HAVE NOT SKIPPED TO Q4.1, STOP THE INTERVIEW
HERE AND THANK THE RESPONDENT
Now I would like to ask you some more questions about the illness of the baby before he/she died
Breathing difficulties
4.1 Did the baby cry at birth? 1 = Yes
2 = No
Q4.3
4.2 How long after birth did the baby first cry? 1 = Within 5 minutes
2 = Within 5-30 minutes
3 = More than 30 minutes
4 = Never
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4.3 Was anything done to try to help the baby to breathe at birth? 1 = Yes
2 = No Q4.5
4.4 What was done to try to help the baby to breathe? 1 = Stimulation
2 = Mouth to mouth
3 = Mouth to tube or mask
4 = Bag and mask
4.5 Was the baby sleepy and floppy at the time of birth? 1 = Yes
2 = No
4.6 Did the baby ever have difficulty breathing? 1 = Yes
2 = No Q4.15
4.7 What was the difficulty? 1 = Intermittent breathing
2 = Fast breathing
4.8 When did the difficulty start? 1 = Immediately at birth
2 = Not immediately but within 6 hours
3 = More than 6 hours after birth
4.9 How long did the difficulty continue? |__|__| days
4.10 Did the difficulty continue until the baby died? 1 = Yes
2 = No
4.11 Was there chest indrawing? 1 = Yes
2 = No
4.12 Was there grunting (demonstrate)? 1 = Yes
2 = No
4.13 Was there nostril flaring (demonstrate)? 1 = Yes
2 = No
4.14 Did the baby have pneumonia? 1 = Yes
2 = No
Difficulty feeding
4.15 Did the baby ever suckle normally? 1 = Yes
2 = No Q4.20
4.16 Did the baby always suckle normally? 1 = Yes
2 = No
Q4.20
4.17 When did the problem start? 1 = On the day he/she was born
2 = After the day of birth but in the first 3 days
3 = After the first 3 days
4.18 How long did the problem continue? |__|__| days
4.19 Did the feeding problem continue until the baby died? 1 = Yes
2 = No
Tetanus
4.20 Could the baby open her mouth? 1 = Yes
2 = No
4.21 Did the baby arch her back and have spasms?
show photo
1 = Yes
2 = No
4.22 Did the baby have tetanus? 1 = Yes
2 = No
Diarrhoea
4.23 Did the baby have more frequent liquid stools than usual? 1 = Yes
2 = No
4.24 Did the baby have diarrhoea? 1 = Yes
2 = No Q4.27
4.25 Was there blood in the stool? 1 = Yes
2 = No
4.26 How long did the diarrhoea continue? |__|__| days
4.27 Did the baby vomit everything? 1 = Yes
2 = No
Other illness
4.28 Did the baby have a fever? 1 = Yes
2 = No Q4.31
4.29 When did the fever start |__|__| days after birth
4.30 How long did the fever continue? |__|__| days
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4.31 Were the baby's skin and eyes very yellow? 1 = Yes
2 = No
4.32 Did the baby have any fits/convulsions/seizures? 1 = Yes
2 = No Q4.34
4.33 On which day of life? 1 = First day
2 = After first day
4.34 Did the baby feel cold? 1 = Yes
2 = No Q4.37
4.35 When did the baby start feeling cold? |__| days
4.36 How long did the baby feel cold? |__|__| days
|__|__| hours
4.37 Did the baby have pustules on the skin? 1 = Yes
2 = No
4.38 Did the baby have ear discharge? 1 = Yes
2 = No
4.39 Did the baby have red eyes with pus in them? 1 = Yes
2 = No
4.40 Did the baby have a bright red ring on the skin around the umbilical cord
stump?
1 = Yes
2 = No
4.41 Did the baby bleed? 1 = Yes
2 = No Q4.43
4.42 Where did the baby bleed from?
4.43 What did the baby's fontanelle look like? 1 = Sunken down
2 = Normal
3 = Bulging up
4.44 Did the baby become drowsy and unconscious when he/she had been
normal before?
1 = Yes
2 = No
4.45 How long was the baby ill before he/she died? |__|__| days
4.46 Did the baby die suddenly without any sign of illness? 1 = Yes
2 = No
4.47 Did the baby have some other problem that we haven't discussed? 1 = Yes
2 = No Q5.1
4.48 What was the problem?
Part C: The Newborn Baby
Now I would like to ask you some details about how you looked after the baby after he/she was born
Newborn care
5.1 What was the cord cut with?
5.2 What was the cord tied with?
5.3 What substances were put on the cord stump after it was cut?
5.4 How long after birth was (NAME) wrapped up? |__|__| hours |__|__| minutes
5.5 How long after the birth was (NAME) bathed? |__|__| hours |__|__| minutes
5.6 What was the first thing the baby swallowed after he/she was born?
5.7 Did (NAME) have a BCG immunisation?
CHECK HEALTH PASSPORT IF AVAILABLE
1 = Yes
2 = No
5.8 Did (NAME) have oral polio vaccine?
CHECK HEALTH PASSPORT IF AVAILABLE
1 = Yes
2 = No
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Post-natal Check-up
6.1 After the baby was born, did a health professional or a traditional birth
attendant check on your or your baby’s health?
THIS DOES NOT INCLUDE CHECKS MADE BY HEALTH WORKERS
IMMEDIATELY AFTER A DELIVERY AT A HEALTH FACILITY
1 = Yes
2 = No Q6.6
6.2 How many days after delivery did the first check take place? |__|__| days
6.3 Why did you go? 1 = Normal check-up
2 = Problem for mother
3 = Problem for baby
6.4 Where did this first check take place?
FOR OUTREACH SPECIFY WHERE THE OUTREACH WAS, NOT THE
HEALTH FACILITY THAT IT CAME FROM
1 = Mchinji District Hospital
2 = Kapiri
3 = Kaigwazanga
4 = Kochilira
5 = Mkanda
6 = Guillime
7 = Nkhwazi
8 = Chipumi
9 = Chiwosha
10 = Ludzi
11 = Mikundi
12 = Kapanga
13 = Tembwe
14 = St Gabriel’s
15 = TBA
16 = Outreach (specify _________________)
17 = Other (specify ____________________)
6.5 Since the delivery, have you received a dose of Vitamin A?
SHOW VITAMIN A TABLET
1 = Yes
2 = No 
Q7.1
Q7.1
6.6 Why was there not a check?
Now I would like you to tell me about how you fed your baby
Breastfeeding
7.1 Did you ever breastfeed (NAME)? 1 = Yes
2 = No
3 = Baby died immediately, before it could be
given anything
Q7.3
Q9.1
7.2 How long after birth did you first breastfeed the baby/put (NAME) to the
breast?
|__|__| hours |__|__| minutes
7.3 What did you give (NAME) to drink in the first three days after delivery,
before your milk began flowing regularly?
PROBE ‘Anything else?’
RECORD ALL FOODS/DRINKS MENTIONED
IF BREAST MILK ONLY, GO TO Q7.5
7.4 Why did you give these things?
7.5 Did (NAME) drink any pharmaceutical medicine after he/she was born?
INCLUDE LIQUID MEDICINES AND LIQUID VITAMINS OR MINERALS
AND COMMERCIAL GRIPE WATER
1 = Yes (specify _______________________)
2 = No Q7.8
7.6 What was the medicine for?
7.7 How many times did (NAME) drink pharmaceutical medicine? |__|__| times
7.8 Did (NAME) drink any traditional medicine after he/she was born? 1 = Yes (specify _______________________)
2 = No Q7.11
7.9 What was the medicine for?
7.10 How many times did (NAME) drink traditional medicine? |__|__| times
7.11 Did (NAME) drink any water after he/she was born? 1 = Yes
2 = No Q7.13
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7.12 How many times did (NAME) drink water? 1 = Only on the first day
2 = On some days
3 = Every day
4 = Other (specify) _____________________
7.13 Were you still breastfeeding (NAME), until the day he/she died? 1 = Yes
2 = No
Q7.15
7.14 Why did you stop breastfeeding?
7.15 Did you have any problems with breastfeeding? 1 = Yes
2 = No Q7.20
7.16 What were they?
7.17 Did you go, or were you referred to a health facility because of these
problems?
1 = Went without referral
2 = Was referred
3 = Didn’t go
7.18 Did you change the way you fed your baby during the time you had breast
problems?
1 = Yes
2 = No Q7.20
7.19 What did you do differently?
WRITE ALL CHANGES MENTIONED
7.20 Did you change the way you fed your baby at any time the time when you
or your baby were sick after the delivery?
1 = No
2 = Yes, when I was sick
3 = Yes, when the baby was sick
4 = Yes, for another reason (specify
_____________________________________)
Q7.22
7.21 What did you do differently?
WRITE ALL CHANGES MENTIONED
7.22 Did anyone else (beside yourself) ever breastfed (NAME)? 1 = Yes
2 = No
3 = Don’t know 
Q7.24
Q7.24
7.23 Why did the other person breastfeed (NAME)?
7.24 Did you ever express your breast milk after (NAME) was born? 1 = Yes
2 = No Q8.1
7.25 Did you give the expressed breast milk to (NAME)? 1 = Yes
2 = No Q7.27
7.26 How did you give the milk to (NAME)? 1 = Cup
2 = Bottle
3 = Other (specify _____________________)
7.27 Did you heat-treat your breast milk? 1 = Yes
2 = No
7.28 Why did you express milk?
7.29 Who explained to you how to express the milk? 1 = Health worker
2 = Sister
3 = Mother
4 = Other family member
5 = Neighbour
6 = MaiMwana IF counsellor
7 = Other (specify _____________________)
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Feeding recall
Now I would like you to tell me the details about how you fed (NAME)
First I’m going to ask you about all the things
(NAME) drank during the first week after birth
IF THE BABY DIED WITHIN 7 DAYS
AFTER BIRTH, GO TO Q9.1
Now I want to ask you about all the
things (NAME) drank in the last 7 days
before he/she died
8.1 8.2 8.3 8.4 8.5
Before you
gave any
breast milk,
was (NAME)
given…
On the day
he/she was
born, was
(NAME)
given…
Between day 2
and day 7 after
(NAME) was
born, was
he/she given…
On the day before
(NAME) died, was
he/she given…
Apart from the day
before (NAME)
died, in the last
week, was he/she
given…
01 Breast milk?
02 Other milks?
03 Water/dawale?
04 Home-made gripe water/rice
water/mzuwa?
05 Phala?
06 Other foods or drinks (specify)?
07 Traditional medicines
08 Pharmaceutical medicines
09 Unsure of other foods or drinks given
1= Yes
2 = No
3 = Baby died
4 = Don’t
know
1= Yes
2 = No
3 = Baby died
4 = Don’t
know
1= Yes
2 = No
3 = Baby died
4 = Don’t know
1= Yes
2 = No
3 = Baby died
4 = Don’t know
1= Yes
2 = No
3 = Baby died
4 = Don’t know
REMEMBER: OTHER milks Include COMMERCIAL FORMULA MILK, fresh animal milk, tinned or powdered milk, fermented or sour milk, yoghurt,
cheese, and all other milk from a cow or other animal
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Part H: Problems, Healthcare-seeking and Treatment – Baby
Now I would like to ask you about any help you sought for the problems (NAME) had, that we talked about earlier
9.1
What was the
first/next problem
(NAME) had?
CONTINUE UNTIL
YOU HAVE
COVERED ALL OF
THE PROBLEMS
MENTIONED IN
PART 4
9.2
Did you
consult
anybody?
9.3
If NO, why not?
SKIP TO NEXT
PROBLEM AT
Q9.1
9.4
If YES, who was
the first/next
person you
consulted?
9.5
What did the person
you consulted do?
WRITE ALL THAT
APPLY
9.6
Did you have to
ask permission
from anyone
before you could
go there? If
YES, who?
9.7
How long was it
from the start of
the illness until
(NAME) received
treatment?
9.8
Did you go to anyone else
for help for (NAME)? If
YES, were you referred or
did you go of your own
accord?
9.9
Did you
go?
9.10
If NO, why not?
1 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
2 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
3 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
4 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
5 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
6 |__| |__| |__| |__|__| days
|__|__| hours
|__| |__|
1 = Yes 9.4
2 = No
1 = Sing’anga
2 = TBA
3 = HSA
4 = Health worker in
Mchinji
5 = Health worker
outside Mchinji
6 = Grandmother
7 = Other relative
8 = Other (specify)
1 = No
2 = Husband
3 = Mother
4 = Father
5 = Mother-in-law
6 = Other relative
7 = Other (specify)
1 = Didn’t go Q9.1 (SKIP TO
NEXT PROBLEM)
2 = Went without referral
Q9.4 (START A NEW LINE)
3 = Was referred Q9.9
1 = Yes
2 = No
IF YES,
START AT
Q9.4 WITH
A NEW
LINE
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RECORD TIME FNISHED INTERVIEW: __ __ : __ __
This is the end of the interview…
This is the end of the interview. Thank you for sharing with us the details of the recent death of your baby. We hope that we will be able to learn
from your experiences and help other mothers and babies in Mchinji in the future.
Feedback from the interviewer…
Apart from the respondent, did anyone else help to answer
the questions in the interview?
1 = Father of the baby
2 = Grandmother of the baby
3 = Relative of the mother of the baby
4 = Relative of the father of the baby
5 = Friend/neighbour of the mother of the baby
6 = TBA
7 = Other (specify
__________________________________________________)
Was the interview interrupted at all?
(Explain what happened)
Were there any other people around during the interview?
(Specify who)
Were there any questions that the respondent had problems
answering?
(Explain)
Were there any questions that the respondent seemed to be
holding back information on?
(Explain why if possible)
Any other comments
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Appendix 5 – Letter of ethical approval from Malawi National Health
Sciences Research Committee
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Appendix 6 – Intra-cluster correlation coefficients and intercluster
coefficients of variation
Intracluster correlation coefficients and intercluster coefficients of variation for primary and secondary
outcomes
Intra-cluster correlation coefficient (SE) Intercluster coefficient of variation (SE)
All clusters
(48)
Control
clusters (24)
True control
clusters (12)
All clusters
(48)
Control
clusters (24)
True control
clusters (12)
Stillbirth rate
per 1000 births
0.0014
(0.0008)
<0.00001
(0.00074)
<0.00001
(0.0010) 0.264 <0.02 <0.02
Perinatal mortality rate
per 1000 births
0.0050
(0.0016)
0.0031
(0.0017)
0.00076
(0.0014) 0.368 0.297 0.140
Early neonatal mortality rate
per 1000 live births
0.0058
(0.0017)
0.0054
(0.0024)
0.0036
(0.0026) 0.580 0.561 0.426
Late neonatal mortality rate
per 1000 live births
0.00081
(0.00071)
0.0010
(0.0011)
0.0010
(0.0015) 0.347 0.392 0.357
Neonatal mortality rate
per 1000 live births
0.0049
(0.0016)
0.0058
(0.0025)
0.0027
(0.0022) 0.449 0.491 0.309
Infant mortality rate
per 1000 live births
0.0096
(0.0029)
0.015
(0.0056)
0.022
(0.011) 0.467 0.581 0.656
Maternal mortality ratio
per 100,000 live births
<0.00001
(0.00054)
<0.00001
(0.00075)
0.00060
(0.0013) <0.05 <0.05 0.349
Antenatal care attendance
(%)
0.037
(0.0079)
0.032
(0.0099)
0.019
(0.0065) 0.044 0.043 0.056
Received any tetanus toxoid
vaccine (%)
0.047
(0.0098)
0.051
(0.015)
0.049
(0.021) 0.089 0.101 0.108
Received any SP
(%)
0.030
(0.0066)
0.021
(0.0069)
0.027
(0.013) 0.048 0.041 0.050
Always used bednet during
pregnancy (%)
0.095
(0.018)
0.11
(0.031)
0.080
(0.033) 0.281 0.309 0.279
Maternal morbidity (antenatal
problem) (%)
0.14
(0.026)
0.19
(0.047)
0.19
(0.068) 0.501 0.586 0.579
Maternal morbidity (delivery
problem (%)
0.027
(0.0059)
0.028
(0.0088)
0.031
(0.014) 0.494 0.501 0.534
Maternal morbidity (postnatal
problem) (%)
0.082
(0.016)
0.092
(0.026)
0.088
(0.036) 0.636 0.716 0.718
Skilled birth attendance
(%)
0.12
(0.02)
0.13
(0.03)
0.16
(0.06) 0.348 0.352 0.449
Postnatal care attendance
(%)
0.17
(0.03)
0.19
(0.05)
0.24
(0.08) 0.520 0.544 0.691
Infant morbidity (cough)
(%)
0.10
(0.02)
0.11
(0.03)
0.12
(0.05) 0.523 0.549 0.497
Infant morbidity (fever)
(%)
0.06
(0.01)
0.06
(0.02)
0.06
(0.03) 0.485 0.487 0.443
Infant morbidity (diarrhoea)
(%)
0.008
(0.002)
0.011
(0.004)
0.009
(0.005) 0.695 0.870 0.648
Exclusive breastfeeding to 6m
(%)
0.14
(0.027)
0.08
(0.025)
0.04
(0.021) 0.909 0.798 0.641
Ever attending women’s group
(%)
0.41
(0.051)
0.09
(0.025)*
0.07
(0.030)** 1.048 0.281 0.265
*Women’s group areas and women’s group plus infant feeding areas
**Women’s group only areas
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Appendix 7 – Interaction plots for primary mortality outcomes
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